Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
2435 714 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
395 714 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
520 714 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
5386 714 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
CHEMBL844 714 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
DB00484 714 98 None 1 8 Human 9.2 pEC50 = 9.2 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
521 1377 64 None -4 4 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
5311068 1377 64 None -4 4 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
835 1377 64 None -4 4 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
CHEMBL778 1377 64 None -4 4 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
DB00633 1377 64 None -4 4 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
2435 714 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 714 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 714 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 714 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 714 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 714 98 None 1 8 Human 9.1 pEC50 = 9.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
218362 203092 5 None 1 3 Human 8.9 pEC50 = 8.9 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 203092 5 None 1 3 Human 8.9 pEC50 = 8.9 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
185076 186507 4 None 11 3 Human 8.9 pEC50 = 8.9 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL49137 186507 4 None 11 3 Human 8.9 pEC50 = 8.9 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
521 1377 64 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1016/j.bmc.2010.11.020
5311068 1377 64 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1016/j.bmc.2010.11.020
835 1377 64 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1016/j.bmc.2010.11.020
CHEMBL778 1377 64 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1016/j.bmc.2010.11.020
DB00633 1377 64 None -4 4 Human 8.8 pEC50 = 8.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1016/j.bmc.2010.11.020
44314198 103933 0 None 2 3 Human 8.8 pEC50 = 8.8 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 103933 0 None 2 3 Human 8.8 pEC50 = 8.8 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
9815707 100999 0 None 2 3 Human 8.8 pEC50 = 8.8 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297752 100999 0 None 2 3 Human 8.8 pEC50 = 8.8 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
2803 941 53 None -5 11 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 941 53 None -5 11 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 941 53 None -5 11 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 941 53 None -5 11 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 941 53 None -5 11 Human 8.0 pEC50 = 8 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
44292232 100851 0 None 1 3 Human 8.0 pEC50 = 8.0 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL296660 100851 0 None 1 3 Human 8.0 pEC50 = 8.0 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
11140345 202470 0 None -12 5 Human 7.0 pEC50 = 7 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 202470 0 None -12 5 Human 7.0 pEC50 = 7 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
24906200 192553 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 328 5 1 3 4.5 c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
CHEMBL523048 192553 0 None -1 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 328 5 1 3 4.5 c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
11211035 84579 0 None -1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL223836 84579 0 None -1 2 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm0408215
11211035 84579 0 None -1 2 Human 7.0 pEC50 = 7.0 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm061487a
CHEMBL223836 84579 0 None -1 2 Human 7.0 pEC50 = 7.0 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm061487a
10382537 202465 11 None 4 2 Human 7.9 pEC50 = 7.9 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL70676 202465 11 None 4 2 Human 7.9 pEC50 = 7.9 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
44371864 50868 0 None 2 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL157955 50868 0 None 2 3 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
1960 2815 64 None -26 13 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2010.11.020
439260 2815 64 None -26 13 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2010.11.020
505 2815 64 None -26 13 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2010.11.020
CHEMBL1437 2815 64 None -26 13 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2010.11.020
DB00368 2815 64 None -26 13 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2010.11.020
44352207 18668 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL128168 18668 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
44352207 18668 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL128168 18668 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
44352207 18668 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL128168 18668 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
44352207 18668 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL128168 18668 1 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
1960 2815 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2011.11.025
439260 2815 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2011.11.025
505 2815 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2011.11.025
CHEMBL1437 2815 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2011.11.025
DB00368 2815 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.bmc.2011.11.025
9859437 167459 0 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
CHEMBL432155 167459 0 None -1 3 Human 6.9 pEC50 = 6.9 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
1960 2815 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.ejmech.2014.09.083
439260 2815 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.ejmech.2014.09.083
505 2815 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.ejmech.2014.09.083
CHEMBL1437 2815 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.ejmech.2014.09.083
DB00368 2815 64 None -26 13 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1016/j.ejmech.2014.09.083
50994258 59773 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 215 1 3 2 1.1 Cc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1641682 59773 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 215 1 3 2 1.1 Cc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1739118 59773 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 215 1 3 2 1.1 Cc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
53323136 56283 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 2 3 1.0 Clc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1641690 56283 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 2 3 1.0 Clc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
44312036 202859 0 None -19 2 Human 4.8 pEC50 = 4.8 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 305 1 2 5 2.2 CC1CN=C(Nc2ccc3nccnc3c2Br)N1 10.1016/0960-894X(95)00391-6
CHEMBL72995 202859 0 None -19 2 Human 4.8 pEC50 = 4.8 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 305 1 2 5 2.2 CC1CN=C(Nc2ccc3nccnc3c2Br)N1 10.1016/0960-894X(95)00391-6
24882007 12367 1 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.bmc.2010.11.020
CHEMBL1186220 12367 1 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.bmc.2010.11.020
56950526 71164 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 234 2 1 4 1.7 Clc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
CHEMBL1928323 71164 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 234 2 1 4 1.7 Clc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
CHEMBL1962709 71164 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 234 2 1 4 1.7 Clc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
57400570 71158 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 214 2 1 4 1.3 Cc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
CHEMBL1928322 71158 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 214 2 1 4 1.3 Cc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
CHEMBL1962686 71158 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 214 2 1 4 1.3 Cc1cccc2cnn(CC3=NCCN3)c12 10.1016/j.bmc.2011.11.025
44371755 48513 0 None 1 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL155866 48513 0 None 1 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
24882106 12459 2 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 2 3 1.0 Clc1cccc2c1cnn2N=C1NCCN1 10.1016/j.bmc.2010.11.020
CHEMBL1186774 12459 2 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 2 3 1.0 Clc1cccc2c1cnn2N=C1NCCN1 10.1016/j.bmc.2010.11.020
118717249 114627 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 219 1 2 3 0.5 Fc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.ejmech.2014.09.083
CHEMBL3343700 114627 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 219 1 2 3 0.5 Fc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.ejmech.2014.09.083
11098175 202469 0 None -186 4 Human 6.7 pEC50 = 6.7 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 202469 0 None -186 4 Human 6.7 pEC50 = 6.7 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
135399666 168198 4 None -23 6 Human 5.7 pEC50 = 5.7 Functional
Activity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assayActivity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assay
ChEMBL 191 2 2 4 1.1 C[C@@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
CHEMBL437314 168198 4 None -23 6 Human 5.7 pEC50 = 5.7 Functional
Activity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assayActivity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assay
ChEMBL 191 2 2 4 1.1 C[C@@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
3086326 202826 17 None 13 3 Human 8.6 pEC50 = 8.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL72753 202826 17 None 13 3 Human 8.6 pEC50 = 8.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
131829 203020 11 None 37 3 Human 8.6 pEC50 = 8.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
CHEMBL74283 203020 11 None 37 3 Human 8.6 pEC50 = 8.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
44314200 102479 0 None -9 3 Human 6.6 pEC50 = 6.6 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 102479 0 None -9 3 Human 6.6 pEC50 = 6.6 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
53324490 59776 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1641681 59776 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1739173 59776 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2[nH]nc(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
10934575 202781 0 None -229 5 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 202781 0 None -229 5 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
11140347 202828 0 None -13 5 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 202828 0 None -13 5 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
11000184 12941 0 None -74 5 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 12941 0 None -74 5 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 12941 0 None -74 5 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
11173568 84218 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 281 4 2 4 2.7 CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL222371 84218 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 281 4 2 4 2.7 CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1 10.1021/jm0408215
135453290 133083 23 None -1318 7 Human 5.6 pEC50 = 5.6 Functional
Activity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assayActivity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assay
ChEMBL 191 2 2 4 1.1 C[C@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
CHEMBL371300 133083 23 None -1318 7 Human 5.6 pEC50 = 5.6 Functional
Activity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assayActivity at adrenergic alpha2A receptor expressed in human clonic adenocarcinoma HT29 cell by tissue contraction assay
ChEMBL 191 2 2 4 1.1 C[C@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
44449277 154644 2 None 1 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 214 2 1 2 2.5 COc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL402388 154644 2 None 1 2 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 214 2 1 2 2.5 COc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
68712 99874 57 None -1 4 Human 6.6 pEC50 = 6.6 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 99874 57 None -1 4 Human 6.6 pEC50 = 6.6 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
44312037 202913 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73392 202913 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
2803 941 53 None -5 11 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2010.11.020
516 941 53 None -5 11 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2010.11.020
704 941 53 None -5 11 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2010.11.020
CHEMBL134 941 53 None -5 11 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2010.11.020
DB00575 941 53 None -5 11 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2010.11.020
11043720 91740 0 None -257 3 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL242265 91740 0 None -257 3 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
11043720 91740 0 None -257 3 Human 4.5 pEC50 = 4.5 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL242265 91740 0 None -257 3 Human 4.5 pEC50 = 4.5 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
124 2933 44 None -4 21 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 2933 44 None -4 21 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 2933 44 None -4 21 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 2933 44 None -4 21 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 2933 44 None -4 21 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2803 941 53 None -5 11 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2011.11.025
516 941 53 None -5 11 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2011.11.025
704 941 53 None -5 11 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2011.11.025
CHEMBL134 941 53 None -5 11 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2011.11.025
DB00575 941 53 None -5 11 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2011.11.025
2146 3051 63 None -52 10 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
485 3051 63 None -52 10 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
6041 3051 63 None -52 10 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
CHEMBL1215 3051 63 None -52 10 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
DB00388 3051 63 None -52 10 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
57402718 70845 2 None 3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956201 70845 2 None 3 3 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
11265631 135886 0 None -9 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
CHEMBL373535 135886 0 None -9 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
11097789 102524 0 None -52 5 Human 6.5 pEC50 = 6.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 102524 0 None -52 5 Human 6.5 pEC50 = 6.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
11265631 135886 0 None -9 3 Human 6.5 pEC50 = 6.5 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
CHEMBL373535 135886 0 None -9 3 Human 6.5 pEC50 = 6.5 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
49836306 18388 0 None -31 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276247 18388 0 None -31 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
44449247 94970 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 228 2 1 2 2.8 COc1c(C)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL256984 94970 0 None -1 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 228 2 1 2 2.8 COc1c(C)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
9817256 202536 0 None -251 2 Human 5.5 pEC50 = 5.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71001 202536 0 None -251 2 Human 5.5 pEC50 = 5.5 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
9971924 183644 0 None 1 2 Human 7.5 pEC50 = 7.5 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 298 5 1 3 3.4 c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL48341 183644 0 None 1 2 Human 7.5 pEC50 = 7.5 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 298 5 1 3 3.4 c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
44421258 84322 0 None -1 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL1204386 84322 0 None -1 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL222933 84322 0 None -1 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
24882019 12461 2 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 215 1 2 3 0.7 Cc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
CHEMBL1186788 12461 2 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 215 1 2 3 0.7 Cc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.bmc.2010.11.020
1960 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
439260 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
505 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
CHEMBL1437 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
DB00368 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
1960 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm901262f
439260 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm901262f
505 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm901262f
CHEMBL1437 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm901262f
DB00368 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm901262f
1960 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
439260 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
505 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
CHEMBL1437 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
DB00368 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
1960 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
439260 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
505 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
CHEMBL1437 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
DB00368 2815 64 None -26 13 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
294234 102420 3 None 2 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 102420 3 None 2 3 Human 7.4 pEC50 = 7.4 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
118717248 114626 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 219 1 2 3 0.5 Fc1ccc2cnn(N=C3NCCN3)c2c1 10.1016/j.ejmech.2014.09.083
CHEMBL3343699 114626 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 219 1 2 3 0.5 Fc1ccc2cnn(N=C3NCCN3)c2c1 10.1016/j.ejmech.2014.09.083
11140033 20483 0 None -4 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL130884 20483 0 None -4 3 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
11108001 10771 2 None -7 5 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2aAgonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2a
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 10771 2 None -7 5 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2aAgonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2a
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 10771 2 None -7 5 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2aAgonist potency at Alpha-2A adrenergic receptor assayed in CHO cells expressing human alpha 2a
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
2435 714 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
395 714 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
520 714 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
5386 714 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
CHEMBL844 714 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
DB00484 714 98 None 1 8 Human 8.4 pEC50 = 8.4 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
11360447 84577 0 None 1 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
CHEMBL223829 84577 0 None 1 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
10859076 13570 0 None -83 4 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 13570 0 None -83 4 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 13570 0 None -83 4 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-2A adrenergic receptor expressed in CHO cellsAgonist potency at Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
44449276 95207 0 None -1 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 241 2 2 2 1.8 CNC(=O)c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257976 95207 0 None -1 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 241 2 2 2 1.8 CNC(=O)c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
11098175 202469 0 None -186 4 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 202469 0 None -186 4 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
57391904 71137 2 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 200 2 1 4 1.0 c1ccc2c(c1)cnn2CC1=NCCN1 10.1016/j.bmc.2011.11.025
CHEMBL1928316 71137 2 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 200 2 1 4 1.0 c1ccc2c(c1)cnn2CC1=NCCN1 10.1016/j.bmc.2011.11.025
CHEMBL1962472 71137 2 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation countingAgonist activity at human adrenoceptor alpha2A expressed in CHOK1 cells assessed as stimulation of agonist-induced [35S]GTPgammaS binding by scintillation counting
ChEMBL 200 2 1 4 1.0 c1ccc2c(c1)cnn2CC1=NCCN1 10.1016/j.bmc.2011.11.025
44449691 95715 0 None -2 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 261 2 1 2 3.6 c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1 10.1016/j.bmcl.2008.03.070
CHEMBL260576 95715 0 None -2 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 261 2 1 2 3.6 c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1 10.1016/j.bmcl.2008.03.070
24906159 186822 12 None -3 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
CHEMBL493675 186822 12 None -3 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
57400959 70844 0 None -1 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956200 70844 0 None -1 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
11265631 135886 0 None -9 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
CHEMBL373535 135886 0 None -9 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
1593 2308 60 None -4 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
30668 2308 60 None -4 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
9868 2308 60 None -4 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
CHEMBL17860 2308 60 None -4 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
DB04948 2308 60 None -4 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
11109088 202479 0 None -14 5 Human 8.2 pEC50 = 8.2 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 202479 0 None -14 5 Human 8.2 pEC50 = 8.2 Functional
Agonist potency at Alpha-2A stably expressed in CHO cells.Agonist potency at Alpha-2A stably expressed in CHO cells.
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
57395731 70846 0 None 3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956202 70846 0 None 3 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2A expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
49836305 18389 0 None -9 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276248 18389 0 None -9 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
24906199 187082 12 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL495096 187082 12 None -6 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
44292386 101012 0 None -35 2 Human 7.2 pEC50 = 7.2 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 296 4 1 3 3.5 C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297827 101012 0 None -35 2 Human 7.2 pEC50 = 7.2 Functional
Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 296 4 1 3 3.5 C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
17804479 95216 16 None -1 4 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 198 1 1 1 2.9 c1ccc2c(c1)CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL258007 95216 16 None -1 4 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assayAgonist activity at human cloned adrenergic alpha-2A receptor expressed in CHOK1 cells by beta-lactamase reporter gene assay
ChEMBL 198 1 1 1 2.9 c1ccc2c(c1)CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
50994260 59775 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2c(N=C3NCCN3)n[nH]c12 10.1016/j.bmc.2010.11.020
CHEMBL1641689 59775 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2c(N=C3NCCN3)n[nH]c12 10.1016/j.bmc.2010.11.020
CHEMBL1739136 59775 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 235 1 3 2 1.4 Clc1cccc2c(N=C3NCCN3)n[nH]c12 10.1016/j.bmc.2010.11.020
10333157 150706 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL396013 150706 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
10333157 150706 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL396013 150706 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2A receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
11371902 141106 0 None 1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm0408215
CHEMBL385310 141106 0 None 1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2A receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm0408215
11371902 141106 0 None 1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL385310 141106 0 None 1 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
23622576 172203 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL451229 172203 0 None -3 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidificationAgonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as stimulation of extracellular acidification
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
2803 941 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 941 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 941 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 941 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 941 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2A adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
2803 941 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
516 941 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
704 941 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
CHEMBL134 941 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
DB00575 941 53 None -5 11 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2A adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
10176999 103079 14 None -1 3 Human 8.1 pEC50 = 8.1 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
CHEMBL308570 103079 14 None -1 3 Human 8.1 pEC50 = 8.1 Functional
Effective concentration at Alpha-2A adrenergic receptor from CHO-C10 cellsEffective concentration at Alpha-2A adrenergic receptor from CHO-C10 cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
53322686 59777 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 201 1 3 2 0.7 c1ccc2c(N=C3NCCN3)n[nH]c2c1 10.1016/j.bmc.2010.11.020
CHEMBL1641679 59777 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 201 1 3 2 0.7 c1ccc2c(N=C3NCCN3)n[nH]c2c1 10.1016/j.bmc.2010.11.020
CHEMBL1739201 59777 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
ChEMBL 201 1 3 2 0.7 c1ccc2c(N=C3NCCN3)n[nH]c2c1 10.1016/j.bmc.2010.11.020
15675860 202724 0 None -1 2 Human 6.1 pEC50 = 6.1 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 305 1 2 5 2.1 Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL72147 202724 0 None -1 2 Human 6.1 pEC50 = 6.1 Functional
Alpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphateAlpha-2A adrenergic receptor agonistic potency as inhibition of forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 305 1 2 5 2.1 Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
2683 3774 57 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
5487 3774 57 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
7308 3774 57 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
CHEMBL1079 3774 57 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
DB00697 3774 57 None 1 3 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
24882007 12367 1 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.ejmech.2014.09.083
CHEMBL1186220 12367 1 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assayAgonist activity at human alpha2A adrenoceptor expressed in CHO-K1 cells after 30 mins by [35S]GTPgammaS binding assay
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.ejmech.2014.09.083
132111 102521 5 None - 1 Human 4.9 pIC50 = 4.9 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
CHEMBL306751 102521 5 None - 1 Human 4.9 pIC50 = 4.9 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
132111 102521 5 None - 1 Human 5.9 pIC50 = 5.9 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
CHEMBL306751 102521 5 None - 1 Human 5.9 pIC50 = 5.9 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
123132228 155765 46 None -1 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against alpha2a adrenergic receptor (unknown origin)Antagonist activity against alpha2a adrenergic receptor (unknown origin)
ChEMBL 369 5 1 8 2.4 CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1 10.1021/acs.jmedchem.1c02148
CHEMBL4065484 155765 46 None -1 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against alpha2a adrenergic receptor (unknown origin)Antagonist activity against alpha2a adrenergic receptor (unknown origin)
ChEMBL 369 5 1 8 2.4 CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1 10.1021/acs.jmedchem.1c02148
11820372 13379 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 208 2 1 1 3.2 c1ccc2c(Cc3c[nH]cn3)cccc2c1 10.1021/jm00041a011
CHEMBL1193371 13379 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 208 2 1 1 3.2 c1ccc2c(Cc3c[nH]cn3)cccc2c1 10.1021/jm00041a011
CHEMBL544765 13379 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 208 2 1 1 3.2 c1ccc2c(Cc3c[nH]cn3)cccc2c1 10.1021/jm00041a011
68602 203416 72 None - 1 Human 5.5 pIC50 = 5.5 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1021/jm00041a011
CHEMBL77921 203416 72 None - 1 Human 5.5 pIC50 = 5.5 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1021/jm00041a011
10376336 13092 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 224 2 2 2 2.6 OC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
CHEMBL1191106 13092 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 224 2 2 2 2.6 OC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
CHEMBL542155 13092 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 224 2 2 2 2.6 OC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
132111 102521 5 None - 1 Human 5.0 pIC50 = 5.0 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
CHEMBL306751 102521 5 None - 1 Human 5.0 pIC50 = 5.0 Functional
Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.Tested for its ability to antagonize epinephrine induced primary wave aggregation in human platelets at alpha-2A-adrenergic receptor sites.
ChEMBL 222 2 1 1 3.7 CC(c1c[nH]cn1)c1cccc2ccccc12 10.1021/jm00041a011
132256889 189853 0 None -1 2 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against alpha2a adrenergic receptor (unknown origin)Antagonist activity against alpha2a adrenergic receptor (unknown origin)
ChEMBL 378 5 1 7 3.6 COc1cccc(F)c1CNc1ccc(-c2cnc(C)nc2C)c2nncn12 10.1021/acs.jmedchem.1c02148
CHEMBL5178464 189853 0 None -1 2 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity against alpha2a adrenergic receptor (unknown origin)Antagonist activity against alpha2a adrenergic receptor (unknown origin)
ChEMBL 378 5 1 7 3.6 COc1cccc(F)c1CNc1ccc(-c2cnc(C)nc2C)c2nncn12 10.1021/acs.jmedchem.1c02148
CHEMBL4755618 212282 35 None -1 2 Human 5.0 pIC50 = 5.0 Functional
Agonist activity at adrenergic receptor alpha2a (unknown origin)Agonist activity at adrenergic receptor alpha2a (unknown origin)
ChEMBL None None None Cc1ncccc1-c1cnc(NCc2c(F)ccc3c2CCO3)n2cnnc12 10.1021/acs.jmedchem.1c02148
13305910 11731 1 None - 0 Rat 6.9 pKd = 6.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 11731 1 None - 0 Rat 6.9 pKd = 6.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 11731 1 None - 0 Rat 6.9 pKd = 6.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 11731 1 None - 0 Rat 6.9 pKd = 6.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
16121006 11736 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182182 11736 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL217469 11736 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
499 4014 15 None - 1 Rat 6.6 pKd = 6.6 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
5685 4014 15 None - 1 Rat 6.6 pKd = 6.6 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
CHEMBL25554 4014 15 None - 1 Rat 6.6 pKd = 6.6 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
6603808 127000 2 None - 2 Rat 6.3 pKd = 6.3 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 127000 2 None - 2 Rat 6.3 pKd = 6.3 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 127000 2 None - 2 Rat 6.3 pKd = 6.3 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 127000 2 None - 2 Rat 6.3 pKd = 6.3 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
44417713 12316 0 None - 0 Rat 6.2 pKd = 6.2 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1185884 12316 0 None - 0 Rat 6.2 pKd = 6.2 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL439346 12316 0 None - 0 Rat 6.2 pKd = 6.2 Functional
Activity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 2A receptor assessed as antagonism on noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
44324800 205220 0 None - 0 Human 9.1 pKi = 9.1 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL91157 205220 0 None - 0 Human 9.1 pKi = 9.1 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
44324972 162820 0 None - 0 Human 8.9 pKi = 8.9 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL419316 162820 0 None - 0 Human 8.9 pKi = 8.9 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
44579272 186512 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491420 186512 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
10758200 63087 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL179648 63087 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
44579184 190359 4 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL518592 190359 4 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
44579271 186511 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491419 186511 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
44579228 181072 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL477608 181072 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
44404321 69949 0 None - 0 Human 8.4 pKi = 8.4 Functional
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 297 4 1 5 3.0 COc1cccc(N(NC2=NCCO2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL194323 69949 0 None - 0 Human 8.4 pKi = 8.4 Functional
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 297 4 1 5 3.0 COc1cccc(N(NC2=NCCO2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
44579185 181232 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL477816 181232 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
44579230 180962 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
CHEMBL476569 180962 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
44324737 205508 0 None - 0 Human 8.3 pKi = 8.3 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL92860 205508 0 None - 0 Human 8.3 pKi = 8.3 Functional
Binding affinity for alpha-2A-adrenergic receptorBinding affinity for alpha-2A-adrenergic receptor
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1021/jm049619s
44579187 189087 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
CHEMBL515331 189087 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
44579229 189024 0 None - 0 Human 7.1 pKi = 7.1 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL514837 189024 0 None - 0 Human 7.1 pKi = 7.1 Functional
Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
2683 3774 57 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
5487 3774 57 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
7308 3774 57 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
CHEMBL1079 3774 57 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
DB00697 3774 57 None 1 3 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassayAgonist activity at human recombinant alpha-2A receptor expressed in PC12 cells assessed as inhibition of forskolin-stimulated intracellular cAMP accumulation measured after 10 mins by cAMP enzyme immunoassay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
1343 1858 55 None -2 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1858 55 None -2 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1858 55 None -2 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1858 55 None -2 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1858 55 None -2 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
2435 714 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 714 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 714 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 714 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 714 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 714 98 None 1 8 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
521 1377 64 None -4 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 1377 64 None -4 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 1377 64 None -4 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 1377 64 None -4 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 1377 64 None -4 4 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation countingAgonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
2136 3046 29 None 1 4 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
4768 3046 29 None 1 4 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
7268 3046 29 None 1 4 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
CHEMBL753 3046 29 None 1 4 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
DB00925 3046 29 None 1 4 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
176 394 63 None 6 34 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
2157 394 63 None 6 34 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
2566 394 63 None 6 34 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
CHEMBL633 394 63 None 6 34 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
DB01118 394 63 None 6 34 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
1816 2504 99 None -1 5 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
4205 2504 99 None -1 5 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
7241 2504 99 None -1 5 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
CHEMBL654 2504 99 None -1 5 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
DB00370 2504 99 None -1 5 Human 7.1 pIC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
3952 1857 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5353646 1857 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5443 1857 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5702063 1857 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL1331786 1857 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL420 1857 33 None 1 14 Human 7.4 pIC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
168295528 192429 0 None -11 20 Human 5.9 pEC50 = 5.9 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 192429 0 None -11 20 Human 5.9 pEC50 = 5.9 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 192429 0 None -11 20 Human 5.9 pEC50 = 5.9 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
168294767 192417 0 None -11 20 Human 5.3 pEC50 = 5.3 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 192417 0 None -11 20 Human 5.3 pEC50 = 5.3 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 192417 0 None -11 20 Human 5.3 pEC50 = 5.3 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
102 4064 44 None -5 49 Human 8.1 pEC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/np058114h
3659 4064 44 None -5 49 Human 8.1 pEC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/np058114h
8969 4064 44 None -5 49 Human 8.1 pEC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/np058114h
CHEMBL15245 4064 44 None -5 49 Human 8.1 pEC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/np058114h
DB01392 4064 44 None -5 49 Human 8.1 pEC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]MK912 from human recombinant adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/np058114h
168290235 192366 0 None -40 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 192366 0 None -40 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 192366 0 None -40 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
164612037 184795 0 None -11 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 184795 0 None -11 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
44377036 119651 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351483 119651 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376984 55930 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162682 55930 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376923 56133 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163190 56133 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
22120332 55754 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
CHEMBL162490 55754 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
1588 2294 24 None 2 43 Human 9.5 pIC50 = 9.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 2294 24 None 2 43 Human 9.5 pIC50 = 9.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 2294 24 None 2 43 Human 9.5 pIC50 = 9.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 2294 24 None 2 43 Human 9.5 pIC50 = 9.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 2294 24 None 2 43 Human 9.5 pIC50 = 9.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
44376954 55451 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162232 55451 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
22120322 55631 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162370 55631 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
44377200 57119 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165350 57119 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
3294 1975 106 None - 44 Rat 9.4 pIC50 = 9.4 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1021/jm00007a009
71360 1975 106 None - 44 Rat 9.4 pIC50 = 9.4 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1021/jm00007a009
87 1975 106 None - 44 Rat 9.4 pIC50 = 9.4 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1021/jm00007a009
CHEMBL14376 1975 106 None - 44 Rat 9.4 pIC50 = 9.4 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1021/jm00007a009
DB04946 1975 106 None - 44 Rat 9.4 pIC50 = 9.4 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1021/jm00007a009
44376958 57177 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL165796 57177 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
3682 188847 7 None - 8 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to human adrenergic alpha2 receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2 receptor by radioligand displacement assay
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1016/j.bmc.2013.03.016
CHEMBL1256784 188847 7 None - 8 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to human adrenergic alpha2 receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2 receptor by radioligand displacement assay
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1016/j.bmc.2013.03.016
CHEMBL513389 188847 7 None - 8 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to human adrenergic alpha2 receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2 receptor by radioligand displacement assay
ChEMBL 277 6 2 3 2.6 Cc1ccc(OCC(O)C(C)NC(C)C)c2c1CCC2 10.1016/j.bmc.2013.03.016
3045401 55767 28 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162501 55767 28 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376993 56190 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163247 56190 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44377035 119625 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351200 119625 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376900 55975 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162826 55975 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44377007 56853 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL164612 56853 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
10531 1392 18 None -5 24 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 1392 18 None -5 24 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 1392 18 None -5 24 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 1392 18 None -5 24 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 1392 18 None -5 24 Human 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
44376927 55348 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162147 55348 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
9951544 57078 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165181 57078 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
107715 199260 18 None -6 20 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 199260 18 None -6 20 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 199260 18 None -6 20 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
44376936 57172 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165776 57172 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
10095594 12262 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1185501 12262 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL417550 12262 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10342423 99010 0 None - 1 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL28312 99010 0 None - 1 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL48925 99010 0 None - 1 Bovine 7.0 pIC50 = 7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
44401591 68555 0 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 8 3 7 5.1 Nc1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL192266 68555 0 None - 0 Human 7.0 pIC50 = 7 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 8 3 7 5.1 Nc1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
1220 186 46 None - 44 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
31 186 46 None - 44 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
7 186 46 None - 44 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
CHEMBL56 186 46 None - 44 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
10070029 164865 0 None - 1 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL423841 164865 0 None - 1 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL54089 164865 0 None - 1 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
59271992 117545 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of alpha-adrenoceptor 2A (unknown origin)Inhibition of alpha-adrenoceptor 2A (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
CHEMBL3403995 117545 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of alpha-adrenoceptor 2A (unknown origin)Inhibition of alpha-adrenoceptor 2A (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
2477 734 54 None - 28 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
36 734 54 None - 28 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
437 734 54 None - 28 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL49 734 54 None - 28 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
DB00490 734 54 None - 28 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
121852 10071 7 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 10071 7 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 10071 7 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9981024 95651 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26018 95651 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL300735 95651 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10040815 96613 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 306 7 1 4 1.8 CCCN(CCNC(C)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL264027 96613 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 306 7 1 4 1.8 CCCN(CCNC(C)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26715 96613 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 306 7 1 4 1.8 CCCN(CCNC(C)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10047322 96692 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL26783 96692 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL50993 96692 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
10364722 98628 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280608 98628 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51888 98628 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10338595 161949 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 360 9 0 4 4.0 CCCN(CCCCN1CCCCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL416747 161949 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 360 9 0 4 4.0 CCCN(CCCCN1CCCCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10265863 192721 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 283 5 0 2 4.3 CCCN(CCC)C1COc2ccc3ccccc3c2C1 10.1021/jm00038a007
CHEMBL52438 192721 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 283 5 0 2 4.3 CCCN(CCC)C1COc2ccc3ccccc3c2C1 10.1021/jm00038a007
14450375 164318 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 233 0 1 3 2.3 Cc1ccc(O)c2c1[C@H]1CCCN(C)[C@@H]1CO2 10.1021/jm00123a039
CHEMBL422024 164318 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 233 0 1 3 2.3 Cc1ccc(O)c2c1[C@H]1CCCN(C)[C@@H]1CO2 10.1021/jm00123a039
1305 508 10 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
9934033 508 10 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL182150 508 10 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
2585 790 100 None -28 22 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 790 100 None -28 22 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 790 100 None -28 22 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 790 100 None -28 22 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 790 100 None -28 22 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
25208878 180481 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of human adrenergic alpha2A receptorInhibition of human adrenergic alpha2A receptor
ChEMBL 406 6 1 3 4.9 CC1=C(CCN(C)C)c2cc(S(=O)(=O)Nc3cccc4ccccc34)ccc2C1 10.1021/jm8009469
CHEMBL475969 180481 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of human adrenergic alpha2A receptorInhibition of human adrenergic alpha2A receptor
ChEMBL 406 6 1 3 4.9 CC1=C(CCN(C)C)c2cc(S(=O)(=O)Nc3cccc4ccccc34)ccc2C1 10.1021/jm8009469
44390778 63948 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 403 5 2 5 4.2 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1 10.1016/j.bmcl.2005.05.121
CHEMBL180962 63948 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 403 5 2 5 4.2 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1 10.1016/j.bmcl.2005.05.121
11284878 70098 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL194602 70098 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
9885114 119099 3 None -95 12 Human 6.0 pIC50 = 6.0 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 119099 3 None -95 12 Human 6.0 pIC50 = 6.0 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL5070958 212478 3 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None NCCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21 10.1021/acs.jmedchem.1c01564
4098 32289 24 None -13 11 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1255739 32289 24 None -13 11 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1411979 32289 24 None -13 11 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
2812 4711 96 None -32 34 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 4711 96 None -32 34 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
16718919 198099 0 None - 1 Human 5.9 pIC50 = 5.9 Binding
Inhibition of human alpha-2a adrenergic receptorInhibition of human alpha-2a adrenergic receptor
ChEMBL 462 4 1 6 4.5 CC1=C(C2CCCN(C)C2)c2cc(NS(=O)(=O)c3c(Cl)nc4sccn34)ccc2C1 10.1016/j.bmc.2009.08.006
CHEMBL593889 198099 0 None - 1 Human 5.9 pIC50 = 5.9 Binding
Inhibition of human alpha-2a adrenergic receptorInhibition of human alpha-2a adrenergic receptor
ChEMBL 462 4 1 6 4.5 CC1=C(C2CCCN(C)C2)c2cc(NS(=O)(=O)c3c(Cl)nc4sccn34)ccc2C1 10.1016/j.bmc.2009.08.006
3561 18886 34 None -1 11 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
CHEMBL1289 18886 34 None -1 11 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
23027211 195574 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 421 5 2 5 4.3 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL568400 195574 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 421 5 2 5 4.3 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
11284878 64012 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(N[C@H]2CC[C@@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181217 64012 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(N[C@H]2CC[C@@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
44390713 123178 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 407 5 2 5 4.0 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(F)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL362193 123178 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 407 5 2 5 4.0 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(F)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
44401626 71010 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 558 7 2 6 5.2 O=S(=O)(NCC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL195810 71010 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 558 7 2 6 5.2 O=S(=O)(NCC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL5076569 212678 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None NCCCCN(C[C@H]1Cc2cccnc2CN1)[C@H]1CCCc2cccnc21 10.1021/acs.jmedchem.1c01564
191 399 92 None -41 28 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 399 92 None -41 28 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 399 92 None -41 28 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 399 92 None -41 28 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 399 92 None -41 28 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
100 3745 52 None -33 55 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 3745 52 None -33 55 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 3745 52 None -33 55 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 3745 52 None -33 55 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 3745 52 None -33 55 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
3158 55974 21 None -3467 20 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 55974 21 None -3467 20 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
1343 1858 55 None -9 9 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 1858 55 None -9 9 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 1858 55 None -9 9 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 1858 55 None -9 9 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 1858 55 None -9 9 Human 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
4735 193445 92 None -9 10 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL361506 193445 92 None -9 10 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL55 193445 92 None -9 10 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
3584 3718 60 None -251 14 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 3718 60 None -251 14 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 3718 60 None -251 14 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 3718 60 None -251 14 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 3718 60 None -251 14 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
44401552 165353 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 572 8 2 6 5.5 O=S(=O)(NCC1CCC(CNc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL425012 165353 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 572 8 2 6 5.5 O=S(=O)(NCC1CCC(CNc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
448537 159703 86 None -33 25 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 159703 86 None -33 25 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
2801 161325 56 None -14 28 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
CHEMBL1200710 161325 56 None -14 28 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
CHEMBL415 161325 56 None -14 28 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
15730 70774 73 None -2 10 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
CHEMBL195437 70774 73 None -2 10 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
6075 149575 36 None -11 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 149575 36 None -11 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
31101 720 39 None -12 35 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 720 39 None -12 35 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 720 39 None -12 35 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 720 39 None -12 35 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 720 39 None -12 35 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
44390730 63986 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 414 5 2 6 3.7 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C#N)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181099 63986 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 414 5 2 6 3.7 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C#N)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
44390742 122774 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 407 5 2 5 4.0 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL361442 122774 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 407 5 2 5 4.0 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
14450355 119463 0 None - 0 Bovine 6.8 pIC50 = 6.8 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 259 3 0 3 3.0 CCCN1CCC=C2c3c(OC)cccc3OCC21 10.1021/jm00123a039
CHEMBL349824 119463 0 None - 0 Bovine 6.8 pIC50 = 6.8 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 259 3 0 3 3.0 CCCN1CCC=C2c3c(OC)cccc3OCC21 10.1021/jm00123a039
6726 1254 46 None -10 13 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
7151 1254 46 None -10 13 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
749 1254 46 None -10 13 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL648 1254 46 None -10 13 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB01176 1254 46 None -10 13 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
150 2473 18 None -45 15 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
1764 2473 18 None -45 15 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
8226 2473 18 None -45 15 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
CHEMBL1201356 2473 18 None -45 15 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
DB00353 2473 18 None -45 15 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
23027411 196843 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 387 5 2 5 3.7 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL577912 196843 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 387 5 2 5 3.7 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
134 2478 19 None -74 67 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
1775 2478 19 None -74 67 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
9681 2478 19 None -74 67 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
CHEMBL1065 2478 19 None -74 67 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
DB00247 2478 19 None -74 67 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
44190762 176306 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of radioligand from adrenergic alpha2A receptorDisplacement of radioligand from adrenergic alpha2A receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
CHEMBL461571 176306 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of radioligand from adrenergic alpha2A receptorDisplacement of radioligand from adrenergic alpha2A receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
2750 202363 69 None -3 12 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
CHEMBL7002 202363 69 None -3 12 Human 4.8 pIC50 = 4.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
2351 3234 60 None -9 21 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 3234 60 None -9 21 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 3234 60 None -9 21 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 3234 60 None -9 21 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 3234 60 None -9 21 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
1042 1551 20 None -97 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
148 1551 20 None -97 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
443884 1551 20 None -97 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
CHEMBL119443 1551 20 None -97 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
DB01253 1551 20 None -97 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
2274 3124 53 None -10 32 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 3124 53 None -10 32 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 3124 53 None -10 32 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 3124 53 None -10 32 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 3124 53 None -10 32 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
44390733 62165 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 537 7 2 6 5.9 CN(C)c1nc(NC2CCC(NCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL178084 62165 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 537 7 2 6 5.9 CN(C)c1nc(NC2CCC(NCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
11342160 122420 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL360671 122420 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
11342160 122420 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL360671 122420 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 573 6 1 7 4.6 CN(C)c1nc(NC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
23027035 196870 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 367 5 2 5 3.3 Cc1ccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)cc1 10.1016/j.bmcl.2009.09.003
CHEMBL578170 196870 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 367 5 2 5 3.3 Cc1ccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)cc1 10.1016/j.bmcl.2009.09.003
240 931 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 931 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 931 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 931 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 931 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 931 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 931 39 None -12 25 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
26757 206239 29 None -1 2 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
CHEMBL972 206239 29 None -1 2 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
196129 67456 12 None -85 15 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 67456 12 None -85 15 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
4011 81996 43 None -35 23 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 81996 43 None -35 23 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
26987 936 29 None -158 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 936 29 None -158 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 936 29 None -158 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 936 29 None -158 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 936 29 None -158 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
28417 39799 48 None -1 12 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
CHEMBL1479 39799 48 None -1 12 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
16215415 186749 1 None 3 5 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptorDisplacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor
ChEMBL 471 9 2 3 3.8 CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br 10.1021/np800339e
CHEMBL493091 186749 1 None 3 5 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptorDisplacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor
ChEMBL 471 9 2 3 3.8 CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br 10.1021/np800339e
10331436 321 7 None - 6 Human 4.7 pIC50 = 4.7 Binding
Inhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligandInhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligand
ChEMBL 230 2 2 2 2.4 C[C@@H](Cc1c[nH]c2c1c1CCCOc1cc2)N 10.1021/jm030205t
160 321 7 None - 6 Human 4.7 pIC50 = 4.7 Binding
Inhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligandInhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligand
ChEMBL 230 2 2 2 2.4 C[C@@H](Cc1c[nH]c2c1c1CCCOc1cc2)N 10.1021/jm030205t
CHEMBL133455 321 7 None - 6 Human 4.7 pIC50 = 4.7 Binding
Inhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligandInhibitory concentration required against Alpha-2A adrenergic receptor using [3H]clonidine radioligand
ChEMBL 230 2 2 2 2.4 C[C@@H](Cc1c[nH]c2c1c1CCCOc1cc2)N 10.1021/jm030205t
45482789 197247 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 428 4 2 2 4.5 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1 10.1016/j.bmcl.2009.09.002
CHEMBL584554 197247 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 428 4 2 2 4.5 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1 10.1016/j.bmcl.2009.09.002
1016 3690 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 3690 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 3690 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 3690 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 3690 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 3690 75 None -12 35 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
3823 49951 38 None -40 11 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 49951 38 None -40 11 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 49951 38 None -40 11 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
2803 941 53 None - 19 Bovine 8.7 pIC50 = 8.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00123a039
516 941 53 None - 19 Bovine 8.7 pIC50 = 8.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00123a039
704 941 53 None - 19 Bovine 8.7 pIC50 = 8.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00123a039
CHEMBL134 941 53 None - 19 Bovine 8.7 pIC50 = 8.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00123a039
DB00575 941 53 None - 19 Bovine 8.7 pIC50 = 8.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00123a039
1043 1552 13 None -8 28 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 1552 13 None -8 28 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 1552 13 None -8 28 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 1552 13 None -8 28 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 1552 13 None -8 28 Human 8.7 pIC50 = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
44376975 55695 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
CHEMBL162436 55695 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
121852 10071 7 None - 1 Bovine 7.7 pIC50 = 7.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 10071 7 None - 1 Bovine 7.7 pIC50 = 7.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 10071 7 None - 1 Bovine 7.7 pIC50 = 7.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
135 2496 38 None -4 57 Human 7.7 pIC50 = 7.7 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
1796 2496 38 None -4 57 Human 7.7 pIC50 = 7.7 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
4184 2496 38 None -4 57 Human 7.7 pIC50 = 7.7 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
CHEMBL6437 2496 38 None -4 57 Human 7.7 pIC50 = 7.7 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
DB06148 2496 38 None -4 57 Human 7.7 pIC50 = 7.7 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
45485061 197076 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 489 5 2 5 5.0 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL583014 197076 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 489 5 2 5 5.0 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
44390787 122050 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 443 5 2 5 4.3 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL360159 122050 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 443 5 2 5 4.3 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)c(F)c3F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
9981024 95651 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26018 95651 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL300735 95651 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
131001 98536 7 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 249 5 1 3 2.8 CCCN(CCC)C1COc2cccc(O)c2C1 10.1021/jm00038a007
CHEMBL27995 98536 7 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 249 5 1 3 2.8 CCCN(CCC)C1COc2cccc(O)c2C1 10.1021/jm00038a007
10321248 98967 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL28287 98967 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50722 98967 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10251673 99030 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283207 99030 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL52396 99030 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9978353 11149 0 None - 0 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
CHEMBL1178987 11149 0 None - 0 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
CHEMBL52785 11149 0 None - 0 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
10105405 95586 0 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 233 5 0 2 3.1 CCCN(CCC)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL25984 95586 0 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 233 5 0 2 3.1 CCCN(CCC)C1COc2ccccc2C1 10.1021/jm00038a007
11743327 98249 0 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 1 5 3.9 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(O)c2C1 10.1021/jm00038a007
CHEMBL27763 98249 0 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 1 5 3.9 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(O)c2C1 10.1021/jm00038a007
1577 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
164512405 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
2537 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
5355 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
5501 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
643497 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
688272 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
958 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
960 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL196677 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL26 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL267044 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
DB00391 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
DB16021 3647 104 None -2 25 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
657255 197406 29 None -10 15 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 nan
CHEMBL588119 197406 29 None -10 15 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 nan
1210 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
1213 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
2725 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
33036 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
4411 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
616 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
6976 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
716121 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
90475904 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1201353 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1554789 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL505 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
DB01114 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
DB13679 905 45 None -263 20 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
5467 204212 40 None -6 5 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC nan
CHEMBL84158 204212 40 None -6 5 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC nan
14151683 56243 0 None - 0 Bovine 6.7 pIC50 = 6.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 2 0 2 2.9 CCCN1CCC=C2c3ccccc3OCC21 10.1021/jm00123a039
CHEMBL163803 56243 0 None - 0 Bovine 6.7 pIC50 = 6.7 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 229 2 0 2 2.9 CCCN1CCC=C2c3ccccc3OCC21 10.1021/jm00123a039
44401616 69690 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NCC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL193970 69690 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 601 8 2 7 5.3 CN(C)c1nc(NCC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
45484995 196842 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 403 6 2 5 3.5 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL577904 196842 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 403 6 2 5 3.5 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
5897 104732 71 None -7 3 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 223 1 1 1 3.2 CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2 nan
CHEMBL311469 104732 71 None -7 3 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 223 1 1 1 3.2 CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2 nan
1212 1632 45 None -165 65 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 1632 45 None -165 65 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 1632 45 None -165 65 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 1632 45 None -165 65 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 1632 45 None -165 65 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
4601 205020 29 None -2 17 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL1201023 205020 29 None -2 17 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL900 205020 29 None -2 17 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
1530 2151 44 None -70 20 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
3827 2151 44 None -70 20 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
7206 2151 44 None -70 20 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
CHEMBL534 2151 44 None -70 20 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
DB00920 2151 44 None -70 20 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
237 203157 43 None -1 13 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL546257 203157 43 None -1 13 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL554190 203157 43 None -1 13 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL7568 203157 43 None -1 13 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
124 2933 44 None -4 32 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 2933 44 None -4 32 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 2933 44 None -4 32 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 2933 44 None -4 32 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 2933 44 None -4 32 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL5083458 213091 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None c1cnc2c(c1)CN[C@@H](CN(CCCCNC1COC1)[C@H]1CCCc3cccnc31)C2 10.1021/acs.jmedchem.1c01564
25014630 83126 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Inhibition of alpha2A adrenergic receptorInhibition of alpha2A adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
CHEMBL2203713 83126 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Inhibition of alpha2A adrenergic receptorInhibition of alpha2A adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
2683 102415 24 None -12 16 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL305906 102415 24 None -12 16 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL334255 102415 24 None -12 16 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
14151624 55516 0 None - 0 Bovine 6.6 pIC50 = 6.6 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3ccc(O)cc3OC[C@H]21 10.1021/jm00123a039
CHEMBL162282 55516 0 None - 0 Bovine 6.6 pIC50 = 6.6 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3ccc(O)cc3OC[C@H]21 10.1021/jm00123a039
2337 3205 72 None -50 62 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3205 72 None -50 62 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3205 72 None -50 62 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3205 72 None -50 62 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3205 72 None -50 62 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
1305 508 10 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2005.05.121
9934033 508 10 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2005.05.121
CHEMBL182150 508 10 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2005.05.121
4209 3114 71 None -3235 33 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 3114 71 None -3235 33 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 3114 71 None -3235 33 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 3114 71 None -3235 33 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 3114 71 None -3235 33 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 3114 71 None -3235 33 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
2105 3005 34 None -58 33 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 3005 34 None -58 33 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 3005 34 None -58 33 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 3005 34 None -58 33 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 3005 34 None -58 33 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
1782 2482 81 None -5 22 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
241 2482 81 None -5 22 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
4168 2482 81 None -5 22 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
CHEMBL86 2482 81 None -5 22 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
DB01233 2482 81 None -5 22 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
3151 1434 93 None -99 26 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 1434 93 None -99 26 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 1434 93 None -99 26 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 1434 93 None -99 26 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 1434 93 None -99 26 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
2803 941 53 None -1 19 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 941 53 None -1 19 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 941 53 None -1 19 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 941 53 None -1 19 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 941 53 None -1 19 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
42 2032 50 None - 17 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
56971 2032 50 None - 17 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL8412 2032 50 None - 17 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL5077132 212713 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCOCC1 10.1021/acs.jmedchem.1c01564
277 1274 55 None -33 45 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 1274 55 None -33 45 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 1274 55 None -33 45 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 1274 55 None -33 45 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 1274 55 None -33 45 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
24180125 95212 63 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 469 5 2 8 3.7 O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1 10.1021/jm8012954
CHEMBL257991 95212 63 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 469 5 2 8 3.7 O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1cnc2ccccc2n1 10.1021/jm8012954
68617 203816 60 None -3 25 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL1709 203816 60 None -3 25 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL809 203816 60 None -3 25 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
3168 9172 84 None -123 21 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 9172 84 None -123 21 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
1227 2454 35 None -91 11 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
2331 2454 35 None -91 11 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
3957 2454 35 None -91 11 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
4992 2454 35 None -91 11 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
CHEMBL511 2454 35 None -91 11 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
DB06691 2454 35 None -91 11 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
2435 714 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 714 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 714 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 714 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 714 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 714 98 None -4 12 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
44376845 55257 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
CHEMBL162058 55257 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
102 4064 44 None -5 49 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm900458r
3659 4064 44 None -5 49 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm900458r
8969 4064 44 None -5 49 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm900458r
CHEMBL15245 4064 44 None -5 49 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm900458r
DB01392 4064 44 None -5 49 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm900458r
44377006 57161 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccc(Cl)cc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165677 57161 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccc(Cl)cc3c2C1 10.1016/s0960-894x(99)00591-0
10014217 99287 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 233 2 0 3 2.1 COc1cccc2c1CC(N1CCCC1)CO2 10.1021/jm00038a007
CHEMBL285010 99287 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 233 2 0 3 2.1 COc1cccc2c1CC(N1CCCC1)CO2 10.1021/jm00038a007
10019102 32304 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 323 3 0 3 3.7 COC1Cc2ccccc2C2(CCN(Cc3ccccc3)CC2)O1 10.1021/jm010992z
CHEMBL141209 32304 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 323 3 0 3 3.7 COC1Cc2ccccc2C2(CCN(Cc3ccccc3)CC2)O1 10.1021/jm010992z
44390385 122001 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 565 9 2 6 6.4 CN(C)c1nc(NCC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL360117 122001 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 565 9 2 6 6.4 CN(C)c1nc(NCC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
15987265 195212 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 503 6 2 5 5.3 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL566075 195212 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 503 6 2 5 5.3 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
10915140 29261 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 351 5 0 3 4.2 COC1Cc2ccccc2C2(CCN(CCCc3ccccc3)CC2)O1 10.1021/jm010992z
CHEMBL138458 29261 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 351 5 0 3 4.2 COC1Cc2ccccc2C2(CCN(CCCc3ccccc3)CC2)O1 10.1021/jm010992z
2335 11743 21 None -5 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
8478 11743 21 None -5 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL1182210 11743 21 None -5 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL221753 11743 21 None -5 12 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
176 394 63 None -3 31 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2157 394 63 None -3 31 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2566 394 63 None -3 31 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
CHEMBL633 394 63 None -3 31 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
DB01118 394 63 None -3 31 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
44596863 197249 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 367 6 1 6 2.3 C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N 10.1021/jm900458r
CHEMBL584606 197249 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsDisplacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 mins
ChEMBL 367 6 1 6 2.3 C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N 10.1021/jm900458r
2284 3133 27 None -12 28 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 3133 27 None -12 28 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 3133 27 None -12 28 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 3133 27 None -12 28 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 3133 27 None -12 28 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
44390369 64279 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 629 9 1 7 5.9 CN(C)c1nc(NCC2CCC(CN(C)S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181727 64279 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 629 9 1 7 5.9 CN(C)c1nc(NCC2CCC(CN(C)S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
3038525 13438 107 None -2 3 Human 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
CHEMBL119385 13438 107 None -2 3 Human 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
44240743 6679 15 None - 1 Human 4.5 pIC50 = 4.5 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 370 7 2 3 4.3 O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)nc1 10.1021/jm901692q
CHEMBL1083787 6679 15 None - 1 Human 4.5 pIC50 = 4.5 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 370 7 2 3 4.3 O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)nc1 10.1021/jm901692q
180 397 50 None -58 38 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 397 50 None -58 38 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 397 50 None -58 38 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 397 50 None -58 38 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 397 50 None -58 38 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2726 906 64 None -64 72 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 906 64 None -64 72 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 906 64 None -64 72 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 906 64 None -64 72 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 906 64 None -64 72 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL1350036 67455 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1909062 67455 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
9807658 64215 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 551 8 2 6 6.1 CN(C)c1nc(NC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181466 64215 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 551 8 2 6 6.1 CN(C)c1nc(NC2CCC(CNCc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
14151619 55128 0 None - 0 Bovine 6.4 pIC50 = 6.4 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3c(O)cccc3OC[C@H]21 10.1021/jm00123a039
CHEMBL161947 55128 0 None - 0 Bovine 6.4 pIC50 = 6.4 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3c(O)cccc3OC[C@H]21 10.1021/jm00123a039
2484 206552 64 None - 1 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 nan
CHEMBL990 206552 64 None - 1 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 nan
119584 2557 99 None -2 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
1848 2557 99 None -2 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
242 2557 99 None -2 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
CHEMBL60889 2557 99 None -2 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
DB11675 2557 99 None -2 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
57345320 3772 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin)Inhibition of adrenergic alpha2A receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acsmedchemlett.8b00030
9882 3772 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin)Inhibition of adrenergic alpha2A receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acsmedchemlett.8b00030
CHEMBL3091687 3772 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin)Inhibition of adrenergic alpha2A receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acsmedchemlett.8b00030
57345320 3772 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acs.jmedchem.1c01564
9882 3772 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acs.jmedchem.1c01564
CHEMBL3091687 3772 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL 364 7 2 4 3.2 NCCCCN([C@H]1CCCc2c1nccc2)C[C@@H]1NCc2c(C1)cccc2 10.1021/acs.jmedchem.1c01564
9904205 204135 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL83658 204135 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(02)00796-5
9904205 204135 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL83658 204135 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
10219 188210 30 None -1 5 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL493439 188210 30 None -1 5 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL50588 188210 30 None -1 5 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
5472 204104 69 None -1 3 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL1717 204104 69 None -1 3 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL833 204104 69 None -1 3 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
2406 99938 84 None -16 12 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
CHEMBL290106 99938 84 None -16 12 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
14151652 96192 0 None - 0 Bovine 7.4 pIC50 = 7.4 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 261 3 1 3 3.1 CCCCN1CCC[C@@H]2c3cccc(O)c3OC[C@H]21 10.1021/jm00123a039
CHEMBL263574 96192 0 None - 0 Bovine 7.4 pIC50 = 7.4 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 261 3 1 3 3.1 CCCCN1CCC[C@@H]2c3cccc(O)c3OC[C@H]21 10.1021/jm00123a039
10231050 64003 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 551 6 2 6 5.5 CN(C)c1nc(NC2CCC(NC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181184 64003 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 551 6 2 6 5.5 CN(C)c1nc(NC2CCC(NC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
1836 2554 56 None -43 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
3340 2554 56 None -43 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
5281040 2554 56 None -43 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
CHEMBL787 2554 56 None -43 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
DB00471 2554 56 None -43 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
4189 205195 91 None -18 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1559 205195 91 None -18 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL91 205195 91 None -18 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
10024943 96940 0 None - 1 Bovine 6.4 pIC50 = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26975 96940 0 None - 1 Bovine 6.4 pIC50 = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL52485 96940 0 None - 1 Bovine 6.4 pIC50 = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10429859 11937 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 380 7 1 5 2.7 COc1cccc2c1CC(NCCCCN1C(=O)c3ccccc3C1=O)CO2 10.1021/jm00038a007
CHEMBL1183429 11937 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 380 7 1 5 2.7 COc1cccc2c1CC(NCCCCN1C(=O)c3ccccc3C1=O)CO2 10.1021/jm00038a007
CHEMBL296395 11937 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 380 7 1 5 2.7 COc1cccc2c1CC(NCCCCN1C(=O)c3ccccc3C1=O)CO2 10.1021/jm00038a007
10092409 11941 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1183479 11941 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL299561 11941 0 None - 0 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10319624 98530 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL27991 98530 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL298534 98530 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
3082597 99098 8 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99098 8 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9975915 99275 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 362 9 0 5 2.8 CCCN(CCCCN1CCOCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL284912 99275 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 362 9 0 5 2.8 CCCN(CCCCN1CCOCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10072866 195799 0 None - 0 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51561 195799 0 None - 0 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL56990 195799 0 None - 0 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
5318 15400 44 None -1 13 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1200348 15400 44 None -1 13 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1221 15400 44 None -1 13 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
5353853 17803 41 None -16 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
9556529 17803 41 None -16 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1262 17803 41 None -16 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
3952 1857 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 1857 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 1857 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 1857 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 1857 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 1857 33 None -2 12 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
135 2496 38 None -4 57 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 2496 38 None -4 57 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 2496 38 None -4 57 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 2496 38 None -4 57 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 2496 38 None -4 57 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
10660 14298 55 None -43 12 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
CHEMBL1200406 14298 55 None -43 12 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
6918276 15435 4 None -16 8 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 559 18 4 9 1.7 CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS nan
CHEMBL1221512 15435 4 None -16 8 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 559 18 4 9 1.7 CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS nan
3198 203802 73 None -19 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 203802 73 None -19 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 203802 73 None -19 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
19426635 203881 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 280 2 1 3 3.1 CNCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL81485 203881 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 280 2 1 3 3.1 CNCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
44390456 64570 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 579 9 1 6 6.7 CN(Cc1ccc(Br)cc1OC(F)(F)F)CC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1 10.1016/j.bmcl.2005.05.121
CHEMBL182235 64570 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 579 9 1 6 6.7 CN(Cc1ccc(Br)cc1OC(F)(F)F)CC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1 10.1016/j.bmcl.2005.05.121
1547484 927 70 None -5 20 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 927 70 None -5 20 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 927 70 None -5 20 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 927 70 None -5 20 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 927 70 None -5 20 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL1441214 39578 0 None - 1 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1476898 39578 0 None - 1 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
44390715 123302 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 457 5 2 5 5.2 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL362400 123302 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 457 5 2 5 5.2 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)c(Cl)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
11204090 69493 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(NC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL193771 69493 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(NC2CCC(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
23027527 195117 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 371 5 2 5 3.1 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL565551 195117 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 371 5 2 5 3.1 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
10381889 106586 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL315772 106586 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(02)00796-5
10381889 106586 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL315772 106586 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(01)00721-1
5198 19235 46 None - 1 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 nan
CHEMBL12948 19235 46 None - 1 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 nan
2247 502 77 None -58 41 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 502 77 None -58 41 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 502 77 None -58 41 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 502 77 None -58 41 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 502 77 None -58 41 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
3117 206106 100 None -2 16 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 206106 100 None -2 16 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
1353 1880 85 None -190 85 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1880 85 None -190 85 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1880 85 None -190 85 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1880 85 None -190 85 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1880 85 None -190 85 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
44401671 69923 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 7 1 7 4.9 CN(C)c1nc(NCC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL194173 69923 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 587 7 1 7 4.9 CN(C)c1nc(NCC2CCN(S(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
9980269 98626 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280586 98626 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL54266 98626 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10251234 11141 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 11141 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 11141 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10476735 13619 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1195096 13619 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL553833 13619 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10364722 98628 0 None - 1 Bovine 4.3 pIC50 = 4.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280608 98628 0 None - 1 Bovine 4.3 pIC50 = 4.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51888 98628 0 None - 1 Bovine 4.3 pIC50 = 4.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
44318454 204290 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 312 2 0 3 3.5 CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL84931 204290 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-2A adrenergic receptorBinding affinity for human cloned Alpha-2A adrenergic receptor
ChEMBL 312 2 0 3 3.5 CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
14450361 55781 0 None - 0 Bovine 6.3 pIC50 = 6.3 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 275 3 0 3 3.4 CCCN1CCC[C@@H]2c3c(OC)cc(C)cc3OC[C@H]21 10.1021/jm00123a039
CHEMBL162510 55781 0 None - 0 Bovine 6.3 pIC50 = 6.3 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 275 3 0 3 3.4 CCCN1CCC[C@@H]2c3c(OC)cc(C)cc3OC[C@H]21 10.1021/jm00123a039
44390752 122480 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 523 6 1 6 5.4 CN(C)c1nc(NC2CCN(Cc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL360876 122480 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 523 6 1 6 5.4 CN(C)c1nc(NC2CCN(Cc3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL508338 188379 0 None -6 6 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
11057 175575 19 None -1 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
3468 175575 19 None -1 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL459265 175575 19 None -1 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL64894 175575 19 None -1 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
135398745 2869 108 None -93 65 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2869 108 None -93 65 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2869 108 None -93 65 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2869 108 None -93 65 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
1201549 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 590 22 None -33 20 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
3598 187238 73 None -2 7 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl nan
CHEMBL496 187238 73 None -2 7 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl nan
10243700 55990 1 None - 0 Bovine 6.3 pIC50 = 6.3 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3cc(O)ccc3OC[C@H]21 10.1021/jm00123a039
CHEMBL162955 55990 1 None - 0 Bovine 6.3 pIC50 = 6.3 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3cc(O)ccc3OC[C@H]21 10.1021/jm00123a039
11204090 63177 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(N[C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL180003 63177 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 587 7 2 7 5.1 CN(C)c1nc(N[C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
44401449 70750 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 544 6 2 6 5.0 O=S(=O)(NC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
CHEMBL195346 70750 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 544 6 2 6 5.0 O=S(=O)(NC1CCC(Nc2ncc3ccccc3n2)CC1)c1ccc(Br)cc1OC(F)(F)F 10.1016/j.bmcl.2005.03.052
10303307 64145 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 565 7 2 6 5.8 CN(C)c1nc(NC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181393 64145 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 565 7 2 6 5.8 CN(C)c1nc(NC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
1549008 203967 81 None - 1 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 nan
CHEMBL822 203967 81 None - 1 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 nan
2520 202310 65 None -6 11 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL1280 202310 65 None -6 11 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL6966 202310 65 None -6 11 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
133 2460 48 None -23 42 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 2460 48 None -23 42 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 2460 48 None -23 42 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 2460 48 None -23 42 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 2460 48 None -23 42 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
44401508 69478 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 433 10 2 6 3.6 CCCCS(=O)(=O)NCC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1 10.1016/j.bmcl.2005.03.052
CHEMBL193666 69478 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 433 10 2 6 3.6 CCCCS(=O)(=O)NCC1CCC(CNc2nc(N(C)C)c3ccccc3n2)CC1 10.1016/j.bmcl.2005.03.052
45485062 195492 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 367 5 2 5 3.3 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1 10.1016/j.bmcl.2009.09.003
CHEMBL567993 195492 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 367 5 2 5 3.3 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1 10.1016/j.bmcl.2009.09.003
12488 1627 51 None -6 23 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 1627 51 None -6 23 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 1627 51 None -6 23 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 1627 51 None -6 23 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL1200633 206858 3 None -7 8 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O nan
145949343 162382 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin)Inhibition of adrenergic alpha2A receptor (unknown origin)
ChEMBL 404 6 2 4 3.9 c1ccc2c(c1)CN[C@@H](CN(CC[C@H]1CCCNC1)[C@H]1CCCc3cccnc31)C2 10.1021/acsmedchemlett.8b00030
CHEMBL4174290 162382 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin)Inhibition of adrenergic alpha2A receptor (unknown origin)
ChEMBL 404 6 2 4 3.9 c1ccc2c(c1)CN[C@@H](CN(CC[C@H]1CCCNC1)[C@H]1CCCc3cccnc31)C2 10.1021/acsmedchemlett.8b00030
2142 3047 54 None -2 36 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 3047 54 None -2 36 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 3047 54 None -2 36 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 3047 54 None -2 36 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 3047 54 None -2 36 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 3047 54 None -2 36 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
102 4064 44 None -5 49 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 4064 44 None -5 49 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 4064 44 None -5 49 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 4064 44 None -5 49 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 4064 44 None -5 49 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
73453 29403 22 None -3 17 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 29403 22 None -3 17 Human 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
44390710 64258 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 457 5 2 5 4.9 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C(F)(F)F)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181632 64258 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 457 5 2 5 4.9 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C(F)(F)F)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
10252000 98095 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL27650 98095 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50188 98095 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
2162 41273 97 None 1 6 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl nan
CHEMBL1491 41273 97 None 1 6 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl nan
CHEMBL5082142 213015 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None c1cnc2c(c1)CN[C@@H](CN(CCCCN1CCOCC1)[C@H]1CCCc3cccnc31)C2 10.1021/acs.jmedchem.1c01564
10357986 29691 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 309 3 0 3 3.9 COC1OC2(CCN(Cc3ccccc3)CC2)c2ccccc21 10.1021/jm010992z
CHEMBL138809 29691 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of idazoxane binding to noradrenaline alpha-2 receptorInhibition of idazoxane binding to noradrenaline alpha-2 receptor
ChEMBL 309 3 0 3 3.9 COC1OC2(CCN(Cc3ccccc3)CC2)c2ccccc21 10.1021/jm010992z
11080 28872 74 None 1 6 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 185 1 0 2 3.6 S=C=Nc1cccc2ccccc12 nan
CHEMBL1381098 28872 74 None 1 6 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 185 1 0 2 3.6 S=C=Nc1cccc2ccccc12 nan
44390706 121519 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 467 5 2 5 4.6 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Br)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL359510 121519 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 467 5 2 5 4.6 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Br)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
14151702 56052 1 None - 0 Bovine 6.2 pIC50 = 6.2 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 245 2 1 3 2.7 CCCN1CCC=C2c3cc(O)ccc3OCC21 10.1021/jm00123a039
CHEMBL163061 56052 1 None - 0 Bovine 6.2 pIC50 = 6.2 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 245 2 1 3 2.7 CCCN1CCC=C2c3cc(O)ccc3OCC21 10.1021/jm00123a039
6761 67457 17 None -6 18 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 67457 17 None -6 18 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
1752 45504 56 None -2 5 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 220 8 1 1 4.7 CCCCCCCCCc1ccc(O)cc1 nan
CHEMBL153062 45504 56 None -2 5 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 220 8 1 1 4.7 CCCCCCCCCc1ccc(O)cc1 nan
2286 3134 48 None -13 29 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 3134 48 None -13 29 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 3134 48 None -13 29 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 3134 48 None -13 29 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 3134 48 None -13 29 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL1458880 37617 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
9895868 12790 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL1188966 12790 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL537846 12790 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NC[C@H]2CC[C@H](CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
9895868 69239 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL193438 69239 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 615 9 2 7 5.6 CN(C)c1nc(NCC2CCC(CNS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
134551 355 25 None -3 21 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 355 25 None -3 21 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 355 25 None -3 21 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 355 25 None -3 21 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
16718917 181100 0 None - 1 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human adrenergic alpha2A receptorInhibition of human adrenergic alpha2A receptor
ChEMBL 412 6 1 4 5.0 CC1=C(CCN(C)C)c2cc(NS(=O)(=O)c3csc4ccccc34)ccc2C1 10.1021/jm8009469
CHEMBL477650 181100 0 None - 1 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human adrenergic alpha2A receptorInhibition of human adrenergic alpha2A receptor
ChEMBL 412 6 1 4 5.0 CC1=C(CCN(C)C)c2cc(NS(=O)(=O)c3csc4ccccc34)ccc2C1 10.1021/jm8009469
168281847 190442 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Displacement of [3H]NECA from A2AAR in rat striatal membrane assessed as inhibition constant by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striatal membrane assessed as inhibition constant by radioligand competitive binding assay
ChEMBL 310 3 1 4 3.6 COc1ccc(/C=C2\CCc3c(O)cccc3C2=O)cc1OC 10.1016/j.ejmech.2021.113964
CHEMBL5187030 190442 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Displacement of [3H]NECA from A2AAR in rat striatal membrane assessed as inhibition constant by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striatal membrane assessed as inhibition constant by radioligand competitive binding assay
ChEMBL 310 3 1 4 3.6 COc1ccc(/C=C2\CCc3c(O)cccc3C2=O)cc1OC 10.1016/j.ejmech.2021.113964
14151613 56196 0 None - 0 Bovine 7.2 pIC50 = 7.2 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 261 3 0 3 3.0 CCCN1CCC[C@@H]2c3c(OC)cccc3OC[C@H]21 10.1021/jm00123a039
CHEMBL163281 56196 0 None - 0 Bovine 7.2 pIC50 = 7.2 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 261 3 0 3 3.0 CCCN1CCC[C@@H]2c3c(OC)cccc3OC[C@H]21 10.1021/jm00123a039
44390726 121889 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 449 7 2 7 3.9 COc1cc(OC)cc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1 10.1016/j.bmcl.2005.05.121
CHEMBL360081 121889 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 449 7 2 7 3.9 COc1cc(OC)cc(C(=O)N[C@H]2CC[C@@H](Nc3nc(N(C)C)c4ccccc4n3)CC2)c1 10.1016/j.bmcl.2005.05.121
23027245 195452 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 387 5 2 5 3.7 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL567791 195452 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]MK-912 from human adrenergic alpha2A receptorDisplacement of [3H]MK-912 from human adrenergic alpha2A receptor
ChEMBL 387 5 2 5 3.7 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1 10.1016/j.bmcl.2009.09.003
4543 169982 36 None -5 29 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
CHEMBL1201156 169982 36 None -5 29 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
CHEMBL445 169982 36 None -5 29 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
4211 57517 81 None -1 4 Human 5.1 pIC50 = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 nan
CHEMBL1670 57517 81 None -1 4 Human 5.1 pIC50 = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 nan
1028 287 69 None -30 29 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 287 69 None -30 29 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 287 69 None -30 29 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 287 69 None -30 29 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 287 69 None -30 29 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 287 69 None -30 29 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
44390750 63148 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 423 5 2 5 4.5 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Cl)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL179878 63148 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 423 5 2 5 4.5 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc(Cl)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
14151647 55374 1 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3cccc(O)c3OC[C@H]21 10.1021/jm00123a039
CHEMBL162170 55374 1 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 2 1 3 2.7 CCCN1CCC[C@@H]2c3cccc(O)c3OC[C@H]21 10.1021/jm00123a039
3082597 99098 8 None - 1 Bovine 6.1 pIC50 = 6.1 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99098 8 None - 1 Bovine 6.1 pIC50 = 6.1 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
12575 1957 28 None -5 16 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
54459 1957 28 None -5 16 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
CHEMBL10316 1957 28 None -5 16 Human 8.1 pIC50 = 8.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
102 4064 44 None -5 49 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
3659 4064 44 None -5 49 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
8969 4064 44 None -5 49 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
CHEMBL15245 4064 44 None -5 49 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
DB01392 4064 44 None -5 49 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
118112300 155453 12 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at alpha2A-adrenergic receptor (unknown origin)Antagonist activity at alpha2A-adrenergic receptor (unknown origin)
ChEMBL 430 6 2 6 3.8 O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CCCN2CCC3)cc1F 10.1016/j.bmcl.2017.03.085
CHEMBL4061793 155453 12 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at alpha2A-adrenergic receptor (unknown origin)Antagonist activity at alpha2A-adrenergic receptor (unknown origin)
ChEMBL 430 6 2 6 3.8 O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CCCN2CCC3)cc1F 10.1016/j.bmcl.2017.03.085
CHEMBL5093818 213670 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of alpha 2A adrenergic receptor (unknown origin)Inhibition of alpha 2A adrenergic receptor (unknown origin)
ChEMBL None None None CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.1c01564
3191 102385 93 None -8 25 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 102385 93 None -8 25 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
1816 2504 99 None -33 16 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
4205 2504 99 None -33 16 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
7241 2504 99 None -33 16 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
CHEMBL654 2504 99 None -33 16 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
DB00370 2504 99 None -33 16 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2A adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
44401460 70563 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 391 7 2 6 2.5 CN(C)c1nc(NCC2CCC(CNS(C)(=O)=O)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
CHEMBL195123 70563 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 391 7 2 6 2.5 CN(C)c1nc(NCC2CCC(CNS(C)(=O)=O)CC2)nc2ccccc12 10.1016/j.bmcl.2005.03.052
14151595 56217 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 231 2 0 2 3.0 CCCN1CCC[C@@H]2c3ccccc3OC[C@H]21 10.1021/jm00123a039
CHEMBL163532 56217 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 231 2 0 2 3.0 CCCN1CCC[C@@H]2c3ccccc3OC[C@H]21 10.1021/jm00123a039
70788951 26948 1 None -1 5 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1366 26948 1 None -1 5 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
46227396 199955 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Inhibition of human alpha-2a adrenergic receptorInhibition of human alpha-2a adrenergic receptor
ChEMBL 420 4 2 6 3.4 O=S(=O)(Nc1ccc2c(c1)C(C1CCNC1)=CC2)c1c(Cl)nc2sccn12 10.1016/j.bmc.2009.08.006
CHEMBL605938 199955 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Inhibition of human alpha-2a adrenergic receptorInhibition of human alpha-2a adrenergic receptor
ChEMBL 420 4 2 6 3.4 O=S(=O)(Nc1ccc2c(c1)C(C1CCNC1)=CC2)c1c(Cl)nc2sccn12 10.1016/j.bmc.2009.08.006
42636941 178371 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]RX821002 form human recombinant alpha2A adrenergic receptorDisplacement of [3H]RX821002 form human recombinant alpha2A adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
CHEMBL470432 178371 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]RX821002 form human recombinant alpha2A adrenergic receptorDisplacement of [3H]RX821002 form human recombinant alpha2A adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
8447 188362 80 None -4 13 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
CHEMBL508112 188362 80 None -4 13 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
2389 3279 114 None -69 67 Human 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3279 114 None -69 67 Human 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3279 114 None -69 67 Human 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3279 114 None -69 67 Human 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3279 114 None -69 67 Human 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
44390499 129135 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 579 8 2 6 6.0 CN(C)c1nc(NCC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL367355 129135 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 579 8 2 6 6.0 CN(C)c1nc(NCC2CCC(CNC(=O)c3ccc(Br)cc3OC(F)(F)F)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
135398737 944 89 None -26 91 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 944 89 None -26 91 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 944 89 None -26 91 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 944 89 None -26 91 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 944 89 None -26 91 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
213 3792 50 None -6 43 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 3792 50 None -6 43 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 3792 50 None -6 43 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 3792 50 None -6 43 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 3792 50 None -6 43 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
3082597 99098 8 None - 1 Bovine 5.0 pIC50 = 5.0 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99098 8 None - 1 Bovine 5.0 pIC50 = 5.0 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
36324 26916 71 None - 1 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 293 4 0 2 4.9 Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1 nan
CHEMBL1365675 26916 71 None - 1 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 293 4 0 2 4.9 Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1 nan
1548953 205945 24 None -1 17 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
CHEMBL954 205945 24 None -1 17 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
14450364 55712 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 1 0 3 2.6 COc1cc(C)cc2c1[C@H]1CCCN(C)[C@@H]1CO2 10.1021/jm00123a039
CHEMBL162449 55712 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor at 1 uM
ChEMBL 247 1 0 3 2.6 COc1cc(C)cc2c1[C@H]1CCCN(C)[C@@H]1CO2 10.1021/jm00123a039
44390768 64143 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 434 6 2 7 3.8 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc([N+](=O)[O-])c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
CHEMBL181383 64143 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cellsInhibitory activity against alpha-2A adrenergic receptor by using [3H]MK-912 as radioligand expressed in COS-1 cells
ChEMBL 434 6 2 7 3.8 CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)c3cccc([N+](=O)[O-])c3)CC2)nc2ccccc12 10.1016/j.bmcl.2005.05.121
1562 886 8 None - 2 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
5312114 886 8 None - 2 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
CHEMBL17645 886 8 None - 2 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
CHEMBL195380 886 8 None - 2 Human 7.0 pIC50 = 7.0 Binding
Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912Inhibitory activity against constitutively activated human Alpha-2A adrenergic receptor transiently expressed in COS-1 cells using [3H]MK-912
ChEMBL 475 7 3 6 4.6 Nc1nc(NCC2CCC(CC2)CNS(=O)(=O)c2cccc3c2cccc3)nc2c1cccc2 10.1016/j.bmcl.2005.03.052
441383 20133 54 None -2 17 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 20133 54 None -2 17 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
164612037 184795 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 184795 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
168290235 192366 0 None -40 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 192366 0 None -40 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 192366 0 None -40 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
168294767 192417 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 192417 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 192417 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
168295528 192429 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 192429 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 192429 0 None -11 20 Human 9.2 pKd = 9.2 Binding
Displacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]RX821002 from human alpha-2A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
118714540 114013 0 None 5 4 Human 9.0 pKd = 9.0 Binding
Displacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from human adenosine A2a receptor K150A mutant expressed in COS-7 cells assessed as radioligand Kd compound preincubated for 30 minsDisplacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from human adenosine A2a receptor K150A mutant expressed in COS-7 cells assessed as radioligand Kd compound preincubated for 30 mins
ChEMBL 677 13 6 15 1.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)Nc5ccc(OC(C)=O)c([N+](=O)[O-])c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/ml5002486
CHEMBL3335523 114013 0 None 5 4 Human 9.0 pKd = 9.0 Binding
Displacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from human adenosine A2a receptor K150A mutant expressed in COS-7 cells assessed as radioligand Kd compound preincubated for 30 minsDisplacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from human adenosine A2a receptor K150A mutant expressed in COS-7 cells assessed as radioligand Kd compound preincubated for 30 mins
ChEMBL 677 13 6 15 1.2 CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(NCCc4ccc(CCC(=O)Nc5ccc(OC(C)=O)c([N+](=O)[O-])c5)cc4)nc32)[C@H](O)[C@@H]1O 10.1021/ml5002486
10220232 99260 5 None 54 6 Rat 11.1 pKi = 11.1 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm990569e
CHEMBL284795 99260 5 None 54 6 Rat 11.1 pKi = 11.1 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm990569e
521 1377 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm990569e
5311068 1377 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm990569e
835 1377 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm990569e
CHEMBL778 1377 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm990569e
DB00633 1377 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm990569e
521 1377 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
5311068 1377 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
835 1377 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
CHEMBL778 1377 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
DB00633 1377 64 None -2 7 Rat 10.8 pKi = 10.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
49781228 17023 1 None 2 4 Human 10.6 pKi = 10.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
CHEMBL1256414 17023 1 None 2 4 Human 10.6 pKi = 10.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
155540329 171908 0 None - 1 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 426 7 0 6 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4482861 171908 0 None - 1 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 426 7 0 6 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
78114674 173154 0 None - 1 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 380 7 0 7 2.5 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4536304 173154 0 None - 1 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 380 7 0 7 2.5 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
155513359 169196 0 None - 1 Human 10.2 pKi = 10.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 471 8 0 8 3.9 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cccc([N+](=O)[O-])c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4438801 169196 0 None - 1 Human 10.2 pKi = 10.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 471 8 0 8 3.9 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cccc([N+](=O)[O-])c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
49781228 17023 1 None 2 4 Human 10.2 pKi = 10.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
CHEMBL1256414 17023 1 None 2 4 Human 10.2 pKi = 10.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
49781228 17023 1 None 2 4 Human 10.1 pKi = 10.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
CHEMBL1256414 17023 1 None 2 4 Human 10.1 pKi = 10.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
11271808 60669 0 None 1 2 Human 10.0 pKi = 10 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 490 9 0 7 3.5 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OCCN(C)C)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL176261 60669 0 None 1 2 Human 10.0 pKi = 10 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 490 9 0 7 3.5 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OCCN(C)C)cc4OC[C@H]32)CC1 10.1021/jm049619s
11306100 167942 0 None -3 2 Human 10.0 pKi = 10 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 477 9 0 7 3.5 COCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL435352 167942 0 None -3 2 Human 10.0 pKi = 10 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 477 9 0 7 3.5 COCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
1588 2294 24 None 2 43 Human 9.9 pKi = 9.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 2294 24 None 2 43 Human 9.9 pKi = 9.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 2294 24 None 2 43 Human 9.9 pKi = 9.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 2294 24 None 2 43 Human 9.9 pKi = 9.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 2294 24 None 2 43 Human 9.9 pKi = 9.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
52944548 16971 0 None 1 4 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.0 CC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255723 16971 0 None 1 4 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.0 CC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
52941512 17016 0 None 1 4 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256378 17016 0 None 1 4 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
135519400 63563 0 None -1 2 Human 9.7 pKi = 9.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 419 5 1 6 3.2 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(O)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL180470 63563 0 None -1 2 Human 9.7 pKi = 9.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 419 5 1 6 3.2 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(O)cc4OC[C@H]32)CC1 10.1021/jm049619s
49781222 17069 0 None 2 4 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 3.0 C[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256609 17069 0 None 2 4 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 3.0 C[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
46224879 199862 3 None -1 7 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 302 2 0 2 4.6 Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL605405 199862 3 None -1 7 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 302 2 0 2 4.6 Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
124 2933 44 None -4 32 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
2032 2933 44 None -4 32 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
4636 2933 44 None -4 32 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
CHEMBL762 2933 44 None -4 32 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
DB00935 2933 44 None -4 32 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
44330168 4254 0 None -1 2 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4cccs4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL100879 4254 0 None -1 2 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4cccs4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
11225779 107246 0 None -1 2 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cc(F)ccc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL319119 107246 0 None -1 2 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cc(F)ccc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44324972 162820 0 None -2 4 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL419316 162820 0 None -2 4 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44324972 162820 0 None -2 4 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL419316 162820 0 None -2 4 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324800 205220 0 None -5 7 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL91157 205220 0 None -5 7 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324972 162820 0 None -2 4 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL419316 162820 0 None -2 4 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
44324800 205220 0 None -5 7 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL91157 205220 0 None -5 7 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
78114597 171917 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 356 6 0 6 2.6 CCOP(=O)(OCC)C1N=CC2C(=O)N(C3CCCCC3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4483022 171917 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 356 6 0 6 2.6 CCOP(=O)(OCC)C1N=CC2C(=O)N(C3CCCCC3)C(=O)C21 10.1021/acs.jmedchem.9b02080
49781887 16963 0 None 3 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
CHEMBL1255617 16963 0 None 3 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
9837136 99476 2 None - 1 Rat 9.5 pKi = 9.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3ccsc32)c[nH]1 10.1021/jm990569e
CHEMBL286269 99476 2 None - 1 Rat 9.5 pKi = 9.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3ccsc32)c[nH]1 10.1021/jm990569e
9837136 99476 2 None - 1 Rat 9.5 pKi = 9.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3ccsc32)c[nH]1 10.1021/jm000128r
CHEMBL286269 99476 2 None - 1 Rat 9.5 pKi = 9.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3ccsc32)c[nH]1 10.1021/jm000128r
108094 3368 22 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
526 3368 22 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
528 3368 22 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
CHEMBL10332 3368 22 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
10531 1392 18 None -5 24 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 1392 18 None -5 24 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 1392 18 None -5 24 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 1392 18 None -5 24 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 1392 18 None -5 24 Human 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
10056237 13632 0 None 47 2 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 817 13 6 6 7.3 O=C(NCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1195197 13632 0 None 47 2 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 817 13 6 6 7.3 O=C(NCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL554019 13632 0 None 47 2 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 817 13 6 6 7.3 O=C(NCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
2803 941 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
516 941 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
704 941 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
CHEMBL134 941 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
DB00575 941 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
2803 941 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
516 941 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
704 941 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
CHEMBL134 941 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
DB00575 941 53 None 1 19 Rat 9.4 pKi = 9.4 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
11259744 60472 0 None -1 2 Human 9.4 pKi = 9.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 461 6 0 7 3.4 CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL176116 60472 0 None -1 2 Human 9.4 pKi = 9.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 461 6 0 7 3.4 CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
52948958 16972 0 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.4 CCC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255724 16972 0 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.4 CCC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
102 4064 44 None -5 49 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
3659 4064 44 None -5 49 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
8969 4064 44 None -5 49 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
CHEMBL15245 4064 44 None -5 49 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
DB01392 4064 44 None -5 49 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
52943739 16978 0 None 2 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@]12C[C@@]1(c1c[nH]cn1)Cc1ccccc12 10.1021/jm1006269
CHEMBL1255771 16978 0 None 2 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@]12C[C@@]1(c1c[nH]cn1)Cc1ccccc12 10.1021/jm1006269
44387789 60251 0 None -2 2 Human 9.3 pKi = 9.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 433 6 0 6 3.5 COc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL176002 60251 0 None -2 2 Human 9.3 pKi = 9.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 433 6 0 6 3.5 COc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
44330114 107596 0 None -1 2 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 453 7 0 8 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccco4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL319530 107596 0 None -1 2 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 453 7 0 8 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccco4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44324906 205060 0 None 3 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)OCC1C2=NOC1CN1CCN(C/C=C/c2ccccc2)CC1 10.1016/s0960-894x(03)00525-0
CHEMBL90247 205060 0 None 3 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)OCC1C2=NOC1CN1CCN(C/C=C/c2ccccc2)CC1 10.1016/s0960-894x(03)00525-0
49781223 17070 0 None 2 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.3 CC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256610 17070 0 None 2 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.3 CC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
9815633 99174 2 None 6 6 Rat 9.3 pKi = 9.3 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm990569e
CHEMBL284213 99174 2 None 6 6 Rat 9.3 pKi = 9.3 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm990569e
9815633 99174 2 None 6 6 Rat 9.3 pKi = 9.3 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm000128r
CHEMBL284213 99174 2 None 6 6 Rat 9.3 pKi = 9.3 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm000128r
49781005 17032 0 None 3 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256503 17032 0 None 3 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
49781887 16963 0 None 3 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
CHEMBL1255617 16963 0 None 3 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
11214030 60220 0 None -3 2 Human 9.2 pKi = 9.2 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 491 8 0 8 3.1 COCC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL175853 60220 0 None -3 2 Human 9.2 pKi = 9.2 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 491 8 0 8 3.1 COCC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
107715 199260 18 None -6 20 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 199260 18 None -6 20 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 199260 18 None -6 20 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
11765813 12869 0 None 60 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 788 11 6 6 6.5 O=C(NCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1189483 12869 0 None 60 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 788 11 6 6 6.5 O=C(NCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL538808 12869 0 None 60 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 788 11 6 6 6.5 O=C(NCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
13938361 184781 0 None 141 2 Bovine 9.1 pKi = 9.1 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@@H]1CCN2CCc3c(oc4ccccc34)[C@@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL48603 184781 0 None 141 2 Bovine 9.1 pKi = 9.1 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@@H]1CCN2CCc3c(oc4ccccc34)[C@@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
1043 1552 13 None -8 28 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 1552 13 None -8 28 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 1552 13 None -8 28 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 1552 13 None -8 28 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 1552 13 None -8 28 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
44324800 205220 0 None -5 7 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL91157 205220 0 None -5 7 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44324887 164463 0 None 2 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL422597 164463 0 None 2 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44325050 205550 0 None -3 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL93171 205550 0 None -3 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44126269 199799 4 None -2 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 318 3 0 2 4.5 Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1 10.1016/j.bmcl.2009.11.037
CHEMBL605081 199799 4 None -2 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 318 3 0 2 4.5 Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1 10.1016/j.bmcl.2009.11.037
49781224 16962 0 None 1 4 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.7 CCC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255616 16962 0 None 1 4 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.7 CCC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
12114852 13209 0 None 31 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 774 10 6 6 6.1 O=C(NCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1192051 13209 0 None 31 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 774 10 6 6 6.1 O=C(NCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL543232 13209 0 None 31 2 Human 9.1 pKi = 9.1 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 774 10 6 6 6.1 O=C(NCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
11785068 60232 0 None -2 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 487 7 0 7 3.8 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C5CC5)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL175911 60232 0 None -2 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 487 7 0 7 3.8 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C5CC5)cc4OC[C@H]32)CC1 10.1021/jm049619s
11260018 63528 0 None -1 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 473 7 0 7 3.6 C=CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL180322 63528 0 None -1 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 473 7 0 7 3.6 C=CC(=O)Oc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
71450907 78529 0 None 1 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 389 5 0 5 3.1 C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL2112978 78529 0 None 1 2 Human 9.1 pKi = 9.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 389 5 0 5 3.1 C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4OC[C@H]32)CC1 10.1021/jm049619s
44324937 205186 0 None 1 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 389 5 0 5 3.1 C(=C/c1ccccc1)\CN1CCN(CC2ON=C3c4ccccc4OCC32)CC1 10.1016/s0960-894x(03)00525-0
CHEMBL90943 205186 0 None 1 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 389 5 0 5 3.1 C(=C/c1ccccc1)\CN1CCN(CC2ON=C3c4ccccc4OCC32)CC1 10.1016/s0960-894x(03)00525-0
2142 3047 54 None 1 36 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
4920903 3047 54 None 1 36 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
502 3047 54 None 1 36 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
5775 3047 54 None 1 36 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
CHEMBL597 3047 54 None 1 36 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
DB00692 3047 54 None 1 36 Bovine 9.0 pKi = 9.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
155547631 173122 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 432 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C3CCCCC3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4535472 173122 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 432 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C3CCCCC3)C(=O)C21 10.1021/acs.jmedchem.9b02080
11318438 165431 0 None -1 2 Human 9.0 pKi = 9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 524 7 0 8 4.1 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)c5ccncc5)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL425324 165431 0 None -1 2 Human 9.0 pKi = 9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 524 7 0 8 4.1 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)c5ccncc5)cc4OC[C@H]32)CC1 10.1021/jm049619s
9805944 55934 31 None -1 9 Human 9.0 pKi = 9 Binding
Displacement of [125I]HEAT from adrenergic alpha2A receptorDisplacement of [125I]HEAT from adrenergic alpha2A receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
CHEMBL1627 55934 31 None -1 9 Human 9.0 pKi = 9 Binding
Displacement of [125I]HEAT from adrenergic alpha2A receptorDisplacement of [125I]HEAT from adrenergic alpha2A receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
44330635 206684 0 None -2 2 Human 9.0 pKi = 9 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 493 8 0 8 3.5 COc1ccccc1/C=C(\C)CN1CCN(C[C@@H]2ON=C3c4cc(OC)c(OC)cc4OC[C@H]32)CC1 10.1016/j.bmcl.2004.03.031
CHEMBL99868 206684 0 None -2 2 Human 9.0 pKi = 9 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 493 8 0 8 3.5 COc1ccccc1/C=C(\C)CN1CCN(C[C@@H]2ON=C3c4cc(OC)c(OC)cc4OC[C@H]32)CC1 10.1016/j.bmcl.2004.03.031
52950140 16977 0 None 1 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 1 1 1 3.0 CC1(C)[C@@H]2c3ccccc3C[C@@]21c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255770 16977 0 None 1 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 1 1 1 3.0 CC1(C)[C@@H]2c3ccccc3C[C@@]21c1c[nH]cn1 10.1021/jm1006269
44330668 4370 0 None -5 2 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccsc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL101596 4370 0 None -5 2 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccsc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44330617 96172 0 None -5 2 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL263424 96172 0 None -5 2 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44371848 13514 0 None 15 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 845 15 6 6 8.1 O=C(NCCCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1194334 13514 0 None 15 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 845 15 6 6 8.1 O=C(NCCCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL551711 13514 0 None 15 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 845 15 6 6 8.1 O=C(NCCCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
9837551 101153 0 None 7 3 Human 8.9 pKi = 8.9 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 232 1 3 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCO2 10.1021/jm960359r
CHEMBL298936 101153 0 None 7 3 Human 8.9 pKi = 8.9 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 232 1 3 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCO2 10.1021/jm960359r
12114853 12918 0 None 35 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 803 12 6 6 6.9 O=C(NCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1189875 12918 0 None 35 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 803 12 6 6 6.9 O=C(NCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL539606 12918 0 None 35 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 803 12 6 6 6.9 O=C(NCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
10847653 57144 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 240 0 1 2 2.6 C1=NC[C@]2(CC[C@@H]3Cc4ccccc4C[C@H]3C2)N1 10.1021/jm001040g
CHEMBL165529 57144 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 240 0 1 2 2.6 C1=NC[C@]2(CC[C@@H]3Cc4ccccc4C[C@H]3C2)N1 10.1021/jm001040g
11785961 62950 0 None -6 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 535 13 0 8 4.0 CCOCCOCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL179237 62950 0 None -6 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 535 13 0 8 4.0 CCOCCOCCOc1ccc2c(c1)OC[C@@H]1C2=NO[C@H]1CN1CCN(C/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
11190988 131281 0 None -2 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 487 7 0 6 4.8 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC5CCCC5)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL369378 131281 0 None -2 2 Human 8.9 pKi = 8.9 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 487 7 0 6 4.8 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC5CCCC5)cc4OC[C@H]32)CC1 10.1021/jm049619s
136019934 143997 0 None -7 3 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
CHEMBL390718 143997 0 None -7 3 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
44324737 205508 0 None -2 5 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL92860 205508 0 None -2 5 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324737 205508 0 None -2 5 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL92860 205508 0 None -2 5 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1021/jm049619s
10123375 13139 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 760 9 6 6 5.8 O=C(NCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1191431 13139 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 760 9 6 6 5.8 O=C(NCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL542527 13139 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 760 9 6 6 5.8 O=C(NCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
13938356 184495 0 None 154 2 Bovine 8.9 pKi = 8.9 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN(C1CCN2CCc3c(oc4ccccc34)C2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL48558 184495 0 None 154 2 Bovine 8.9 pKi = 8.9 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN(C1CCN2CCc3c(oc4ccccc34)C2C1)S(=O)(=O)CCO 10.1021/jm00150a002
44330369 111093 0 None -4 2 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccsc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL328195 111093 0 None -4 2 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccsc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
102 4064 44 None -5 49 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
3659 4064 44 None -5 49 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
8969 4064 44 None -5 49 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
CHEMBL15245 4064 44 None -5 49 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
DB01392 4064 44 None -5 49 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
44325049 111035 0 None -2 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C(\C)c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL327875 111035 0 None -2 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C(\C)c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
10707358 178705 0 None 4 3 Human 8.8 pKi = 8.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 272 4 1 3 3.2 c1ccc(CC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL47313 178705 0 None 4 3 Human 8.8 pKi = 8.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 272 4 1 3 3.2 c1ccc(CC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
12575 1957 28 None 1 16 Bovine 8.8 pKi = 8.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
54459 1957 28 None 1 16 Bovine 8.8 pKi = 8.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
CHEMBL10316 1957 28 None 1 16 Bovine 8.8 pKi = 8.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
9815610 99471 15 None 13 4 Rat 8.8 pKi = 8.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm990569e
CHEMBL286246 99471 15 None 13 4 Rat 8.8 pKi = 8.8 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm990569e
124 2933 44 None -5 32 Bovine 8.8 pKi = 8.8 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
2032 2933 44 None -5 32 Bovine 8.8 pKi = 8.8 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
4636 2933 44 None -5 32 Bovine 8.8 pKi = 8.8 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
CHEMBL762 2933 44 None -5 32 Bovine 8.8 pKi = 8.8 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
DB00935 2933 44 None -5 32 Bovine 8.8 pKi = 8.8 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
9815610 99471 15 None 13 4 Rat 8.8 pKi = 8.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm000128r
CHEMBL286246 99471 15 None 13 4 Rat 8.8 pKi = 8.8 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm000128r
11200476 78521 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Binding affinity for Alpha-2A adrenergic receptorBinding affinity for Alpha-2A adrenergic receptor
ChEMBL 402 5 0 5 3.2 CN1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
CHEMBL2112970 78521 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Binding affinity for Alpha-2A adrenergic receptorBinding affinity for Alpha-2A adrenergic receptor
ChEMBL 402 5 0 5 3.2 CN1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
9837600 23117 0 None 12 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 236 0 1 3 1.9 NC1=NC2(CCc3cccc(Cl)c3C2)CO1 10.1021/jm00020a021
CHEMBL133231 23117 0 None 12 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 236 0 1 3 1.9 NC1=NC2(CCc3cccc(Cl)c3C2)CO1 10.1021/jm00020a021
46891598 7097 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]rauwolscine from adrenergic alpha2A receptorDisplacement of [3H]rauwolscine from adrenergic alpha2A receptor
ChEMBL 402 5 0 5 3.2 CN1CC2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1016/j.bmcl.2010.04.099
CHEMBL1085510 7097 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]rauwolscine from adrenergic alpha2A receptorDisplacement of [3H]rauwolscine from adrenergic alpha2A receptor
ChEMBL 402 5 0 5 3.2 CN1CC2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1016/j.bmcl.2010.04.099
42266865 15427 2 None 1 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 389 6 1 4 3.4 COc1ccccc1N1CCN(CCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221498 15427 2 None 1 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 389 6 1 4 3.4 COc1ccccc1N1CCN(CCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
2142 3047 54 None -2 36 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
4920903 3047 54 None -2 36 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
502 3047 54 None -2 36 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
5775 3047 54 None -2 36 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
CHEMBL597 3047 54 None -2 36 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
DB00692 3047 54 None -2 36 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/np50094a001
10176999 103079 14 None 11 3 Human 8.8 pKi = 8.8 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
CHEMBL308570 103079 14 None 11 3 Human 8.8 pKi = 8.8 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
44330653 206491 0 None -8 2 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccs4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL98646 206491 0 None -8 2 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 469 7 0 8 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccs4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44330645 206692 0 None -3 2 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 453 7 0 8 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccco4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL99916 206692 0 None -3 2 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 453 7 0 8 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccco4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
10350094 13705 0 None 77 2 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 746 8 6 6 5.4 O=C(NCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1195716 13705 0 None 77 2 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 746 8 6 6 5.4 O=C(NCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL555190 13705 0 None 77 2 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 746 8 6 6 5.4 O=C(NCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
49781005 17032 0 None 3 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256503 17032 0 None 3 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
13123525 188609 0 None - 1 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 265 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)c2ccccc2)cc1 10.1021/jm00366a022
CHEMBL51131 188609 0 None - 1 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 265 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)c2ccccc2)cc1 10.1021/jm00366a022
13123534 188863 1 None - 1 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 209 3 2 3 1.8 Clc1ccccc1NCC1=NCCN1 10.1021/jm00366a022
CHEMBL51358 188863 1 None - 1 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 209 3 2 3 1.8 Clc1ccccc1NCC1=NCCN1 10.1021/jm00366a022
71461647 78523 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 439 5 0 5 4.4 COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1 10.1021/jm049619s
CHEMBL2112972 78523 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 439 5 0 5 4.4 COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1 10.1021/jm049619s
71456240 78532 0 None 2 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 415 6 0 5 3.8 COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(C/C=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL2112982 78532 0 None 2 2 Human 8.7 pKi = 8.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 415 6 0 5 3.8 COc1ccc2c(c1)C=C[C@@H]1C2=NO[C@H]1CN1CCN(C/C=C/c2ccccc2)CC1 10.1021/jm049619s
102 4064 44 None -5 49 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
3659 4064 44 None -5 49 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
8969 4064 44 None -5 49 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
CHEMBL15245 4064 44 None -5 49 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
DB01392 4064 44 None -5 49 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
12576 511 87 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
71310 511 87 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
CHEMBL353972 511 87 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
DB11481 511 87 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
44330368 111700 0 None -3 2 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 479 7 1 8 3.2 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(O)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL329065 111700 0 None -3 2 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 479 7 1 8 3.2 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(O)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
108094 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1016/j.ejmech.2014.05.057
526 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1016/j.ejmech.2014.05.057
528 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1016/j.ejmech.2014.05.057
CHEMBL10332 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1016/j.ejmech.2014.05.057
42631003 197937 10 None -10 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 304 3 0 2 4.2 Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL592752 197937 10 None -10 8 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 304 3 0 2 4.2 Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
10198135 203415 3 None 43 3 Human 8.0 pKi = 8 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 203 3 2 3 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1 10.1021/jm9605142
CHEMBL77913 203415 3 None 43 3 Human 8.0 pKi = 8 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 203 3 2 3 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1 10.1021/jm9605142
2389 3279 114 None -69 67 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm049632c
5073 3279 114 None -69 67 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm049632c
96 3279 114 None -69 67 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm049632c
CHEMBL85 3279 114 None -69 67 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm049632c
DB00734 3279 114 None -69 67 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm049632c
44401243 167929 0 None -4 9 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.6 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL435301 167929 0 None -4 9 Human 8.0 pKi = 8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.6 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1 10.1021/jm049632c
49836302 18379 1 None 1 3 Human 7.0 pKi = 7 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml400232p
CHEMBL1276139 18379 1 None 1 3 Human 7.0 pKi = 7 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml400232p
10176715 156592 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 2 2.4 C1=NCC(CC2=Cc3ccccc3CC2)N1 10.1021/jm001040g
CHEMBL407509 156592 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 2 2.4 C1=NCC(CC2=Cc3ccccc3CC2)N1 10.1021/jm001040g
242 467 117 None -26 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
34 467 117 None -26 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
60795 467 117 None -26 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
CHEMBL1112 467 117 None -26 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
DB01238 467 117 None -26 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
250 3334 5 None -2818 13 Human 7.0 pKi = 7 Binding
Compound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
5311416 3334 5 None -2818 13 Human 7.0 pKi = 7 Binding
Compound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
CHEMBL69733 3334 5 None -2818 13 Human 7.0 pKi = 7 Binding
Compound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-2A adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
135398737 944 89 None -10 91 Rat 7.0 pKi = 7 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1016/j.ejmech.2012.08.011
38 944 89 None -10 91 Rat 7.0 pKi = 7 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1016/j.ejmech.2012.08.011
722 944 89 None -10 91 Rat 7.0 pKi = 7 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1016/j.ejmech.2012.08.011
CHEMBL42 944 89 None -10 91 Rat 7.0 pKi = 7 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1016/j.ejmech.2012.08.011
DB00363 944 89 None -10 91 Rat 7.0 pKi = 7 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1016/j.ejmech.2012.08.011
49836302 18379 1 None 1 3 Human 7.0 pKi = 7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/jm100977d
CHEMBL1276139 18379 1 None 1 3 Human 7.0 pKi = 7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/jm100977d
49836302 18379 1 None 1 3 Human 7.0 pKi = 7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml300064v
CHEMBL1276139 18379 1 None 1 3 Human 7.0 pKi = 7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml300064v
13938357 101260 0 None 79 2 Bovine 7.0 pKi = 7 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@H]1CCN2CCc3c(oc4ccccc34)[C@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL299595 101260 0 None 79 2 Bovine 7.0 pKi = 7 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@H]1CCN2CCc3c(oc4ccccc34)[C@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
135398737 944 89 None -26 91 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
38 944 89 None -26 91 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
722 944 89 None -26 91 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
CHEMBL42 944 89 None -26 91 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
DB00363 944 89 None -26 91 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
135398745 2869 108 None -93 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
47 2869 108 None -93 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
CHEMBL715 2869 108 None -93 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
DB00334 2869 108 None -93 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
2389 3279 114 None -69 67 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
5073 3279 114 None -69 67 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
96 3279 114 None -69 67 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
CHEMBL85 3279 114 None -69 67 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
DB00734 3279 114 None -69 67 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
90644728 112255 0 None - 1 Human 6.0 pKi = 6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 1 2.1 CC1CN/C(=N/c2ccc3c(c2)CCCC3)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3289543 112255 0 None - 1 Human 6.0 pKi = 6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 1 2.1 CC1CN/C(=N/c2ccc3c(c2)CCCC3)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3305161 112255 0 None - 1 Human 6.0 pKi = 6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 1 2.1 CC1CN/C(=N/c2ccc3c(c2)CCCC3)N1 10.1016/j.ejmech.2014.05.057
16090600 168615 0 None -10 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 6 2 4 5.1 Cc1nc2ccccc2c(Nc2ccc(NCCN3CCCC3)cc2)c1C 10.1021/jm060262x
CHEMBL440594 168615 0 None -10 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 6 2 4 5.1 Cc1nc2ccccc2c(Nc2ccc(NCCN3CCCC3)cc2)c1C 10.1021/jm060262x
10324985 76428 7 None -741 17 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha-2A receptorBinding affinity to adrenergic alpha-2A receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
CHEMBL199824 76428 7 None -741 17 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha-2A receptorBinding affinity to adrenergic alpha-2A receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
CHEMBL2068762 76428 7 None -741 17 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha-2A receptorBinding affinity to adrenergic alpha-2A receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
127035062 135928 0 None -3 19 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha 2A receptor stably expressed in MDCK cells after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human recombinant alpha 2A receptor stably expressed in MDCK cells after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
CHEMBL3735756 135928 0 None -3 19 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha 2A receptor stably expressed in MDCK cells after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human recombinant alpha 2A receptor stably expressed in MDCK cells after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
10443343 18314 1 None - 1 Bovine 6.0 pKi = 6.0 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 0 5 0.5 CN1CCN(c2nccn3ccnc23)CC1 10.1021/jm00099a012
CHEMBL127303 18314 1 None - 1 Bovine 6.0 pKi = 6.0 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 0 5 0.5 CN1CCN(c2nccn3ccnc23)CC1 10.1021/jm00099a012
1782 2482 81 None -5 22 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
241 2482 81 None -5 22 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
4168 2482 81 None -5 22 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
CHEMBL86 2482 81 None -5 22 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
DB01233 2482 81 None -5 22 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC nan
44574076 171894 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 251 2 0 4 2.9 c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448147 171894 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 251 2 0 4 2.9 c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
9960497 116574 0 None -309 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL3392246 116574 0 None -309 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
57395731 70846 0 None 6 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956202 70846 0 None 6 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
44312037 202913 1 None 1 6 Human 5.0 pKi = 5.0 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73392 202913 1 None 1 6 Human 5.0 pKi = 5.0 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
3151 1434 93 None -99 26 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 1434 93 None -99 26 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 1434 93 None -99 26 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 1434 93 None -99 26 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 1434 93 None -99 26 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
12909387 62308 0 None -33 2 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 301 0 0 3 3.8 CN1CCC(=C2c3cc(C#N)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL178376 62308 0 None -33 2 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 301 0 0 3 3.8 CN1CCC(=C2c3cc(C#N)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
9904117 9312 3 None 1 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111554 9312 3 None 1 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11091738 117589 0 None -1584 6 Rat 6.0 pKi = 6.0 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 456 7 1 4 4.9 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2cn1 10.1021/jm0211220
CHEMBL340641 117589 0 None -1584 6 Rat 6.0 pKi = 6.0 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 456 7 1 4 4.9 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2cn1 10.1021/jm0211220
57402718 70845 2 None 1 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956201 70845 2 None 1 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
2803 941 53 None -1 19 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 941 53 None -1 19 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 941 53 None -1 19 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 941 53 None -1 19 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 941 53 None -1 19 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
16090624 81989 0 None -13 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL217278 81989 0 None -13 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
4209 3114 71 None -173 33 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3114 71 None -173 33 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3114 71 None -173 33 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3114 71 None -173 33 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3114 71 None -173 33 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3114 71 None -173 33 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
277 1274 55 None -33 45 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 1274 55 None -33 45 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 1274 55 None -33 45 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 1274 55 None -33 45 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 1274 55 None -33 45 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
1268096 15989 21 None -3 4 Human 7.0 pKi = 7.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL122404 15989 21 None -3 4 Human 7.0 pKi = 7.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12 10.1021/jm00019a001
90644708 112245 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 5 3 3 2.4 CCNc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289530 112245 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 5 3 3 2.4 CCNc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304993 112245 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 5 3 3 2.4 CCNc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
68617 203816 60 None -3 25 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL1709 203816 60 None -3 25 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL809 203816 60 None -3 25 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
10769331 111045 0 None -208 6 Human 7.0 pKi = 7.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
CHEMBL327931 111045 0 None -208 6 Human 7.0 pKi = 7.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
197033 197473 58 None -13 8 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 319 3 0 3 3.9 Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL589390 197473 58 None -13 8 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cellsDisplacement of [3H]MK-912 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells
ChEMBL 319 3 0 3 3.9 Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
13298529 100749 50 None 134 2 Bovine 8.0 pKi = 8.0 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 241 1 1 3 1.3 Brc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL295921 100749 50 None 134 2 Bovine 8.0 pKi = 8.0 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 241 1 1 3 1.3 Brc1cccnc1N1CCNCC1 10.1021/jm00366a007
71456238 78528 0 None -2 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 504 9 0 7 4.4 COc1cc2c(cc1OC)N(C)C[C@@H]1C2=NO[C@H]1CN1CCN(CCC/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
CHEMBL2112977 78528 0 None -2 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 504 9 0 7 4.4 COc1cc2c(cc1OC)N(C)C[C@@H]1C2=NO[C@H]1CN1CCN(CCC/C(C)=C/c2ccccc2)CC1 10.1021/jm049619s
46934426 15449 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 431 9 1 4 4.6 COc1ccccc1N1CCN(CCCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221591 15449 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 431 9 1 4 4.6 COc1ccccc1N1CCN(CCCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
49781004 17031 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256502 17031 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1 10.1021/jm1006269
44371755 48513 0 None 15 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL155866 48513 0 None 15 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
90469115 185260 2 None -36 17 Human 7.0 pKi = 7.0 Binding
Binding affinity to human adrenergic alpha 2A receptorBinding affinity to human adrenergic alpha 2A receptor
ChEMBL 410 3 1 6 3.0 O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21 10.1021/acs.jmedchem.1c00224
CHEMBL4867565 185260 2 None -36 17 Human 7.0 pKi = 7.0 Binding
Binding affinity to human adrenergic alpha 2A receptorBinding affinity to human adrenergic alpha 2A receptor
ChEMBL 410 3 1 6 3.0 O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21 10.1021/acs.jmedchem.1c00224
9809007 171996 6 None -1905 6 Human 6.0 pKi = 6.0 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 171996 6 None -1905 6 Human 6.0 pKi = 6.0 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
10109188 165522 0 None -43 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 4 1 4 4.6 CCc1c(C)nc2ccccc2c1Nc1ccc(N2CCN(C)CC2)cc1 10.1021/jm060262x
CHEMBL425803 165522 0 None -43 2 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 4 1 4 4.6 CCc1c(C)nc2ccccc2c1Nc1ccc(N2CCN(C)CC2)cc1 10.1021/jm060262x
44574103 172019 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 250 2 0 4 2.4 c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448908 172019 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 250 2 0 4 2.4 c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
162661022 180866 0 None - 1 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 485 9 5 11 0.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4764318 180866 0 None - 1 Rat 5.0 pKi = 5.0 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 485 9 5 11 0.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
3168 9172 84 None -123 21 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 9172 84 None -123 21 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
1227 2454 35 None -91 11 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
2331 2454 35 None -91 11 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
3957 2454 35 None -91 11 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
4992 2454 35 None -91 11 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
CHEMBL511 2454 35 None -91 11 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
DB06691 2454 35 None -91 11 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C nan
2435 714 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 714 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 714 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 714 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 714 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 714 98 None -4 12 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
44574079 188720 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 261 2 0 3 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL512289 188720 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 261 2 0 3 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1 10.1016/j.bmcl.2009.03.166
10531766 205269 0 None -999 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL91415 205269 0 None -999 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
62381476 112270 2 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 4 3 2 2.1 CCCNC(=N)Nc1ccc(N(C)C)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289536 112270 2 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 4 3 2 2.1 CCCNC(=N)Nc1ccc(N(C)C)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305461 112270 2 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 4 3 2 2.1 CCCNC(=N)Nc1ccc(N(C)C)cc1 10.1016/j.ejmech.2014.05.057
122295 9775 6 None -1 9 Human 6.9 pKi = 6.9 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00018a001
CHEMBL114166 9775 6 None -1 9 Human 6.9 pKi = 6.9 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00018a001
122295 9775 6 None -1 9 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
CHEMBL114166 9775 6 None -1 9 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
44574104 188899 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 353 4 1 4 3.3 CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL513871 188899 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 353 4 1 4 3.3 CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
145990586 166290 0 None -89 11 Human 5.9 pKi = 5.9 Binding
Binding affinity to andrenergic alpha2A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assayBinding affinity to andrenergic alpha2A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
CHEMBL4285281 166290 0 None -89 11 Human 5.9 pKi = 5.9 Binding
Binding affinity to andrenergic alpha2A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assayBinding affinity to andrenergic alpha2A receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
2335 11743 21 None -5 12 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
8478 11743 21 None -5 12 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL1182210 11743 21 None -5 12 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL221753 11743 21 None -5 12 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
176 394 63 None -3 31 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2157 394 63 None -3 31 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2566 394 63 None -3 31 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
CHEMBL633 394 63 None -3 31 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
DB01118 394 63 None -3 31 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
44424855 85029 0 None -1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
CHEMBL226636 85029 0 None -1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
44325038 205189 0 None -3 3 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 474 6 0 8 3.2 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ncccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL90966 205189 0 None -3 3 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 474 6 0 8 3.2 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ncccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
127026052 137028 0 None -7 19 Human 6.9 pKi = 6.9 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754496 137028 0 None -7 19 Human 6.9 pKi = 6.9 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
16090630 82824 0 None -309 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 4 2 5 4.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)(C)C3)cc2)c1CO 10.1021/jm060262x
CHEMBL218675 82824 0 None -309 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 4 2 5 4.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)(C)C3)cc2)c1CO 10.1021/jm060262x
10579368 105524 0 None -5 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL313251 105524 0 None -5 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
155526524 170619 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 364 6 0 6 2.4 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4459090 170619 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 364 6 0 6 2.4 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C)C(=O)C21 10.1021/acs.jmedchem.9b02080
90644720 112261 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 3 4 4 0.3 N=C(NCCO)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3289524 112261 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 3 4 4 0.3 N=C(NCCO)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3305319 112261 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 3 4 4 0.3 N=C(NCCO)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
44579230 180962 0 None -50 3 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
CHEMBL476569 180962 0 None -50 3 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
10316512 16688 2 None -18 2 Bovine 4.9 pKi = 4.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 359 1 1 5 1.7 Brc1cnc(N2CCNCC2)c2ncc(Br)n12 10.1021/jm00099a012
CHEMBL124926 16688 2 None -18 2 Bovine 4.9 pKi = 4.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 359 1 1 5 1.7 Brc1cnc(N2CCNCC2)c2ncc(Br)n12 10.1021/jm00099a012
10081626 20895 0 None 12 2 Human 7.9 pKi = 7.9 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 204 0 1 2 1.7 Fc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL131220 20895 0 None 12 2 Human 7.9 pKi = 7.9 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 204 0 1 2 1.7 Fc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
10262765 116055 0 None 13 2 Human 7.9 pKi = 7.9 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CCC1(CN=CN1)C2 10.1021/jm00020a021
CHEMBL336332 116055 0 None 13 2 Human 7.9 pKi = 7.9 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CCC1(CN=CN1)C2 10.1021/jm00020a021
398712 77516 5 None -12 5 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]RX 821002 from Adrenergic alpha-2a receptor in rat cerebral cortex cellsDisplacement of [3H]RX 821002 from Adrenergic alpha-2a receptor in rat cerebral cortex cells
ChEMBL 417 9 1 5 2.9 COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc(C)cc2)CC1 10.1021/jm0508641
CHEMBL209324 77516 5 None -12 5 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]RX 821002 from Adrenergic alpha-2a receptor in rat cerebral cortex cellsDisplacement of [3H]RX 821002 from Adrenergic alpha-2a receptor in rat cerebral cortex cells
ChEMBL 417 9 1 5 2.9 COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc(C)cc2)CC1 10.1021/jm0508641
44325075 111273 0 None -2 2 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 465 8 0 8 2.7 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCC(=O)c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328735 111273 0 None -2 2 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 465 8 0 8 2.7 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCC(=O)c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44292196 179426 0 None 5 2 Bovine 6.9 pKi = 6.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 287 3 0 3 3.1 Clc1cccnc1N1CCN(Cc2ccccc2)CC1 10.1021/jm00366a007
CHEMBL47471 179426 0 None 5 2 Bovine 6.9 pKi = 6.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 287 3 0 3 3.1 Clc1cccnc1N1CCN(Cc2ccccc2)CC1 10.1021/jm00366a007
9809007 171996 6 None -1905 6 Human 5.9 pKi = 5.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 171996 6 None -1905 6 Human 5.9 pKi = 5.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
2775690 92579 47 None -45 6 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha2A adrenoceptor receptor (unknown origin)Binding affinity to alpha2A adrenoceptor receptor (unknown origin)
ChEMBL 295 1 1 3 3.0 Cc1ccc2nc(C(F)(F)F)cc(N3CCNCC3)c2c1 10.1021/ml400312j
CHEMBL2441619 92579 47 None -45 6 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha2A adrenoceptor receptor (unknown origin)Binding affinity to alpha2A adrenoceptor receptor (unknown origin)
ChEMBL 295 1 1 3 3.0 Cc1ccc2nc(C(F)(F)F)cc(N3CCNCC3)c2c1 10.1021/ml400312j
9809007 171996 6 None -1905 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL448620 171996 6 None -1905 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
11380132 83998 0 None 1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccccn1)C1=NCCN1 10.1021/jm0408215
CHEMBL221989 83998 0 None 1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccccn1)C1=NCCN1 10.1021/jm0408215
1268096 15989 21 None -42 4 Rat 5.9 pKi = 5.9 Binding
Compound was evaluated for the ability to inhibit binding of [3H]nitrendipine to membrane homogenates of of rat alpha-2D adrenergic receptorCompound was evaluated for the ability to inhibit binding of [3H]nitrendipine to membrane homogenates of of rat alpha-2D adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL122404 15989 21 None -42 4 Rat 5.9 pKi = 5.9 Binding
Compound was evaluated for the ability to inhibit binding of [3H]nitrendipine to membrane homogenates of of rat alpha-2D adrenergic receptorCompound was evaluated for the ability to inhibit binding of [3H]nitrendipine to membrane homogenates of of rat alpha-2D adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12 10.1021/jm00019a001
92766 106060 30 None -12 6 Human 5.9 pKi = 5.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL31410 106060 30 None -12 6 Human 5.9 pKi = 5.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
24839550 136791 14 None -1 15 Human 6.9 pKi = 6.9 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752576 136791 14 None -1 15 Human 6.9 pKi = 6.9 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
11246610 83895 0 None 2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccc([N+](=O)[O-])cc1)C1=NCCN1 10.1021/jm0408215
CHEMBL221523 83895 0 None 2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccc([N+](=O)[O-])cc1)C1=NCCN1 10.1021/jm0408215
16090626 81723 0 None -77 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 378 3 1 4 4.9 Cc1nc2ccc(F)cc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL216727 81723 0 None -77 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 378 3 1 4 4.9 Cc1nc2ccc(F)cc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
44421258 84322 0 None 3 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL1204386 84322 0 None 3 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL222933 84322 0 None 3 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
90644730 112274 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 3 3 2 1.7 CCNc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289544 112274 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 3 3 2 1.7 CCNc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305465 112274 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 3 3 2 1.7 CCNc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
71452341 83283 4 None -4 4 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 376 6 0 3 5.3 Cc1c(C(=O)N(CCCN2CCCCC2)c2ccccc2)oc2ccccc12 10.1016/j.bmc.2012.09.044
CHEMBL2205361 83283 4 None -4 4 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 376 6 0 3 5.3 Cc1c(C(=O)N(CCCN2CCCCC2)c2ccccc2)oc2ccccc12 10.1016/j.bmc.2012.09.044
44269006 32137 1 None -1 4 Human 6.9 pKi = 6.9 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 5 1 3 1.8 C=CCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL14107 32137 1 None -1 4 Human 6.9 pKi = 6.9 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 5 1 3 1.8 C=CCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
24906243 186665 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2cccc(-c3ccccc3)c2O1 10.1021/jm800250z
CHEMBL492648 186665 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2cccc(-c3ccccc3)c2O1 10.1021/jm800250z
1267 3744 43 None -52 25 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 10.1021/jm8003625
3035905 3744 43 None -52 25 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 10.1021/jm8003625
CHEMBL260374 3744 43 None -52 25 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 10.1021/jm8003625
2284 3133 27 None -12 28 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 3133 27 None -12 28 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 3133 27 None -12 28 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 3133 27 None -12 28 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 3133 27 None -12 28 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
9839050 111886 0 None -263 9 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 293 2 0 2 3.8 CN(C)C[C@H]1C[C@@H]2c3ccccc3Cc3ccccc3[C@H]2O1 10.1021/jm049632c
CHEMBL329566 111886 0 None -263 9 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 293 2 0 2 3.8 CN(C)C[C@H]1C[C@@H]2c3ccccc3Cc3ccccc3[C@H]2O1 10.1021/jm049632c
9928335 119592 1 None -3 6 Rat 6.9 pKi = 6.9 Binding
In vivo binding affinity was evaluated against Alpha-1 adrenergic receptorIn vivo binding affinity was evaluated against Alpha-1 adrenergic receptor
ChEMBL 349 4 1 3 3.3 Cc1ccc(N2CCN(CC[C@H]3NC(=O)c4ccccc43)CC2)cc1C 10.1016/s0960-894x(98)00252-2
CHEMBL35093 119592 1 None -3 6 Rat 6.9 pKi = 6.9 Binding
In vivo binding affinity was evaluated against Alpha-1 adrenergic receptorIn vivo binding affinity was evaluated against Alpha-1 adrenergic receptor
ChEMBL 349 4 1 3 3.3 Cc1ccc(N2CCN(CC[C@H]3NC(=O)c4ccccc43)CC2)cc1C 10.1016/s0960-894x(98)00252-2
CHEMBL4520788 212225 6 None -6 25 Human 6.9 pKi = 6.9 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000743a ADRA2ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000743a ADRA2A
ChEMBL None None None CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1 nan
3038525 13438 107 None -2 3 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
CHEMBL119385 13438 107 None -2 3 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
181743 177997 3 None -645 22 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]Clonidine from human adrenergic alpha2A receptorDisplacement of [3H]Clonidine from human adrenergic alpha2A receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
CHEMBL467094 177997 3 None -645 22 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]Clonidine from human adrenergic alpha2A receptorDisplacement of [3H]Clonidine from human adrenergic alpha2A receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
9827677 167858 0 None -6456 7 Human 5.9 pKi = 5.9 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43491 167858 0 None -6456 7 Human 5.9 pKi = 5.9 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
10627021 106611 0 None -933 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
CHEMBL315914 106611 0 None -933 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
129211 3692 75 None -120 16 Human 7.9 pKi = 7.9 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 3692 75 None -120 16 Human 7.9 pKi = 7.9 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 3692 75 None -120 16 Human 7.9 pKi = 7.9 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 3692 75 None -120 16 Human 7.9 pKi = 7.9 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 3692 75 None -120 16 Human 7.9 pKi = 7.9 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
44292385 100652 0 None 2 3 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 270 3 1 3 2.6 c1ccc(C[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL295186 100652 0 None 2 3 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 270 3 1 3 2.6 c1ccc(C[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
10609673 103300 0 None 11 3 Human 6.9 pKi = 6.9 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 233 4 2 4 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1OC 10.1021/jm9605142
CHEMBL308863 103300 0 None 11 3 Human 6.9 pKi = 6.9 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 233 4 2 4 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1OC 10.1021/jm9605142
CHEMBL179334 62973 0 None -7079 6 Human 5.9 pKi = 5.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
162664874 181594 0 None - 1 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 519 9 5 11 1.1 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccc(Cl)cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4782649 181594 0 None - 1 Rat 4.9 pKi = 4.9 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 519 9 5 11 1.1 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccc(Cl)cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
71450550 83393 0 None -2 16 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha2A adrenergic receptorBinding affinity to alpha2A adrenergic receptor
ChEMBL 309 4 1 3 2.0 COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53 10.1016/j.bmcl.2012.08.046
CHEMBL2205836 83393 0 None -2 16 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha2A adrenergic receptorBinding affinity to alpha2A adrenergic receptor
ChEMBL 309 4 1 3 2.0 COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53 10.1016/j.bmcl.2012.08.046
9926529 9299 2 None -1 5 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111496 9299 2 None -1 5 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
10221004 202530 0 None -1 5 Human 5.9 pKi = 5.9 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70973 202530 0 None -1 5 Human 5.9 pKi = 5.9 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
90644736 112275 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 3 2 3 2.3 CN(C)c1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289547 112275 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 3 2 3 2.3 CN(C)c1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305466 112275 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 3 2 3 2.3 CN(C)c1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
180 397 50 None -58 38 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 397 50 None -58 38 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 397 50 None -58 38 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 397 50 None -58 38 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 397 50 None -58 38 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2726 906 64 None -64 72 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 906 64 None -64 72 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 906 64 None -64 72 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 906 64 None -64 72 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 906 64 None -64 72 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
10475736 165310 0 None -26 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 4 2 5 4.1 CN1CCN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CC1(C)C 10.1021/jm060262x
CHEMBL424917 165310 0 None -26 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 4 2 5 4.1 CN1CCN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CC1(C)C 10.1021/jm060262x
3805301 100867 76 None -1 2 Bovine 5.9 pKi = 5.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL296787 100867 76 None -1 2 Bovine 5.9 pKi = 5.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL1350036 67455 0 None - 1 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1909062 67455 0 None - 1 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
44438148 93057 0 None -14 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL246229 93057 0 None -14 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 10.1016/j.bmcl.2006.12.094
11779308 18317 8 None 4 2 Bovine 5.9 pKi = 5.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 295 1 0 5 1.2 CN1CCN(c2nccn3c(Br)cnc23)CC1 10.1021/jm00099a012
CHEMBL127318 18317 8 None 4 2 Bovine 5.9 pKi = 5.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 295 1 0 5 1.2 CN1CCN(c2nccn3c(Br)cnc23)CC1 10.1021/jm00099a012
44288877 168034 0 None -1905 5 Human 4.9 pKi = 4.9 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL43594 168034 0 None -1905 5 Human 4.9 pKi = 4.9 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
2484 206552 64 None - 1 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 nan
CHEMBL990 206552 64 None - 1 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 nan
599482 201295 9 None -9 5 Human 5.9 pKi = 5.9 Binding
Binding affinity towards alpha-2A-Adrenergic receptorBinding affinity towards alpha-2A-Adrenergic receptor
ChEMBL 202 1 2 2 1.8 COc1ccc2c3c([nH]c2c1)CNCC3 10.1016/j.bmcl.2003.09.027
CHEMBL6310 201295 9 None -9 5 Human 5.9 pKi = 5.9 Binding
Binding affinity towards alpha-2A-Adrenergic receptorBinding affinity towards alpha-2A-Adrenergic receptor
ChEMBL 202 1 2 2 1.8 COc1ccc2c3c([nH]c2c1)CNCC3 10.1016/j.bmcl.2003.09.027
119584 2557 99 None -2 6 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
1848 2557 99 None -2 6 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
242 2557 99 None -2 6 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
CHEMBL60889 2557 99 None -2 6 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
DB11675 2557 99 None -2 6 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
44579228 181072 0 None -57 3 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL477608 181072 0 None -57 3 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
11265631 135886 0 None -2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
CHEMBL373535 135886 0 None -2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
11265631 135886 0 None -2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
CHEMBL373535 135886 0 None -2 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
10317643 98088 0 None -32 2 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 380 4 2 5 3.8 CC1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C 10.1021/jm060262x
CHEMBL276417 98088 0 None -32 2 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 380 4 2 5 3.8 CC1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C 10.1021/jm060262x
2737203 183342 76 None 141 2 Bovine 7.9 pKi = 7.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 188 1 1 4 0.4 N#Cc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL48137 183342 76 None 141 2 Bovine 7.9 pKi = 7.9 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 188 1 1 4 0.4 N#Cc1cccnc1N1CCNCC1 10.1021/jm00366a007
13123527 101320 3 None - 1 Bovine 7.9 pKi = 7.9 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 189 3 2 3 1.4 Cc1ccc(NCC2=NCCN2)cc1 10.1021/jm00366a022
CHEMBL300053 101320 3 None - 1 Bovine 7.9 pKi = 7.9 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 189 3 2 3 1.4 Cc1ccc(NCC2=NCCN2)cc1 10.1021/jm00366a022
13123531 187658 0 None - 1 Bovine 7.9 pKi = 7.9 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 217 4 1 3 1.8 CCN(CC1=NCCN1)c1ccc(C)cc1 10.1021/jm00366a022
CHEMBL49953 187658 0 None - 1 Bovine 7.9 pKi = 7.9 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 217 4 1 3 1.8 CCN(CC1=NCCN1)c1ccc(C)cc1 10.1021/jm00366a022
10219 188210 30 None -1 5 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL493439 188210 30 None -1 5 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL50588 188210 30 None -1 5 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
11211035 84579 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm061487a
CHEMBL223836 84579 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm061487a
11211035 84579 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL223836 84579 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm0408215
10376053 13024 0 None 2 3 Bovine 6.9 pKi = 6.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL1190547 13024 0 None 2 3 Bovine 6.9 pKi = 6.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL541088 13024 0 None 2 3 Bovine 6.9 pKi = 6.9 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
16090622 81886 0 None -165 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 346 3 1 4 4.4 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)C2)cc1 10.1021/jm060262x
CHEMBL217202 81886 0 None -165 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 346 3 1 4 4.4 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)C2)cc1 10.1021/jm060262x
10070896 82783 0 None -281 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 422 4 1 4 6.1 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1-c1ccccc1 10.1021/jm060262x
CHEMBL218457 82783 0 None -281 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 422 4 1 4 6.1 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1-c1ccccc1 10.1021/jm060262x
44438166 93384 0 None -33 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL247664 93384 0 None -33 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 10.1016/j.bmcl.2006.12.094
4428003 112267 16 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 179 3 3 2 1.4 CCOc1ccc(NC(=N)N)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289540 112267 16 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 179 3 3 2 1.4 CCOc1ccc(NC(=N)N)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305332 112267 16 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 179 3 3 2 1.4 CCOc1ccc(NC(=N)N)cc1 10.1016/j.ejmech.2014.05.057
155566429 175354 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 378 7 0 6 2.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4587519 175354 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 378 7 0 6 2.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC)C(=O)C21 10.1021/acs.jmedchem.9b02080
90644758 112254 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 3 2 2 1.7 CCOc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289541 112254 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 3 2 2 1.7 CCOc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305160 112254 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 3 2 2 1.7 CCOc1ccc(/N=C2/NCC(C)N2)cc1 10.1016/j.ejmech.2014.05.057
5472 204104 69 None -1 3 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL1717 204104 69 None -1 3 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL833 204104 69 None -1 3 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
10318507 58645 0 None -173 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cc(Cl)ccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL1689423 58645 0 None -173 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cc(Cl)ccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
2406 99938 84 None -16 12 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
CHEMBL290106 99938 84 None -16 12 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
43260 5408 61 None 1 5 Human 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
CHEMBL1076 5408 61 None 1 5 Human 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
10758200 63087 0 None -43 5 Human 6.8 pKi = 6.8 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL179648 63087 0 None -43 5 Human 6.8 pKi = 6.8 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
1836 2554 56 None -43 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
3340 2554 56 None -43 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
5281040 2554 56 None -43 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
CHEMBL787 2554 56 None -43 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
DB00471 2554 56 None -43 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 nan
44574135 188589 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 268 2 1 3 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL511211 188589 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 268 2 1 3 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1 10.1016/j.bmcl.2009.03.166
90644702 112219 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 5 2 3 2.4 CCOc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289533 112219 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 5 2 3 2.4 CCOc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304532 112219 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 5 2 3 2.4 CCOc1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
44311789 203028 0 None -1 5 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL74342 203028 0 None -1 5 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
9894818 98468 0 None -83 7 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
CHEMBL279436 98468 0 None -83 7 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
4189 205195 91 None -18 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1559 205195 91 None -18 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL91 205195 91 None -18 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
131268 112403 24 None 26 3 Bovine 7.8 pKi = 7.8 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 203 1 1 5 0.1 c1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL331036 112403 24 None 26 3 Bovine 7.8 pKi = 7.8 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 203 1 1 5 0.1 c1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
3952 1857 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 1857 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 1857 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 1857 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 1857 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 1857 33 None -2 12 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
10266032 188294 0 None 2 3 Human 7.8 pKi = 7.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 286 5 1 3 3.5 c1ccc(CCC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL50720 188294 0 None 2 3 Human 7.8 pKi = 7.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 286 5 1 3 3.5 c1ccc(CCC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
12114851 12931 0 None 12 2 Human 7.8 pKi = 7.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 732 7 6 6 5.0 O=C(NCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1189965 12931 0 None 12 2 Human 7.8 pKi = 7.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 732 7 6 6 5.0 O=C(NCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL539824 12931 0 None 12 2 Human 7.8 pKi = 7.8 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 732 7 6 6 5.0 O=C(NCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
44292386 101012 0 None 5 3 Human 7.8 pKi = 7.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 296 4 1 3 3.5 C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297827 101012 0 None 5 3 Human 7.8 pKi = 7.8 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 296 4 1 3 3.5 C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
13123529 101393 0 None - 1 Bovine 6.8 pKi = 6.8 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 203 3 1 3 1.4 Cc1ccc(N(C)CC2=NCCN2)cc1 10.1021/jm00366a022
CHEMBL300628 101393 0 None - 1 Bovine 6.8 pKi = 6.8 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 203 3 1 3 1.4 Cc1ccc(N(C)CC2=NCCN2)cc1 10.1021/jm00366a022
12574 2567 84 None -4 5 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
4810 2567 84 None -4 5 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
CHEMBL19236 2567 84 None -4 5 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
DB09242 2567 84 None -4 5 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
3584 3718 60 None -251 14 Human 5.8 pKi = 5.8 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 3718 60 None -251 14 Human 5.8 pKi = 5.8 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 3718 60 None -251 14 Human 5.8 pKi = 5.8 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 3718 60 None -251 14 Human 5.8 pKi = 5.8 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 3718 60 None -251 14 Human 5.8 pKi = 5.8 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
11041026 179645 43 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 162 1 2 2 0.7 NCC1Cc2ccccc2CN1 10.1021/acs.jmedchem.0c01475
CHEMBL4749860 179645 43 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 162 1 2 2 0.7 NCC1Cc2ccccc2CN1 10.1021/acs.jmedchem.0c01475
162645059 178834 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 471 8 5 11 0.1 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4740168 178834 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 471 8 5 11 0.1 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
162653032 179810 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 505 8 5 11 0.7 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccc(Cl)cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4751862 179810 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 505 8 5 11 0.7 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccc(Cl)cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
162654934 180009 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 485 9 5 11 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2CNCc3ccccc32)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4754362 180009 0 None - 1 Rat 4.8 pKi = 4.8 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 485 9 5 11 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2CNCc3ccccc32)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
9894818 98468 0 None -83 7 Human 6.8 pKi = 6.8 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98468 0 None -83 7 Human 6.8 pKi = 6.8 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10474335 193025 16 None -52 10 Human 5.8 pKi = 5.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 370 6 0 3 4.8 COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1 10.1038/s41586-020-2286-9
CHEMBL53325 193025 16 None -52 10 Human 5.8 pKi = 5.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 370 6 0 3 4.8 COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1 10.1038/s41586-020-2286-9
90644710 112232 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 3 3 4 2.1 N=C(NCc1ccco1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3289529 112232 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 3 3 4 2.1 N=C(NCc1ccco1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3304670 112232 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 259 3 3 4 2.1 N=C(NCc1ccco1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
44421258 84322 0 None 3 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL1204386 84322 0 None 3 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL222933 84322 0 None 3 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
62379598 112272 3 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 3 3 3 1.8 CCCNC(=N)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3289539 112272 3 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 3 3 3 1.8 CCCNC(=N)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3305463 112272 3 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 3 3 3 1.8 CCCNC(=N)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
5318 15400 44 None -1 13 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1200348 15400 44 None -1 13 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1221 15400 44 None -1 13 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
5353853 17803 41 None -16 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
9556529 17803 41 None -16 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1262 17803 41 None -16 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
101333429 116575 0 None -3890 6 Human 5.8 pKi = 5.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
CHEMBL3392247 116575 0 None -3890 6 Human 5.8 pKi = 5.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
11186523 126989 0 None -109 9 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1C[C@@H]2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL366164 126989 0 None -109 9 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1C[C@@H]2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
135356876 173502 0 None -9 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human alpha2A receptor expressed in MDCK cells by PDSP assayBinding affinity to human alpha2A receptor expressed in MDCK cells by PDSP assay
ChEMBL 464 5 2 6 5.5 O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-n2cc(-c3ccc(Cl)s3)nn2)c1 10.1021/acs.jmedchem.6b00044
CHEMBL4544251 173502 0 None -9 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human alpha2A receptor expressed in MDCK cells by PDSP assayBinding affinity to human alpha2A receptor expressed in MDCK cells by PDSP assay
ChEMBL 464 5 2 6 5.5 O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-n2cc(-c3ccc(Cl)s3)nn2)c1 10.1021/acs.jmedchem.6b00044
114697 3631 4 None -8 3 Human 5.8 pKi = 5.8 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 263 1 2 3 2.7 Clc1ccc(cc1NC1=NCCN1)C(F)(F)F 10.1021/jm00020a021
513 3631 4 None -8 3 Human 5.8 pKi = 5.8 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 263 1 2 3 2.7 Clc1ccc(cc1NC1=NCCN1)C(F)(F)F 10.1021/jm00020a021
CHEMBL101340 3631 4 None -8 3 Human 5.8 pKi = 5.8 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 263 1 2 3 2.7 Clc1ccc(cc1NC1=NCCN1)C(F)(F)F 10.1021/jm00020a021
12981869 168071 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 230 2 1 2 2.5 Fc1ccc2c(c1)C=C(CC1CN=CN1)CC2 10.1021/jm001040g
CHEMBL436234 168071 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 230 2 1 2 2.5 Fc1ccc2c(c1)C=C(CC1CN=CN1)CC2 10.1021/jm001040g
10508016 205427 0 None -43 6 Human 5.8 pKi = 5.8 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
CHEMBL92322 205427 0 None -43 6 Human 5.8 pKi = 5.8 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
132584404 142817 0 None -3 5 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]Rauwolscine from human Alpha2A receptor expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]Rauwolscine from human Alpha2A receptor expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 416 3 0 2 6.7 CCCN1CC[C@H]2c3cc4ccc(C(F)(F)F)cc4nc3[C@H](CC)[C@H]3CCC[C@@H]1[C@@H]32 10.1016/j.bmcl.2016.10.065
CHEMBL3897499 142817 0 None -3 5 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]Rauwolscine from human Alpha2A receptor expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]Rauwolscine from human Alpha2A receptor expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 416 3 0 2 6.7 CCCN1CC[C@H]2c3cc4ccc(C(F)(F)F)cc4nc3[C@H](CC)[C@H]3CCC[C@@H]1[C@@H]32 10.1016/j.bmcl.2016.10.065
135 2496 38 None -4 57 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 2496 38 None -4 57 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 2496 38 None -4 57 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 2496 38 None -4 57 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 2496 38 None -4 57 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
44324800 205220 0 None -5 7 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL91157 205220 0 None -5 7 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
14004040 51359 0 None 6 2 Bovine 7.8 pKi = 7.8 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL158371 51359 0 None 6 2 Bovine 7.8 pKi = 7.8 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
124 2933 44 None -4 32 Human 7.8 pKi = 7.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 2933 44 None -4 32 Human 7.8 pKi = 7.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 2933 44 None -4 32 Human 7.8 pKi = 7.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 2933 44 None -4 32 Human 7.8 pKi = 7.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 2933 44 None -4 32 Human 7.8 pKi = 7.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
14004040 51359 0 None 6 2 Bovine 7.8 pKi = 7.8 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL158371 51359 0 None 6 2 Bovine 7.8 pKi = 7.8 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
15391752 181748 0 None -7 7 Human 7.8 pKi = 7.8 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 411 7 1 5 4.6 CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1 10.1016/j.bmcl.2020.127506
CHEMBL4784373 181748 0 None -7 7 Human 7.8 pKi = 7.8 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 411 7 1 5 4.6 CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1 10.1016/j.bmcl.2020.127506
44371744 50050 0 None 7 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 270 7 1 3 2.9 C=CCc1cccc(CC=C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL157206 50050 0 None 7 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 270 7 1 3 2.9 C=CCc1cccc(CC=C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
11360447 84577 0 None 4 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
CHEMBL223829 84577 0 None 4 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
44350012 17840 0 None 6 3 Bovine 5.8 pKi = 5.8 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 363 4 3 7 0.4 CC1CN=C2C(N3CCNCC3)=NC=CN21.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
CHEMBL126394 17840 0 None 6 3 Bovine 5.8 pKi = 5.8 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 363 4 3 7 0.4 CC1CN=C2C(N3CCNCC3)=NC=CN21.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
6604117 187264 6 None -16 6 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL2062340 187264 6 None -16 6 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL49623 187264 6 None -16 6 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
168290009 191222 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 267 1 2 5 2.0 Nc1ncc(/C=C2\CCc3c(O)cccc3C2=O)cn1 10.1016/j.ejmech.2021.113964
CHEMBL5198566 191222 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 267 1 2 5 2.0 Nc1ncc(/C=C2\CCc3c(O)cccc3C2=O)cn1 10.1016/j.ejmech.2021.113964
10660 14298 55 None -43 12 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
CHEMBL1200406 14298 55 None -43 12 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
6918276 15435 4 None -16 8 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 559 18 4 9 1.7 CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS nan
CHEMBL1221512 15435 4 None -16 8 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 559 18 4 9 1.7 CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS nan
3198 203802 73 None -19 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 203802 73 None -19 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 203802 73 None -19 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
11140345 202470 0 None -1 6 Human 6.8 pKi = 6.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 202470 0 None -1 6 Human 6.8 pKi = 6.8 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
122442272 137820 0 None -11 15 Human 6.8 pKi = 6.8 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3769968 137820 0 None -11 15 Human 6.8 pKi = 6.8 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3771384 137820 0 None -11 15 Human 6.8 pKi = 6.8 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
49836306 18388 0 None 1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276247 18388 0 None 1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
21392988 203109 4 None -1 3 Human 4.8 pKi = 4.8 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 156 0 0 4 -0.3 C1COC(N2CCOCC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL75201 203109 4 None -1 3 Human 4.8 pKi = 4.8 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 156 0 0 4 -0.3 C1COC(N2CCOCC2)=N1 10.1016/0960-894X(94)85032-1
4209 3114 71 None -616 33 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3114 71 None -616 33 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3114 71 None -616 33 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3114 71 None -616 33 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3114 71 None -616 33 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3114 71 None -616 33 Rat 5.8 pKi = 5.8 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
1547484 927 70 None -5 20 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 927 70 None -5 20 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 927 70 None -5 20 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 927 70 None -5 20 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 927 70 None -5 20 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
3645619 2985 13 None -104 9 Rat 6.8 pKi = 6.8 Binding
Binding affinity at alpha-1 adrenergic receptorBinding affinity at alpha-1 adrenergic receptor
ChEMBL 334 4 1 4 2.4 N#Cc1ccccc1N1CCN(CC1)CNC(=O)c1cccc(c1)C 10.1021/jm970021c
975 2985 13 None -104 9 Rat 6.8 pKi = 6.8 Binding
Binding affinity at alpha-1 adrenergic receptorBinding affinity at alpha-1 adrenergic receptor
ChEMBL 334 4 1 4 2.4 N#Cc1ccccc1N1CCN(CC1)CNC(=O)c1cccc(c1)C 10.1021/jm970021c
CHEMBL45244 2985 13 None -104 9 Rat 6.8 pKi = 6.8 Binding
Binding affinity at alpha-1 adrenergic receptorBinding affinity at alpha-1 adrenergic receptor
ChEMBL 334 4 1 4 2.4 N#Cc1ccccc1N1CCN(CC1)CNC(=O)c1cccc(c1)C 10.1021/jm970021c
132060720 161939 0 None -4 9 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 315 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
CHEMBL4167315 161939 0 None -4 9 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 315 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
44415569 165381 0 None -107 6 Human 6.8 pKi = 6.8 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 505 4 1 7 4.5 COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
CHEMBL425069 165381 0 None -107 6 Human 6.8 pKi = 6.8 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 505 4 1 7 4.5 COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
26987 936 29 None -158 21 Human 6.8 pKi = 6.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
6063 936 29 None -158 21 Human 6.8 pKi = 6.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
671 936 29 None -158 21 Human 6.8 pKi = 6.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
CHEMBL1626 936 29 None -158 21 Human 6.8 pKi = 6.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
DB00283 936 29 None -158 21 Human 6.8 pKi = 6.8 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
9838192 110824 13 None 2 6 Human 6.8 pKi = 6.8 Binding
Binding affinity to Homo sapiens (human) alpha2A receptorBinding affinity to Homo sapiens (human) alpha2A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
CHEMBL326702 110824 13 None 2 6 Human 6.8 pKi = 6.8 Binding
Binding affinity to Homo sapiens (human) alpha2A receptorBinding affinity to Homo sapiens (human) alpha2A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
155523897 170303 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 444 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4454147 170303 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 444 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
155556443 173912 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 406 6 0 6 3.6 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C(C)(C)C)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4554450 173912 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 406 6 0 6 3.6 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(C(C)(C)C)C(=O)C21 10.1021/acs.jmedchem.9b02080
9838192 110824 13 None 2 6 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
CHEMBL326702 110824 13 None 2 6 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
136680384 205921 0 None -380 6 Human 5.8 pKi = 5.8 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44328799 205921 0 None -380 6 Human 5.8 pKi = 5.8 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL95290 205921 0 None -380 6 Human 5.8 pKi = 5.8 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
90644742 112243 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 2 2 4 1.9 c1coc(C2CN/C(=N/c3ccc4c(c3)OCO4)N2)c1 10.1016/j.ejmech.2014.05.057
CHEMBL3289550 112243 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 2 2 4 1.9 c1coc(C2CN/C(=N/c3ccc4c(c3)OCO4)N2)c1 10.1016/j.ejmech.2014.05.057
CHEMBL3304990 112243 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 2 2 4 1.9 c1coc(C2CN/C(=N/c3ccc4c(c3)OCO4)N2)c1 10.1016/j.ejmech.2014.05.057
135 2496 38 None -5 57 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
1796 2496 38 None -5 57 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
4184 2496 38 None -5 57 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
CHEMBL6437 2496 38 None -5 57 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
DB06148 2496 38 None -5 57 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
3303 2213 41 None -245 15 Human 6.8 pKi = 6.8 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
5311200 2213 41 None -245 15 Human 6.8 pKi = 6.8 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
CHEMBL267014 2213 41 None -245 15 Human 6.8 pKi = 6.8 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
10319299 81175 0 None -48 2 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 408 4 1 4 5.7 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1-c1ccccc1 10.1021/jm060262x
CHEMBL216290 81175 0 None -48 2 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 408 4 1 4 5.7 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1-c1ccccc1 10.1021/jm060262x
10177445 165489 0 None -32 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 4 1 4 5.2 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C(C)C 10.1021/jm060262x
CHEMBL425622 165489 0 None -32 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 4 1 4 5.2 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C(C)C 10.1021/jm060262x
CHEMBL1441214 39578 0 None - 1 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1476898 39578 0 None - 1 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
71454275 83634 0 None -41 5 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]UK 14.304 from human adrenergic alpha2A receptorDisplacement of [3H]UK 14.304 from human adrenergic alpha2A receptor
ChEMBL 293 3 1 3 3.0 CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1 10.1021/jm300975f
CHEMBL2207493 83634 0 None -41 5 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]UK 14.304 from human adrenergic alpha2A receptorDisplacement of [3H]UK 14.304 from human adrenergic alpha2A receptor
ChEMBL 293 3 1 3 3.0 CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1 10.1021/jm300975f
11221758 84194 0 None 7 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccccc1[N+](=O)[O-])C1=NCCN1 10.1021/jm0408215
CHEMBL222138 84194 0 None 7 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccccc1[N+](=O)[O-])C1=NCCN1 10.1021/jm0408215
90644716 112220 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 233 3 4 2 1.5 N=C(NCCO)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3289526 112220 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 233 3 4 2 1.5 N=C(NCCO)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3304535 112220 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 233 3 4 2 1.5 N=C(NCCO)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
16725934 146890 0 None -87 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL392992 146890 0 None -87 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 10.1016/j.bmcl.2006.12.094
44574077 178183 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 267 2 0 4 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL468710 178183 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 267 2 0 4 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1 10.1016/j.bmcl.2009.03.166
136 3240 28 None -16 16 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
223 3240 28 None -16 16 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
643606 3240 28 None -16 16 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
CHEMBL10347 3240 28 None -16 16 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
3024499 174900 67 None 20 2 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccc(N2CCNCC2)n1 10.1021/jm00366a007
CHEMBL45773 174900 67 None 20 2 Bovine 7.8 pKi = 7.8 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccc(N2CCNCC2)n1 10.1021/jm00366a007
11140347 202828 0 None -2 6 Human 7.7 pKi = 7.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 202828 0 None -2 6 Human 7.7 pKi = 7.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
44292381 100924 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 244 2 1 3 2.7 c1ccc([C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL297228 100924 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 244 2 1 3 2.7 c1ccc([C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
25142456 81994 2 None -89 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human cloned adrenergic alpha 2A receptorBinding affinity to human cloned adrenergic alpha 2A receptor
ChEMBL 269 0 3 4 2.1 Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2 10.1021/jm0604979
CHEMBL217299 81994 2 None -89 9 Human 6.8 pKi = 6.8 Binding
Binding affinity to human cloned adrenergic alpha 2A receptorBinding affinity to human cloned adrenergic alpha 2A receptor
ChEMBL 269 0 3 4 2.1 Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2 10.1021/jm0604979
188249 39415 4 None -1 5 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 328 0 0 5 3.2 CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1 10.1021/jm2013419
CHEMBL147463 39415 4 None -1 5 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 328 0 0 5 3.2 CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1 10.1021/jm2013419
CHEMBL2022280 39415 4 None -1 5 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 328 0 0 5 3.2 CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1 10.1021/jm2013419
73213195 103980 0 None -61 12 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104092 103980 0 None -61 12 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
164615845 184607 0 None -1 6 Human 5.8 pKi = 5.8 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 389 2 1 4 3.7 O=C(O)c1ccc(C#Cc2ccc3c(c2)C=C([N+](=O)[O-])C(C(F)(F)F)O3)cc1 10.1016/j.bmcl.2021.128008
CHEMBL4857492 184607 0 None -1 6 Human 5.8 pKi = 5.8 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 389 2 1 4 3.7 O=C(O)c1ccc(C#Cc2ccc3c(c2)C=C([N+](=O)[O-])C(C(F)(F)F)O3)cc1 10.1016/j.bmcl.2021.128008
5198 19235 46 None - 1 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 nan
CHEMBL12948 19235 46 None - 1 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 nan
68712 99874 57 None -1 5 Human 6.7 pKi = 6.7 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 99874 57 None -1 5 Human 6.7 pKi = 6.7 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
57395663 70837 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.5 CC(Oc1ccccc1C(F)(F)F)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956193 70837 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.5 CC(Oc1ccccc1C(F)(F)F)C1=NCCN1 10.1016/j.bmc.2012.01.035
122065 188958 3 None -3630 8 Human 5.7 pKi = 5.7 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
CHEMBL51433 188958 3 None -3630 8 Human 5.7 pKi = 5.7 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
2247 502 77 None -58 41 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 502 77 None -58 41 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 502 77 None -58 41 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 502 77 None -58 41 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 502 77 None -58 41 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
73213195 103980 0 None -61 12 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104092 103980 0 None -61 12 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
10379016 16315 2 None -1 3 Bovine 6.7 pKi = 6.7 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 281 1 1 5 0.9 Brc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
CHEMBL123566 16315 2 None -1 3 Bovine 6.7 pKi = 6.7 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 281 1 1 5 0.9 Brc1cnc(N2CCNCC2)c2nccn12 10.1021/jm00099a012
3117 206106 100 None -2 16 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 206106 100 None -2 16 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
135398737 944 89 None -26 91 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm2013419
38 944 89 None -26 91 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm2013419
722 944 89 None -26 91 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm2013419
CHEMBL42 944 89 None -26 91 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm2013419
DB00363 944 89 None -26 91 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm2013419
10362866 81887 0 None -371 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
CHEMBL217203 81887 0 None -371 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
10474679 96729 0 None -288 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 4.0 CN1CCN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CC1(C)C 10.1021/jm060262x
CHEMBL268217 96729 0 None -288 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 4.0 CN1CCN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CC1(C)C 10.1021/jm060262x
44438168 93385 0 None -53 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL247665 93385 0 None -53 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 10.1016/j.bmcl.2006.12.094
44324900 205171 0 None -2 3 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 423 6 0 7 2.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL90843 205171 0 None -2 3 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 423 6 0 7 2.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
11043720 91740 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL242265 91740 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
11043720 91740 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL242265 91740 0 None 5 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
44289035 100048 0 None -977 7 Human 5.7 pKi = 5.7 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL291166 100048 0 None -977 7 Human 5.7 pKi = 5.7 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
90644714 112273 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 4 4 3 0.7 CN(C)c1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289527 112273 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 4 4 3 0.7 CN(C)c1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305464 112273 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 4 4 3 0.7 CN(C)c1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
155538461 171835 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 494 7 0 6 5.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(C(F)(F)F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4476557 171835 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 494 7 0 6 5.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(C(F)(F)F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
90644718 112263 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 5 5 3 1.0 CCNc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289525 112263 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 5 5 3 1.0 CCNc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305320 112263 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 222 5 5 3 1.0 CCNc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
1353 1880 85 None -190 85 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1880 85 None -190 85 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1880 85 None -190 85 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1880 85 None -190 85 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1880 85 None -190 85 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
16090601 81980 0 None -208 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 3.9 Cc1c(CO)nc2ccccc2c1Nc1ccc(N2CCN(C)[C@H](C)C2)cc1 10.1021/jm060262x
CHEMBL217254 81980 0 None -208 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 3.9 Cc1c(CO)nc2ccccc2c1Nc1ccc(N2CCN(C)[C@H](C)C2)cc1 10.1021/jm060262x
10873978 167921 0 None -4677 6 Rat 5.7 pKi = 5.7 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 445 7 1 4 5.1 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2o1 10.1021/jm0211220
CHEMBL435218 167921 0 None -4677 6 Rat 5.7 pKi = 5.7 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 445 7 1 4 5.1 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2o1 10.1021/jm0211220
135398737 944 89 None -10 91 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
38 944 89 None -10 91 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
722 944 89 None -10 91 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
CHEMBL42 944 89 None -10 91 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
DB00363 944 89 None -10 91 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
10106205 205408 1 None -1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity towards Alpha-2 adrenergic receptorBinding affinity towards Alpha-2 adrenergic receptor
ChEMBL 251 2 2 3 3.0 Cc1c(NC2=NCCN2)cccc1-c1ccccc1 10.1021/jm030030n
CHEMBL92221 205408 1 None -1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity towards Alpha-2 adrenergic receptorBinding affinity towards Alpha-2 adrenergic receptor
ChEMBL 251 2 2 3 3.0 Cc1c(NC2=NCCN2)cccc1-c1ccccc1 10.1021/jm030030n
12981870 57812 2 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 200 2 1 3 2.0 C1=NCC(Cc2cc3ccccc3o2)N1 10.1021/jm001040g
CHEMBL167644 57812 2 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 200 2 1 3 2.0 C1=NCC(Cc2cc3ccccc3o2)N1 10.1021/jm001040g
10465942 13434 0 None 1 3 Bovine 6.7 pKi = 6.7 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL1193821 13434 0 None 1 3 Bovine 6.7 pKi = 6.7 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL545289 13434 0 None 1 3 Bovine 6.7 pKi = 6.7 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
16090596 81879 0 None -275 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2c(C)cccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL217177 81879 0 None -275 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2c(C)cccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
21584368 198170 3 None -4 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 208 2 2 4 0.6 O=[N+]([O-])c1ccc2c(c1)CNC(CO)C2 10.1021/acs.jmedchem.0c01475
CHEMBL59441 198170 3 None -4 2 Rat 4.7 pKi = 4.7 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 208 2 2 4 0.6 O=[N+]([O-])c1ccc2c(c1)CNC(CO)C2 10.1021/acs.jmedchem.0c01475
90644712 112253 1 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 5 4 3 1.0 CCOc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289528 112253 1 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 5 4 3 1.0 CCOc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305159 112253 1 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 223 5 4 3 1.0 CCOc1ccc(NC(=N)NCCO)cc1 10.1016/j.ejmech.2014.05.057
135398745 2869 108 None -93 65 Human 6.7 pKi = 6.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm049632c
47 2869 108 None -93 65 Human 6.7 pKi = 6.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm049632c
CHEMBL715 2869 108 None -93 65 Human 6.7 pKi = 6.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm049632c
DB00334 2869 108 None -93 65 Human 6.7 pKi = 6.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm049632c
162672516 182540 0 None -3 7 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 425 8 1 5 5.0 CC(=O)Nc1ccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1 10.1016/j.bmcl.2020.127506
CHEMBL4794963 182540 0 None -3 7 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 425 8 1 5 5.0 CC(=O)Nc1ccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1 10.1016/j.bmcl.2020.127506
127036186 136889 0 None -6 19 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3753318 136889 0 None -6 19 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
14004039 119056 3 None 5 2 Bovine 6.7 pKi = 6.7 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
CHEMBL346016 119056 3 None 5 2 Bovine 6.7 pKi = 6.7 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
12699315 75945 0 None -1 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 243 1 2 3 2.8 CC1CNC(Nc2c(Cl)cccc2Cl)=N1 10.1016/j.bmc.2012.06.008
CHEMBL2058631 75945 0 None -1 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 243 1 2 3 2.8 CC1CNC(Nc2c(Cl)cccc2Cl)=N1 10.1016/j.bmc.2012.06.008
14004039 119056 3 None 5 2 Bovine 6.7 pKi = 6.7 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
CHEMBL346016 119056 3 None 5 2 Bovine 6.7 pKi = 6.7 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
44288874 100626 0 None -1949 7 Human 5.7 pKi = 5.7 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL295001 100626 0 None -1949 7 Human 5.7 pKi = 5.7 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
11034737 202823 0 None 2 6 Human 6.7 pKi = 6.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72724 202823 0 None 2 6 Human 6.7 pKi = 6.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
14004032 119329 2 None 1 2 Bovine 5.7 pKi = 5.7 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL348538 119329 2 None 1 2 Bovine 5.7 pKi = 5.7 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
185076 186507 4 None 2 7 Human 8.7 pKi = 8.7 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm960359r
CHEMBL49137 186507 4 None 2 7 Human 8.7 pKi = 8.7 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm960359r
185076 186507 4 None 2 7 Human 8.7 pKi = 8.7 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm9605142
CHEMBL49137 186507 4 None 2 7 Human 8.7 pKi = 8.7 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm9605142
2142 3047 54 None 1 36 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
4920903 3047 54 None 1 36 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
502 3047 54 None 1 36 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
5775 3047 54 None 1 36 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
CHEMBL597 3047 54 None 1 36 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
DB00692 3047 54 None 1 36 Bovine 8.7 pKi = 8.7 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00366a022
2142 3047 54 None -2 36 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 3047 54 None -2 36 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 3047 54 None -2 36 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 3047 54 None -2 36 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 3047 54 None -2 36 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 3047 54 None -2 36 Human 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
124 2933 44 None -4 32 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
2032 2933 44 None -4 32 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
4636 2933 44 None -4 32 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
CHEMBL762 2933 44 None -4 32 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
DB00935 2933 44 None -4 32 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/j.bmcl.2013.12.024
102 4064 44 None -5 49 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 4064 44 None -5 49 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 4064 44 None -5 49 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 4064 44 None -5 49 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 4064 44 None -5 49 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
218362 203092 5 None -1 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 203092 5 None -1 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
73453 29403 22 None -3 17 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 29403 22 None -3 17 Human 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
135440165 78535 0 None -23 2 Human 8.6 pKi = 8.6 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
CHEMBL2112985 78535 0 None -23 2 Human 8.6 pKi = 8.6 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
136019934 143997 0 None -7 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
CHEMBL390718 143997 0 None -7 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
9928332 96732 4 None -1 9 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1016/s0960-894x(03)00525-0
CHEMBL268258 96732 4 None -1 9 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1016/s0960-894x(03)00525-0
9928332 96732 4 None -1 9 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1021/jm049619s
CHEMBL268258 96732 4 None -1 9 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1021/jm049619s
10176567 102327 3 None 10 4 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm990569e
CHEMBL30534 102327 3 None 10 4 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm990569e
44324765 111080 0 None -2 5 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328114 111080 0 None -2 5 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
10176567 102327 3 None 10 4 Rat 8.6 pKi = 8.6 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm000128r
CHEMBL30534 102327 3 None 10 4 Rat 8.6 pKi = 8.6 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm000128r
44324765 111080 0 None -2 5 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL328114 111080 0 None -2 5 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
2142 3047 54 None -2 36 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
4920903 3047 54 None -2 36 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
502 3047 54 None -2 36 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
5775 3047 54 None -2 36 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
CHEMBL597 3047 54 None -2 36 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
DB00692 3047 54 None -2 36 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
11959098 178956 50 None 79 2 Bovine 8.6 pKi = 8.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 211 1 0 3 1.5 CN1CCN(c2ncccc2Cl)CC1 10.1021/jm00366a007
CHEMBL47415 178956 50 None 79 2 Bovine 8.6 pKi = 8.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 211 1 0 3 1.5 CN1CCN(c2ncccc2Cl)CC1 10.1021/jm00366a007
2435 714 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
395 714 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
520 714 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
5386 714 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
CHEMBL844 714 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
DB00484 714 98 None -4 12 Human 8.6 pKi = 8.6 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
3038495 700 30 None -1 19 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2010.07.002
7625 700 30 None -1 19 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2010.07.002
CHEMBL25236 700 30 None -1 19 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2010.07.002
46934427 15452 0 None 3 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 481 11 1 5 4.5 COc1ccccc1N1CCN(CCCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221594 15452 0 None 3 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 481 11 1 5 4.5 COc1ccccc1N1CCN(CCCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
12203911 187699 20 None 54 2 Bovine 8.5 pKi = 8.5 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 255 1 0 3 1.6 CN1CCN(c2ncccc2Br)CC1 10.1021/jm00366a007
CHEMBL50017 187699 20 None 54 2 Bovine 8.5 pKi = 8.5 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 255 1 0 3 1.6 CN1CCN(c2ncccc2Br)CC1 10.1021/jm00366a007
9816063 102600 0 None 4 6 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm990569e
CHEMBL30739 102600 0 None 4 6 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm990569e
2216 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
229 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
7117 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
CHEMBL647 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
DB00964 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
44330584 107633 0 None -1 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL319573 107633 0 None -1 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
10480357 206477 0 None -9 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL98541 206477 0 None -9 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
9816063 102600 0 None 4 6 Rat 8.5 pKi = 8.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm000128r
CHEMBL30739 102600 0 None 4 6 Rat 8.5 pKi = 8.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm000128r
44314198 103933 0 None 1 4 Human 8.5 pKi = 8.5 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 103933 0 None 1 4 Human 8.5 pKi = 8.5 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
9815707 100999 0 None 1 3 Human 8.5 pKi = 8.5 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297752 100999 0 None 1 3 Human 8.5 pKi = 8.5 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
134551 355 25 None -3 21 Human 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 355 25 None -3 21 Human 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 355 25 None -3 21 Human 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 355 25 None -3 21 Human 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
11224953 78524 0 None -7 2 Human 7.7 pKi = 7.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 459 6 1 5 3.3 CCNC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
CHEMBL2112973 78524 0 None -7 2 Human 7.7 pKi = 7.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 459 6 1 5 3.3 CCNC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
135499867 78531 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 388 5 1 5 3.2 C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4NC[C@H]32)CC1 10.1021/jm049619s
CHEMBL2112981 78531 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 388 5 1 5 3.2 C(=C/c1ccccc1)\CN1CCN(C[C@@H]2ON=C3c4ccccc4NC[C@H]32)CC1 10.1021/jm049619s
1816 2504 99 None -33 16 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1021/jm049632c
4205 2504 99 None -33 16 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1021/jm049632c
7241 2504 99 None -33 16 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1021/jm049632c
CHEMBL654 2504 99 None -33 16 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1021/jm049632c
DB00370 2504 99 None -33 16 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1021/jm049632c
49836303 18385 1 None -3 4 Human 7.7 pKi = 7.7 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276220 18385 1 None -3 4 Human 7.7 pKi = 7.7 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
2803 941 53 None -1 19 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.ejmech.2014.05.057
516 941 53 None -1 19 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.ejmech.2014.05.057
704 941 53 None -1 19 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.ejmech.2014.05.057
CHEMBL134 941 53 None -1 19 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.ejmech.2014.05.057
DB00575 941 53 None -1 19 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.ejmech.2014.05.057
49836303 18385 1 None -3 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276220 18385 1 None -3 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
10848826 188293 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 258 3 1 3 2.8 c1ccc(C[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL50719 188293 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 258 3 1 3 2.8 c1ccc(C[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL508338 188379 0 None -6 6 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
14004032 119329 2 None 1 2 Bovine 5.7 pKi = 5.7 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL348538 119329 2 None 1 2 Bovine 5.7 pKi = 5.7 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
44415672 79764 0 None -1659 6 Human 5.7 pKi = 5.7 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 531 2 1 5 5.6 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
CHEMBL213492 79764 0 None -1659 6 Human 5.7 pKi = 5.7 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 531 2 1 5 5.6 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
11057 175575 19 None -1 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
3468 175575 19 None -1 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL459265 175575 19 None -1 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL64894 175575 19 None -1 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
44574106 177851 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 317 3 1 3 3.3 CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466012 177851 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 317 3 1 3 3.3 CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
135398745 2869 108 None -93 65 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2869 108 None -93 65 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2869 108 None -93 65 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2869 108 None -93 65 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
1201549 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 590 22 None -33 20 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
11750482 146888 0 None -25 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL392991 146888 0 None -25 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 10.1016/j.bmcl.2006.12.094
12909388 60731 0 None -14 2 Bovine 5.7 pKi = 5.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 303 0 0 3 3.4 CN1CCC(=C2c3cc(C#N)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL176365 60731 0 None -14 2 Bovine 5.7 pKi = 5.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 303 0 0 3 3.4 CN1CCC(=C2c3cc(C#N)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
3598 187238 73 None -2 7 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl nan
CHEMBL496 187238 73 None -2 7 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl nan
44579187 189087 0 None -263 3 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
CHEMBL515331 189087 0 None -263 3 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
132060733 161575 0 None 1 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 294 3 0 3 3.0 c1ccc(CN2Cc3ccc(N4CCOCC4)cc3C2)cc1 10.1016/j.ejmech.2018.02.024
CHEMBL4161503 161575 0 None 1 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 294 3 0 3 3.0 c1ccc(CN2Cc3ccc(N4CCOCC4)cc3C2)cc1 10.1016/j.ejmech.2018.02.024
11801828 204818 0 None -128 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88628 204818 0 None -128 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
124 2933 44 None -16 32 Pig 7.7 pKi = 7.7 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
2032 2933 44 None -16 32 Pig 7.7 pKi = 7.7 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
4636 2933 44 None -16 32 Pig 7.7 pKi = 7.7 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
CHEMBL762 2933 44 None -16 32 Pig 7.7 pKi = 7.7 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
DB00935 2933 44 None -16 32 Pig 7.7 pKi = 7.7 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm00018a001
123920 99691 34 None 309 2 Rat 7.7 pKi = 7.7 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 201 0 1 1 2.6 Clc1ccc2c(c1Cl)CNCC2 10.1021/jm0205752
CHEMBL287837 99691 34 None 309 2 Rat 7.7 pKi = 7.7 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 201 0 1 1 2.6 Clc1ccc2c(c1Cl)CNCC2 10.1021/jm0205752
4209 3114 71 None -3235 33 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
4893 3114 71 None -3235 33 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
503 3114 71 None -3235 33 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
5385 3114 71 None -3235 33 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
CHEMBL2 3114 71 None -3235 33 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
DB00457 3114 71 None -3235 33 Human 6.7 pKi = 6.7 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
13141182 130371 1 None -10 2 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 354 0 0 2 4.7 CN1CCC(=C2c3cc(Br)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368578 130371 1 None -10 2 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 354 0 0 2 4.7 CN1CCC(=C2c3cc(Br)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
10490084 203250 1 None 7 3 Human 6.7 pKi = 6.7 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 237 2 2 2 2.9 Brc1ccccc1Nc1ncc[nH]1 10.1021/jm9605142
CHEMBL76457 203250 1 None 7 3 Human 6.7 pKi = 6.7 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 237 2 2 2 2.9 Brc1ccccc1Nc1ncc[nH]1 10.1021/jm9605142
44574045 188697 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 260 2 0 2 3.9 c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.166
CHEMBL512062 188697 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 260 2 0 2 3.9 c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.166
50878551 90314 60 None -5 18 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 270 8 1 2 3.4 C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL2391541 90314 60 None -5 18 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 270 8 1 2 3.4 C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12 10.1016/j.bmcl.2015.12.053
24906197 187083 0 None 3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 323 7 1 5 3.0 CC(Oc1ccccc1/C=N/OCc1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL495097 187083 0 None 3 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 323 7 1 5 3.0 CC(Oc1ccccc1/C=N/OCc1ccccc1)C1=NCCN1 10.1021/jm800250z
90644704 112218 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 4 2 3 2.1 CN(C)c1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289532 112218 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 4 2 3 2.1 CN(C)c1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304530 112218 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 258 4 2 3 2.1 CN(C)c1ccc(/N=C(/N)NCc2ccco2)cc1 10.1016/j.ejmech.2014.05.057
4209 3114 71 None -3235 33 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3114 71 None -3235 33 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3114 71 None -3235 33 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3114 71 None -3235 33 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3114 71 None -3235 33 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3114 71 None -3235 33 Human 5.7 pKi = 5.7 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
10793665 106469 0 None -1202 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
CHEMBL314960 106469 0 None -1202 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
1549008 203967 81 None - 1 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 nan
CHEMBL822 203967 81 None - 1 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 nan
44438161 146608 0 None -22 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL392771 146608 0 None -22 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 10.1016/j.bmcl.2006.12.094
2520 202310 65 None -6 11 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL1280 202310 65 None -6 11 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL6966 202310 65 None -6 11 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
12488 1627 51 None -6 23 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 1627 51 None -6 23 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 1627 51 None -6 23 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 1627 51 None -6 23 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
11098175 202469 0 None -2 5 Human 6.7 pKi = 6.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 202469 0 None -2 5 Human 6.7 pKi = 6.7 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
10841190 106559 0 None -309 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
CHEMBL315538 106559 0 None -309 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
90644740 112233 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 4 3 3 2.6 CCNc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289549 112233 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 4 3 3 2.6 CCNc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304693 112233 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 270 4 3 3 2.6 CCNc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL1200633 206858 3 None -7 8 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O nan
133 2460 48 None -23 42 Human 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 2460 48 None -23 42 Human 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 2460 48 None -23 42 Human 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 2460 48 None -23 42 Human 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 2460 48 None -23 42 Human 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
44330679 206533 0 None -10 2 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 464 7 0 8 2.9 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccnc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL98889 206533 0 None -10 2 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 464 7 0 8 2.9 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccnc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44324859 111122 0 None -4 3 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 461 6 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CC4=Cc5ccccc5C4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328377 111122 0 None -4 3 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 461 6 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CC4=Cc5ccccc5C4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44549156 18383 0 None -3 4 Human 7.6 pKi = 7.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276218 18383 0 None -3 4 Human 7.6 pKi = 7.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
57345626 70836 2 None 6 4 Human 7.6 pKi = 7.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1021/ml400232p
CHEMBL1956192 70836 2 None 6 4 Human 7.6 pKi = 7.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1021/ml400232p
57345626 70836 2 None 6 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956192 70836 2 None 6 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1016/j.bmc.2012.01.035
45487956 196690 0 None 3 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 3 1 3 2.6 CC(OC1=NCCN1)c1ccccc1C1CC1 10.1021/jm901262f
CHEMBL576623 196690 0 None 3 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 3 1 3 2.6 CC(OC1=NCCN1)c1ccccc1C1CC1 10.1021/jm901262f
44549156 18383 0 None -3 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276218 18383 0 None -3 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
11347303 110892 0 None -1 5 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL327116 110892 0 None -1 5 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
44579185 181232 0 None -28 3 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL477816 181232 0 None -28 3 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
5288606 96736 25 None - 1 Rat 6.7 pKi = 6.7 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 259 0 1 1 1.9 Ic1ccc2c(c1)CNCC2 10.1021/jm0205752
CHEMBL26828 96736 25 None - 1 Rat 6.7 pKi = 6.7 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 259 0 1 1 1.9 Ic1ccc2c(c1)CNCC2 10.1021/jm0205752
16090602 82036 0 None -239 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 362 4 2 5 3.6 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1C 10.1021/jm060262x
CHEMBL217542 82036 0 None -239 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 362 4 2 5 3.6 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1C 10.1021/jm060262x
164618319 184010 0 None -1 3 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 340 2 1 4 2.1 CC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4848838 184010 0 None -1 3 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 340 2 1 4 2.1 CC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
10132386 96651 1 None -63 2 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 346 3 1 4 4.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C 10.1021/jm060262x
CHEMBL267464 96651 1 None -63 2 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 346 3 1 4 4.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C 10.1021/jm060262x
155566702 175333 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 472 9 0 6 4.2 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CCc3ccc(F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4587003 175333 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 472 9 0 6 4.2 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CCc3ccc(F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
90644722 112217 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 4 3 2 3.5 CCOc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289523 112217 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 4 3 2 3.5 CCOc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304529 112217 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 4 3 2 3.5 CCOc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
49783209 17427 0 None -3890 27 Human 5.7 pKi = 5.7 Binding
Binding affinity to human adrenergic alpha2A receptorBinding affinity to human adrenergic alpha2A receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
CHEMBL1258223 17427 0 None -3890 27 Human 5.7 pKi = 5.7 Binding
Binding affinity to human adrenergic alpha2A receptorBinding affinity to human adrenergic alpha2A receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
9906978 42466 1 None -165 12 Human 5.7 pKi = 5.7 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 42466 1 None -165 12 Human 5.7 pKi = 5.7 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
9837106 103680 2 None -8 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm990569e
CHEMBL30955 103680 2 None -8 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm990569e
9837106 103680 2 None 8 4 Rat 6.7 pKi = 6.7 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm000128r
CHEMBL30955 103680 2 None 8 4 Rat 6.7 pKi = 6.7 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm000128r
1443 1997 30 None -23 10 Human 5.7 pKi = 5.7 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
33625 1997 30 None -23 10 Human 5.7 pKi = 5.7 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
501 1997 30 None -23 10 Human 5.7 pKi = 5.7 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
CHEMBL279516 1997 30 None -23 10 Human 5.7 pKi = 5.7 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
DB08950 1997 30 None -23 10 Human 5.7 pKi = 5.7 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
2162 41273 97 None 1 6 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl nan
CHEMBL1491 41273 97 None 1 6 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl nan
12909385 60108 1 None -7 2 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 276 0 0 2 4.0 CN1CCC(=C2c3ccccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL175154 60108 1 None -7 2 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 276 0 0 2 4.0 CN1CCC(=C2c3ccccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
135453290 133083 23 None -758 8 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]clonidine from cloned human adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]clonidine from cloned human adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 191 2 2 4 1.1 C[C@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
CHEMBL371300 133083 23 None -758 8 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]clonidine from cloned human adrenergic alpha2A receptor expressed in Sf9 cellsDisplacement of [3H]clonidine from cloned human adrenergic alpha2A receptor expressed in Sf9 cells
ChEMBL 191 2 2 4 1.1 C[C@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
21509921 103979 0 None -22 24 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 103979 0 None -22 24 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
44288945 168349 0 None -575 7 Human 6.6 pKi = 6.6 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43860 168349 0 None -575 7 Human 6.6 pKi = 6.6 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
21509921 103979 0 None -22 24 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 103979 0 None -22 24 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
3080926 155055 18 None 10 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 186 1 1 3 1.8 c1ccc2oc(C3=NCCN3)cc2c1 10.1021/acs.jmedchem.9b02080
CHEMBL404505 155055 18 None 10 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 186 1 1 3 1.8 c1ccc2oc(C3=NCCN3)cc2c1 10.1021/acs.jmedchem.9b02080
44330571 163447 0 None -2 2 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL420830 163447 0 None -2 2 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
44330571 163447 0 None -2 2 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL420830 163447 0 None -2 2 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C\c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
9883506 70220 0 None -1 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL194849 70220 0 None -1 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
44371745 49024 0 None 11 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 4 1 3 2.0 CCc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL156336 49024 0 None 11 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 218 4 1 3 2.0 CCc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
13123527 101320 3 None - 1 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 189 3 2 3 1.4 Cc1ccc(NCC2=NCCN2)cc1 10.1021/jm00366a022
CHEMBL300053 101320 3 None - 1 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 189 3 2 3 1.4 Cc1ccc(NCC2=NCCN2)cc1 10.1021/jm00366a022
13141184 165337 0 None -17 2 Bovine 6.6 pKi = 6.6 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 376 1 0 3 5.6 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL424967 165337 0 None -17 2 Bovine 6.6 pKi = 6.6 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 376 1 0 3 5.6 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
11198145 9722 2 None -85 5 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL113830 9722 2 None -85 5 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
16090597 140938 0 None -5 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1nc2c(C)ccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL384318 140938 0 None -5 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1nc2c(C)ccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
44328920 108154 0 None -199 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
CHEMBL320736 108154 0 None -199 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
44325028 205243 0 None -2 2 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cccc5ccccc45)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL91297 205243 0 None -2 2 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cccc5ccccc45)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44325079 205456 0 None -2 2 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 437 7 0 7 2.7 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL92496 205456 0 None -2 2 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 437 7 0 7 2.7 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
90644732 112221 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 1 2 3 1.0 CC1CN/C(=N/c2ccc3c(c2)OCO3)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3289545 112221 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 1 2 3 1.0 CC1CN/C(=N/c2ccc3c(c2)OCO3)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3304536 112221 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 219 1 2 3 1.0 CC1CN/C(=N/c2ccc3c(c2)OCO3)N1 10.1016/j.ejmech.2014.05.057
11080 28872 74 None 1 6 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 185 1 0 2 3.6 S=C=Nc1cccc2ccccc12 nan
CHEMBL1381098 28872 74 None 1 6 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 185 1 0 2 3.6 S=C=Nc1cccc2ccccc12 nan
CHEMBL4549667 212245 3 None -1 2 Human 5.6 pKi = 5.6 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000720a ADRA2ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000720a ADRA2A
ChEMBL None None None CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21 nan
CHEMBL4777443 212286 0 None -11 14 Human 6.6 pKi = 6.6 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000741a ADRA2ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000741a ADRA2A
ChEMBL None None None CC(C)(C)OC(=O)N1CCCC1CN[C@H]1CC[C@@](c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1 nan
24906241 192215 0 None 1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
CHEMBL522151 192215 0 None 1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
24906200 192553 0 None -1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 328 5 1 3 4.5 c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
CHEMBL523048 192553 0 None -1 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 328 5 1 3 4.5 c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
135398737 944 89 None -26 91 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm049632c
38 944 89 None -26 91 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm049632c
722 944 89 None -26 91 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm049632c
CHEMBL42 944 89 None -26 91 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm049632c
DB00363 944 89 None -26 91 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm049632c
126225 94535 4 None -10 8 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL25467 94535 4 None -10 8 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
45487089 195963 0 None 10 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 204 2 1 3 2.0 Cc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL570863 195963 0 None 10 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 204 2 1 3 2.0 Cc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
10082076 13748 0 None 9 3 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1195953 13748 0 None 9 3 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL555637 13748 0 None 9 3 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
12841592 112995 1 None - 1 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 237 1 1 5 0.8 Clc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL331981 112995 1 None - 1 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 237 1 1 5 0.8 Clc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL538788 112995 1 None - 1 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 237 1 1 5 0.8 Clc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
9809007 171996 6 None -1905 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL448620 171996 6 None -1905 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
9884781 38438 1 None 1 5 Human 6.6 pKi = 6.6 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 350 3 0 4 3.0 c1ccc2c(c1)CC(CN1CCN(c3ccc4c(c3)OCCO4)CC1)C2 10.1021/acs.jmedchem.7b00151
CHEMBL146556 38438 1 None 1 5 Human 6.6 pKi = 6.6 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 350 3 0 4 3.0 c1ccc2c(c1)CC(CN1CCN(c3ccc4c(c3)OCCO4)CC1)C2 10.1021/acs.jmedchem.7b00151
11624518 198659 3 None -18 6 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 352 4 0 4 3.8 Clc1ccc(-n2cc(CN3CCN(c4ccccc4)CC3)cn2)cc1 10.1016/j.ejmech.2012.08.011
CHEMBL597601 198659 3 None -18 6 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 352 4 0 4 3.8 Clc1ccc(-n2cc(CN3CCN(c4ccccc4)CC3)cn2)cc1 10.1016/j.ejmech.2012.08.011
415628 206451 89 None -2 5 Bovine 7.6 pKi = 7.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00366a007
CHEMBL9841 206451 89 None -2 5 Bovine 7.6 pKi = 7.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00366a007
2389 3279 114 None -35 67 Rat 7.6 pKi = 7.6 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
5073 3279 114 None -35 67 Rat 7.6 pKi = 7.6 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
96 3279 114 None -35 67 Rat 7.6 pKi = 7.6 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
CHEMBL85 3279 114 None -35 67 Rat 7.6 pKi = 7.6 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
DB00734 3279 114 None -35 67 Rat 7.6 pKi = 7.6 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
10220232 99260 5 None -54 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm990569e
CHEMBL284795 99260 5 None -54 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm990569e
6761 67457 17 None -6 18 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 67457 17 None -6 18 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
44324765 111080 0 None -2 5 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328114 111080 0 None -2 5 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
10220232 99260 5 None 54 6 Rat 7.6 pKi = 7.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm000128r
CHEMBL284795 99260 5 None 54 6 Rat 7.6 pKi = 7.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm000128r
23292293 57859 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 244 2 1 2 3.0 Clc1cccc2ccc(CC3CN=CN3)cc12 10.1021/jm001040g
CHEMBL168168 57859 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 244 2 1 2 3.0 Clc1cccc2ccc(CC3CN=CN3)cc12 10.1021/jm001040g
44314200 102479 0 None -1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 102479 0 None -1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
11948707 165614 0 None -616 13 Human 6.6 pKi = 6.6 Binding
Binding affinity to alpha 2A adrenergic receptor by radioligand binding assayBinding affinity to alpha 2A adrenergic receptor by radioligand binding assay
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1016/j.bmcl.2006.01.052
CHEMBL426317 165614 0 None -616 13 Human 6.6 pKi = 6.6 Binding
Binding affinity to alpha 2A adrenergic receptor by radioligand binding assayBinding affinity to alpha 2A adrenergic receptor by radioligand binding assay
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1016/j.bmcl.2006.01.052
11393666 192384 0 None -6456 19 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5201983 192384 0 None -6456 19 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5222597 192384 0 None -6456 19 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
44401194 70951 0 None -33 7 Human 6.6 pKi = 6.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 313 2 0 3 4.1 CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL195706 70951 0 None -33 7 Human 6.6 pKi = 6.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 313 2 0 3 4.1 CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
9815610 99471 15 None -13 4 Human 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm990569e
CHEMBL286246 99471 15 None -13 4 Human 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm990569e
9815610 99471 15 None 13 4 Rat 6.6 pKi = 6.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm000128r
CHEMBL286246 99471 15 None 13 4 Rat 6.6 pKi = 6.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm000128r
5280953 96913 102 None -3 8 Human 5.6 pKi = 5.6 Binding
Binding affinity towards alpha-2A-Adrenergic receptorBinding affinity towards alpha-2A-Adrenergic receptor
ChEMBL 212 1 1 2 3.0 COc1ccc2c(c1)[nH]c1c(C)nccc12 10.1016/j.bmcl.2003.09.027
CHEMBL269538 96913 102 None -3 8 Human 5.6 pKi = 5.6 Binding
Binding affinity towards alpha-2A-Adrenergic receptorBinding affinity towards alpha-2A-Adrenergic receptor
ChEMBL 212 1 1 2 3.0 COc1ccc2c(c1)[nH]c1c(C)nccc12 10.1016/j.bmcl.2003.09.027
1752 45504 56 None -2 5 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 220 8 1 1 4.7 CCCCCCCCCc1ccc(O)cc1 nan
CHEMBL153062 45504 56 None -2 5 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 220 8 1 1 4.7 CCCCCCCCCc1ccc(O)cc1 nan
44438152 93175 0 None -134 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 10.1016/j.bmcl.2006.12.094
CHEMBL246639 93175 0 None -134 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 10.1016/j.bmcl.2006.12.094
2286 3134 48 None -13 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 3134 48 None -13 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 3134 48 None -13 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 3134 48 None -13 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 3134 48 None -13 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
24906242 186664 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2c(cccc2-c2ccccc2)O1 10.1021/jm800250z
CHEMBL492647 186664 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2c(cccc2-c2ccccc2)O1 10.1021/jm800250z
10073773 160576 13 None -1288 4 Human 5.6 pKi = 5.6 Binding
Displacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 minsDisplacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 mins
ChEMBL 477 5 0 6 3.4 COc1ccc2c(c1)c(CN1CCN(C)CC1)cn2S(=O)(=O)c1ccccc1Br 10.1021/acs.jmedchem.6b01662
CHEMBL4082473 160576 13 None -1288 4 Human 5.6 pKi = 5.6 Binding
Displacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 minsDisplacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 mins
ChEMBL 477 5 0 6 3.4 COc1ccc2c(c1)c(CN1CCN(C)CC1)cn2S(=O)(=O)c1ccccc1Br 10.1021/acs.jmedchem.6b01662
CHEMBL4117187 160576 13 None -1288 4 Human 5.6 pKi = 5.6 Binding
Displacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 minsDisplacement of [3H] MK-912 from human adrenergic alpha 2A receptor expressed in HT29 cells after 60 mins
ChEMBL 477 5 0 6 3.4 COc1ccc2c(c1)c(CN1CCN(C)CC1)cn2S(=O)(=O)c1ccccc1Br 10.1021/acs.jmedchem.6b01662
10042547 75948 3 None 1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 334 1 1 2 3.9 CC1CCC(Nc2ccc(I)cc2Cl)=N1 10.1016/j.bmc.2012.06.008
CHEMBL2058635 75948 3 None 1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 334 1 1 2 3.9 CC1CCC(Nc2ccc(I)cc2Cl)=N1 10.1016/j.bmc.2012.06.008
155546767 173067 0 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 456 8 0 7 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4534152 173067 0 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 456 8 0 7 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(OC)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL1458880 37617 0 None - 1 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
3778834 100850 70 None 144 2 Bovine 7.6 pKi = 7.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 208 2 1 5 0.4 O=[N+]([O-])c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL296653 100850 70 None 144 2 Bovine 7.6 pKi = 7.6 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 208 2 1 5 0.4 O=[N+]([O-])c1cccnc1N1CCNCC1 10.1021/jm00366a007
44324725 205090 0 None -13 3 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 451 8 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCCc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL90419 205090 0 None -13 3 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 451 8 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCCc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
12114850 13137 0 None 57 2 Human 7.6 pKi = 7.6 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 704 5 6 6 4.2 O=C(NCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1191424 13137 0 None 57 2 Human 7.6 pKi = 7.6 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 704 5 6 6 4.2 O=C(NCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL542520 13137 0 None 57 2 Human 7.6 pKi = 7.6 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 704 5 6 6 4.2 O=C(NCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
44269122 97658 2 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL273485 97658 2 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm800250z
45487144 196024 0 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.7 CC(OC1=NCCN1)c1ccccc1 10.1021/jm901262f
CHEMBL571314 196024 0 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.7 CC(OC1=NCCN1)c1ccccc1 10.1021/jm901262f
44269122 97658 2 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL273485 97658 2 None 6 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm100977d
146025727 171119 0 None -97 27 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4466483 171119 0 None -97 27 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
90644746 112225 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 265 2 3 1 4.0 N=C(Nc1ccccc1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3289521 112225 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 265 2 3 1 4.0 N=C(Nc1ccccc1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3304553 112225 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 265 2 3 1 4.0 N=C(Nc1ccccc1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
90644734 112222 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 4 2 3 2.6 CCOc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289546 112222 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 4 2 3 2.6 CCOc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304537 112222 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 271 4 2 3 2.6 CCOc1ccc(/N=C2/NCC(c3ccco3)N2)cc1 10.1016/j.ejmech.2014.05.057
44312198 202883 0 None 1 4 Human 4.6 pKi = 4.6 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73164 202883 0 None 1 4 Human 4.6 pKi = 4.6 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL4576555 212264 3 None -2 14 Human 5.6 pKi = 5.6 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA2ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA2A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 nan
9926143 113027 1 None -467 4 Rat 5.6 pKi = 5.6 Binding
Compound was tested for binding affinity using [3H]prazosin against Alpha-1 adrenergic receptorCompound was tested for binding affinity using [3H]prazosin against Alpha-1 adrenergic receptor
ChEMBL 294 6 2 4 3.0 O=c1ccc2ccc(CNCCNc3ccccc3)cc2o1 10.1021/jm990266k
CHEMBL332154 113027 1 None -467 4 Rat 5.6 pKi = 5.6 Binding
Compound was tested for binding affinity using [3H]prazosin against Alpha-1 adrenergic receptorCompound was tested for binding affinity using [3H]prazosin against Alpha-1 adrenergic receptor
ChEMBL 294 6 2 4 3.0 O=c1ccc2ccc(CNCCNc3ccccc3)cc2o1 10.1021/jm990266k
44401041 70143 0 None -63 7 Human 6.6 pKi = 6.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 313 2 0 3 4.1 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL194659 70143 0 None -63 7 Human 6.6 pKi = 6.6 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 313 2 0 3 4.1 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
3080926 155055 18 None 10 3 Human 4.6 pKi = 4.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 186 1 1 3 1.8 c1ccc2oc(C3=NCCN3)cc2c1 10.1021/ml400232p
CHEMBL404505 155055 18 None 10 3 Human 4.6 pKi = 4.6 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 186 1 1 3 1.8 c1ccc2oc(C3=NCCN3)cc2c1 10.1021/ml400232p
44579186 181394 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 474 8 1 7 3.1 O=C(NCCN1CCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL478026 181394 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 474 8 1 7 3.1 O=C(NCCN1CCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
9815633 99174 2 None -6 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm990569e
CHEMBL284213 99174 2 None -6 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm990569e
9815633 99174 2 None 6 6 Rat 7.6 pKi = 7.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm000128r
CHEMBL284213 99174 2 None 6 6 Rat 7.6 pKi = 7.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm000128r
11346584 136460 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm061487a
CHEMBL374584 136460 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm061487a
11346584 136460 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL374584 136460 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm0408215
11346584 136460 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
CHEMBL374584 136460 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
10266538 116470 2 None 1 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 295 1 0 5 1.2 CN1CCN(c2ncc(Br)n3ccnc23)CC1 10.1021/jm00099a012
CHEMBL338704 116470 2 None 1 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 295 1 0 5 1.2 CN1CCN(c2ncc(Br)n3ccnc23)CC1 10.1021/jm00099a012
4543 169982 36 None -5 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
CHEMBL1201156 169982 36 None -5 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
CHEMBL445 169982 36 None -5 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 nan
9828476 205197 0 None -1202 6 Human 6.6 pKi = 6.6 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91022 205197 0 None -1202 6 Human 6.6 pKi = 6.6 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
162265 200587 19 None -12 44 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
4786 200587 19 None -12 44 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
CHEMBL61006 200587 19 None -12 44 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
73346042 91402 3 None -27542 17 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
CHEMBL2413153 91402 3 None -27542 17 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
4211 57517 81 None -1 4 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 nan
CHEMBL1670 57517 81 None -1 4 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 nan
1028 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
10176567 102327 3 None -10 4 Human 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm990569e
CHEMBL30534 102327 3 None -10 4 Human 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm990569e
10176567 102327 3 None 10 4 Rat 6.6 pKi = 6.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm000128r
CHEMBL30534 102327 3 None 10 4 Rat 6.6 pKi = 6.6 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm000128r
126720252 164123 0 None 12 12 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
CHEMBL4216870 164123 0 None 12 12 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
16655023 106955 1 None -5 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 106955 1 None -5 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
44292232 100851 0 None 3 3 Human 7.6 pKi = 7.6 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL296660 100851 0 None 3 3 Human 7.6 pKi = 7.6 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
2389 3279 114 None -69 67 Human 7.6 pKi = 7.6 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2020.127506
5073 3279 114 None -69 67 Human 7.6 pKi = 7.6 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2020.127506
96 3279 114 None -69 67 Human 7.6 pKi = 7.6 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2020.127506
CHEMBL85 3279 114 None -69 67 Human 7.6 pKi = 7.6 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2020.127506
DB00734 3279 114 None -69 67 Human 7.6 pKi = 7.6 Binding
Binding affinity to alpha2 adrenergic receptor (unknown origin)Binding affinity to alpha2 adrenergic receptor (unknown origin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2020.127506
57345625 70835 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 224 3 1 3 2.1 CC(Oc1ccccc1Cl)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956191 70835 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 224 3 1 3 2.1 CC(Oc1ccccc1Cl)C1=NCCN1 10.1016/j.bmc.2012.01.035
44574105 178230 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 305 5 1 4 1.3 CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL469127 178230 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 305 5 1 4 1.3 CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
24906202 186634 0 None 5 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
CHEMBL492444 186634 0 None 5 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
11380133 168801 0 None 5 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccncc1)C1=NCCN1 10.1021/jm0408215
CHEMBL442045 168801 0 None 5 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccncc1)C1=NCCN1 10.1021/jm0408215
44456400 12725 0 None -1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL1188501 12725 0 None -1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL2436555 12725 0 None -1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL536539 12725 0 None -1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
13091268 77845 0 None -3090 14 Human 5.6 pKi = 5.6 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL210578 77845 0 None -3090 14 Human 5.6 pKi = 5.6 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
24906159 186822 12 None 2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
CHEMBL493675 186822 12 None 2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
11203101 71339 0 None -44 3 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 515 7 3 5 4.1 O=C(CCCNC(=O)[C@@H]1C2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)OCc1ccccc1 10.1016/j.bmcl.2005.03.116
CHEMBL196451 71339 0 None -44 3 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-2a adrenergic receptorIn vitro binding affinity towards alpha-2a adrenergic receptor
ChEMBL 515 7 3 5 4.1 O=C(CCCNC(=O)[C@@H]1C2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)OCc1ccccc1 10.1016/j.bmcl.2005.03.116
11811395 202995 0 None -2 4 Human 5.5 pKi = 5.5 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74071 202995 0 None -2 4 Human 5.5 pKi = 5.5 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
11777109 116466 0 None 31 2 Human 8.5 pKi = 8.5 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 254 0 1 2 2.9 Clc1cc(Cl)c2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL338683 116466 0 None 31 2 Human 8.5 pKi = 8.5 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 254 0 1 2 2.9 Clc1cc(Cl)c2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
9837106 103680 2 None 8 4 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm990569e
CHEMBL30955 103680 2 None 8 4 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm990569e
44330427 162823 0 None -4 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL419336 162823 0 None -4 2 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4cccc(F)c4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
9837106 103680 2 None 8 4 Rat 8.5 pKi = 8.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm000128r
CHEMBL30955 103680 2 None 8 4 Rat 8.5 pKi = 8.5 Binding
In vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidineIn vitro rat alpha-2D adrenergic receptor binding using p-aminoclonidine
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm000128r
102 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
3659 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
8969 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
CHEMBL15245 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
DB01392 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 minsDisplacement of [3H]MK912 from human recombinant alpha2A adrenergic receptor expressed in Sf9 cells after 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.01.025
16655023 106955 1 None -5 7 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 106955 1 None -5 7 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
102 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
3659 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
8969 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
CHEMBL15245 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
DB01392 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
102 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
3659 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
8969 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
CHEMBL15245 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
DB01392 4064 44 None -5 49 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
12576 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm001040g
71310 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm001040g
CHEMBL353972 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm001040g
DB11481 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm001040g
10585356 120098 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 1 1 2 2.2 C1=NC[C@@H](C2C[C@@]23CCc2ccccc2C3)N1 10.1021/jm001040g
135433755 120098 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 1 1 2 2.2 C1=NC[C@@H](C2C[C@@]23CCc2ccccc2C3)N1 10.1021/jm001040g
CHEMBL354611 120098 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 1 1 2 2.2 C1=NC[C@@H](C2C[C@@]23CCc2ccccc2C3)N1 10.1021/jm001040g
78114676 169274 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 402 6 0 6 3.3 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4439953 169274 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 402 6 0 6 3.3 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
13123529 101393 0 None - 1 Bovine 8.5 pKi = 8.5 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 203 3 1 3 1.4 Cc1ccc(N(C)CC2=NCCN2)cc1 10.1021/jm00366a022
CHEMBL300628 101393 0 None - 1 Bovine 8.5 pKi = 8.5 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 203 3 1 3 1.4 Cc1ccc(N(C)CC2=NCCN2)cc1 10.1021/jm00366a022
49781006 17058 0 None 2 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 240 3 1 2 2.9 CCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256565 17058 0 None 2 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 240 3 1 2 2.9 CCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
136 3240 28 None -16 16 Bovine 8.5 pKi = 8.5 Binding
Compound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
223 3240 28 None -16 16 Bovine 8.5 pKi = 8.5 Binding
Compound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
643606 3240 28 None -16 16 Bovine 8.5 pKi = 8.5 Binding
Compound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
CHEMBL10347 3240 28 None -16 16 Bovine 8.5 pKi = 8.5 Binding
Compound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]rauwolscine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
16655023 106955 1 None -5 7 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 106955 1 None -5 7 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
16655023 106955 1 None -5 7 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL318235 106955 1 None -5 7 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
499 4014 15 None -16 15 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4014 15 None -16 15 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4014 15 None -16 15 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
2389 3279 114 None -69 67 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3279 114 None -69 67 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3279 114 None -69 67 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3279 114 None -69 67 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3279 114 None -69 67 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
2803 941 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
516 941 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
704 941 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
CHEMBL134 941 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
DB00575 941 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
2803 941 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
516 941 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
704 941 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
CHEMBL134 941 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
DB00575 941 53 None -1 19 Human 8.4 pKi = 8.4 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
49781887 16963 0 None 3 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
CHEMBL1255617 16963 0 None 3 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
9990389 119926 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 200 2 1 2 1.8 C1=NCC(CC2Cc3ccccc3C2)N1 10.1021/jm001040g
CHEMBL353843 119926 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 200 2 1 2 1.8 C1=NCC(CC2Cc3ccccc3C2)N1 10.1021/jm001040g
49781007 17059 0 None -2 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 4 1 2 3.3 CCCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256566 17059 0 None -2 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 4 1 2 3.3 CCCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
240 931 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
2769 931 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
44279790 931 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
660 931 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
CHEMBL1729 931 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
CHEMBL560739 931 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
DB00604 931 39 None -3 25 Rat 7.5 pKi = 7.5 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00013a009
44324972 162820 0 None -2 4 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL419316 162820 0 None -2 4 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
9971924 183644 0 None 3 3 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 298 5 1 3 3.4 c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL48341 183644 0 None 3 3 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscineInhibitory constant against human Alpha-2A adrenergic receptor expressed in LM(tk-) cells using [3H]rauwolscine
ChEMBL 298 5 1 3 3.4 c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
13123531 187658 0 None - 1 Bovine 6.5 pKi = 6.5 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 217 4 1 3 1.8 CCN(CC1=NCCN1)c1ccc(C)cc1 10.1021/jm00366a022
CHEMBL49953 187658 0 None - 1 Bovine 6.5 pKi = 6.5 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 217 4 1 3 1.8 CCN(CC1=NCCN1)c1ccc(C)cc1 10.1021/jm00366a022
9953974 77480 0 None -24 3 Human 5.5 pKi = 5.5 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL2092927 77480 0 None -24 3 Human 5.5 pKi = 5.5 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
7059292 75947 7 None -3 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 1 1 2 2.9 Clc1ccccc1NC1=NCCC1 10.1016/j.bmc.2012.06.008
CHEMBL2058633 75947 7 None -3 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 1 1 2 2.9 Clc1ccccc1NC1=NCCC1 10.1016/j.bmc.2012.06.008
9894818 98468 0 None -83 7 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98468 0 None -83 7 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
44401042 124309 0 None -81 9 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.6 CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL364270 124309 0 None -81 9 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.6 CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1 10.1021/jm049632c
11225732 93224 0 None -16 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL246852 93224 0 None -16 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 10.1016/j.bmcl.2006.12.094
10198248 186866 35 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL49395 186866 35 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
11199581 136036 0 None 3 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccccc1O)C1=NCCN1 10.1021/jm0408215
CHEMBL373830 136036 0 None 3 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccccc1O)C1=NCCN1 10.1021/jm0408215
9944467 9161 0 None -1 4 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
CHEMBL110751 9161 0 None -1 4 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
9794524 203135 2 None 10 3 Human 7.5 pKi = 7.5 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 225 2 2 4 2.4 Cc1c(Nc2ncc[nH]2)ccc2nccnc12 10.1021/jm9605142
CHEMBL75491 203135 2 None 10 3 Human 7.5 pKi = 7.5 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 225 2 2 4 2.4 Cc1c(Nc2ncc[nH]2)ccc2nccnc12 10.1021/jm9605142
10946567 16292 0 None -25 6 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL123448 16292 0 None -25 6 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
15463615 119858 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 246 2 1 2 3.1 Clc1cccc2c1C=C(CC1CN=CN1)CC2 10.1021/jm001040g
CHEMBL353200 119858 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 246 2 1 2 3.1 Clc1cccc2c1C=C(CC1CN=CN1)CC2 10.1021/jm001040g
44371864 50868 0 None 8 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL157955 50868 0 None 8 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
13141183 161414 1 None -15 2 Bovine 6.5 pKi = 6.5 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 310 0 0 2 4.6 CN1CCC(=C2c3cc(Cl)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL415761 161414 1 None -15 2 Bovine 6.5 pKi = 6.5 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 310 0 0 2 4.6 CN1CCC(=C2c3cc(Cl)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
10045088 80176 0 None -407 2 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 3.9 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1CO 10.1021/jm060262x
CHEMBL214996 80176 0 None -407 2 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 376 4 2 5 3.9 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1CO 10.1021/jm060262x
16090631 81979 0 None -630 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 4 2 5 4.5 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C(C)O 10.1021/jm060262x
CHEMBL217253 81979 0 None -630 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 4 2 5 4.5 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C(C)O 10.1021/jm060262x
10632290 203038 4 None 2 3 Human 5.5 pKi = 5.5 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 211 2 2 4 2.1 c1c[nH]c(Nc2ccc3nccnc3c2)n1 10.1021/jm9605142
CHEMBL74449 203038 4 None 2 3 Human 5.5 pKi = 5.5 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 211 2 2 4 2.1 c1c[nH]c(Nc2ccc3nccnc3c2)n1 10.1021/jm9605142
3191 102385 93 None -8 25 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 102385 93 None -8 25 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
122295 9775 6 None -9 9 Rat 6.5 pKi = 6.5 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00018a001
CHEMBL114166 9775 6 None -9 9 Rat 6.5 pKi = 6.5 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00018a001
72947315 92057 0 None -3 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 232 5 1 4 1.6 c1ccc(OC2CC2)c(OCC2=NCCN2)c1 10.1021/ml400232p
CHEMBL2431280 92057 0 None -3 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 232 5 1 4 1.6 c1ccc(OC2CC2)c(OCC2=NCCN2)c1 10.1021/ml400232p
44456400 12725 0 None -1 10 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL1188501 12725 0 None -1 10 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL2436555 12725 0 None -1 10 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL536539 12725 0 None -1 10 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2A-adrenoceptor expressed in MDCK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
57400959 70844 0 None 1 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956200 70844 0 None 1 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
10337773 101114 0 None -79 10 Human 4.5 pKi = 4.5 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
CHEMBL298612 101114 0 None -79 10 Human 4.5 pKi = 4.5 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
6424833 98715 94 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 178 1 1 3 1.2 O=[N+]([O-])c1ccc2c(c1)CNCC2 10.1016/j.bmcl.2004.12.013
CHEMBL281289 98715 94 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 178 1 1 3 1.2 O=[N+]([O-])c1ccc2c(c1)CNCC2 10.1016/j.bmcl.2004.12.013
10584556 206255 3 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 210 2 1 3 1.6 O=[N+]([O-])c1ccc2c(c1)CNC(CF)C2 10.1016/j.bmcl.2004.12.013
CHEMBL97282 206255 3 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 210 2 1 3 1.6 O=[N+]([O-])c1ccc2c(c1)CNC(CF)C2 10.1016/j.bmcl.2004.12.013
3930 2120 36 None -112 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 368 3 1 4 4.9 CN1CCN(CC1)c1ccc(cc1)Nc1c2ccccc2nc2c1cccc2 10.1021/jm060262x
540335 2120 36 None -112 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 368 3 1 4 4.9 CN1CCN(CC1)c1ccc(cc1)Nc1c2ccccc2nc2c1cccc2 10.1021/jm060262x
CHEMBL106525 2120 36 None -112 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 368 3 1 4 4.9 CN1CCN(CC1)c1ccc(cc1)Nc1c2ccccc2nc2c1cccc2 10.1021/jm060262x
132075278 162094 0 None -5 5 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 308 3 0 3 3.1 c1ccc(CN2CCc3cc(N4CCOCC4)ccc3C2)cc1 10.1016/j.ejmech.2018.02.024
CHEMBL4169752 162094 0 None -5 5 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 308 3 0 3 3.1 c1ccc(CN2CCc3cc(N4CCOCC4)ccc3C2)cc1 10.1016/j.ejmech.2018.02.024
44415689 138579 0 None -363 6 Human 6.5 pKi = 6.5 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 494 2 2 6 4.7 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
CHEMBL378669 138579 0 None -363 6 Human 6.5 pKi = 6.5 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 494 2 2 6 4.7 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
11385652 78526 0 None -3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 460 6 0 6 3.7 CCOC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
CHEMBL2112975 78526 0 None -3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 460 6 0 6 3.7 CCOC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
118717248 114626 0 None 2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1ccc2cnn(N=C3NCCN3)c2c1 10.1016/j.ejmech.2014.09.083
CHEMBL3343699 114626 0 None 2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1ccc2cnn(N=C3NCCN3)c2c1 10.1016/j.ejmech.2014.09.083
4038180 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
Binding affinity to Homo sapiens (human) alpha2A receptorBinding affinity to Homo sapiens (human) alpha2A receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
480 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
Binding affinity to Homo sapiens (human) alpha2A receptorBinding affinity to Homo sapiens (human) alpha2A receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109783 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
Binding affinity to Homo sapiens (human) alpha2A receptorBinding affinity to Homo sapiens (human) alpha2A receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
4038180 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
480 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
CHEMBL109783 202 11 None -3 6 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
11186227 84298 0 None 9 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccc(O)cc1)C1=NCCN1 10.1021/jm0408215
CHEMBL222798 84298 0 None 9 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccc(O)cc1)C1=NCCN1 10.1021/jm0408215
13141187 130194 0 None -9 2 Bovine 6.5 pKi = 6.5 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 378 1 0 3 5.2 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368475 130194 0 None -9 2 Bovine 6.5 pKi = 6.5 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 378 1 0 3 5.2 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
9809007 171996 6 None -1905 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL448620 171996 6 None -1905 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
162658038 180564 0 None - 1 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 530 10 5 13 0.4 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccc([N+](=O)[O-])cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4760727 180564 0 None - 1 Rat 4.5 pKi = 4.5 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 530 10 5 13 0.4 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCNCC2Cc3ccc([N+](=O)[O-])cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
70788951 26948 1 None -1 5 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
CHEMBL1366 26948 1 None -1 5 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL None None None None nan
90644726 112211 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 2 2 2 1.3 CC1CN/C(=N/c2ccc(N(C)C)cc2)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3289542 112211 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 2 2 2 1.3 CC1CN/C(=N/c2ccc(N(C)C)cc2)N1 10.1016/j.ejmech.2014.05.057
CHEMBL3304469 112211 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 218 2 2 2 1.3 CC1CN/C(=N/c2ccc(N(C)C)cc2)N1 10.1016/j.ejmech.2014.05.057
155539605 172276 0 None -14 6 Human 5.5 pKi = 5.5 Binding
Displacement of [3H] NECA from human adrenergic alpha 2A receptor expressed in MDCK cells by radioligand binding assayDisplacement of [3H] NECA from human adrenergic alpha 2A receptor expressed in MDCK cells by radioligand binding assay
ChEMBL 313 1 0 4 2.1 CC1=NC2(CCN(C)CC2)C(=O)N(c2c(C)cccc2C)C1=O 10.1016/j.ejmech.2018.12.048
CHEMBL4514672 172276 0 None -14 6 Human 5.5 pKi = 5.5 Binding
Displacement of [3H] NECA from human adrenergic alpha 2A receptor expressed in MDCK cells by radioligand binding assayDisplacement of [3H] NECA from human adrenergic alpha 2A receptor expressed in MDCK cells by radioligand binding assay
ChEMBL 313 1 0 4 2.1 CC1=NC2(CCN(C)CC2)C(=O)N(c2c(C)cccc2C)C1=O 10.1016/j.ejmech.2018.12.048
8447 188362 80 None -4 13 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
CHEMBL508112 188362 80 None -4 13 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
11199593 136675 0 None 2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 1 3 3.8 CC(Sc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL374954 136675 0 None 2 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 282 4 1 3 3.8 CC(Sc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
44288769 100679 0 None -3090 7 Human 5.5 pKi = 5.5 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL295395 100679 0 None -3090 7 Human 5.5 pKi = 5.5 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
10176433 20448 0 None 8 2 Human 7.5 pKi = 7.5 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 186 0 1 2 1.5 C1=NCC2(CCc3ccccc3C2)N1 10.1021/jm00020a021
CHEMBL130853 20448 0 None 8 2 Human 7.5 pKi = 7.5 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 186 0 1 2 1.5 C1=NCC2(CCc3ccccc3C2)N1 10.1021/jm00020a021
135398737 944 89 None -26 91 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 944 89 None -26 91 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 944 89 None -26 91 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 944 89 None -26 91 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 944 89 None -26 91 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
44325027 205345 0 None -1 2 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 474 6 0 8 3.2 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cnc5ccccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL91824 205345 0 None -1 2 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 474 6 0 8 3.2 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cnc5ccccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
45487958 196714 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.5 Cc1ccccc1COC1=NCCN1 10.1021/jm901262f
CHEMBL576819 196714 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.5 Cc1ccccc1COC1=NCCN1 10.1021/jm901262f
10376607 13249 0 None 1 2 Bovine 6.5 pKi = 6.5 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
CHEMBL1192423 13249 0 None 1 2 Bovine 6.5 pKi = 6.5 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
CHEMBL543653 13249 0 None 1 2 Bovine 6.5 pKi = 6.5 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cnc(N2CCNCC2)c2ncc(C)n12 10.1021/jm00099a012
10332138 9468 3 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 246 1 1 3 2.2 O=[N+]([O-])c1ccc2c(c1)CNC(C(F)(F)F)C2 10.1016/j.bmcl.2004.12.013
CHEMBL112351 9468 3 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 246 1 1 3 2.2 O=[N+]([O-])c1ccc2c(c1)CNC(C(F)(F)F)C2 10.1016/j.bmcl.2004.12.013
5226 96616 29 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 212 1 2 3 -0.0 NS(=O)(=O)c1ccc2c(c1)CNCC2 10.1016/j.bmcl.2004.12.013
CHEMBL26717 96616 29 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 212 1 2 3 -0.0 NS(=O)(=O)c1ccc2c(c1)CNCC2 10.1016/j.bmcl.2004.12.013
75201901 165872 14 None -251 24 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4277264 165872 14 None -251 24 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
213 3792 50 None -6 43 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 3792 50 None -6 43 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 3792 50 None -6 43 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 3792 50 None -6 43 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 3792 50 None -6 43 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
9798466 133755 1 None -44 6 Rat 6.5 pKi = 6.5 Binding
In vivo binding affinity was evaluated against Alpha-1 adrenergic receptorIn vivo binding affinity was evaluated against Alpha-1 adrenergic receptor
ChEMBL 349 4 1 3 3.3 Cc1ccc(N2CCN(CC[C@@H]3NC(=O)c4ccccc43)CC2)cc1C 10.1016/s0960-894x(98)00252-2
CHEMBL37170 133755 1 None -44 6 Rat 6.5 pKi = 6.5 Binding
In vivo binding affinity was evaluated against Alpha-1 adrenergic receptorIn vivo binding affinity was evaluated against Alpha-1 adrenergic receptor
ChEMBL 349 4 1 3 3.3 Cc1ccc(N2CCN(CC[C@@H]3NC(=O)c4ccccc43)CC2)cc1C 10.1016/s0960-894x(98)00252-2
14004037 53489 2 None 8 2 Bovine 6.5 pKi = 6.5 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL160388 53489 2 None 8 2 Bovine 6.5 pKi = 6.5 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
36324 26916 71 None - 1 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 293 4 0 2 4.9 Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1 nan
CHEMBL1365675 26916 71 None - 1 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 293 4 0 2 4.9 Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1 nan
14004037 53489 2 None 8 2 Bovine 6.5 pKi = 6.5 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL160388 53489 2 None 8 2 Bovine 6.5 pKi = 6.5 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
46869265 16081 0 None -16 7 Human 5.5 pKi = 5.5 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 295 1 3 3 3.1 Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21 10.1016/j.bmc.2010.07.052
CHEMBL1224527 16081 0 None -16 7 Human 5.5 pKi = 5.5 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 295 1 3 3 3.1 Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21 10.1016/j.bmc.2010.07.052
1548953 205945 24 None -1 17 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
CHEMBL954 205945 24 None -1 17 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
9895326 205299 0 None -331 6 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
CHEMBL91550 205299 0 None -331 6 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
57345628 70839 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1956195 70839 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
57345628 70839 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956195 70839 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
68712 99874 57 None -1 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
CHEMBL289480 99874 57 None -1 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
57345628 70839 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL1956195 70839 0 None -3 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
11608298 64745 4 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 228 2 1 3 1.9 O=[N+]([O-])c1ccc2c(c1)CNC(C(F)F)C2 10.1016/j.bmcl.2004.12.013
CHEMBL182376 64745 4 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 228 2 1 3 1.9 O=[N+]([O-])c1ccc2c(c1)CNC(C(F)F)C2 10.1016/j.bmcl.2004.12.013
16090634 81882 0 None -4 2 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 296 3 1 4 3.2 Cc1cncc(C)c1Nc1ccc(N2CCN(C)CC2)cc1 10.1021/jm060262x
CHEMBL217180 81882 0 None -4 2 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 296 3 1 4 3.2 Cc1cncc(C)c1Nc1ccc(N2CCN(C)CC2)cc1 10.1021/jm060262x
3072540 82003 13 None -97 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 382 4 1 4 5.3 CCN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1 10.1021/jm060262x
CHEMBL217366 82003 13 None -97 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 382 4 1 4 5.3 CCN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1 10.1021/jm060262x
9817256 202536 0 None -2 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71001 202536 0 None -2 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44390749 63579 0 None -199 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
CHEMBL180561 63579 0 None -199 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
441383 20133 54 None -2 17 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 20133 54 None -2 17 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
94459 63943 121 None 64 2 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL18094 63943 121 None 64 2 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
3086326 202826 17 None 1 6 Human 7.4 pKi = 7.4 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL72753 202826 17 None 1 6 Human 7.4 pKi = 7.4 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
11173568 84218 0 None 8 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 281 4 2 4 2.7 CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL222371 84218 0 None 8 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 281 4 2 4 2.7 CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1 10.1021/jm0408215
10083242 13722 0 None 5 3 Bovine 6.4 pKi = 6.4 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1195814 13722 0 None 5 3 Bovine 6.4 pKi = 6.4 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL555391 13722 0 None 5 3 Bovine 6.4 pKi = 6.4 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 2 1 5 1.3 CC(C)c1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
3584 3718 60 None -251 14 Human 5.4 pKi = 5.4 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
5401 3718 60 None -251 14 Human 5.4 pKi = 5.4 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
7302 3718 60 None -251 14 Human 5.4 pKi = 5.4 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
CHEMBL611 3718 60 None -251 14 Human 5.4 pKi = 5.4 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
DB01162 3718 60 None -251 14 Human 5.4 pKi = 5.4 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
9894818 98468 0 None -83 7 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98468 0 None -83 7 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
155547141 173047 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 518 9 0 7 5.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(Oc4ccccc4)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4533687 173047 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 518 9 0 7 5.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(Oc4ccccc4)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
56964794 73716 0 None -19 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 418 3 0 5 4.8 Clc1ccc2c(c1)N=C(N1CCN(CCc3ccccc3)CC1)c1cccnc1O2 10.1021/jm2013419
CHEMBL2022272 73716 0 None -19 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 418 3 0 5 4.8 Clc1ccc2c(c1)N=C(N1CCN(CCc3ccccc3)CC1)c1cccnc1O2 10.1021/jm2013419
12774559 189018 0 None - 1 Bovine 6.4 pKi = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 191 3 3 4 0.8 Oc1cccc(NCC2=NCCN2)c1 10.1021/jm00366a022
CHEMBL51479 189018 0 None - 1 Bovine 6.4 pKi = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 191 3 3 4 0.8 Oc1cccc(NCC2=NCCN2)c1 10.1021/jm00366a022
44574080 188359 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 264 2 0 4 2.6 Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1 10.1016/j.bmcl.2009.03.166
CHEMBL508084 188359 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 264 2 0 4 2.6 Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1 10.1016/j.bmcl.2009.03.166
44312036 202859 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.2 CC1CN=C(Nc2ccc3nccnc3c2Br)N1 10.1016/0960-894X(95)00391-6
CHEMBL72995 202859 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.2 CC1CN=C(Nc2ccc3nccnc3c2Br)N1 10.1016/0960-894X(95)00391-6
57401787 70909 0 None 1 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 308 3 1 4 2.3 c1ccc(C2(c3ccccc3)COCC(C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956906 70909 0 None 1 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 308 3 1 4 2.3 c1ccc(C2(c3ccccc3)COCC(C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
90644724 112213 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 3 3 2 3.2 CN(C)c1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289522 112213 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 3 3 2 3.2 CN(C)c1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304483 112213 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 3 3 2 3.2 CN(C)c1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
10221005 202619 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71479 202619 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
10682720 203451 0 None 7 3 Human 7.4 pKi = 7.4 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 259 3 2 3 3.8 COc1cc(C)c(Nc2ncc[nH]2)cc1C(C)(C)C 10.1021/jm9605142
CHEMBL78190 203451 0 None 7 3 Human 7.4 pKi = 7.4 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 259 3 2 3 3.8 COc1cc(C)c(Nc2ncc[nH]2)cc1C(C)(C)C 10.1021/jm9605142
12981867 119851 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 230 2 1 2 2.5 Fc1cccc2c1C=C(CC1CN=CN1)CC2 10.1021/jm001040g
CHEMBL353139 119851 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 230 2 1 2 2.5 Fc1cccc2c1C=C(CC1CN=CN1)CC2 10.1021/jm001040g
49836308 18597 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
CHEMBL1278084 18597 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
11651319 181046 24 None 17 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cnccc1N1CCNCC1 10.1021/jm00366a007
CHEMBL47740 181046 24 None 17 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cnccc1N1CCNCC1 10.1021/jm00366a007
21584368 198170 3 None 4 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 208 2 2 4 0.6 O=[N+]([O-])c1ccc2c(c1)CNC(CO)C2 10.1016/j.bmcl.2004.12.013
CHEMBL59441 198170 3 None 4 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 208 2 2 4 0.6 O=[N+]([O-])c1ccc2c(c1)CNC(CO)C2 10.1016/j.bmcl.2004.12.013
164585473 183979 0 None -7 5 Human 5.4 pKi = 5.4 Binding
Binding affinity to alpha2a (unknown origin)Binding affinity to alpha2a (unknown origin)
ChEMBL 503 5 1 2 7.2 O=CN1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1 10.1021/acs.jmedchem.1c00164
CHEMBL4848380 183979 0 None -7 5 Human 5.4 pKi = 5.4 Binding
Binding affinity to alpha2a (unknown origin)Binding affinity to alpha2a (unknown origin)
ChEMBL 503 5 1 2 7.2 O=CN1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1 10.1021/acs.jmedchem.1c00164
10841387 99157 0 None -112 6 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL284103 99157 0 None -112 6 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
11079593 202415 0 None 1 4 Human 6.4 pKi = 6.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70326 202415 0 None 1 4 Human 6.4 pKi = 6.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
10841387 99157 0 None -112 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284103 99157 0 None -112 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
153287574 174675 0 None -5 10 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
CHEMBL4572167 174675 0 None -5 10 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
24906203 186635 0 None 2 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
CHEMBL492445 186635 0 None 2 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
57384051 70905 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@@H]2CO[C@@H](C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956902 70905 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@@H]2CO[C@@H](C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
136274357 78534 0 None 2 2 Human 8.4 pKi = 8.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 412 4 1 5 3.8 c1ccc2c(c1)NC[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1 10.1021/jm049619s
CHEMBL2112984 78534 0 None 2 2 Human 8.4 pKi = 8.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 412 4 1 5 3.8 c1ccc2c(c1)NC[C@@H]1C2=NO[C@H]1CN1CCN(Cc2ccc3ccccc3c2)CC1 10.1021/jm049619s
49864336 15441 0 None 11 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 453 9 1 5 3.7 COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221545 15441 0 None 11 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 453 9 1 5 3.7 COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
13507646 119109 0 None 3 2 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL346492 119109 0 None 3 2 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
13507646 119109 0 None 3 2 Bovine 8.4 pKi = 8.4 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL346492 119109 0 None 3 2 Bovine 8.4 pKi = 8.4 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
1593 2308 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
30668 2308 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
9868 2308 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
CHEMBL17860 2308 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
DB04948 2308 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
102 4064 44 None -15 49 Pig 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
3659 4064 44 None -15 49 Pig 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
8969 4064 44 None -15 49 Pig 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
CHEMBL15245 4064 44 None -15 49 Pig 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
DB01392 4064 44 None -15 49 Pig 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
78114881 171215 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 288 5 0 6 0.9 CCOP(=O)(OCC)C1N=CC2C(=O)N(C)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4467833 171215 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 288 5 0 6 0.9 CCOP(=O)(OCC)C1N=CC2C(=O)N(C)C(=O)C21 10.1021/acs.jmedchem.9b02080
42273326 15440 0 None 3 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 403 7 1 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221544 15440 0 None 3 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 403 7 1 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
136 3240 28 None -3 16 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
223 3240 28 None -3 16 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
643606 3240 28 None -3 16 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL10347 3240 28 None -3 16 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
42388639 187471 0 None -1 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 439 8 1 5 3.3 COc1ccccc1N1CCN(CCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL497749 187471 0 None -1 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 439 8 1 5 3.3 COc1ccccc1N1CCN(CCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
11191321 62656 0 None -2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 503 6 0 7 4.5 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C(C)(C)C)cc4OC[C@H]32)CC1 10.1021/jm049619s
CHEMBL178588 62656 0 None -2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 503 6 0 7 4.5 C/C(=C\c1ccccc1)CN1CCN(C[C@@H]2ON=C3c4ccc(OC(=O)C(C)(C)C)cc4OC[C@H]32)CC1 10.1021/jm049619s
2142 3047 54 None -2 36 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
4920903 3047 54 None -2 36 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
502 3047 54 None -2 36 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
5775 3047 54 None -2 36 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
CHEMBL597 3047 54 None -2 36 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
DB00692 3047 54 None -2 36 Rat 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
44404326 133001 0 None 1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 283 3 2 5 2.7 Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL370818 133001 0 None 1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 283 3 2 5 2.7 Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
135 2496 38 None -4 57 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm049632c
1796 2496 38 None -4 57 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm049632c
4184 2496 38 None -4 57 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm049632c
CHEMBL6437 2496 38 None -4 57 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm049632c
DB06148 2496 38 None -4 57 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm049632c
9795515 203112 0 None 17 3 Human 8.3 pKi = 8.3 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 273 3 2 3 4.1 COc1c(C(C)(C)C)cc(C)c(Nc2ncc[nH]2)c1C 10.1021/jm9605142
CHEMBL75257 203112 0 None 17 3 Human 8.3 pKi = 8.3 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 273 3 2 3 4.1 COc1c(C(C)(C)C)cc(C)c(Nc2ncc[nH]2)c1C 10.1021/jm9605142
2585 790 100 None -28 22 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 790 100 None -28 22 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 790 100 None -28 22 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 790 100 None -28 22 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 790 100 None -28 22 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
155515982 169443 0 None -1584 17 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4442460 169443 0 None -1584 17 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
44438147 93056 0 None -20 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL246228 93056 0 None -20 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 10.1016/j.bmcl.2006.12.094
10032383 109621 0 None -389 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 109621 0 None -389 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 109621 0 None -389 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
73213196 103981 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha 2A receptor (unknown origin)Binding affinity to adrenergic alpha 2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2014.05.016
CHEMBL3104093 103981 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha 2A receptor (unknown origin)Binding affinity to adrenergic alpha 2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2014.05.016
73213196 103981 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 103981 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
44401105 69233 0 None -45 9 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 373 2 0 3 4.7 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL193435 69233 0 None -45 9 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 373 2 0 3 4.7 CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1 10.1021/jm049632c
73213196 103981 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 103981 1 None -3 13 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
11109088 202479 0 None -8 6 Human 7.4 pKi = 7.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 202479 0 None -8 6 Human 7.4 pKi = 7.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
70695474 77319 0 None -7 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL2089156 77319 0 None -7 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
11173544 165708 0 None 6 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccc(-c2ccccc2OC(C)C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL426900 165708 0 None 6 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccc(-c2ccccc2OC(C)C2=NCCN2)cc1 10.1021/jm0408215
70695474 77319 0 None -7 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL2089156 77319 0 None -7 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
4209 3114 71 None -1862 33 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3114 71 None -1862 33 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3114 71 None -1862 33 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3114 71 None -1862 33 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3114 71 None -1862 33 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3114 71 None -1862 33 Pig 5.4 pKi = 5.4 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
9885114 119099 3 None -95 12 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 119099 3 None -95 12 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptorInhibition of [3H]- MK-912 binding against human recombinant Alpha-2A adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
9885114 119099 3 None -95 12 Human 6.4 pKi = 6.4 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/acs.jmedchem.7b00151
CHEMBL346389 119099 3 None -95 12 Human 6.4 pKi = 6.4 Binding
Inhibition of alpha2A adrenergic receptor (unknown origin)Inhibition of alpha2A adrenergic receptor (unknown origin)
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/acs.jmedchem.7b00151
57326584 73717 0 None -4 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 396 1 0 5 4.9 Clc1ccc2c(c1)N=C(N1CCN(C3CCCCC3)CC1)c1cccnc1O2 10.1021/jm2013419
CHEMBL2022273 73717 0 None -4 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 396 1 0 5 4.9 Clc1ccc2c(c1)N=C(N1CCN(C3CCCCC3)CC1)c1cccnc1O2 10.1021/jm2013419
24906196 186663 0 None -1 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 261 6 1 5 1.8 CCO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
CHEMBL492639 186663 0 None -1 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 261 6 1 5 1.8 CCO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
11500225 100731 57 None 38 2 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 289 1 1 3 1.1 Ic1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL295764 100731 57 None 38 2 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 289 1 1 3 1.1 Ic1cccnc1N1CCNCC1 10.1021/jm00366a007
44438167 148438 0 None -52 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL394218 148438 0 None -52 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 10.1016/j.bmcl.2006.12.094
1265 929 54 None -75 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 270 7 1 3 3.0 O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1 10.1021/jm8003625
6422124 929 54 None -75 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 270 7 1 3 3.0 O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1 10.1021/jm8003625
CHEMBL14638 929 54 None -75 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 270 7 1 3 3.0 O=C(c1ccc(cc1)OCCCc1[nH]cnc1)C1CC1 10.1021/jm8003625
13123533 193240 1 None - 1 Bovine 6.4 pKi = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 271 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)C2CCCCC2)cc1 10.1021/jm00366a022
CHEMBL541208 193240 1 None - 1 Bovine 6.4 pKi = 6.4 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 271 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)C2CCCCC2)cc1 10.1021/jm00366a022
62381256 112269 2 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 5 3 2 2.4 CCCNC(=N)Nc1ccc(OCC)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289535 112269 2 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 5 3 2 2.4 CCCNC(=N)Nc1ccc(OCC)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3305460 112269 2 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 221 5 3 2 2.4 CCCNC(=N)Nc1ccc(OCC)cc1 10.1016/j.ejmech.2014.05.057
13869716 159733 7 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 199 1 1 3 1.5 Cn1c(C2=NCCN2)cc2ccccc21 10.1021/acs.jmedchem.9b02080
CHEMBL41103 159733 7 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 199 1 1 3 1.5 Cn1c(C2=NCCN2)cc2ccccc21 10.1021/acs.jmedchem.9b02080
71456239 78530 0 None 2 2 Human 7.4 pKi = 7.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 385 5 0 4 3.8 C1=C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
CHEMBL2112979 78530 0 None 2 2 Human 7.4 pKi = 7.4 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 385 5 0 4 3.8 C1=C[C@@H]2C(=NO[C@H]2CN2CCN(C/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
13141185 60165 0 None -9 2 Bovine 6.4 pKi = 6.4 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 356 0 0 2 4.3 CN1CCC(=C2c3cc(Br)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL175508 60165 0 None -9 2 Bovine 6.4 pKi = 6.4 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 356 0 0 2 4.3 CN1CCC(=C2c3cc(Br)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
10401405 9585 15 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 279 0 1 1 3.0 FC(F)(F)C1Cc2ccc(Br)cc2CN1 10.1016/j.bmcl.2004.12.013
CHEMBL112964 9585 15 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 279 0 1 1 3.0 FC(F)(F)C1Cc2ccc(Br)cc2CN1 10.1016/j.bmcl.2004.12.013
2719 904 66 None -4 11 Human 5.4 pKi = 5.4 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
5535 904 66 None -4 11 Human 5.4 pKi = 5.4 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
607 904 66 None -4 11 Human 5.4 pKi = 5.4 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
CHEMBL76 904 66 None -4 11 Human 5.4 pKi = 5.4 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
DB00608 904 66 None -4 11 Human 5.4 pKi = 5.4 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
45588795 112260 4 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 2 3 3 2.9 N=C(Nc1ccccc1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3289534 112260 4 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 2 3 3 2.9 N=C(Nc1ccccc1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
CHEMBL3305316 112260 4 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 255 2 3 3 2.9 N=C(Nc1ccccc1)Nc1ccc2c(c1)OCO2 10.1016/j.ejmech.2014.05.057
4098 32289 24 None -13 11 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1255739 32289 24 None -13 11 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1411979 32289 24 None -13 11 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
49836304 18384 1 None 2 3 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276219 18384 1 None 2 3 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
70693375 77318 0 None -1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL2089155 77318 0 None -1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
49836304 18384 1 None 2 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276219 18384 1 None 2 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
49836305 18389 0 None 2 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276248 18389 0 None 2 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
70693375 77318 0 None -1 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL2089155 77318 0 None -1 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
9944409 7532 0 None -1 5 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL108804 7532 0 None -1 5 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
44579272 186512 0 None -14 3 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491420 186512 0 None -14 3 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
10397358 174415 39 None 70 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 178 1 2 4 0.1 Nc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL45665 174415 39 None 70 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 178 1 2 4 0.1 Nc1cccnc1N1CCNCC1 10.1021/jm00366a007
44579231 180985 0 None -28 3 Human 6.4 pKi = 6.4 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 396 6 1 6 1.7 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1 10.1016/j.bmcl.2008.08.055
CHEMBL476774 180985 0 None -28 3 Human 6.4 pKi = 6.4 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 396 6 1 6 1.7 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1 10.1016/j.bmcl.2008.08.055
135418497 62710 0 None -1949 4 Human 6.4 pKi = 6.4 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL1788222 62710 0 None -1949 4 Human 6.4 pKi = 6.4 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
2812 4711 96 None -32 34 Human 5.4 pKi = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 4711 96 None -32 34 Human 5.4 pKi = 5.4 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
10531532 205365 0 None -51 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91956 205365 0 None -51 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10199335 203039 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74467 203039 0 None -5 4 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
49781008 17068 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 3 1 2 3.3 CC(C)O[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256608 17068 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 3 1 2 3.3 CC(C)O[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
11371902 141106 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm0408215
CHEMBL385310 141106 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm0408215
11371902 141106 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL385310 141106 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
121938 141363 15 None - 1 Rat 5.4 pKi = 5.4 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 215 0 1 1 3.0 Clc1ccc2c(c1Cl)CNCCC2 10.1021/jm0205752
CHEMBL38681 141363 15 None - 1 Rat 5.4 pKi = 5.4 Binding
Inhibitory potency against alpha-2-adrenoceptorInhibitory potency against alpha-2-adrenoceptor
ChEMBL 215 0 1 1 3.0 Clc1ccc2c(c1Cl)CNCCC2 10.1021/jm0205752
10436842 99792 0 None -5754 7 Human 5.3 pKi = 5.3 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL288772 99792 0 None -5754 7 Human 5.3 pKi = 5.3 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
57326586 73718 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 402 5 1 7 2.5 OCCOCCN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1 10.1021/jm2013419
CHEMBL2022275 73718 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 402 5 1 7 2.5 OCCOCCN1CCN(C2=Nc3cc(Cl)ccc3Oc3ncccc32)CC1 10.1021/jm2013419
44438165 166231 0 None -48 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL428407 166231 0 None -48 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 10.1016/j.bmcl.2006.12.094
16007117 79626 0 None -457 6 Human 6.3 pKi = 6.3 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 479 2 1 5 5.1 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
CHEMBL212912 79626 0 None -457 6 Human 6.3 pKi = 6.3 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 479 2 1 5 5.1 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
44415704 79749 0 None -158 6 Human 6.3 pKi = 6.3 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 474 2 2 6 4.4 Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
CHEMBL213424 79749 0 None -158 6 Human 6.3 pKi = 6.3 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 474 2 2 6 4.4 Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
155538007 171789 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 444 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4475933 171789 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 444 7 0 6 4.1 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
3561 18886 34 None -1 11 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
CHEMBL1289 18886 34 None -1 11 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
499 4014 15 None -426 15 Rat 7.3 pKi = 7.3 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4014 15 None -426 15 Rat 7.3 pKi = 7.3 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4014 15 None -426 15 Rat 7.3 pKi = 7.3 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
11300487 84578 0 None 5 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccccc1-c1ccccc1OC(C)C1=NCCN1 10.1021/jm0408215
CHEMBL223830 84578 0 None 5 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccccc1-c1ccccc1OC(C)C1=NCCN1 10.1021/jm0408215
10467319 202145 11 None -9 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity at alpha-2 adrenergic receptor of rat.Binding affinity at alpha-2 adrenergic receptor of rat.
ChEMBL 250 0 2 1 2.6 Brc1cccc2c3c([nH]c12)CNCC3 10.1016/j.bmcl.2003.11.078
CHEMBL6857 202145 11 None -9 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity at alpha-2 adrenergic receptor of rat.Binding affinity at alpha-2 adrenergic receptor of rat.
ChEMBL 250 0 2 1 2.6 Brc1cccc2c3c([nH]c12)CNCC3 10.1016/j.bmcl.2003.11.078
6455104 98034 5 None - 1 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 172 2 1 2 1.7 C(=C/c1ccccc1)\C1=NCCN1 10.1021/acs.jmedchem.9b02080
CHEMBL275970 98034 5 None - 1 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 172 2 1 2 1.7 C(=C/c1ccccc1)\C1=NCCN1 10.1021/acs.jmedchem.9b02080
15853467 206393 0 None -141 6 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-2A adrenergic receptorBinding affinity against human Alpha-2A adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
CHEMBL98063 206393 0 None -141 6 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-2A adrenergic receptorBinding affinity against human Alpha-2A adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
44574134 177929 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 269 2 0 4 3.0 Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466634 177929 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 269 2 0 4 3.0 Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44387798 165720 0 None -4 2 Human 7.3 pKi = 7.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 458 7 0 5 3.9 CC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(CCC/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
CHEMBL426959 165720 0 None -4 2 Human 7.3 pKi = 7.3 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 458 7 0 5 3.9 CC(=O)N1C[C@@H]2C(=NO[C@H]2CN2CCN(CCC/C=C/c3ccccc3)CC2)c2ccccc21 10.1021/jm049619s
11108001 10771 2 None -4 6 Human 7.3 pKi = 7.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 10771 2 None -4 6 Human 7.3 pKi = 7.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 10771 2 None -4 6 Human 7.3 pKi = 7.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
44352207 18668 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL128168 18668 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
44352207 18668 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL128168 18668 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
44352207 18668 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL128168 18668 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
44352207 18668 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL128168 18668 1 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
162674829 182692 0 None - 1 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 513 11 5 11 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4796664 182692 0 None - 1 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 513 11 5 11 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
164614469 184198 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 341 1 0 3 3.9 C[Si](C)(C)C#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4851349 184198 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 341 1 0 3 3.9 C[Si](C)(C)C#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
3034396 101168 33 None -77 17 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC 10.1021/acs.jmedchem.9b01465
CHEMBL299031 101168 33 None -77 17 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCc3c([nH]c4cccc(OC)c34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC 10.1021/acs.jmedchem.9b01465
44269013 30128 1 None 1 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 218 5 1 3 2.0 CCCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL13917 30128 1 None 1 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 218 5 1 3 2.0 CCCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
45487962 195809 0 None 10 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 218 4 1 3 2.1 CCCc1ccccc1COC1=NCCN1 10.1021/jm901262f
CHEMBL569933 195809 0 None 10 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 218 4 1 3 2.1 CCCc1ccccc1COC1=NCCN1 10.1021/jm901262f
11776640 13435 0 None 2 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1193824 13435 0 None 2 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL545293 13435 0 None 2 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 245 3 1 5 1.1 CCCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
163198500 185816 2 None -3 2 Human 5.3 pKi = 5.3 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 371 1 0 3 3.2 O=[N+]([O-])C1=Cc2cc(I)ccc2OC1C(F)(F)F 10.1016/j.bmcl.2021.128008
CHEMBL4875858 185816 2 None -3 2 Human 5.3 pKi = 5.3 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 371 1 0 3 3.2 O=[N+]([O-])C1=Cc2cc(I)ccc2OC1C(F)(F)F 10.1016/j.bmcl.2021.128008
15407445 198594 2 None - 1 Human 5.3 pKi = 5.3 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 192 1 1 3 1.6 CC1Cc2ccc([N+](=O)[O-])cc2CN1 10.1016/j.bmcl.2004.12.013
CHEMBL59719 198594 2 None - 1 Human 5.3 pKi = 5.3 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 192 1 1 3 1.6 CC1Cc2ccc([N+](=O)[O-])cc2CN1 10.1016/j.bmcl.2004.12.013
132060743 161686 0 None -1 13 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 351 3 0 4 3.1 CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1 10.1016/j.ejmech.2018.02.024
CHEMBL4163428 161686 0 None -1 13 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 351 3 0 4 3.1 CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1 10.1016/j.ejmech.2018.02.024
57395732 70847 0 None 1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 342 5 1 3 4.8 CC(Oc1c(-c2ccccc2)cccc1-c1ccccc1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956203 70847 0 None 1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 342 5 1 3 4.8 CC(Oc1c(-c2ccccc2)cccc1-c1ccccc1)C1=NCCN1 10.1016/j.bmc.2012.01.035
70696790 75946 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 3 1 3 1.5 CC1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
CHEMBL2058632 75946 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 3 1 3 1.5 CC1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
90644748 112238 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 4 4 2 3.6 CCNc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289520 112238 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 4 4 2 3.6 CCNc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304855 112238 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 254 4 4 2 3.6 CCNc1ccc(NC(=N)Nc2ccccc2)cc1 10.1016/j.ejmech.2014.05.057
155517797 169646 0 None - 1 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 498 8 0 6 5.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC34CC5CC(CC(C5)C3)C4)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4445396 169646 0 None - 1 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 498 8 0 6 5.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(CC34CC5CC(CC(C5)C3)C4)C(=O)C21 10.1021/acs.jmedchem.9b02080
102 4064 44 None -47 49 Bovine 7.3 pKi = 7.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
3659 4064 44 None -47 49 Bovine 7.3 pKi = 7.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
8969 4064 44 None -47 49 Bovine 7.3 pKi = 7.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
CHEMBL15245 4064 44 None -47 49 Bovine 7.3 pKi = 7.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
DB01392 4064 44 None -47 49 Bovine 7.3 pKi = 7.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
102 4064 44 None -47 49 Bovine 7.3 pKi = 7.3 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
3659 4064 44 None -47 49 Bovine 7.3 pKi = 7.3 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
8969 4064 44 None -47 49 Bovine 7.3 pKi = 7.3 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
CHEMBL15245 4064 44 None -47 49 Bovine 7.3 pKi = 7.3 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
DB01392 4064 44 None -47 49 Bovine 7.3 pKi = 7.3 Binding
Evaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortexEvaluated for its ability to displace [3H]clonidine from alpha-2 adrenergic receptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
191 399 92 None -41 28 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 399 92 None -41 28 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 399 92 None -41 28 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 399 92 None -41 28 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 399 92 None -41 28 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
13298530 98615 18 None 97 2 Bovine 8.3 pKi = 8.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00366a007
CHEMBL280514 98615 18 None 97 2 Bovine 8.3 pKi = 8.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00366a007
44215744 205709 0 None -1 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ccccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL94129 205709 0 None -1 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ccccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
521 1377 64 None -2 7 Rat 8.3 pKi = 8.3 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
5311068 1377 64 None -2 7 Rat 8.3 pKi = 8.3 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
835 1377 64 None -2 7 Rat 8.3 pKi = 8.3 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
CHEMBL778 1377 64 None -2 7 Rat 8.3 pKi = 8.3 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
DB00633 1377 64 None -2 7 Rat 8.3 pKi = 8.3 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 10.1021/jm000128r
42267840 15428 2 None 4 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 425 7 1 5 2.9 COc1ccccc1N1CCN(CCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221499 15428 2 None 4 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 425 7 1 5 2.9 COc1ccccc1N1CCN(CCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
44330857 4328 0 None -5 2 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 493 8 0 8 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4OC)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL101361 4328 0 None -5 2 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 493 8 0 8 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4OC)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
294234 102420 3 None 1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 102420 3 None 1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
31101 720 39 None -12 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 720 39 None -12 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 720 39 None -12 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 720 39 None -12 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 720 39 None -12 35 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
13123525 188609 0 None - 1 Bovine 8.3 pKi = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 265 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)c2ccccc2)cc1 10.1021/jm00366a022
CHEMBL51131 188609 0 None - 1 Bovine 8.3 pKi = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 265 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)c2ccccc2)cc1 10.1021/jm00366a022
44330598 205904 0 None -8 2 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4cccc(F)c4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL95218 205904 0 None -8 2 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4cccc(F)c4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
10220053 205193 0 None 3 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1016/s0960-894x(03)00525-0
CHEMBL90997 205193 0 None 3 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1016/s0960-894x(03)00525-0
10220053 205193 0 None 3 3 Human 8.2 pKi = 8.2 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1021/jm049619s
CHEMBL90997 205193 0 None 3 3 Human 8.2 pKi = 8.2 Binding
Inhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptorInhibition of [3H]- rauwolscine binding to human alpha-2A adrenergic receptor
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1021/jm049619s
1343 1858 55 None -9 9 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 1858 55 None -9 9 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 1858 55 None -9 9 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 1858 55 None -9 9 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 1858 55 None -9 9 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
100 3745 52 None -33 55 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 3745 52 None -33 55 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 3745 52 None -33 55 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 3745 52 None -33 55 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 3745 52 None -33 55 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
73291731 92059 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 232 5 1 3 2.4 CCCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
CHEMBL2431282 92059 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 232 5 1 3 2.4 CCCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
117590588 96077 34 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O 10.1021/jm001040g
14969 96077 34 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O 10.1021/jm001040g
CHEMBL262777 96077 34 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O 10.1021/jm001040g
24906199 187082 12 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL495096 187082 12 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
45487955 196633 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 232 4 1 3 2.7 CCCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL576078 196633 0 None 2 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 232 4 1 3 2.7 CCCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
2771431 187698 47 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 231 1 1 3 1.8 Clc1cnc(N2CCNCC2)c(Cl)c1 10.1021/jm00366a007
CHEMBL50016 187698 47 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 231 1 1 3 1.8 Clc1cnc(N2CCNCC2)c(Cl)c1 10.1021/jm00366a007
9923679 81350 0 None 1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 332 3 1 4 4.0 Cc1cc(Nc2ccc(N3CCN(C)CC3)cc2)c2ccccc2n1 10.1021/jm060262x
CHEMBL216399 81350 0 None 1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 332 3 1 4 4.0 Cc1cc(Nc2ccc(N3CCN(C)CC3)cc2)c2ccccc2n1 10.1021/jm060262x
162651072 179600 0 None - 1 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 527 12 5 11 1.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4749263 179600 0 None - 1 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 527 12 5 11 1.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
137641762 157554 0 None -15 5 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor
ChEMBL 476 5 4 10 1.1 CCCNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.7b00141
CHEMBL4086593 157554 0 None -15 5 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor
ChEMBL 476 5 4 10 1.1 CCCNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.7b00141
137643541 157885 0 None -4 3 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor
ChEMBL 448 3 4 10 0.3 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC)nc(C#Cc4ccc(Cl)s4)nc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.7b00141
CHEMBL4090355 157885 0 None -4 3 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor
ChEMBL 448 3 4 10 0.3 CNC(=O)[C@H]1O[C@@H](n2cnc3c(NC)nc(C#Cc4ccc(Cl)s4)nc32)[C@H](O)[C@@H]1O 10.1021/acs.jmedchem.7b00141
3158 55974 21 None -3467 20 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 55974 21 None -3467 20 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
10651080 105462 0 None -57 6 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL312871 105462 0 None -57 6 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
57398332 70903 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc(C2COC(C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956900 70903 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc(C2COC(C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
10916464 202452 0 None -10 5 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70563 202452 0 None -10 5 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
44579184 190359 4 None -10 3 Human 6.3 pKi = 6.3 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL518592 190359 4 None -10 3 Human 6.3 pKi = 6.3 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
132060776 161852 0 None -1 16 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
CHEMBL4165863 161852 0 None -1 16 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
11820657 13333 1 None 6 2 Bovine 7.3 pKi = 7.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
CHEMBL1193017 13333 1 None 6 2 Bovine 7.3 pKi = 7.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
CHEMBL544354 13333 1 None 6 2 Bovine 7.3 pKi = 7.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 217 1 1 5 0.4 Cc1cn2ccnc(N3CCNCC3)c2n1 10.1021/jm00099a012
10036255 21159 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL131417 21159 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
10036256 23577 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL133579 23577 0 None 1 2 Human 7.3 pKi = 7.3 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
11277479 84326 0 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1cccc(-c2ccccc2OC(C)C2=NCCN2)c1 10.1021/jm0408215
CHEMBL222973 84326 0 None 4 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1cccc(-c2ccccc2OC(C)C2=NCCN2)c1 10.1021/jm0408215
10214826 4412 15 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 289 2 2 4 2.9 Brc1c(Nc2ncc[nH]2)ccc2nccnc12 10.1021/jm9605142
CHEMBL1019 4412 15 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 289 2 2 4 2.9 Brc1c(Nc2ncc[nH]2)ccc2nccnc12 10.1021/jm9605142
130442572 171342 0 None -109 24 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4469848 171342 0 None -109 24 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
90644706 112246 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 269 3 3 2 3.3 N=C(NCc1ccco1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3289531 112246 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 269 3 3 2 3.3 N=C(NCc1ccco1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3304994 112246 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 269 3 3 2 3.3 N=C(NCc1ccco1)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
4735 193445 92 None -9 10 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL361506 193445 92 None -9 10 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL55 193445 92 None -9 10 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
3584 3718 60 None -251 14 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 3718 60 None -251 14 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 3718 60 None -251 14 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 3718 60 None -251 14 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 3718 60 None -251 14 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
10101373 12982 0 None 19 2 Human 7.3 pKi = 7.3 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 718 6 6 6 4.6 O=C(NCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1190317 12982 0 None 19 2 Human 7.3 pKi = 7.3 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 718 6 6 6 4.6 O=C(NCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL540594 12982 0 None 19 2 Human 7.3 pKi = 7.3 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 718 6 6 6 4.6 O=C(NCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
24882007 12367 1 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.ejmech.2014.09.083
CHEMBL1186220 12367 1 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.ejmech.2014.09.083
49836301 18380 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml400232p
CHEMBL1276140 18380 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml400232p
49836301 18380 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/jm100977d
CHEMBL1276140 18380 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/jm100977d
49836301 18380 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml300064v
CHEMBL1276140 18380 1 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml300064v
16785637 180995 77 None 11 2 Bovine 5.3 pKi = 5.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 206 2 2 4 -0.4 NC(=O)c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL47688 180995 77 None 11 2 Bovine 5.3 pKi = 5.3 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 206 2 2 4 -0.4 NC(=O)c1cccnc1N1CCNCC1 10.1021/jm00366a007
162664704 181629 0 None - 1 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 471 8 5 11 0.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2CNCc3ccccc32)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4783068 181629 0 None - 1 Rat 4.3 pKi = 4.3 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 471 8 5 11 0.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2CNCc3ccccc32)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
73347825 92108 0 None -3 3 Human 5.3 pKi = 5.3 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 311 5 1 3 2.9 COc1ccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc1OC 10.1016/j.bmc.2013.07.045
CHEMBL2432046 92108 0 None -3 3 Human 5.3 pKi = 5.3 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 311 5 1 3 2.9 COc1ccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc1OC 10.1016/j.bmc.2013.07.045
145973771 164167 0 None -6 7 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method
ChEMBL 797 16 2 7 10.8 CC(C)(C)OC(=O)NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
CHEMBL4217398 164167 0 None -6 7 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human adrenergic alpha2A receptor expressed in MDCK cell membranes after 90 mins by scintillation counting method
ChEMBL 797 16 2 7 10.8 CC(C)(C)OC(=O)NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
448537 159703 86 None -33 25 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 159703 86 None -33 25 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
155521287 170011 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 478 7 0 6 4.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4450506 170011 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 478 7 0 6 4.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
487 3577 17 None -1513 12 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
60602 3577 17 None -1513 12 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL405355 3577 17 None -1513 12 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB09239 3577 17 None -1513 12 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
10059780 12850 0 None 6 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL1189347 12850 0 None 6 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
CHEMBL538537 12850 0 None 6 3 Bovine 6.3 pKi = 6.3 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 2 1 5 0.7 CCc1cnc2c(N3CCNCC3)nccn12 10.1021/jm00099a012
289 240 6 None -47 14 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha2A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
9948320 240 6 None -47 14 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha2A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
CHEMBL1242950 240 6 None -47 14 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha2A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha2A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
2801 161325 56 None -14 28 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
CHEMBL1200710 161325 56 None -14 28 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
CHEMBL415 161325 56 None -14 28 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 nan
162643475 181161 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha 2A adrenoceptor (unknown origin)Binding affinity to alpha 2A adrenoceptor (unknown origin)
ChEMBL 283 1 0 2 4.3 C=C1CCN2Cc3ccc(OC)cc3[C@H]3CCCC[C@]32C1 10.1021/acs.jmedchem.0c01192
CHEMBL4777306 181161 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha 2A adrenoceptor (unknown origin)Binding affinity to alpha 2A adrenoceptor (unknown origin)
ChEMBL 283 1 0 2 4.3 C=C1CCN2Cc3ccc(OC)cc3[C@H]3CCCC[C@]32C1 10.1021/acs.jmedchem.0c01192
15730 70774 73 None -2 10 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
CHEMBL195437 70774 73 None -2 10 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
155521287 170011 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 478 7 0 6 4.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4450506 170011 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 478 7 0 6 4.8 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(F)c(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
57394788 70906 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@H]2COC[C@@H](C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956903 70906 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@H]2COC[C@@H](C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
10092819 16594 0 None -51 12 Rat 7.3 pKi = 7.3 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 407 8 1 5 3.8 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1 10.1021/jm0211220
CHEMBL124444 16594 0 None -51 12 Rat 7.3 pKi = 7.3 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 407 8 1 5 3.8 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1 10.1021/jm0211220
44424855 85029 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
CHEMBL226636 85029 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
518 3555 1 None -3 6 Human 7.3 pKi = 7.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
9839317 3555 1 None -3 6 Human 7.3 pKi = 7.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
CHEMBL123138 3555 1 None -3 6 Human 7.3 pKi = 7.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
49781005 17032 0 None 3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256503 17032 0 None 3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
6075 149575 36 None -11 16 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 149575 36 None -11 16 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
155548049 173125 0 None -3 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 266 1 2 3 3.3 O=C1/C(=C/c2cccc(O)c2)CCc2c(O)cccc21 10.1016/j.ejmech.2021.113964
CHEMBL4535634 173125 0 None -3 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 266 1 2 3 3.3 O=C1/C(=C/c2cccc(O)c2)CCc2c(O)cccc21 10.1016/j.ejmech.2021.113964
135559170 101590 0 None -851 7 Human 6.3 pKi = 6.3 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
CHEMBL302021 101590 0 None -851 7 Human 6.3 pKi = 6.3 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
3584 3718 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
5401 3718 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
7302 3718 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
CHEMBL611 3718 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
DB01162 3718 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
9813756 8928 0 None -1 3 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL109848 8928 0 None -1 3 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
13123534 188863 1 None - 1 Bovine 7.3 pKi = 7.3 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 209 3 2 3 1.8 Clc1ccccc1NCC1=NCCN1 10.1021/jm00366a022
CHEMBL51358 188863 1 None - 1 Bovine 7.3 pKi = 7.3 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]prazosin as the radioligand
ChEMBL 209 3 2 3 1.8 Clc1ccccc1NCC1=NCCN1 10.1021/jm00366a022
2142 3047 54 None -2 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
4920903 3047 54 None -2 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
502 3047 54 None -2 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
5775 3047 54 None -2 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
CHEMBL597 3047 54 None -2 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
DB00692 3047 54 None -2 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
3584 3718 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
5401 3718 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
7302 3718 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
CHEMBL611 3718 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
DB01162 3718 60 None -251 14 Human 6.3 pKi = 6.3 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
12613159 186743 7 None -16 4 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL493054 186743 7 None -16 4 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
11465618 101926 18 None -2089 19 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL3039528 101926 18 None -2089 19 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL5191141 101926 18 None -2089 19 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
9816461 10619 6 None -9 4 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117094 10619 6 None -9 4 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL544290 10619 6 None -9 4 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
24906198 187081 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
CHEMBL495095 187081 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
57402717 70843 2 None 14 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 220 4 1 4 1.5 COc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956199 70843 2 None 14 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 220 4 1 4 1.5 COc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
24906198 187081 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
CHEMBL495095 187081 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
45487145 195982 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 4 1 3 2.5 C=CCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL570973 195982 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 4 1 3 2.5 C=CCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
24906198 187081 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm100977d
CHEMBL495095 187081 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm100977d
24906198 187081 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml300064v
CHEMBL495095 187081 3 None -2 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml300064v
44329027 4104 0 None -29 6 Human 6.2 pKi = 6.2 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL100045 4104 0 None -29 6 Human 6.2 pKi = 6.2 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
11097789 102524 0 None -11 6 Human 7.2 pKi = 7.2 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 102524 0 None -11 6 Human 7.2 pKi = 7.2 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
2765 930 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
515 930 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
CHEMBL13852 930 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
DB09202 930 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
2765 930 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
515 930 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
CHEMBL13852 930 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
DB09202 930 16 None -1 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
16090621 141043 0 None -16 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 422 5 1 4 5.6 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1Cc1ccccc1 10.1021/jm060262x
CHEMBL384925 141043 0 None -16 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 422 5 1 4 5.6 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1Cc1ccccc1 10.1021/jm060262x
1960 2815 64 None -35 26 Mouse 5.2 pKi = 5.2 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O nan
439260 2815 64 None -35 26 Mouse 5.2 pKi = 5.2 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O nan
505 2815 64 None -35 26 Mouse 5.2 pKi = 5.2 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL1437 2815 64 None -35 26 Mouse 5.2 pKi = 5.2 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O nan
DB00368 2815 64 None -35 26 Mouse 5.2 pKi = 5.2 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O nan
9906978 42466 1 None -165 12 Human 5.2 pKi = 5.2 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 42466 1 None -165 12 Human 5.2 pKi = 5.2 Binding
Binding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
6726 1254 46 None -10 13 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
7151 1254 46 None -10 13 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
749 1254 46 None -10 13 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL648 1254 46 None -10 13 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB01176 1254 46 None -10 13 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
150 2473 18 None -45 15 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
1764 2473 18 None -45 15 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
8226 2473 18 None -45 15 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
CHEMBL1201356 2473 18 None -45 15 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
DB00353 2473 18 None -45 15 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
9859437 167459 0 None 38 3 Human 8.2 pKi = 8.2 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
CHEMBL432155 167459 0 None 38 3 Human 8.2 pKi = 8.2 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
49864360 15451 0 None 15 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 445 10 1 4 5.0 COc1ccccc1N1CCN(CCCCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221593 15451 0 None 15 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 445 10 1 4 5.0 COc1ccccc1N1CCN(CCCCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
11653915 123494 0 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL362954 123494 0 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2A adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
1209 1628 69 None -1 31 Human 8.2 pKi = 8.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1021/jm001040g
203 1628 69 None -1 31 Human 8.2 pKi = 8.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1021/jm001040g
3386 1628 69 None -1 31 Human 8.2 pKi = 8.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1021/jm001040g
CHEMBL41 1628 69 None -1 31 Human 8.2 pKi = 8.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1021/jm001040g
DB00472 1628 69 None -1 31 Human 8.2 pKi = 8.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1021/jm001040g
131829 203020 11 None 7 6 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
CHEMBL74283 203020 11 None 7 6 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
135477797 78522 0 None -1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
CHEMBL2112971 78522 0 None -1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
2435 714 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
395 714 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
520 714 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
5386 714 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
CHEMBL844 714 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
DB00484 714 98 None -4 12 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
10382537 202465 11 None 6 6 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL70676 202465 11 None 6 6 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
98358 118981 8 None -1 2 Bovine 7.2 pKi = 7.2 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL345349 118981 8 None -1 2 Bovine 7.2 pKi = 7.2 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
98358 118981 8 None -1 2 Bovine 7.2 pKi = 7.2 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL345349 118981 8 None -1 2 Bovine 7.2 pKi = 7.2 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
11361608 84321 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
CHEMBL222928 84321 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
11361608 84321 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm0408215
CHEMBL222928 84321 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm0408215
11361608 84321 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
CHEMBL222928 84321 1 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
13141186 130169 0 None -7 2 Bovine 6.2 pKi = 6.2 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 312 0 0 2 4.2 CN1CCC(=C2c3cc(Cl)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368357 130169 0 None -7 2 Bovine 6.2 pKi = 6.2 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 312 0 0 2 4.2 CN1CCC(=C2c3cc(Cl)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
9851486 204972 0 None -512 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL89685 204972 0 None -512 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
155525779 170475 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 494 7 0 6 5.3 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cc(Cl)cc(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4456882 170475 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 494 7 0 6 5.3 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3cc(Cl)cc(Cl)c3)C(=O)C21 10.1021/acs.jmedchem.9b02080
11771731 107760 2 None -16 3 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL319706 107760 2 None -16 3 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)Displacement of [3H]RX821002 from alpha-2A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
134 2478 19 None -74 67 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
1775 2478 19 None -74 67 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
9681 2478 19 None -74 67 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
CHEMBL1065 2478 19 None -74 67 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
DB00247 2478 19 None -74 67 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
489 145 22 None -1778 13 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 145 22 None -1778 13 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 145 22 None -1778 13 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
10082625 13681 0 None -4 3 Bovine 6.2 pKi = 6.2 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL1195526 13681 0 None -4 3 Bovine 6.2 pKi = 6.2 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL554785 13681 0 None -4 3 Bovine 6.2 pKi = 6.2 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 1 5 0.8 Cc1cn2c(C)cnc2c(N2CCNCC2)n1 10.1021/jm00099a012
2750 202363 69 None -3 12 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
CHEMBL7002 202363 69 None -3 12 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
2351 3234 60 None -9 21 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 3234 60 None -9 21 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 3234 60 None -9 21 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 3234 60 None -9 21 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 3234 60 None -9 21 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
129211 3692 75 None -120 16 Human 7.2 pKi = 7.2 Binding
Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligandBinding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
2562 3692 75 None -120 16 Human 7.2 pKi = 7.2 Binding
Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligandBinding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
488 3692 75 None -120 16 Human 7.2 pKi = 7.2 Binding
Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligandBinding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
CHEMBL836 3692 75 None -120 16 Human 7.2 pKi = 7.2 Binding
Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligandBinding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
DB00706 3692 75 None -120 16 Human 7.2 pKi = 7.2 Binding
Binding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligandBinding affinity towards recombinant human alpha-2A adrenergic receptor was determined using [3H]MK-912 as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
2274 3124 53 None -10 32 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 3124 53 None -10 32 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 3124 53 None -10 32 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 3124 53 None -10 32 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 3124 53 None -10 32 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
10934575 202781 0 None -3 6 Human 7.2 pKi = 7.2 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 202781 0 None -3 6 Human 7.2 pKi = 7.2 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
10823140 119860 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 2 1 2 2.5 C1=NC[C@H](C[C@]23CCc4ccccc4C2C3)N1 10.1021/jm001040g
136078488 119860 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 2 1 2 2.5 C1=NC[C@H](C[C@]23CCc4ccccc4C2C3)N1 10.1021/jm001040g
CHEMBL353212 119860 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity for human alpha-2 adrenergic receptor expressed in CHO cellBinding affinity for human alpha-2 adrenergic receptor expressed in CHO cell
ChEMBL 226 2 1 2 2.5 C1=NC[C@H](C[C@]23CCc4ccccc4C2C3)N1 10.1021/jm001040g
75306277 108767 0 None -31 23 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
CHEMBL3217984 108767 0 None -31 23 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
155550341 174531 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 458 8 0 6 4.2 CCOP(=O)(OCC)C1(Cc2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4568994 174531 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 458 8 0 6 4.2 CCOP(=O)(OCC)C1(Cc2ccc(F)cc2)N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
1042 1551 20 None -97 16 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
148 1551 20 None -97 16 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
443884 1551 20 None -97 16 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
CHEMBL119443 1551 20 None -97 16 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
DB01253 1551 20 None -97 16 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
16090635 82103 0 None -5 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 378 4 1 4 4.7 CCc1c(C)nc2c(c1Nc1ccc(N3CCN(C)C(C)C3)cc1)CCCC2 10.1021/jm060262x
CHEMBL217768 82103 0 None -5 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 378 4 1 4 4.7 CCc1c(C)nc2c(c1Nc1ccc(N3CCN(C)C(C)C3)cc1)CCCC2 10.1021/jm060262x
10508332 105511 0 None -426 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
CHEMBL313160 105511 0 None -426 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
10626982 111007 0 None -11 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL327775 111007 0 None -11 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
1534 102566 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
9287 102566 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
CHEMBL30713 102566 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
155536080 171548 0 None -43 10 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 219 2 1 2 2.9 CC[C@H]1c2cc(OC)ccc2CC[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
CHEMBL4472703 171548 0 None -43 10 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 219 2 1 2 2.9 CC[C@H]1c2cc(OC)ccc2CC[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
57394789 70907 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@@H]2COC[C@@H](C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956904 70907 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@@H]2COC[C@@H](C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
1534 102566 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
9287 102566 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
CHEMBL30713 102566 51 None -6 12 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysisDisplacement of [3H]Clonidine from human recombinant adrenergic alpha2A receptor expressed in MDCK cells after 1 to 1.5 hrs by scintillation counting analysis
ChEMBL 174 2 2 1 2.1 CC(N)Cc1c[nH]c2ccccc12 10.1016/j.bmcl.2013.03.066
162677211 182978 0 None - 1 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 516 9 5 13 -0.0 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccc([N+](=O)[O-])cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4800292 182978 0 None - 1 Rat 4.2 pKi = 4.2 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 516 9 5 13 -0.0 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCNCC2Cc3ccc([N+](=O)[O-])cc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
487 3577 17 None -1513 12 Human 6.2 pKi = 6.2 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
60602 3577 17 None -1513 12 Human 6.2 pKi = 6.2 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
CHEMBL405355 3577 17 None -1513 12 Human 6.2 pKi = 6.2 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
DB09239 3577 17 None -1513 12 Human 6.2 pKi = 6.2 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
10793963 99211 0 None -69 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284470 99211 0 None -69 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
71652196 87026 0 None -190 6 Rat 5.2 pKi = 5.2 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 368 4 1 5 3.6 Oc1ccc(N2CCN(Cc3cnn(-c4ccc(Cl)cc4)c3)CC2)cc1 10.1016/j.ejmech.2012.08.011
CHEMBL2333732 87026 0 None -190 6 Rat 5.2 pKi = 5.2 Binding
Displacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from alpha2A adrenergic receptor in Wistar rat cortical membrane after 45 mins by liquid scintillation counting
ChEMBL 368 4 1 5 3.6 Oc1ccc(N2CCN(Cc3cnn(-c4ccc(Cl)cc4)c3)CC2)cc1 10.1016/j.ejmech.2012.08.011
3652 45983 62 None -1 9 Human 5.2 pKi = 5.2 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 10.1038/s41586-020-2286-9
CHEMBL1535 45983 62 None -1 9 Human 5.2 pKi = 5.2 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 10.1038/s41586-020-2286-9
118717249 114627 0 None 2 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.ejmech.2014.09.083
CHEMBL3343700 114627 0 None 2 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2A adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.ejmech.2014.09.083
11741010 82838 0 None -4 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1cc(C)c2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL218730 82838 0 None -4 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1cc(C)c2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
164609539 183817 0 None 2 3 Human 6.2 pKi = 6.2 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 428 2 0 5 3.3 O=C1c2ccccc2C(=O)N1CC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4845850 183817 0 None 2 3 Human 6.2 pKi = 6.2 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 428 2 0 5 3.3 O=C1c2ccccc2C(=O)N1CC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
123920 99691 34 None -309 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 201 0 1 1 2.6 Clc1ccc2c(c1Cl)CNCC2 10.1016/j.bmcl.2004.12.013
CHEMBL287837 99691 34 None -309 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligandBinding affinity against human alpha 2A adrenergic receptor in CHO cells using [3H]RX-821002 as radioligand
ChEMBL 201 0 1 1 2.6 Clc1ccc2c(c1Cl)CNCC2 10.1016/j.bmcl.2004.12.013
71459553 83282 5 None -3 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 406 7 0 4 5.3 COc1ccc2c(C)c(C(=O)N(CCCN3CCCCC3)c3ccccc3)oc2c1 10.1016/j.bmc.2012.09.044
CHEMBL2205360 83282 5 None -3 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 406 7 0 4 5.3 COc1ccc2c(C)c(C(=O)N(CCCN3CCCCC3)c3ccccc3)oc2c1 10.1016/j.bmc.2012.09.044
1960 2815 64 None -10 26 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
439260 2815 64 None -10 26 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
505 2815 64 None -10 26 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
CHEMBL1437 2815 64 None -10 26 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
DB00368 2815 64 None -10 26 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
44325044 205651 0 None -5 3 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 479 6 0 8 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4csc5ccccc45)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL93801 205651 0 None -5 3 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 479 6 0 8 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4csc5ccccc45)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
44401164 69473 0 None -346 9 Human 7.2 pKi = 7.2 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL193639 69473 0 None -346 9 Human 7.2 pKi = 7.2 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
44579271 186511 0 None -32 3 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491419 186511 0 None -32 3 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
14004035 119014 0 None -1 2 Bovine 6.2 pKi = 6.2 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
CHEMBL345621 119014 0 None -1 2 Bovine 6.2 pKi = 6.2 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
14004035 119014 0 None -1 2 Bovine 6.2 pKi = 6.2 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
CHEMBL345621 119014 0 None -1 2 Bovine 6.2 pKi = 6.2 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
24906160 168889 0 None 1 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 247 5 1 5 1.4 CO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
CHEMBL442815 168889 0 None 1 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 247 5 1 5 1.4 CO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
441082 1140 40 None -141 8 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 356 1 0 2 4.8 CN([C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]24[C@H]3CC[C@@H]4[C@@H](N(C2)C)C)C1)C)C 10.1021/jm8003625
8981 1140 40 None -141 8 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 356 1 0 2 4.8 CN([C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]24[C@H]3CC[C@@H]4[C@@H](N(C2)C)C)C1)C)C 10.1021/jm8003625
CHEMBL191703 1140 40 None -141 8 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cellsDisplacement of [3H]rauwolscine from human adrenergic alpha 2C10 receptor expressed in mouse LTK- cells
ChEMBL 356 1 0 2 4.8 CN([C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]24[C@H]3CC[C@@H]4[C@@H](N(C2)C)C)C1)C)C 10.1021/jm8003625
122442272 137820 0 None -11 15 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3769968 137820 0 None -11 15 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3771384 137820 0 None -11 15 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha-2A adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2A adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
240 931 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 931 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 931 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 931 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 931 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 931 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 931 39 None -12 25 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
196129 67456 12 None -85 15 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 67456 12 None -85 15 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
26757 206239 29 None -1 2 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
CHEMBL972 206239 29 None -1 2 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
10818003 105940 0 None -12 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
CHEMBL313953 105940 0 None -12 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
10603951 204790 0 None -33 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL88448 204790 0 None -33 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
90644753 112271 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 231 3 3 1 2.9 CCCNC(=N)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3289537 112271 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 231 3 3 1 2.9 CCCNC(=N)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
CHEMBL3305462 112271 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 231 3 3 1 2.9 CCCNC(=N)Nc1ccc2c(c1)CCCC2 10.1016/j.ejmech.2014.05.057
3073596 43996 24 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 184 1 1 2 2.8 c1ccc2oc(-c3ncc[nH]3)cc2c1 10.1021/acs.jmedchem.9b02080
CHEMBL151697 43996 24 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 184 1 1 2 2.8 c1ccc2oc(-c3ncc[nH]3)cc2c1 10.1021/acs.jmedchem.9b02080
9816063 102600 0 None -4 6 Human 7.2 pKi = 7.2 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm990569e
CHEMBL30739 102600 0 None -4 6 Human 7.2 pKi = 7.2 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm990569e
9816063 102600 0 None 4 6 Rat 7.2 pKi = 7.2 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm000128r
CHEMBL30739 102600 0 None 4 6 Rat 7.2 pKi = 7.2 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm000128r
16090625 82018 0 None -7 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2cccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL217452 82018 0 None -7 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2cccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
130442480 174698 0 None -83 24 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
CHEMBL4572614 174698 0 None -83 24 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-rauwolscine from recombinant human alpha2A adrenergic receptor stably expressed in MDCK cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
155556618 173905 0 None -6456 5 Human 5.2 pKi = 5.2 Binding
Inhibition of alpha2a receptor (unknown origin)Inhibition of alpha2a receptor (unknown origin)
ChEMBL 417 6 3 7 2.7 O[C@H]1[C@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H]2C[C@@]2(CCl)[C@H]1O 10.1021/acs.jmedchem.8b01662
CHEMBL4554295 173905 0 None -6456 5 Human 5.2 pKi = 5.2 Binding
Inhibition of alpha2a receptor (unknown origin)Inhibition of alpha2a receptor (unknown origin)
ChEMBL 417 6 3 7 2.7 O[C@H]1[C@H](n2cnc3c(NC(C4CCC4)C4CCC4)ncnc32)[C@H]2C[C@@]2(CCl)[C@H]1O 10.1021/acs.jmedchem.8b01662
4011 81996 43 None -35 23 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 81996 43 None -35 23 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
28417 39799 48 None -1 12 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
CHEMBL1479 39799 48 None -1 12 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
26987 936 29 None -158 21 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 936 29 None -158 21 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 936 29 None -158 21 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 936 29 None -158 21 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 936 29 None -158 21 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
16215415 186749 1 None 3 5 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptorDisplacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor
ChEMBL 471 9 2 3 3.8 CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br 10.1021/np800339e
CHEMBL493091 186749 1 None 3 5 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]MK912 from human cloned adrenergic alpha-2a receptorDisplacement of [3H]MK912 from human cloned adrenergic alpha-2a receptor
ChEMBL 471 9 2 3 3.8 CN(C)CCCOc1ccc(CCNC(=O)c2cc(Br)c[nH]2)cc1Br 10.1021/np800339e
44330621 4336 0 None -6 2 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 483 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(Cl)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL101411 4336 0 None -6 2 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 483 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(Cl)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
90644738 112236 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 281 2 2 2 3.1 c1coc(C2CN/C(=N/c3ccc4c(c3)CCCC4)N2)c1 10.1016/j.ejmech.2014.05.057
CHEMBL3289548 112236 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 281 2 2 2 3.1 c1coc(C2CN/C(=N/c3ccc4c(c3)CCCC4)N2)c1 10.1016/j.ejmech.2014.05.057
CHEMBL3304843 112236 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 281 2 2 2 3.1 c1coc(C2CN/C(=N/c3ccc4c(c3)CCCC4)N2)c1 10.1016/j.ejmech.2014.05.057
155526672 170643 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 528 7 0 6 6.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3c(Cl)cc(Cl)cc3Cl)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4459403 170643 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 528 7 0 6 6.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3c(Cl)cc(Cl)cc3Cl)C(=O)C21 10.1021/acs.jmedchem.9b02080
155535203 171475 0 None -18 6 Human 5.2 pKi = 5.2 Binding
Inhibition of alpha2a receptor (unknown origin)Inhibition of alpha2a receptor (unknown origin)
ChEMBL 403 5 3 7 2.8 O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NC(C3CCC3)C3CCC3)nc(Cl)nc21 10.1021/acs.jmedchem.8b01662
CHEMBL4471712 171475 0 None -18 6 Human 5.2 pKi = 5.2 Binding
Inhibition of alpha2a receptor (unknown origin)Inhibition of alpha2a receptor (unknown origin)
ChEMBL 403 5 3 7 2.8 O[C@@H]1[C@H](O)[C@@H]2C[C@@H]2[C@H]1n1cnc2c(NC(C3CCC3)C3CCC3)nc(Cl)nc21 10.1021/acs.jmedchem.8b01662
10198108 206464 2 None 7 2 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 200 0 1 2 1.9 Cc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL98471 206464 2 None 7 2 Human 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 200 0 1 2 1.9 Cc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
12575 1957 28 None -5 16 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm800250z
54459 1957 28 None -5 16 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm800250z
CHEMBL10316 1957 28 None -5 16 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm800250z
12575 1957 28 None -5 16 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmc.2012.02.016
54459 1957 28 None -5 16 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmc.2012.02.016
CHEMBL10316 1957 28 None -5 16 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmc.2012.02.016
12774559 189018 0 None - 1 Bovine 8.2 pKi = 8.2 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 191 3 3 4 0.8 Oc1cccc(NCC2=NCCN2)c1 10.1021/jm00366a022
CHEMBL51479 189018 0 None - 1 Bovine 8.2 pKi = 8.2 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 191 3 3 4 0.8 Oc1cccc(NCC2=NCCN2)c1 10.1021/jm00366a022
185076 186507 4 None 2 7 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL49137 186507 4 None 2 7 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
213041 16952 24 None -1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 230 2 1 1 3.0 CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1 10.1021/jm1006269
CHEMBL1255582 16952 24 None -1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2A receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 230 2 1 1 3.0 CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1 10.1021/jm1006269
102 4064 44 None -5 49 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
3659 4064 44 None -5 49 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
8969 4064 44 None -5 49 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL15245 4064 44 None -5 49 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
DB01392 4064 44 None -5 49 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
155513073 169148 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 440 8 0 6 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(Cc3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4438158 169148 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 440 8 0 6 4.0 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(Cc3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
11412944 101039 65 None 223 2 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL298004 101039 65 None 223 2 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccnc1N1CCNCC1 10.1021/jm00366a007
135545454 78533 0 None -1 2 Human 8.1 pKi = 8.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 448 7 1 7 3.2 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
CHEMBL2112983 78533 0 None -1 2 Human 8.1 pKi = 8.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 448 7 1 7 3.2 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CN2 10.1021/jm049619s
2803 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2A adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
13123533 193240 1 None - 1 Bovine 7.2 pKi = 7.2 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 271 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)C2CCCCC2)cc1 10.1021/jm00366a022
CHEMBL541208 193240 1 None - 1 Bovine 7.2 pKi = 7.2 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 271 4 1 3 3.1 Cc1ccc(N(CC2=NCCN2)C2CCCCC2)cc1 10.1021/jm00366a022
155544935 172845 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 460 7 0 6 4.6 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3Cl)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4528557 172845 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 460 7 0 6 4.6 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccccc3Cl)C(=O)C21 10.1021/acs.jmedchem.9b02080
162654541 180031 0 None - 1 Rat 5.2 pKi = 5.2 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 499 10 5 11 0.8 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
CHEMBL4754656 180031 0 None - 1 Rat 5.2 pKi = 5.2 Binding
Displacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assayDisplacement of [3H]-clonidine from Sprague-Dawley rat alpha2 adrenergic receptor by radioligand binding assay
ChEMBL 499 10 5 11 0.8 Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCCCCNCC2Cc3ccccc3CN2)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.0c01475
10045713 165552 0 None -309 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 386 3 1 4 5.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN4CCCCC4C3)cc2)c1C 10.1021/jm060262x
CHEMBL425983 165552 0 None -309 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 386 3 1 4 5.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN4CCCCC4C3)cc2)c1C 10.1021/jm060262x
122186880 122465 0 None -7 5 Human 6.1 pKi = 6.1 Binding
Binding affinity to alpha2A adrenoceptor (unknown origin)Binding affinity to alpha2A adrenoceptor (unknown origin)
ChEMBL 415 3 0 5 4.8 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2c1ccccc1)OCO4 10.1016/j.bmcl.2015.07.012
CHEMBL3608450 122465 0 None -7 5 Human 6.1 pKi = 6.1 Binding
Binding affinity to alpha2A adrenoceptor (unknown origin)Binding affinity to alpha2A adrenoceptor (unknown origin)
ChEMBL 415 3 0 5 4.8 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2c1ccccc1)OCO4 10.1016/j.bmcl.2015.07.012
44401106 123808 0 None -112 9 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL363581 123808 0 None -112 9 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
57345627 70838 0 None 8 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 230 4 1 3 2.5 C=C(C)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956194 70838 0 None 8 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 230 4 1 3 2.5 C=C(C)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
44269089 96557 0 None 6 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 232 4 1 3 2.6 CC(Oc1ccccc1C(C)C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL266613 96557 0 None 6 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 232 4 1 3 2.6 CC(Oc1ccccc1C(C)C)C1=NCCN1 10.1016/j.bmc.2012.01.035
16757182 152717 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
CHEMBL397753 152717 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
16757182 152717 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
CHEMBL397753 152717 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
11183468 109384 2 None -1 6 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL323402 109384 2 None -1 6 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
4567175 82064 5 None 2 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 318 3 1 4 3.7 CN1CCN(c2ccc(Nc3ccnc4ccccc34)cc2)CC1 10.1021/jm060262x
CHEMBL217665 82064 5 None 2 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 318 3 1 4 3.7 CN1CCN(c2ccc(Nc3ccnc4ccccc34)cc2)CC1 10.1021/jm060262x
24906201 186770 0 None 1 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
CHEMBL493272 186770 0 None 1 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
1016 3690 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 3690 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 3690 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 3690 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 3690 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 3690 75 None -12 35 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
3157 1442 69 None -61 12 Human 6.1 pKi = 6.1 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
7170 1442 69 None -61 12 Human 6.1 pKi = 6.1 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
954 1442 69 None -61 12 Human 6.1 pKi = 6.1 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
CHEMBL707 1442 69 None -61 12 Human 6.1 pKi = 6.1 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
DB00590 1442 69 None -61 12 Human 6.1 pKi = 6.1 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
56964693 73714 0 None -5 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 314 0 1 5 2.8 Clc1ccc2c(c1)N=C(N1CCNCC1)c1cccnc1O2 10.1021/jm2013419
CHEMBL2022269 73714 0 None -5 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation countingDisplacement of [3H]-MK-912 from human cloned adrenergic alpha2A receptor expressed in insect Sf9 membranes after 60 mins by liquid scintillation counting
ChEMBL 314 0 1 5 2.8 Clc1ccc2c(c1)N=C(N1CCNCC1)c1cccnc1O2 10.1021/jm2013419
12841596 116957 19 None 3 2 Bovine 7.1 pKi = 7.1 Binding
Binding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligandBinding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL2448004 116957 19 None 3 2 Bovine 7.1 pKi = 7.1 Binding
Binding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligandBinding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL339883 116957 19 None 3 2 Bovine 7.1 pKi = 7.1 Binding
Binding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligandBinding affinity against alpha-2 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]clonidine as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
12909383 130181 1 None -5 2 Bovine 6.1 pKi = 6.1 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 278 0 0 2 3.6 CN1CCC(=C2c3ccccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368413 130181 1 None -5 2 Bovine 6.1 pKi = 6.1 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 278 0 0 2 3.6 CN1CCC(=C2c3ccccc3CCn3cccc32)CC1 10.1021/jm00361a008
44292470 101164 4 None 57 2 Bovine 7.1 pKi = 7.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 211 1 1 3 1.5 Cc1ccnc(N2CCNCC2)c1Cl 10.1021/jm00366a007
CHEMBL299007 101164 4 None 57 2 Bovine 7.1 pKi = 7.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 211 1 1 3 1.5 Cc1ccnc(N2CCNCC2)c1Cl 10.1021/jm00366a007
136044137 78527 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 472 6 1 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CN2 10.1021/jm049619s
CHEMBL2112976 78527 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 472 6 1 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CN2 10.1021/jm049619s
25130235 187004 1 None -2 11 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 294 2 1 6 1.3 CN1CCN(c2cc(-c3ccc(C#N)cc3)nc(N)n2)CC1 10.1021/jm8005959
CHEMBL494678 187004 1 None -2 11 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 294 2 1 6 1.3 CN1CCN(c2cc(-c3ccc(C#N)cc3)nc(N)n2)CC1 10.1021/jm8005959
15675860 202724 0 None 4 4 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.1 Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL72147 202724 0 None 4 4 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscineBinding affinity for human Alpha-2A adrenergic receptor from cultured LM(tk-) cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.1 Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
23622576 172203 0 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL451229 172203 0 None 1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
3823 49951 38 None -40 11 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 49951 38 None -40 11 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 49951 38 None -40 11 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
1577 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
164512405 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
2537 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
5355 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
5501 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
643497 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
688272 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
958 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
960 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL196677 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL26 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
CHEMBL267044 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
DB00391 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
DB16021 3647 104 None -2 25 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N nan
10674896 204918 0 None -416 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
CHEMBL89243 204918 0 None -416 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
657255 197406 29 None -10 15 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 nan
CHEMBL588119 197406 29 None -10 15 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 nan
155567867 175459 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 502 8 0 6 5.7 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(-c4ccccc4)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4590209 175459 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 502 8 0 6 5.7 CCOP(=O)(OCC)C1(c2ccccc2)N=CC2C(=O)N(c3ccc(-c4ccccc4)cc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
10454026 17725 0 None -234 9 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 406 8 2 4 3.5 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1 10.1021/jm0211220
CHEMBL125916 17725 0 None -234 9 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 406 8 2 4 3.5 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1 10.1021/jm0211220
10895039 18334 0 None -154 8 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
CHEMBL127400 18334 0 None -154 8 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
CHEMBL129022 18334 0 None -154 8 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
10655607 203047 5 None 5 3 Human 7.1 pKi = 7.1 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 199 2 3 3 2.0 c1c[nH]c(Nc2ccc3[nH]cnc3c2)n1 10.1021/jm9605142
CHEMBL74544 203047 5 None 5 3 Human 7.1 pKi = 7.1 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 199 2 3 3 2.0 c1c[nH]c(Nc2ccc3[nH]cnc3c2)n1 10.1021/jm9605142
10326069 39059 1 None -42 9 Human 6.1 pKi = 6.1 Binding
Binding affinity for recombinant human Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand.Binding affinity for recombinant human Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand.
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 39059 1 None -42 9 Human 6.1 pKi = 6.1 Binding
Binding affinity for recombinant human Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand.Binding affinity for recombinant human Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand.
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
53324553 56560 0 None -10 10 Human 5.1 pKi = 5.1 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 283 4 1 1 3.1 Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1 10.1016/j.bmc.2013.07.045
CHEMBL1643900 56560 0 None -10 10 Human 5.1 pKi = 5.1 Binding
Inhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 283 4 1 1 3.1 Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1 10.1016/j.bmc.2013.07.045
53324553 56560 0 None -10 10 Human 5.1 pKi = 5.1 Binding
Inhibition of alpha2A adrenergic receptorInhibition of alpha2A adrenergic receptor
ChEMBL 283 4 1 1 3.1 Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1 10.1016/j.bmcl.2010.11.075
CHEMBL1643900 56560 0 None -10 10 Human 5.1 pKi = 5.1 Binding
Inhibition of alpha2A adrenergic receptorInhibition of alpha2A adrenergic receptor
ChEMBL 283 4 1 1 3.1 Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1 10.1016/j.bmcl.2010.11.075
1210 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
1213 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
2725 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
33036 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
4411 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
616 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
6976 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
716121 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
90475904 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1201353 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1554789 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL505 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
DB01114 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
DB13679 905 45 None -263 20 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C nan
72947314 92058 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.0 c1ccc(OCC2=NCCN2)c(CC2CC2)c1 10.1021/ml400232p
CHEMBL2431281 92058 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 230 5 1 3 2.0 c1ccc(OCC2=NCCN2)c(CC2CC2)c1 10.1021/ml400232p
490 190 5 None -758 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 190 5 None -758 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 190 5 None -758 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
12909389 60050 0 None -64 2 Bovine 4.1 pKi = 4.1 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 320 1 1 3 3.7 CN1CCC(=C2c3cc(C(=O)O)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL174649 60050 0 None -64 2 Bovine 4.1 pKi = 4.1 Binding
Displacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortexDisplacement of [3H]- clonidine radioligand binding at the alpha-2 adrenergic receptor binding site of calf cerebral cortex
ChEMBL 320 1 1 3 3.7 CN1CCC(=C2c3cc(C(=O)O)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
16090598 82043 0 None -5 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cccc(Cl)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL217568 82043 0 None -5 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cccc(Cl)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
5467 204212 40 None -6 5 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC nan
CHEMBL84158 204212 40 None -6 5 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC nan
44288847 164757 0 None -5495 5 Human 5.1 pKi = 5.1 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42335 164757 0 None -5495 5 Human 5.1 pKi = 5.1 Binding
In vivo inhibitory effect against Alpha-2A adrenergic receptorIn vivo inhibitory effect against Alpha-2A adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
5897 104732 71 None -7 3 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 223 1 1 1 3.2 CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2 nan
CHEMBL311469 104732 71 None -7 3 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 223 1 1 1 3.2 CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2 nan
44401164 69473 0 None -346 9 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
CHEMBL193639 69473 0 None -346 9 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
ChEMBL 329 2 0 3 4.5 CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1 10.1021/jm049632c
90644744 112244 2 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 205 3 2 2 1.3 CCOc1ccc(N=C2NCCN2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289551 112244 2 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 205 3 2 2 1.3 CCOc1ccc(N=C2NCCN2)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304991 112244 2 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 205 3 2 2 1.3 CCOc1ccc(N=C2NCCN2)cc1 10.1016/j.ejmech.2014.05.057
16090623 82042 0 None -102 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
CHEMBL217567 82042 0 None -102 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
44415690 79727 0 None -363 6 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 473 2 1 5 5.1 Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
CHEMBL213336 79727 0 None -363 6 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 473 2 1 5 5.1 Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21 10.1016/j.bmcl.2006.06.022
10923927 202477 0 None -1 4 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 279 3 2 5 0.8 O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21 10.1021/jm000542r
CHEMBL70740 202477 0 None -1 4 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 279 3 2 5 0.8 O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21 10.1021/jm000542r
6604789 100578 3 None -31 10 Human 5.1 pKi = 5.1 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
CHEMBL294649 100578 3 None -31 10 Human 5.1 pKi = 5.1 Binding
Binding affinity against Alpha-2A adrenergic receptorBinding affinity against Alpha-2A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
57399991 70904 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@H]2CO[C@H](C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956901 70904 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2A adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 232 2 1 4 1.1 c1ccc([C@H]2CO[C@H](C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
12575 1957 28 None -5 16 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmcl.2006.12.094
54459 1957 28 None -5 16 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmcl.2006.12.094
CHEMBL10316 1957 28 None -5 16 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmcl.2006.12.094
134987 186099 43 None 309 2 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 181 1 1 3 0.6 Fc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL48833 186099 43 None 309 2 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 181 1 1 3 0.6 Fc1cccnc1N1CCNCC1 10.1021/jm00366a007
441975 16274 49 None -1 3 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL123325 16274 49 None -1 3 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
49864359 15450 0 None 3 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 467 10 1 5 4.1 COc1ccccc1N1CCN(CCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
CHEMBL1221592 15450 0 None 3 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]MK912 from human alpha2A receptor after 60 minsDisplacement of [3H]MK912 from human alpha2A receptor after 60 mins
ChEMBL 467 10 1 5 4.1 COc1ccccc1N1CCN(CCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2010.07.002
124 2933 44 None -4 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 2933 44 None -4 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 2933 44 None -4 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 2933 44 None -4 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 2933 44 None -4 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2803 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
516 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
704 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
CHEMBL134 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
DB00575 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
10775000 106910 2 None -2 5 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL317912 106910 2 None -2 5 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
44324765 111080 0 None -2 5 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL328114 111080 0 None -2 5 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
9846548 205594 0 None -1 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL93489 205594 0 None -1 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
1212 1632 45 None -165 65 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 1632 45 None -165 65 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 1632 45 None -165 65 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 1632 45 None -165 65 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 1632 45 None -165 65 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
9960497 100010 0 None -2454 6 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL290860 100010 0 None -2454 6 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
16090628 141255 0 None -933 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 4 1 4 5.3 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(N2CCCN(C)CC2)cc1 10.1021/jm060262x
CHEMBL386169 141255 0 None -933 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 4 1 4 5.3 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(N2CCCN(C)CC2)cc1 10.1021/jm060262x
44574075 172008 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 251 2 0 4 2.9 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448802 172008 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 251 2 0 4 2.9 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
4601 205020 29 None -2 17 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL1201023 205020 29 None -2 17 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL900 205020 29 None -2 17 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
10466448 112384 2 None 34 2 Bovine 7.1 pKi = 7.1 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 0 5 0.8 Cc1cnc(N2CCN(C)CC2)c2nccn12 10.1021/jm00099a012
CHEMBL330994 112384 2 None 34 2 Bovine 7.1 pKi = 7.1 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 231 1 0 5 0.8 Cc1cnc(N2CCN(C)CC2)c2nccn12 10.1021/jm00099a012
44579229 189024 0 None -39 3 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL514837 189024 0 None -39 3 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
11000184 12941 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 12941 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 12941 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
10859076 13570 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 13570 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 13570 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
127036932 136824 0 None -2 22 Human 7.1 pKi = 7.1 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752900 136824 0 None -2 22 Human 7.1 pKi = 7.1 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
16757089 91859 0 None 3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
CHEMBL242693 91859 0 None 3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
16757089 91859 0 None 3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
CHEMBL242693 91859 0 None 3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
11448533 84267 0 None -1 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 0 3 3.6 CC(Oc1ccccc1-c1ccccc1)C1=NCCO1 10.1021/jm0408215
CHEMBL222591 84267 0 None -1 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 267 4 0 3 3.6 CC(Oc1ccccc1-c1ccccc1)C1=NCCO1 10.1021/jm0408215
11473729 84268 0 None -1 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 265 4 0 2 4.4 CC(Oc1ccccc1-c1ccccc1)C1=NCCC1 10.1021/jm0408215
CHEMBL222593 84268 0 None -1 3 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 265 4 0 2 4.4 CC(Oc1ccccc1-c1ccccc1)C1=NCCC1 10.1021/jm0408215
136680386 205969 0 None -169 6 Human 6.1 pKi = 6.1 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
44328801 205969 0 None -169 6 Human 6.1 pKi = 6.1 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95578 205969 0 None -169 6 Human 6.1 pKi = 6.1 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
491 191 4 None -1023 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 191 4 None -1023 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 191 4 None -1023 12 Human 7.1 pKi = 7.1 Binding
Ancillary Binding affinity towards cloned human Alpha-2A adrenergic receptorAncillary Binding affinity towards cloned human Alpha-2A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
1530 2151 44 None -70 20 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
3827 2151 44 None -70 20 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
7206 2151 44 None -70 20 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
CHEMBL534 2151 44 None -70 20 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
DB00920 2151 44 None -70 20 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
3038495 700 30 None -56 19 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
7625 700 30 None -56 19 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
CHEMBL25236 700 30 None -56 19 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
57345629 70841 0 None -5 4 Human 7.1 pKi = 7.1 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1956197 70841 0 None -5 4 Human 7.1 pKi = 7.1 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1021/ml400232p
127036953 136990 0 None -8 22 Human 7.1 pKi = 7.1 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754166 136990 0 None -8 22 Human 7.1 pKi = 7.1 Binding
Binding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
44269140 33334 0 None 4 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 248 5 1 4 2.2 CC(C)Oc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL14208 33334 0 None 4 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 248 5 1 4 2.2 CC(C)Oc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
57345629 70841 0 None -5 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956197 70841 0 None -5 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
9817231 157691 17 None 1 7 Human 5.1 pKi = 5.1 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 282 4 0 3 4.1 CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1 10.1038/s41586-020-2286-9
CHEMBL4088272 157691 17 None 1 7 Human 5.1 pKi = 5.1 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 282 4 0 3 4.1 CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1 10.1038/s41586-020-2286-9
90644755 112231 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 5 4 2 2.5 CCCNC(=N)Nc1ccc(NCC)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3289538 112231 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 5 4 2 2.5 CCCNC(=N)Nc1ccc(NCC)cc1 10.1016/j.ejmech.2014.05.057
CHEMBL3304668 112231 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysisDisplacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis
ChEMBL 220 5 4 2 2.5 CCCNC(=N)Nc1ccc(NCC)cc1 10.1016/j.ejmech.2014.05.057
10044968 96098 0 None -54 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL262901 96098 0 None -54 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
56852956 111551 1 None -218 9 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assayDisplacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
CHEMBL3289656 111551 1 None -218 9 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assayDisplacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
9904606 9296 0 None 2 4 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
CHEMBL111463 9296 0 None 2 4 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
16090594 81713 0 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
CHEMBL216674 81713 0 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
56852956 111551 1 None -218 9 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assayDisplacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
CHEMBL3289656 111551 1 None -218 9 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assayDisplacement of [3H]clonidine from human adrenergic-alpha2A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
2803 941 53 None -1 19 Human 6.1 pKi = 6.1 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
516 941 53 None -1 19 Human 6.1 pKi = 6.1 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
704 941 53 None -1 19 Human 6.1 pKi = 6.1 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
CHEMBL134 941 53 None -1 19 Human 6.1 pKi = 6.1 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
DB00575 941 53 None -1 19 Human 6.1 pKi = 6.1 Binding
Binding affinity towards Alpha-2A adrenergic receptorBinding affinity towards Alpha-2A adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm990569e
2803 941 53 None 1 19 Rat 6.1 pKi = 6.1 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
516 941 53 None 1 19 Rat 6.1 pKi = 6.1 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
704 941 53 None 1 19 Rat 6.1 pKi = 6.1 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
CHEMBL134 941 53 None 1 19 Rat 6.1 pKi = 6.1 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
DB00575 941 53 None 1 19 Rat 6.1 pKi = 6.1 Binding
in vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2A adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
237 203157 43 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL546257 203157 43 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL554190 203157 43 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL7568 203157 43 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
11293787 147681 0 None -77 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL393597 147681 0 None -77 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cellsDisplacement of [3H]MK-912 from adrenergic alpha2A receptor in HT29 cells
ChEMBL 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 10.1016/j.bmcl.2006.12.094
155552185 173489 0 None -1548 16 Human 6.1 pKi = 6.1 Binding
Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)
ChEMBL 491 10 2 5 4.3 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4544086 173489 0 None -1548 16 Human 6.1 pKi = 6.1 Binding
Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)Displacement of [3H] RX821002 from alpha2A adrenergic receptor (unknown origin)
ChEMBL 491 10 2 5 4.3 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
44582676 189187 0 None -6 17 Human 6.1 pKi = 6.1 Binding
Inhibition of human cloned alpha2A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha2A adrenergic receptor by competitive binding experiment
ChEMBL 403 9 0 4 4.3 COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
CHEMBL516088 189187 0 None -6 17 Human 6.1 pKi = 6.1 Binding
Inhibition of human cloned alpha2A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha2A adrenergic receptor by competitive binding experiment
ChEMBL 403 9 0 4 4.3 COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
10398419 116141 0 None 13 2 Human 7.1 pKi = 7.1 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CCC1(CN=CN1)C2 10.1021/jm00020a021
CHEMBL336970 116141 0 None 13 2 Human 7.1 pKi = 7.1 Binding
Binding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligandBinding affinity towards Alpha-2A adrenergic receptor in human platelets using [3H]RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CCC1(CN=CN1)C2 10.1021/jm00020a021
136019934 143997 0 None -7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
CHEMBL390718 143997 0 None -7 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
44350063 117445 0 None - 1 Bovine 6.1 pKi = 6.1 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 349 4 3 7 -0.0 C1=CN2CCN=C2C(N2CCNCC2)=N1.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
CHEMBL340358 117445 0 None - 1 Bovine 6.1 pKi = 6.1 Binding
Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.Binding affinity at Alpha-2 adrenergic receptor in calf cerebral cortex homogenates by [3H]clonidine displacement.
ChEMBL 349 4 3 7 -0.0 C1=CN2CCN=C2C(N2CCNCC2)=N1.O=C(O)C/C=C\CC(=O)O 10.1021/jm00099a012
11058166 202999 0 None -2 5 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74114 202999 0 None -2 5 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
9931977 62711 0 None -616 4 Human 6.1 pKi = 6.1 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL1788223 62711 0 None -616 4 Human 6.1 pKi = 6.1 Binding
Compound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2A adrenergic receptor using [3H]prazosin
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
132060763 162311 0 None -3 8 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 405 5 0 4 4.1 C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)CC3)CC1 10.1016/j.ejmech.2018.02.024
CHEMBL4173095 162311 0 None -3 8 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2A receptor expressed in stable MDCK cells after 90 mins by microbeta scintillation counting method
ChEMBL 405 5 0 4 4.1 C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)CC3)CC1 10.1016/j.ejmech.2018.02.024
44415593 79837 0 None -891 6 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 495 2 1 5 5.6 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
CHEMBL213834 79837 0 None -891 6 Human 6.1 pKi = 6.1 Binding
Binding affinity at adrenergic alpha2A receptorBinding affinity at adrenergic alpha2A receptor
ChEMBL 495 2 1 5 5.6 CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1 10.1016/j.bmcl.2006.06.022
11732785 163168 0 None -102 6 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 432 7 0 5 3.7 COc1ccccc1N1CCN(CCCCN2CCn3c(cc4ccccc43)C2=O)CC1 10.1021/jm0211220
CHEMBL420510 163168 0 None -102 6 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 bindingBinding affinity for rat cortex Alpha-2 adrenergic receptor was determined using [3H]-RX 81002 binding
ChEMBL 432 7 0 5 3.7 COc1ccccc1N1CCN(CCCCN2CCn3c(cc4ccccc43)C2=O)CC1 10.1021/jm0211220
10473701 82825 0 None -165 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 3 1 4 4.8 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)(C)C2)cc1 10.1021/jm060262x
CHEMBL218679 82825 0 None -165 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 360 3 1 4 4.8 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)(C)C2)cc1 10.1021/jm060262x
44424855 85029 0 None -1 3 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
CHEMBL226636 85029 0 None -1 3 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha2A receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
44330609 162900 0 None 2 2 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL419894 162900 0 None 2 2 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
135405894 78520 0 None -5 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 470 8 1 8 2.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(CCOc4ccc(F)cc4)CC3)[C@@H]1CN2 10.1021/jm049619s
CHEMBL2112969 78520 0 None -5 2 Human 8.0 pKi = 8.0 Binding
Binding affinity for alpha-2A adrenergic receptorBinding affinity for alpha-2A adrenergic receptor
ChEMBL 470 8 1 8 2.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(CCOc4ccc(F)cc4)CC3)[C@@H]1CN2 10.1021/jm049619s
10028898 111164 0 None -11 2 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
CHEMBL328631 111164 0 None -11 2 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity to the human alpha-2A adrenergic receptorIn vitro binding affinity to the human alpha-2A adrenergic receptor
ChEMBL 499 7 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccc(F)cc4F)CC3)[C@@H]1CO2 10.1016/j.bmcl.2004.03.031
123981 16282 20 None -2 8 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL123349 16282 20 None -2 8 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL536803 16282 20 None -2 8 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2A adrenergic receptor
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
9816048 186695 0 None 12 3 Human 8.0 pKi = 8.0 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 231 1 4 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCN2 10.1021/jm960359r
CHEMBL49284 186695 0 None 12 3 Human 8.0 pKi = 8.0 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 231 1 4 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCN2 10.1021/jm960359r
463 1378 17 None -67 13 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
6918097 1378 17 None -67 13 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
837 1378 17 None -67 13 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL2051956 1378 17 None -67 13 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB14068 1378 17 None -67 13 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
16090627 81155 0 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 9 2 4 5.9 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(NCCN(CC)CC)cc1 10.1021/jm060262x
CHEMBL216197 81155 0 None -10 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 390 9 2 4 5.9 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(NCCN(CC)CC)cc1 10.1021/jm060262x
2683 102415 24 None -12 16 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL305906 102415 24 None -12 16 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL334255 102415 24 None -12 16 Human 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
10333157 150706 0 None 3 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL396013 150706 0 None 3 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
11140033 20483 0 None 7 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL130884 20483 0 None 7 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
10333157 150706 0 None 3 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL396013 150706 0 None 3 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
16090595 140869 0 None -109 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL383978 140869 0 None -109 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
10651654 110995 0 None -489 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
CHEMBL327712 110995 0 None -489 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
10084076 97467 0 None -5 9 Human 7.0 pKi = 7.0 Binding
Binding affinity towards Alpha-2 adrenergic receptorBinding affinity towards Alpha-2 adrenergic receptor
ChEMBL 262 0 1 2 2.8 CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N 10.1021/jm030030n
CHEMBL27251 97467 0 None -5 9 Human 7.0 pKi = 7.0 Binding
Binding affinity towards Alpha-2 adrenergic receptorBinding affinity towards Alpha-2 adrenergic receptor
ChEMBL 262 0 1 2 2.8 CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N 10.1021/jm030030n
44324737 205508 0 None -2 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL92860 205508 0 None -2 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44568614 187040 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 252 4 1 3 2.8 c1ccc(OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
CHEMBL494885 187040 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2A receptor expressed in CHO cells
ChEMBL 252 4 1 3 2.8 c1ccc(OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
2337 3205 72 None -50 62 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3205 72 None -50 62 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3205 72 None -50 62 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3205 72 None -50 62 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3205 72 None -50 62 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5280805 84981 76 None -28 3 Human 5.0 pKi = 5.0 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 610 6 10 16 -1.7 C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O 10.1021/np1000329
CHEMBL226335 84981 76 None -28 3 Human 5.0 pKi = 5.0 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
ChEMBL 610 6 10 16 -1.7 C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O 10.1021/np1000329
25110718 192706 0 None -72 3 Human 7.0 pKi = 7.0 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(C[C@H]2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL524153 192706 0 None -72 3 Human 7.0 pKi = 7.0 Binding
Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(C[C@H]2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
10527469 155724 1 None -204 16 Human 7.0 pKi = 7.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 155724 1 None -204 16 Human 7.0 pKi = 7.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
164609730 184516 0 None 1 3 Human 6.0 pKi = 6.0 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 398 2 1 5 3.5 CC(C)(C)OC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4856060 184516 0 None 1 3 Human 6.0 pKi = 6.0 Binding
Inhibition of alpha2a adrenergic receptor (unknown origin)Inhibition of alpha2a adrenergic receptor (unknown origin)
ChEMBL 398 2 1 5 3.5 CC(C)(C)OC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
71463022 83284 4 None 1 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 436 8 0 5 5.3 COc1cc2oc(C(=O)N(CCCN3CCCCC3)c3ccccc3)c(C)c2cc1OC 10.1016/j.bmc.2012.09.044
CHEMBL2205362 83284 4 None 1 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysisDisplacement of [3H]clonidine from alpha2A adrenergic receptor after 40 mins by scintillation counting analysis
ChEMBL 436 8 0 5 5.3 COc1cc2oc(C(=O)N(CCCN3CCCCC3)c3ccccc3)c(C)c2cc1OC 10.1016/j.bmc.2012.09.044
24841480 183317 0 None -47 20 Human 7.0 pKi = 7.0 Binding
Antagonist activity at adrenergic alpha2A receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 340 3 0 4 4.5 O=C(OCCN1CCCC1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
CHEMBL481153 183317 0 None -47 20 Human 7.0 pKi = 7.0 Binding
Antagonist activity at adrenergic alpha2A receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha2A receptor (unknown origin) by PDSP assay
ChEMBL 340 3 0 4 4.5 O=C(OCCN1CCCC1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
10489502 4451 2 None 6 3 Human 7.0 pKi = 7.0 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 227 2 2 2 3.5 Clc1cccc(Cl)c1Nc1ncc[nH]1 10.1021/jm9605142
CHEMBL1022 4451 2 None 6 3 Human 7.0 pKi = 7.0 Binding
Displacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from human Alpha-2A adrenergic receptor expressed in CHO cells
ChEMBL 227 2 2 2 3.5 Clc1cccc(Cl)c1Nc1ncc[nH]1 10.1021/jm9605142
28918670 92055 2 None 4 4 Human 7.0 pKi = 7.0 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 254 3 1 3 1.8 Brc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL2431279 92055 2 None 4 4 Human 7.0 pKi = 7.0 Binding
Binding affinity at human alpha2A ARBinding affinity at human alpha2A AR
ChEMBL 254 3 1 3 1.8 Brc1ccccc1OCC1=NCCN1 10.1021/ml400232p
10508132 106534 0 None -16 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
CHEMBL315392 106534 0 None -16 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
10507651 204781 0 None -107 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88388 204781 0 None -107 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
9950711 108719 0 None -5 4 Human 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL321644 108719 0 None -5 4 Human 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
14004033 48967 5 None 2 2 Bovine 5.0 pKi = 5.0 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
CHEMBL156283 48967 5 None 2 2 Bovine 5.0 pKi = 5.0 Binding
Compound was evaluated for log 1/Ki at alpha-2 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-2 adrenergic receptor
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
78114671 173592 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 350 6 0 6 2.5 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
CHEMBL4546903 173592 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometryDisplacement of [3H]RX821002 from alpha2-AR in human brain frontal cortex incubated for 30 mins by liquid scintillation spectrometry
ChEMBL 350 6 0 6 2.5 CCOP(=O)(OCC)C1N=CC2C(=O)N(c3ccccc3)C(=O)C21 10.1021/acs.jmedchem.9b02080
44328654 106701 0 None -251 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL316495 106701 0 None -251 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
21830793 91403 5 None -630 46 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
CHEMBL2413154 91403 5 None -630 46 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
139406787 176571 0 None 2 4 Human 6.0 pKi = 6.0 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 492 5 2 5 5.8 O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)c1 10.1021/acs.jmedchem.0c00745
CHEMBL4633982 176571 0 None 2 4 Human 6.0 pKi = 6.0 Binding
Binding affinity to adrenergic alpha2A receptor (unknown origin)Binding affinity to adrenergic alpha2A receptor (unknown origin)
ChEMBL 492 5 2 5 5.8 O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)c1 10.1021/acs.jmedchem.0c00745
10251036 81473 0 None -162 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 410 4 2 5 4.7 CN1CCN(c2ccc(Nc3c(CO)cnc4cc(Cl)ccc34)cc2)CC1(C)C 10.1021/jm060262x
CHEMBL216464 81473 0 None -162 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 410 4 2 5 4.7 CN1CCN(c2ccc(Nc3c(CO)cnc4cc(Cl)ccc34)cc2)CC1(C)C 10.1021/jm060262x
14004033 48967 5 None 2 2 Bovine 5.0 pKi = 5.0 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
CHEMBL156283 48967 5 None 2 2 Bovine 5.0 pKi = 5.0 Binding
Affinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranesAffinity to alpha-2 adrenergic receptor by the displacement of [3H]clonidine from calf cerebral cortex membranes
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
16090632 141184 0 None -46 3 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 348 4 3 5 3.3 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1 10.1021/jm060262x
CHEMBL385722 141184 0 None -46 3 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 348 4 3 5 3.3 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1 10.1021/jm060262x
2777786 174405 77 None 29 2 Bovine 7.0 pKi = 7.0 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL45663 174405 77 None 29 2 Bovine 7.0 pKi = 7.0 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1cccnc1N1CCNCC1 10.1021/jm00366a007
57399145 70840 0 None 7 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 234 5 1 4 1.9 CCOc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956196 70840 0 None 7 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
ChEMBL 234 5 1 4 1.9 CCOc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
49836307 18598 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
CHEMBL1278085 18598 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2A adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
9879119 9355 0 None -4 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111771 9355 0 None -4 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assayIn vitro binding affinity towards alpha-2A adrenergic receptor of human clone in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
11747739 13124 0 None -1 4 Human 6.0 pKi = 6.0 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1191324 13124 0 None -1 4 Human 6.0 pKi = 6.0 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL542402 13124 0 None -1 4 Human 6.0 pKi = 6.0 Binding
Affinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2A adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44324860 205765 0 None -1 2 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 479 6 0 8 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cc5ccccc5s4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL94435 205765 0 None -1 2 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2A adrenergic receptor using [3H]rauwolscine
ChEMBL 479 6 0 8 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4cc5ccccc5s4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
16090633 80051 0 None -25 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 380 4 2 5 3.8 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C 10.1021/jm060262x
CHEMBL214661 80051 0 None -25 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2A expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2A expressed in S115 cells
ChEMBL 380 4 2 5 3.8 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C 10.1021/jm060262x
4209 3114 71 None -3235 33 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 3114 71 None -3235 33 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 3114 71 None -3235 33 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 3114 71 None -3235 33 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 3114 71 None -3235 33 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 3114 71 None -3235 33 Human 6.0 pKi = 6 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
44329026 206683 0 None -19 6 Human 7.0 pKi = 7 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL99864 206683 0 None -19 6 Human 7.0 pKi = 7 Binding
Binding affinity against human Alpha-2a adrenergic receptorBinding affinity against human Alpha-2a adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
2105 3005 34 None -58 33 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 3005 34 None -58 33 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 3005 34 None -58 33 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 3005 34 None -58 33 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 3005 34 None -58 33 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
44574078 178184 0 None - 1 Human 6.0 pKi = 6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 261 2 0 3 3.3 c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL468711 178184 0 None - 1 Human 6.0 pKi = 6 Binding
Inhibition of adrenergic alpha2A receptorInhibition of adrenergic alpha2A receptor
ChEMBL 261 2 0 3 3.3 c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
168274641 189841 0 None - 1 Rat 5.0 pKi = 5 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 266 1 2 3 3.3 O=C1/C(=C/c2ccc(O)cc2)CCc2c(O)cccc21 10.1016/j.ejmech.2021.113964
CHEMBL5178192 189841 0 None - 1 Rat 5.0 pKi = 5 Binding
Displacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assayDisplacement of [3H]NECA from A2AAR in rat striata assessed as inhibition constant in presence of N6-cyclopentyladenosine by radioligand competitive binding assay
ChEMBL 266 1 2 3 3.3 O=C1/C(=C/c2ccc(O)cc2)CCc2c(O)cccc21 10.1016/j.ejmech.2021.113964
2477 734 54 None - 28 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
36 734 54 None - 28 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
437 734 54 None - 28 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
CHEMBL49 734 54 None - 28 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
DB00490 734 54 None - 28 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-2 adrenergic receptor in calf frontal cortexBinding affinity against alpha-2 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
3689 102298 47 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Compound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligandCompound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligand
Drug Central 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 None
CHEMBL1372983 102298 47 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Compound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligandCompound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligand
Drug Central 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 None
CHEMBL305187 102298 47 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Compound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligandCompound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligand
Drug Central 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 None
2803 941 53 None - 19 Bovine 8.1 pIC50 = 8.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 None - 19 Bovine 8.1 pIC50 = 8.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 None - 19 Bovine 8.1 pIC50 = 8.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 None - 19 Bovine 8.1 pIC50 = 8.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 None - 19 Bovine 8.1 pIC50 = 8.1 Binding
Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uMConcentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
3294 1975 106 None - 44 Rat 8.0 pIC50 = 8.0 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 1975 106 None - 44 Rat 8.0 pIC50 = 8.0 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 1975 106 None - 44 Rat 8.0 pIC50 = 8.0 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 1975 106 None - 44 Rat 8.0 pIC50 = 8.0 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 1975 106 None - 44 Rat 8.0 pIC50 = 8.0 Binding
Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligandBinding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
1795 1561 58 None - 1 Human 1.8 pKd = 1.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 299 4 3 5 0.4 CCN(c1nc(N)c(nc1Cl)C(=O)N=C(N)N)C(C)C 1325028
4186 1561 58 None - 1 Human 1.8 pKd = 1.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 299 4 3 5 0.4 CCN(c1nc(N)c(nc1Cl)C(=O)N=C(N)N)C(C)C 1325028
CHEMBL517986 1561 58 None - 1 Human 1.8 pKd = 1.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 299 4 3 5 0.4 CCN(c1nc(N)c(nc1Cl)C(=O)N=C(N)N)C(C)C 1325028
1192 147 41 None -51286 16 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 1325028
1192 147 41 None -51286 16 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 9584219
1794 147 41 None -51286 16 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 1325028
1794 147 41 None -51286 16 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 9584219
CHEMBL501701 147 41 None -51286 16 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 1325028
CHEMBL501701 147 41 None -51286 16 Human 2.5 pKd None 2.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 311 2 3 5 0.5 NC(=NC(=O)c1nc(Cl)c(nc1N)N1CCCCCC1)N 9584219
108094 3368 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
108094 3368 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
526 3368 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
526 3368 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
528 3368 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
528 3368 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
CHEMBL10332 3368 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
CHEMBL10332 3368 22 None -1 4 Human 9.2 pKd None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
136 3240 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
136 3240 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
223 3240 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
223 3240 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
643606 3240 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
643606 3240 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
CHEMBL10347 3240 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
CHEMBL10347 3240 28 None -3 16 Human 9.5 pKd None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
1588 2294 24 3H-RX821002 2 43 Human 10.3 pKi = 10.3 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 2294 24 3H-RX821002 2 43 Human 10.3 pKi = 10.3 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 2294 24 3H-RX821002 2 43 Human 10.3 pKi = 10.3 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 2294 24 3H-RX821002 2 43 Human 10.3 pKi = 10.3 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 2294 24 3H-RX821002 2 43 Human 10.3 pKi = 10.3 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL1196898 214259 0 3H-RAUWOLSCINE 1 3 Human 9.7 pKi = 9.7 Binding
NoneNone
PDSP KiDatabase 248 3 1 5 1.2 CCOC1(COC2=CC=CC=C2O1)C3=NCCN3 None
2601 3721 30 3H-RX821002 -1 21 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 3721 30 3H-RX821002 -1 21 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 3721 30 3H-RX821002 -1 21 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 3721 30 3H-RX821002 -1 21 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 3721 30 3H-RX821002 -1 21 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
138107169 214173 0 3H-RAUWOLSCINE -6 22 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214173 0 3H-RAUWOLSCINE -6 22 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
12576 511 87 3H-RAUWOLSCINE -2 6 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
71310 511 87 3H-RAUWOLSCINE -2 6 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
CHEMBL353972 511 87 3H-RAUWOLSCINE -2 6 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
DB11481 511 87 3H-RAUWOLSCINE -2 6 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
108094 3368 22 35S-GTPGammaS -1 4 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3368 22 35S-GTPGammaS -1 4 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3368 22 35S-GTPGammaS -1 4 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3368 22 35S-GTPGammaS -1 4 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
None 214258 0 3H-RAUWOLSCINE -2 3 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 953 28 10 12 0.9 CCOC1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(CC(=O)N)C(=O)NC(C=S)C(=O)NC(CCCCN)C(=O)N)NC(=O)CC3(CCCCC3)S None
138107169 214173 0 3H-RX821002 1 22 Pig 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214173 0 3H-RX821002 1 22 Pig 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
None 214257 0 3H-RAUWOLSCINE -13 3 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 339 0 0 3 3.3 CN1CCC2(CCN3CCC4=C(C3C2)OC5=CC=CC=C45)N(C1=O)C None
138107169 214173 0 3H-RAUWOLSCINE -6 22 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214173 0 3H-RAUWOLSCINE -6 22 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
102 4064 44 3H-RAUWOLSCINE -5 49 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 3H-RAUWOLSCINE -5 49 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 3H-RAUWOLSCINE -5 49 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 3H-RAUWOLSCINE -5 49 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 3H-RAUWOLSCINE -5 49 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
108094 3368 22 3H-MK912 -1 4 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
108094 3368 22 35S-GTPGammaS 1 4 Mouse 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3368 22 3H-MK912 -1 4 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3368 22 35S-GTPGammaS 1 4 Mouse 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3368 22 3H-MK912 -1 4 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3368 22 35S-GTPGammaS 1 4 Mouse 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3368 22 3H-MK912 -1 4 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3368 22 35S-GTPGammaS 1 4 Mouse 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
102 4064 44 3H-RAUWOLSCINE -5 49 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 3H-RAUWOLSCINE -5 49 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 3H-RAUWOLSCINE -5 49 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 3H-RAUWOLSCINE -5 49 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 3H-RAUWOLSCINE -5 49 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
164512323 214260 0 3H-RAUWOLSCINE -5 5 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214260 0 3H-RAUWOLSCINE -5 5 Human 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
124 2933 44 3H-RAUWOLSCINE -4 32 Human 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 3H-RAUWOLSCINE -4 32 Human 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 3H-RAUWOLSCINE -4 32 Human 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 3H-RAUWOLSCINE -4 32 Human 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 3H-RAUWOLSCINE -4 32 Human 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
None 214179 0 3H-RAUWOLSCINE -14 19 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
108094 3368 22 3H-RAUWOLSCINE -1 4 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3368 22 3H-RAUWOLSCINE -1 4 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3368 22 3H-RAUWOLSCINE -1 4 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3368 22 3H-RAUWOLSCINE -1 4 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
None 214182 0 3H-RAUWOLSCINE -1 5 Human 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 295 5 2 3 3.0 C1CC2=CC=CC=C2C(=O)C1CNCCC3=CC=C(C=C3)O None
None 214179 0 3H-RX821002 -6 19 Pig 9.0 pKi = 9.0 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
108094 3368 22 3H-MK912 -1 4 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3368 22 3H-MK912 -1 4 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3368 22 3H-MK912 -1 4 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3368 22 3H-MK912 -1 4 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
138107169 214173 0 35S-GTPGammaS -6 22 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214173 0 35S-GTPGammaS -6 22 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
None 214179 0 3H-RAUWOLSCINE -14 19 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
41 1629 0 3H-PRAZOSIN -1 16 Rat 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
72036 1629 0 3H-PRAZOSIN -1 16 Rat 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
CHEMBL1765294 1629 0 3H-PRAZOSIN -1 16 Rat 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
None 214179 0 3H-RAUWOLSCINE -14 19 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
124 2933 44 3H-RAUWOLSCINE -4 32 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 3H-RAUWOLSCINE -4 32 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 3H-RAUWOLSCINE -4 32 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 3H-RAUWOLSCINE -4 32 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 3H-RAUWOLSCINE -4 32 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
124 2933 44 3H-CLONIDINE -4 32 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 3H-CLONIDINE -4 32 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 3H-CLONIDINE -4 32 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 3H-CLONIDINE -4 32 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 3H-CLONIDINE -4 32 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
124 2933 44 3H-RAUWOLSCINE -4 32 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 3H-RAUWOLSCINE -4 32 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 3H-RAUWOLSCINE -4 32 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 3H-RAUWOLSCINE -4 32 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 3H-RAUWOLSCINE -4 32 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2142 3047 54 3H-RX821002 -2 36 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 3H-RX821002 -2 36 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 3H-RX821002 -2 36 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 3H-RX821002 -2 36 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 3H-RX821002 -2 36 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 3H-RX821002 -2 36 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
102 4064 44 3H-RAUWOLSCINE -5 49 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 3H-RAUWOLSCINE -5 49 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 3H-RAUWOLSCINE -5 49 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 3H-RAUWOLSCINE -5 49 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 3H-RAUWOLSCINE -5 49 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
None 214967 0 UNDEFINED 1 3 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 390 1 2 4 3.1 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O.Cl None
12575 1957 28 3H-RAUWOLSCINE -5 16 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
54459 1957 28 3H-RAUWOLSCINE -5 16 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
CHEMBL10316 1957 28 3H-RAUWOLSCINE -5 16 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
2389 3279 114 3H-RAUWOLSCINE -69 67 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3279 114 3H-RAUWOLSCINE -69 67 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3279 114 3H-RAUWOLSCINE -69 67 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3279 114 3H-RAUWOLSCINE -69 67 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3279 114 3H-RAUWOLSCINE -69 67 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
164512323 214260 0 3H-RX821002 -18 5 Pig 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214260 0 3H-RX821002 -18 5 Pig 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
46780481 107045 18 3H-CLONIDINE -47 53 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107045 18 3H-CLONIDINE -47 53 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107045 18 3H-CLONIDINE -47 53 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107045 18 3H-CLONIDINE -47 53 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
521 1377 64 None -2 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 1377 64 None -2 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 1377 64 None -2 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 1377 64 None -2 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 1377 64 None -2 7 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
31101 720 39 3H-RX821002 -12 35 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 720 39 3H-RX821002 -12 35 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 720 39 3H-RX821002 -12 35 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 720 39 3H-RX821002 -12 35 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 720 39 3H-RX821002 -12 35 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
202 1480 0 UNDEFINED -9 31 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
60835 1480 0 UNDEFINED -9 31 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
972 1480 0 UNDEFINED -9 31 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
CHEMBL1175 1480 0 UNDEFINED -9 31 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
DB00476 1480 0 UNDEFINED -9 31 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
165193 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
2303 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
4946 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
564 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
62882 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
63 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
66366 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
91536 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
CHEMBL27 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
CHEMBL452861 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
DB00571 3138 60 3H-RAUWOLSCINE -1000 42 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 OC(COc1cccc2c1cccc2)CNC(C)C None
104870 98423 39 3H-Yohimbine -54 21 Pig 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98423 39 3H-Yohimbine -54 21 Pig 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98423 39 3H-Yohimbine -54 21 Pig 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5656 201377 82 UNDEFINED -25 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
CHEMBL637 201377 82 UNDEFINED -25 40 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
54841 201437 51 UNDEFINED -1 28 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 255 6 1 2 3.7 CNCC[C@@H](Oc1ccccc1C)c1ccccc1 None
CHEMBL641 201437 51 UNDEFINED -1 28 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 255 6 1 2 3.7 CNCC[C@@H](Oc1ccccc1C)c1ccccc1 None
3075702 215594 0 3H-RAUWOLSCINE -2 37 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 198 3 1 3 1.5 C1CNC1COC2=CN=C(C=C2)Cl None
1499 2060 43 35S-GTPGammaS -1445 17 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
1499 2060 43 3H-Yohimbine -1445 17 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 2060 43 35S-GTPGammaS -1445 17 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 2060 43 3H-Yohimbine -1445 17 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 2060 43 35S-GTPGammaS -1445 17 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 2060 43 3H-Yohimbine -1445 17 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 2060 43 35S-GTPGammaS -1445 17 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 2060 43 3H-Yohimbine -1445 17 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 2060 43 35S-GTPGammaS -1445 17 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 2060 43 3H-Yohimbine -1445 17 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
243 3153 85 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3052762 3153 85 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3502 3153 85 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
CHEMBL117287 3153 85 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
DB06480 3153 85 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
2 3210 19 3H-RX821002 -2089 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
54562 3210 19 3H-RX821002 -2089 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
CHEMBL240773 3210 19 3H-RX821002 -2089 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
183782 3346 15 3H-RAUWOLSCINE -2398 14 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
237 3346 15 3H-RAUWOLSCINE -2398 14 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL85251 3346 15 3H-RAUWOLSCINE -2398 14 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
6917970 3635 54 3H-CLONIDINE -2290 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
8370 3635 54 3H-CLONIDINE -2290 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
CHEMBL487387 3635 54 3H-CLONIDINE -2290 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
2662 11279 124 3H-CLONIDINE -41 31 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 None
CHEMBL118 11279 124 3H-CLONIDINE -41 31 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 None
156391 46537 95 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 COc1ccc2cc([C@H](C)C(=O)O)ccc2c1 None
CHEMBL1200806 46537 95 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 COc1ccc2cc([C@H](C)C(=O)O)ccc2c1 None
CHEMBL154 46537 95 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 COc1ccc2cc([C@H](C)C(=O)O)ccc2c1 None
10624 69957 17 125I-Clonidine -102 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 284 5 3 3 1.7 CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12 None
138543650 69957 17 125I-Clonidine -102 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 284 5 3 3 1.7 CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12 None
CHEMBL194378 69957 17 125I-Clonidine -102 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 284 5 3 3 1.7 CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12 None
2244 93798 96 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 180 2 1 3 1.3 CC(=O)Oc1ccccc1C(=O)O None
CHEMBL25 93798 96 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 180 2 1 3 1.3 CC(=O)Oc1ccccc1C(=O)O None
3663 99505 79 3H-CLONIDINE -288 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 504 0 6 8 5.1 Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65 None
CHEMBL286494 99505 79 3H-CLONIDINE -288 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 504 0 6 8 5.1 Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65 None
446220 132998 13 3H-CLONIDINE -1778 45 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
CHEMBL370805 132998 13 3H-CLONIDINE -1778 45 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
5280343 187691 119 3H-CLONIDINE -147 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL1520590 187691 119 3H-CLONIDINE -147 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL50 187691 119 3H-CLONIDINE -147 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
54676228 192874 108 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 2 2 5 1.6 CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O None
CHEMBL527 192874 108 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 2 2 5 1.6 CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O None
2771 193347 67 3H-RAUWOLSCINE -120 26 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
2771 193347 67 3H-RX821002 -120 26 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL1200781 193347 67 3H-RAUWOLSCINE -120 26 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL1200781 193347 67 3H-RX821002 -120 26 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL549 193347 67 3H-RAUWOLSCINE -120 26 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL549 193347 67 3H-RX821002 -120 26 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
4495 194860 87 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 None
CHEMBL56367 194860 87 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 None
54677470 198867 110 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 351 2 2 6 2.0 Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1 None
CHEMBL1256873 198867 110 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 351 2 2 6 2.0 Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1 None
CHEMBL599 198867 110 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 351 2 2 6 2.0 Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1 None
5281600 201336 85 3H-CLONIDINE -275 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 538 3 6 10 5.1 O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12 None
CHEMBL63354 201336 85 3H-CLONIDINE -275 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 538 3 6 10 5.1 O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12 None
5656 201377 82 3H-RX821002 -25 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
CHEMBL637 201377 82 3H-RX821002 -25 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
4054 203790 64 125I-Clonidine -1 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
CHEMBL1699 203790 64 125I-Clonidine -1 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
CHEMBL807 203790 64 125I-Clonidine -1 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
None 214217 0 3H-RAUWOLSCINE -1 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 329 2 0 4 3.6 CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl None
104911 214249 0 3H-CLONIDINE -41686 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 530 7 0 5 5.1 COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4.Cl.Cl.Cl None
None 214256 0 3H-RAUWOLSCINE -6309 13 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 453 9 2 6 2.6 COC1=CC(=C(C=C1C(=O)CCC2CCN(CC2)CCNS(=O)(=O)C)Cl)N.Cl None
25137849 214425 0 3H-CLONIDINE -2 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
71290 214425 0 3H-CLONIDINE -2 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
31404 214439 0 3H-Yohimbine - 1 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 253 1 1 4 1.5 CCN1CCC2=C(CC1)OC(=N2)N.Cl.Cl None
127151 214487 0 3H-RX821002 -1584 10 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 313 6 1 4 3.2 CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3 None
None 214560 0 3H-CLONIDINE -1 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 240 7 4 6 -0.8 C(C(C(=O)O)N)SSCC(C(=O)O)N None
None 214561 0 3H-CLONIDINE -1 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 149 4 2 3 0.2 CSCCC(C(=O)O)N None
None 214562 0 3H-CLONIDINE -1 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 135 3 3 3 -0.3 C(CS)C(C(=O)O)N None
None 214563 0 3H-CLONIDINE -1 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 121 2 3 3 -0.7 C(C(C(=O)O)N)S None
None 214564 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 117 0 1 3 -0.0 C1CSC(=O)C1N None
None 214565 0 3H-CLONIDINE -1 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 153 3 3 3 -1.4 C(C(C(=O)O)N)S(=O)O None
None 214566 0 3H-CLONIDINE -1 38 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 3 3 4 -1.7 C(C(C(=O)O)N)S(=O)(=O)O None
None 214567 0 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 183 4 3 4 -1.3 C(CS(=O)(=O)O)C(C(=O)O)N None
None 214576 0 3H-CLONIDINE -16 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 536 11 1 4 9.0 CC(C)C(=O)C12C(=O)C(=C(C(C1=O)(CC(C2(C)CCC=C(C)C)CC=C(C)C)CC=C(C)C)O)CC=C(C)C None
4978 214577 0 3H-CLONIDINE -16 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 520 1 7 9 4.3 CC1=CC(=C2C3=C1C4=C5C(=C(C=C4CO)O)C(=O)C6=C(C=C(C7=C6C5=C3C8=C7C(=CC(=C8C2=O)O)O)O)O)O None
None 214578 0 3H-CLONIDINE 2 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 464 4 8 12 -0.6 C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O None
None 214580 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 448 3 7 11 0.4 CC1C(C(C(C(O1)OC2=C(OC3=CC(=O)C=C(C3=C2O)O)C4=CC(=C(C=C4)O)O)O)O)O None
None 214591 0 3H-RX821002 -1862 19 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 246 2 1 4 1.6 CCCN1CCCC2C1CC3=CN=C(N=C3C2)N None
135269 214639 0 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 222 5 1 3 2.5 CCCCC(=O)OC1=CC=CC=C1C(=O)O None
23681059 214640 0 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O None
5018304 214641 0 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 317 4 1 3 0.0 C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+] None
3672 214642 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 206 4 1 1 3.1 CC(C)CC1=CC=C(C=C1)C(C)C(=O)O None
84003 214643 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 376 6 5 7 -0.0 C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O None
123619 214644 0 3H-CLONIDINE -1412 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 358 3 0 4 4.2 CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl None
119828 214645 0 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 370 5 1 5 3.5 CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C None
5090 214646 0 3H-CLONIDINE -1348 31 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 3 0 4 2.6 CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3 None
119607 214647 0 3H-CLONIDINE -97 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 3 1 4 3.0 CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N None
None 214648 0 3H-CLONIDINE -7 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 517 8 2 5 5.2 CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)NCCC4=CC=C(C=C4)NC(=O)C None
None 214747 0 3H-CLONIDINE -4570 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 347 6 0 3 5.0 CC(=O)N(CC1=CC=CC=C1OC)C2=CC=CC=C2OC3=CC=CC=C3 None
11954224 214174 0 3H-CLONIDINE -446 59 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
1830 2552 39 3H-CLONIDINE -14 27 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
207 2552 39 3H-CLONIDINE -14 27 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
23897 2552 39 3H-CLONIDINE -14 27 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
CHEMBL460 2552 39 3H-CLONIDINE -14 27 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
DB01618 2552 39 3H-CLONIDINE -14 27 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
None 214261 0 3H-RAUWOLSCINE -19 3 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 401 6 1 5 0.6 CS(=O)(=O)NCCN(C1CCN2CCC3=CC=CC=C3C2C1)S(=O)(=O)C None
11079 2693 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
3369 2693 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
4436 2693 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
5509 2693 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
CHEMBL761 2693 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
DB06711 2693 59 35S-GTPGammaS -1 4 Mouse 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
179 396 107 125I-Clonidine -35 50 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
2159 396 107 125I-Clonidine -35 50 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
963 396 107 125I-Clonidine -35 50 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
CHEMBL243712 396 107 125I-Clonidine -35 50 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
DB06288 396 107 125I-Clonidine -35 50 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
1353 1880 85 3H-CLONIDINE -190 85 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
1353 1880 85 3H-RAUWOLSCINE -190 85 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1880 85 3H-CLONIDINE -190 85 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1880 85 3H-RAUWOLSCINE -190 85 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1880 85 3H-CLONIDINE -190 85 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1880 85 3H-RAUWOLSCINE -190 85 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1880 85 3H-CLONIDINE -190 85 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1880 85 3H-RAUWOLSCINE -190 85 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1880 85 3H-CLONIDINE -190 85 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1880 85 3H-RAUWOLSCINE -190 85 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
4209 3114 71 3H-RX821002 -1862 33 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3114 71 3H-RX821002 -1862 33 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3114 71 3H-RX821002 -1862 33 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3114 71 3H-RX821002 -1862 33 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3114 71 3H-RX821002 -1862 33 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3114 71 3H-RX821002 -1862 33 Pig 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
None 214590 0 3H-RX821002 -15 19 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 451 8 2 4 3.2 CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C None
1267 3744 43 3H-RAUWOLSCINE -52 25 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 None
3035905 3744 43 3H-RAUWOLSCINE -52 25 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 None
CHEMBL260374 3744 43 3H-RAUWOLSCINE -52 25 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 292 2 2 2 2.8 S=C(N1CCC(CC1)c1cnc[nH]1)NC1CCCCC1 None
None 214629 0 3H-RAUWOLSCINE -141 11 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 243 3 1 4 2.7 CCC1=CC2=C(O1)C=CC3=C2N(N=C3)CC(C)N None
5268 3599 34 3H-RAUWOLSCINE -60 17 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3599 34 3H-RAUWOLSCINE -60 17 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3599 34 3H-RAUWOLSCINE -60 17 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
68602 203416 72 35S-GTPGammaS -1 8 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 203416 72 35S-GTPGammaS -1 8 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
164512323 214260 0 3H-RAUWOLSCINE -5 5 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214260 0 3H-RAUWOLSCINE -5 5 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
122211 458 0 3H-RAUWOLSCINE -239 6 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 458 0 3H-RAUWOLSCINE -239 6 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
138107169 214173 0 3H-RAUWOLSCINE -6 22 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214173 0 3H-RAUWOLSCINE -6 22 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
122211 458 0 3H-MK912 -239 6 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 458 0 3H-MK912 -239 6 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
10297 26905 29 3H-CLONIDINE -5 43 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 None
CHEMBL136560 26905 29 3H-CLONIDINE -5 43 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 None
100 3745 52 3H-CLONIDINE -33 55 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3745 52 3H-CLONIDINE -33 55 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3745 52 3H-CLONIDINE -33 55 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3745 52 3H-CLONIDINE -33 55 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3745 52 3H-CLONIDINE -33 55 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
100 3745 52 3H-CLONIDINE -33 55 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3745 52 3H-CLONIDINE -33 55 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3745 52 3H-CLONIDINE -33 55 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3745 52 3H-CLONIDINE -33 55 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3745 52 3H-CLONIDINE -33 55 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
44438148 93057 0 UNDEFINED -14 3 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 None
CHEMBL246229 93057 0 UNDEFINED -14 3 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 None
135409468 2004 63 3H-CLONIDINE -48 40 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
333 2004 63 3H-CLONIDINE -48 40 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
CHEMBL845 2004 63 3H-CLONIDINE -48 40 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
2995 202700 49 3H-RAUWOLSCINE -12 22 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL1696 202700 49 3H-RAUWOLSCINE -12 22 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL72 202700 49 3H-RAUWOLSCINE -12 22 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
None 214179 0 3H-MK912 -14 19 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
164512323 214260 0 3H-RX821002 -18 5 Pig 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214260 0 3H-RX821002 -18 5 Pig 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
44438166 93384 0 UNDEFINED -33 3 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 None
CHEMBL247664 93384 0 UNDEFINED -33 3 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 None
25058166 214181 0 3H-RX821002 -70 26 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 267 0 2 3 2.9 CN1CCC2=CC=CC3=C2C1CC4=C3C(=C(C=C4)O)O None
6852389 214181 0 3H-RX821002 -70 26 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 267 0 2 3 2.9 CN1CCC2=CC=CC3=C2C1CC4=C3C(=C(C=C4)O)O None
484 2814 45 35S-GTPGammaS -14 35 Mouse 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2814 45 35S-GTPGammaS -14 35 Mouse 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2814 45 35S-GTPGammaS -14 35 Mouse 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
135398737 944 89 3H-CLONIDINE -26 91 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
135398737 944 89 3H-RAUWOLSCINE -26 91 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 944 89 3H-CLONIDINE -26 91 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 944 89 3H-RAUWOLSCINE -26 91 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 944 89 3H-CLONIDINE -26 91 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 944 89 3H-RAUWOLSCINE -26 91 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 944 89 3H-CLONIDINE -26 91 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 944 89 3H-RAUWOLSCINE -26 91 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 944 89 3H-CLONIDINE -26 91 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 944 89 3H-RAUWOLSCINE -26 91 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
7153 97570 74 3H-CLONIDINE -7 33 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 214 3 1 2 2.5 Cc1cc(Cl)ccc1OC(C)C(=O)O None
CHEMBL272942 97570 74 3H-CLONIDINE -7 33 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 214 3 1 2 2.5 Cc1cc(Cl)ccc1OC(C)C(=O)O None
1028 287 69 35S-GTPGammaS -30 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 287 69 35S-GTPGammaS -30 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 287 69 35S-GTPGammaS -30 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 287 69 35S-GTPGammaS -30 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 287 69 35S-GTPGammaS -30 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 287 69 35S-GTPGammaS -30 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
3658 4044 47 35S-GTPGammaS -4 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4044 47 35S-GTPGammaS -4 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4044 47 35S-GTPGammaS -4 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4044 47 35S-GTPGammaS -4 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4044 47 35S-GTPGammaS -4 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
124 2933 44 35S-GTPGammaS -28 32 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 35S-GTPGammaS -28 32 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 35S-GTPGammaS -28 32 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 35S-GTPGammaS -28 32 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 35S-GTPGammaS -28 32 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
5524 214717 0 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 215 1 2 3 1.9 C1CCC2=C(C1)C=CC=C2NC3=NCCN3 None
68602 203416 72 3H-MK912 -1 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 203416 72 3H-MK912 -1 8 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
1613 2316 44 3H-CLONIDINE -7 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2316 44 3H-CLONIDINE -7 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2316 44 3H-CLONIDINE -7 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2316 44 3H-CLONIDINE -7 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2316 44 3H-CLONIDINE -7 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
2389 3279 114 3H-CLONIDINE -69 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3279 114 3H-CLONIDINE -69 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3279 114 3H-CLONIDINE -69 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3279 114 3H-CLONIDINE -69 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3279 114 3H-CLONIDINE -69 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
1613 2316 44 3H-CLONIDINE -7 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2316 44 3H-CLONIDINE -7 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2316 44 3H-CLONIDINE -7 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2316 44 3H-CLONIDINE -7 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2316 44 3H-CLONIDINE -7 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
2389 3279 114 3H-CLONIDINE -69 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3279 114 3H-CLONIDINE -69 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3279 114 3H-CLONIDINE -69 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3279 114 3H-CLONIDINE -69 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3279 114 3H-CLONIDINE -69 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
68712 99874 57 35S-GTPGammaS -1 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 99874 57 35S-GTPGammaS -1 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
186 1777 47 3H-CLONIDINE -208 16 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 295 5 1 2 3.7 OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1 None
71781 1777 47 3H-CLONIDINE -208 16 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 295 5 1 2 3.7 OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1 None
CHEMBL18972 1777 47 3H-CLONIDINE -208 16 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 295 5 1 2 3.7 OC(c1ccccc1)C1CCN(CC1)CCc1ccccc1 None
16362 3076 67 3H-CLONIDINE -501 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
2172 3076 67 3H-CLONIDINE -501 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
90 3076 67 3H-CLONIDINE -501 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
CHEMBL1423 3076 67 3H-CLONIDINE -501 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
DB01100 3076 67 3H-CLONIDINE -501 29 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
11079 2693 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
3369 2693 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
4436 2693 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
5509 2693 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
CHEMBL761 2693 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
DB06711 2693 59 35S-GTPGammaS -1 4 Mouse 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
2865 4079 67 3H-CLONIDINE -64 53 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
2865 4079 67 3H-RAUWOLSCINE -64 53 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4079 67 3H-CLONIDINE -64 53 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4079 67 3H-RAUWOLSCINE -64 53 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4079 67 3H-CLONIDINE -64 53 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4079 67 3H-RAUWOLSCINE -64 53 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4079 67 3H-CLONIDINE -64 53 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4079 67 3H-RAUWOLSCINE -64 53 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4079 67 3H-CLONIDINE -64 53 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4079 67 3H-RAUWOLSCINE -64 53 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
3294 1975 106 3H-RX821002 -47 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 1975 106 3H-RX821002 -47 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 1975 106 3H-RX821002 -47 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 1975 106 3H-RX821002 -47 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 1975 106 3H-RX821002 -47 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
3294 1975 106 3H-RX821002 -47 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 1975 106 3H-RX821002 -47 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 1975 106 3H-RX821002 -47 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 1975 106 3H-RX821002 -47 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 1975 106 3H-RX821002 -47 44 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
119570 3110 90 3H-RX821002 -69 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 3110 90 3H-RX821002 -69 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 3110 90 3H-RX821002 -69 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 3110 90 3H-RX821002 -69 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 3110 90 3H-RX821002 -69 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
1223 940 32 3H-RAUWOLSCINE -93 11 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 308 6 2 3 3.2 Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N None
2790 940 32 3H-RAUWOLSCINE -93 11 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 308 6 2 3 3.2 Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N None
CHEMBL14690 940 32 3H-RAUWOLSCINE -93 11 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 308 6 2 3 3.2 Clc1ccc(cc1)CN=C(SCCCc1cnc[nH]1)N None
134 2478 19 3H-CLONIDINE -74 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
1775 2478 19 3H-CLONIDINE -74 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
9681 2478 19 3H-CLONIDINE -74 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
CHEMBL1065 2478 19 3H-CLONIDINE -74 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
DB00247 2478 19 3H-CLONIDINE -74 67 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
122211 458 0 3H-RAUWOLSCINE -239 6 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 458 0 3H-RAUWOLSCINE -239 6 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
16725934 146890 0 UNDEFINED -87 3 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 None
CHEMBL392992 146890 0 UNDEFINED -87 3 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 None
15897 2817 0 3H-CLONIDINE -134 36 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
215 2817 0 3H-CLONIDINE -134 36 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
CHEMBL1979333 2817 0 3H-CLONIDINE -134 36 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
103 4089 56 3H-RAUWOLSCINE -54 53 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4089 56 3H-RAUWOLSCINE -54 53 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4089 56 3H-RAUWOLSCINE -54 53 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4089 56 3H-RAUWOLSCINE -54 53 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4089 56 3H-RAUWOLSCINE -54 53 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2726 906 64 3H-CLONIDINE -64 72 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 906 64 3H-CLONIDINE -64 72 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 906 64 3H-CLONIDINE -64 72 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 906 64 3H-CLONIDINE -64 72 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 906 64 3H-CLONIDINE -64 72 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
1220 186 46 3H-RAUWOLSCINE -147 44 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
31 186 46 3H-RAUWOLSCINE -147 44 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
7 186 46 3H-RAUWOLSCINE -147 44 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
CHEMBL56 186 46 3H-RAUWOLSCINE -147 44 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
44438168 93385 0 UNDEFINED -53 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 None
CHEMBL247665 93385 0 UNDEFINED -53 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 None
2402 3318 58 3H-RX821002 -6 25 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
5095 3318 58 3H-RX821002 -6 25 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
7295 3318 58 3H-RX821002 -6 25 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
CHEMBL589 3318 58 3H-RX821002 -6 25 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
DB00268 3318 58 3H-RX821002 -6 25 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
2142 3047 54 3H-RX821002 -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 3H-RX821002 -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 3H-RX821002 -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 3H-RX821002 -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 3H-RX821002 -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 3H-RX821002 -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
185 3943 54 3H-CLONIDINE -5888 37 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
5311271 3943 54 3H-CLONIDINE -5888 37 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
CHEMBL74355 3943 54 3H-CLONIDINE -5888 37 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
DB16351 3943 54 3H-CLONIDINE -5888 37 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
135398745 2869 108 3H-RAUWOLSCINE -93 65 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2869 108 3H-RAUWOLSCINE -93 65 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2869 108 3H-RAUWOLSCINE -93 65 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2869 108 3H-RAUWOLSCINE -93 65 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
484 2814 45 35S-GTPGammaS -9 35 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2814 45 35S-GTPGammaS -9 35 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2814 45 35S-GTPGammaS -9 35 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
68602 203416 72 35S-GTPGammaS -1 8 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 203416 72 35S-GTPGammaS -1 8 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
None 214180 0 3H-RAUWOLSCINE -2 5 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 358 4 0 3 2.8 CCCS(=O)(=O)N(C)C1CCN2CCC3=CC=CC=C3C2C1.Cl None
123981 16282 20 3H-RAUWOLSCINE -2 8 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 None
CHEMBL123349 16282 20 3H-RAUWOLSCINE -2 8 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 None
CHEMBL536803 16282 20 3H-RAUWOLSCINE -2 8 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 None
2142 3047 54 3H-RAUWOLSCINE -2 36 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 3H-RAUWOLSCINE -2 36 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 3H-RAUWOLSCINE -2 36 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 3H-RAUWOLSCINE -2 36 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 3H-RAUWOLSCINE -2 36 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 3H-RAUWOLSCINE -2 36 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
2142 3047 54 3H-RX821002 -1 36 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 3H-RX821002 -1 36 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 3H-RX821002 -1 36 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 3H-RX821002 -1 36 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 3H-RX821002 -1 36 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 3H-RX821002 -1 36 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
1816 2504 99 3H-RAUWOLSCINE -33 16 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
4205 2504 99 3H-RAUWOLSCINE -33 16 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
7241 2504 99 3H-RAUWOLSCINE -33 16 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
CHEMBL654 2504 99 3H-RAUWOLSCINE -33 16 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
DB00370 2504 99 3H-RAUWOLSCINE -33 16 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
1343 1858 55 35S-GTPGammaS -3 9 Mouse 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1858 55 35S-GTPGammaS -3 9 Mouse 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1858 55 35S-GTPGammaS -3 9 Mouse 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1858 55 35S-GTPGammaS -3 9 Mouse 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1858 55 35S-GTPGammaS -3 9 Mouse 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
2142 3047 54 35S-GTPGammaS -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 35S-GTPGammaS -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 35S-GTPGammaS -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 35S-GTPGammaS -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 35S-GTPGammaS -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 35S-GTPGammaS -2 36 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
11079 2693 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
3369 2693 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
4436 2693 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
5509 2693 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
CHEMBL761 2693 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
DB06711 2693 59 35S-GTPGammaS 1 4 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
25137849 214425 0 3H-CLONIDINE -2 40 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
71290 214425 0 3H-CLONIDINE -2 40 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
11750482 146888 0 UNDEFINED -25 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 None
CHEMBL392991 146888 0 UNDEFINED -25 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 None
3952 1857 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 1857 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 1857 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 1857 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 1857 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 1857 33 35S-GTPGammaS -2 12 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
2435 714 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 714 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 714 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 714 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 714 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 714 98 35S-GTPGammaS -4 12 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
4209 3114 71 3H-RAUWOLSCINE -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3114 71 3H-RAUWOLSCINE -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3114 71 3H-RAUWOLSCINE -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3114 71 3H-RAUWOLSCINE -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3114 71 3H-RAUWOLSCINE -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3114 71 3H-RAUWOLSCINE -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
44438161 146608 0 UNDEFINED -22 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 None
CHEMBL392771 146608 0 UNDEFINED -22 3 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 None
2337 3205 72 3H-RAUWOLSCINE -50 62 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3205 72 3H-RAUWOLSCINE -50 62 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3205 72 3H-RAUWOLSCINE -50 62 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3205 72 3H-RAUWOLSCINE -50 62 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3205 72 3H-RAUWOLSCINE -50 62 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
4209 3114 71 3H-MK912 -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3114 71 3H-MK912 -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3114 71 3H-MK912 -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3114 71 3H-MK912 -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3114 71 3H-MK912 -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3114 71 3H-MK912 -3235 33 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
2695 3780 76 35S-GTPGammaS -9 6 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3780 76 35S-GTPGammaS -9 6 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3780 76 35S-GTPGammaS -9 6 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3780 76 35S-GTPGammaS -9 6 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3780 76 35S-GTPGammaS -9 6 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
2389 3279 114 3H-RAUWOLSCINE -69 67 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3279 114 3H-RAUWOLSCINE -69 67 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3279 114 3H-RAUWOLSCINE -69 67 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3279 114 3H-RAUWOLSCINE -69 67 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3279 114 3H-RAUWOLSCINE -69 67 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
3658 4044 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4044 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4044 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4044 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4044 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
103 4089 56 3H-CLONIDINE -54 53 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4089 56 3H-CLONIDINE -54 53 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4089 56 3H-CLONIDINE -54 53 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4089 56 3H-CLONIDINE -54 53 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4089 56 3H-CLONIDINE -54 53 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
523 4043 90 35S-GTPGammaS 1 5 Mouse 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
5707 4043 90 35S-GTPGammaS 1 5 Mouse 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
CHEMBL297362 4043 90 35S-GTPGammaS 1 5 Mouse 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
DB11477 4043 90 35S-GTPGammaS 1 5 Mouse 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
135398737 944 89 3H-RAUWOLSCINE -26 91 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 944 89 3H-RAUWOLSCINE -26 91 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 944 89 3H-RAUWOLSCINE -26 91 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 944 89 3H-RAUWOLSCINE -26 91 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 944 89 3H-RAUWOLSCINE -26 91 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2695 3780 76 3H-RAUWOLSCINE -9 6 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3780 76 3H-RAUWOLSCINE -9 6 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3780 76 3H-RAUWOLSCINE -9 6 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3780 76 3H-RAUWOLSCINE -9 6 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3780 76 3H-RAUWOLSCINE -9 6 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
2803 941 53 3H-RX821002 1 19 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 3H-RX821002 1 19 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 3H-RX821002 1 19 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 3H-RX821002 1 19 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 3H-RX821002 1 19 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
124 2933 44 35S-GTPGammaS -28 32 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 35S-GTPGammaS -28 32 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 35S-GTPGammaS -28 32 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 35S-GTPGammaS -28 32 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 35S-GTPGammaS -28 32 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
3658 4044 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4044 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4044 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4044 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4044 47 35S-GTPGammaS -9 8 Mouse 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
2726 906 64 3H-RAUWOLSCINE -64 72 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 906 64 3H-RAUWOLSCINE -64 72 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 906 64 3H-RAUWOLSCINE -64 72 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 906 64 3H-RAUWOLSCINE -64 72 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 906 64 3H-RAUWOLSCINE -64 72 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
1615 167228 22 3H-CLONIDINE -6 44 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 193 3 1 3 1.6 CNC(C)Cc1ccc2c(c1)OCO2 None
CHEMBL43048 167228 22 3H-CLONIDINE -6 44 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 193 3 1 3 1.6 CNC(C)Cc1ccc2c(c1)OCO2 None
2726 906 64 3H-RAUWOLSCINE -64 72 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 906 64 3H-RAUWOLSCINE -64 72 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 906 64 3H-RAUWOLSCINE -64 72 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 906 64 3H-RAUWOLSCINE -64 72 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 906 64 3H-RAUWOLSCINE -64 72 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
44438152 93175 0 UNDEFINED -134 3 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 None
CHEMBL246639 93175 0 UNDEFINED -134 3 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 None
162265 200587 19 3H-CLONIDINE -12 44 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 200587 19 3H-CLONIDINE -12 44 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 200587 19 3H-CLONIDINE -12 44 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
162265 200587 19 3H-CLONIDINE -12 44 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 200587 19 3H-CLONIDINE -12 44 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 200587 19 3H-CLONIDINE -12 44 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
5268 3599 34 3H-RAUWOLSCINE -60 17 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3599 34 3H-RAUWOLSCINE -60 17 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3599 34 3H-RAUWOLSCINE -60 17 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
None 214486 0 3H-CLONIDINE -30199 29 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 316 7 3 3 3.0 CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O None
2216 442 46 3H-Yohimbine -57 6 Pig 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
229 442 46 3H-Yohimbine -57 6 Pig 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
7117 442 46 3H-Yohimbine -57 6 Pig 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
CHEMBL647 442 46 3H-Yohimbine -57 6 Pig 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
DB00964 442 46 3H-Yohimbine -57 6 Pig 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
102 4064 44 3H-RX821002 -5 49 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 3H-RX821002 -5 49 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 3H-RX821002 -5 49 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 3H-RX821002 -5 49 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 3H-RX821002 -5 49 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
68602 203416 72 3H-RX821002 -1 8 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 203416 72 3H-RX821002 -1 8 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
124 2933 44 3H-RX821002 -16 32 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 3H-RX821002 -16 32 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 3H-RX821002 -16 32 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 3H-RX821002 -16 32 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 3H-RX821002 -16 32 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
124 2933 44 3H-RAUWOLSCINE -4 32 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 3H-RAUWOLSCINE -4 32 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 3H-RAUWOLSCINE -4 32 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 3H-RAUWOLSCINE -4 32 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 3H-RAUWOLSCINE -4 32 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
5268 3599 34 3H-RX821002 -10 17 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3599 34 3H-RX821002 -10 17 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3599 34 3H-RX821002 -10 17 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
68602 203416 72 35S-GTPGammaS 1 8 Mouse 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 203416 72 35S-GTPGammaS 1 8 Mouse 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
138107169 214173 0 3H-RAUWOLSCINE -6 22 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214173 0 3H-RAUWOLSCINE -6 22 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
None 214179 0 3H-RAUWOLSCINE -14 19 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
102 4064 44 3H-MK912 -5 49 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 3H-MK912 -5 49 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 3H-MK912 -5 49 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 3H-MK912 -5 49 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 3H-MK912 -5 49 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
138107169 214173 0 3H-MK912 -6 22 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214173 0 3H-MK912 -6 22 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
115237 55296 113 3H-RAUWOLSCINE -8 54 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55296 113 3H-RAUWOLSCINE -8 54 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
122295 9775 6 3H-RAUWOLSCINE -1 9 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
CHEMBL114166 9775 6 3H-RAUWOLSCINE -1 9 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
4209 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
162265 200587 19 3H-CLONIDINE -12 44 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 200587 19 3H-CLONIDINE -12 44 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 200587 19 3H-CLONIDINE -12 44 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
1212 1632 45 3H-RAUWOLSCINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1632 45 3H-RAUWOLSCINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1632 45 3H-RAUWOLSCINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1632 45 3H-RAUWOLSCINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1632 45 3H-RAUWOLSCINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
11225732 93224 0 UNDEFINED -16 3 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 None
CHEMBL246852 93224 0 UNDEFINED -16 3 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 None
2803 941 53 3H-RX821002 -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 3H-RX821002 -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 3H-RX821002 -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 3H-RX821002 -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 3H-RX821002 -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
5524 214717 0 35S-GTPGammaS 1 4 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 215 1 2 3 1.9 C1CCC2=C(C1)C=CC=C2NC3=NCCN3 None
1212 1632 45 3H-CLONIDINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1632 45 3H-CLONIDINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1632 45 3H-CLONIDINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1632 45 3H-CLONIDINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1632 45 3H-CLONIDINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
135398745 2869 108 3H-CLONIDINE -93 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2869 108 3H-CLONIDINE -93 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2869 108 3H-CLONIDINE -93 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2869 108 3H-CLONIDINE -93 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1212 1632 45 3H-CLONIDINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1632 45 3H-CLONIDINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1632 45 3H-CLONIDINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1632 45 3H-CLONIDINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1632 45 3H-CLONIDINE -165 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
135398745 2869 108 3H-CLONIDINE -93 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2869 108 3H-CLONIDINE -93 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2869 108 3H-CLONIDINE -93 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2869 108 3H-CLONIDINE -93 65 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
4209 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3114 71 3H-RAUWOLSCINE -3235 33 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
133621 1981 0 35S-GTPGammaS -6 5 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 None
3470 1981 0 35S-GTPGammaS -6 5 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 None
CHEMBL347695 1981 0 35S-GTPGammaS -6 5 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 None
523 4043 90 3H-Yohimbine -1 5 Pig 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
5707 4043 90 3H-Yohimbine -1 5 Pig 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
CHEMBL297362 4043 90 3H-Yohimbine -1 5 Pig 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
DB11477 4043 90 3H-Yohimbine -1 5 Pig 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
122295 9775 6 3H-RAUWOLSCINE -1 9 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
CHEMBL114166 9775 6 3H-RAUWOLSCINE -1 9 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
None 214486 0 3H-CLONIDINE -30199 29 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 316 7 3 3 3.0 CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O None
122295 9775 6 3H-RX821002 -1 9 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
CHEMBL114166 9775 6 3H-RX821002 -1 9 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
2803 941 53 35S-GTPGammaS -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 35S-GTPGammaS -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 35S-GTPGammaS -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 35S-GTPGammaS -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 35S-GTPGammaS -1 19 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
124 2933 44 3H-Yohimbine -16 32 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 3H-Yohimbine -16 32 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 3H-Yohimbine -16 32 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 3H-Yohimbine -16 32 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 3H-Yohimbine -16 32 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
138107169 214173 0 35S-GTPGammaS -97 22 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 214173 0 35S-GTPGammaS -97 22 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
2337 3205 72 125I-Clonidine -50 62 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2337 3205 72 3H-CLONIDINE -50 62 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3205 72 125I-Clonidine -50 62 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3205 72 3H-CLONIDINE -50 62 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3205 72 125I-Clonidine -50 62 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3205 72 3H-CLONIDINE -50 62 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3205 72 125I-Clonidine -50 62 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3205 72 3H-CLONIDINE -50 62 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3205 72 125I-Clonidine -50 62 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3205 72 3H-CLONIDINE -50 62 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
122211 458 0 3H-RX821002 -229 6 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 458 0 3H-RX821002 -229 6 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
104870 98423 39 3H-RX821002 -2 21 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98423 39 3H-RX821002 -2 21 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98423 39 3H-RX821002 -2 21 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
484 2814 45 3H-RX821002 -14 35 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2814 45 3H-RX821002 -14 35 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2814 45 3H-RX821002 -14 35 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
1524 2150 89 3H-RAUWOLSCINE -269 51 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
197 2150 89 3H-RAUWOLSCINE -269 51 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
3822 2150 89 3H-RAUWOLSCINE -269 51 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
88 2150 89 3H-RAUWOLSCINE -269 51 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
CHEMBL51 2150 89 3H-RAUWOLSCINE -269 51 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
DB12465 2150 89 3H-RAUWOLSCINE -269 51 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
122211 458 0 3H-RAUWOLSCINE -239 6 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 458 0 3H-RAUWOLSCINE -239 6 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
3337 214441 0 3H-CLONIDINE -27 40 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
65801 214441 0 3H-CLONIDINE -27 40 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
66264 214441 0 3H-CLONIDINE -27 40 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
91452 214441 0 3H-CLONIDINE -27 40 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
67409 214263 0 3H-RAUWOLSCINE -7 3 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 235 2 0 1 3.9 C=CCN1CC2=CC=CC=C2C3=CC=CC=C3C1 None
8966 214263 0 3H-RAUWOLSCINE -7 3 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 235 2 0 1 3.9 C=CCN1CC2=CC=CC=C2C3=CC=CC=C3C1 None
1028 287 69 35S-GTPGammaS -72 29 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 287 69 35S-GTPGammaS -72 29 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 287 69 35S-GTPGammaS -72 29 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 287 69 35S-GTPGammaS -72 29 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 287 69 35S-GTPGammaS -72 29 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 287 69 35S-GTPGammaS -72 29 Mouse 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
484 2814 45 35S-GTPGammaS -9 35 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2814 45 35S-GTPGammaS -9 35 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2814 45 35S-GTPGammaS -9 35 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
104870 98423 39 35S-GTPGammaS -2 21 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98423 39 35S-GTPGammaS -2 21 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98423 39 35S-GTPGammaS -2 21 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
24840389 114714 3 3H-RX821002 -295 15 Rat 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 415 9 0 4 4.6 CCCN(CCC)C1CCc2cc(CS(=O)(=O)c3ccc(OC)cc3)ccc2C1 None
CHEMBL334529 114714 3 3H-RX821002 -295 15 Rat 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 415 9 0 4 4.6 CCCN(CCC)C1CCc2cc(CS(=O)(=O)c3ccc(OC)cc3)ccc2C1 None
2142 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
2142 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 3H-RAUWOLSCINE -2 36 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
931 214716 0 35S-GTPGammaS -1 4 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 128 0 0 0 2.8 C1=CC=C2C=CC=CC2=C1 None
115237 55296 113 3H-CLONIDINE -8 54 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55296 113 3H-CLONIDINE -8 54 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
135 2496 38 3H-RAUWOLSCINE -4 57 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2496 38 3H-RAUWOLSCINE -4 57 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2496 38 3H-RAUWOLSCINE -4 57 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2496 38 3H-RAUWOLSCINE -4 57 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2496 38 3H-RAUWOLSCINE -4 57 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
12057539 206301 39 None -9 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 289 4 1 4 1.9 CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2 None
3661 206301 39 None -9 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 289 4 1 4 1.9 CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2 None
CHEMBL9751 206301 39 None -9 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 289 4 1 4 1.9 CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2 None
124 2933 44 3H-RAUWOLSCINE -4 32 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 3H-RAUWOLSCINE -4 32 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 3H-RAUWOLSCINE -4 32 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 3H-RAUWOLSCINE -4 32 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 3H-RAUWOLSCINE -4 32 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2803 941 53 35S-GTPGammaS -3 19 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 35S-GTPGammaS -3 19 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 35S-GTPGammaS -3 19 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 35S-GTPGammaS -3 19 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 35S-GTPGammaS -3 19 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
44438147 93056 0 UNDEFINED -20 3 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 None
CHEMBL246228 93056 0 UNDEFINED -20 3 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 None
10836 14329 13 3H-CLONIDINE -2 8 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
CHEMBL1201201 14329 13 3H-CLONIDINE -2 8 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
44438167 148438 0 UNDEFINED -52 3 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 None
CHEMBL394218 148438 0 UNDEFINED -52 3 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 None
2435 714 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 714 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 714 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 714 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 714 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 714 98 35S-GTPGammaS -7 12 Mouse 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
100 3745 52 3H-RAUWOLSCINE -33 55 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3745 52 3H-RAUWOLSCINE -33 55 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3745 52 3H-RAUWOLSCINE -33 55 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3745 52 3H-RAUWOLSCINE -33 55 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3745 52 3H-RAUWOLSCINE -33 55 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
44438165 166231 0 UNDEFINED -48 3 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 None
CHEMBL428407 166231 0 UNDEFINED -48 3 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 None
135 2496 38 3H-RAUWOLSCINE -4 57 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2496 38 3H-RAUWOLSCINE -4 57 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2496 38 3H-RAUWOLSCINE -4 57 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2496 38 3H-RAUWOLSCINE -4 57 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2496 38 3H-RAUWOLSCINE -4 57 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
164512323 214260 0 3H-RAUWOLSCINE -5 5 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214260 0 3H-RAUWOLSCINE -5 5 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
135398745 2869 108 3H-RAUWOLSCINE -93 65 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2869 108 3H-RAUWOLSCINE -93 65 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2869 108 3H-RAUWOLSCINE -93 65 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2869 108 3H-RAUWOLSCINE -93 65 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1353 1880 85 3H-RAUWOLSCINE -190 85 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1880 85 3H-RAUWOLSCINE -190 85 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1880 85 3H-RAUWOLSCINE -190 85 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1880 85 3H-RAUWOLSCINE -190 85 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1880 85 3H-RAUWOLSCINE -190 85 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
2435 714 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 714 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 714 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 714 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 714 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 714 98 3H-Yohimbine -81 12 Pig 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5280805 84981 76 None -28 3 Human 8.3 pKi = 8.3 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
Drug Central 610 6 10 16 -1.7 C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O None
CHEMBL226335 84981 76 None -28 3 Human 8.3 pKi = 8.3 Binding
Binding affinity to adrenergic alpha2A receptorBinding affinity to adrenergic alpha2A receptor
Drug Central 610 6 10 16 -1.7 C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O None
1210 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
1213 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
2725 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
33036 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
4411 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
616 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
6976 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
716121 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
90475904 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
CHEMBL1201353 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
CHEMBL1554789 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
CHEMBL505 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
DB01114 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
DB13679 905 45 None -263 20 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 274 5 0 2 3.8 CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C None
3823 49951 38 None -40 11 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
76973198 49951 38 None -40 11 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL157101 49951 38 None -40 11 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
28417 39799 48 None -1 12 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C None
CHEMBL1479 39799 48 None -1 12 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C None
3652 45983 62 None -1 9 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 None
CHEMBL1535 45983 62 None -1 9 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 None
135 2496 38 3H-RAUWOLSCINE -4 57 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2496 38 3H-RAUWOLSCINE -4 57 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2496 38 3H-RAUWOLSCINE -4 57 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2496 38 3H-RAUWOLSCINE -4 57 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2496 38 3H-RAUWOLSCINE -4 57 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1960 2815 64 None -35 26 Mouse 8.3 pKi = 8.3 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 2815 64 None -35 26 Mouse 8.3 pKi = 8.3 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 2815 64 None -35 26 Mouse 8.3 pKi = 8.3 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 2815 64 None -35 26 Mouse 8.3 pKi = 8.3 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 2815 64 None -35 26 Mouse 8.3 pKi = 8.3 Binding
Binding affinity to mouse alpha-2A receptor expressed in COS7 cellsBinding affinity to mouse alpha-2A receptor expressed in COS7 cells
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
4158 203630 21 None -2 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL1722 203630 21 None -2 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL796 203630 21 None -2 20 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
448537 159703 86 None -33 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
CHEMBL411 159703 86 None -33 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
2812 4711 96 None -32 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
CHEMBL104 4711 96 None -32 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
2719 904 66 None -4 11 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
5535 904 66 None -4 11 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
607 904 66 None -4 11 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
CHEMBL76 904 66 None -4 11 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
DB00608 904 66 None -4 11 Human 8.3 pKi = 8.3 Binding
Activity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha-2A (ADRA2A) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
10836 14329 13 None -2 8 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
CHEMBL1201201 14329 13 None -2 8 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
4209 3114 71 None -1862 33 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3114 71 None -1862 33 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3114 71 None -1862 33 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3114 71 None -1862 33 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3114 71 None -1862 33 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3114 71 None -1862 33 Pig 8.3 pKi = 8.3 Binding
Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
6040 214262 0 3H-RAUWOLSCINE -4 3 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 233 2 0 3 2.3 C1CCN(CC1)CC2COC3=CC=CC=C3O2 None
2337 3205 72 None -50 62 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3205 72 None -50 62 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3205 72 None -50 62 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3205 72 None -50 62 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3205 72 None -50 62 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5268 3599 34 3H-RAUWOLSCINE -60 17 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3599 34 3H-RAUWOLSCINE -60 17 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3599 34 3H-RAUWOLSCINE -60 17 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
4211 57517 81 None -1 4 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 None
CHEMBL1670 57517 81 None -1 4 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 318 3 0 0 5.9 Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 None
1443 1997 30 None -23 10 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
33625 1997 30 None -23 10 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
501 1997 30 None -23 10 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
CHEMBL279516 1997 30 None -23 10 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
DB08950 1997 30 None -23 10 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
1549008 203967 81 None - 1 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 None
CHEMBL822 203967 81 None - 1 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 291 4 0 1 4.9 CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 None
121850 717 0 3H-MK912 38 3 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 None
525 717 0 3H-MK912 38 3 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 None
CHEMBL216097 717 0 3H-MK912 38 3 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 None
3598 187238 73 None -2 7 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl None
CHEMBL496 187238 73 None -2 7 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl None
2402 3318 58 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
5095 3318 58 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
7295 3318 58 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
CHEMBL589 3318 58 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
DB00268 3318 58 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
2247 502 77 None -58 41 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
249 502 77 None -58 41 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
2603 502 77 None -58 41 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
CHEMBL296419 502 77 None -58 41 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
DB00637 502 77 None -58 41 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
5198 19235 46 None - 1 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 None
CHEMBL12948 19235 46 None - 1 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 247 4 1 3 2.5 CC1CCC(NC(=O)N(CCCl)N=O)CC1 None
3117 206106 100 None -2 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
CHEMBL964 206106 100 None -2 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
4209 3114 71 None -616 33 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3114 71 None -616 33 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3114 71 None -616 33 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3114 71 None -616 33 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3114 71 None -616 33 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3114 71 None -616 33 Rat 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
3198 203802 73 None -19 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1201049 203802 73 None -19 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL808 203802 73 None -19 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
16362 3076 67 None -501 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
2172 3076 67 None -501 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
90 3076 67 None -501 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
CHEMBL1423 3076 67 None -501 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
DB01100 3076 67 None -501 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
5318 15400 44 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1200348 15400 44 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1221 15400 44 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
5353853 17803 41 None -16 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
9556529 17803 41 None -16 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL1262 17803 41 None -16 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
1836 2554 56 None -43 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 None
3340 2554 56 None -43 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 None
5281040 2554 56 None -43 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 None
CHEMBL787 2554 56 None -43 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 None
DB00471 2554 56 None -43 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 None
4189 205195 91 None -18 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL1559 205195 91 None -18 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL91 205195 91 None -18 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
2406 99938 84 None -16 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O None
CHEMBL290106 99938 84 None -16 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O None
119584 2557 99 None -2 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
1848 2557 99 None -2 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
242 2557 99 None -2 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
CHEMBL60889 2557 99 None -2 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
DB11675 2557 99 None -2 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
2484 206552 64 None - 1 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 None
CHEMBL990 206552 64 None - 1 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 317 4 0 1 5.8 CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 None
2342 592 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
331 592 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
7124 592 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
CHEMBL1201250 592 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
DB00767 592 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
2335 11743 21 None -5 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
8478 11743 21 None -5 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
CHEMBL1182210 11743 21 None -5 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
CHEMBL221753 11743 21 None -5 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
1227 2454 35 None -91 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
2331 2454 35 None -91 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
3957 2454 35 None -91 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
4992 2454 35 None -91 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
CHEMBL511 2454 35 None -91 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
DB06691 2454 35 None -91 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 285 7 0 4 2.7 COc1ccc(cc1)CN(c1ccccn1)CCN(C)C None
3168 9172 84 None -123 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
CHEMBL1108 9172 84 None -123 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
1353 1880 85 None -190 85 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1880 85 None -190 85 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1880 85 None -190 85 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1880 85 None -190 85 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1880 85 None -190 85 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
1830 2552 39 None -14 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
207 2552 39 None -14 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
23897 2552 39 None -14 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
CHEMBL460 2552 39 None -14 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
DB01618 2552 39 None -14 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
3151 1434 93 None -99 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
945 1434 93 None -99 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
965 1434 93 None -99 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
CHEMBL219916 1434 93 None -99 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
DB01184 1434 93 None -99 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
1782 2482 81 None -5 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC None
241 2482 81 None -5 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC None
4168 2482 81 None -5 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC None
CHEMBL86 2482 81 None -5 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC None
DB01233 2482 81 None -5 22 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 299 7 2 4 2.0 CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC None
135398737 944 89 3H-RAUWOLSCINE -26 91 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 944 89 3H-RAUWOLSCINE -26 91 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 944 89 3H-RAUWOLSCINE -26 91 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 944 89 3H-RAUWOLSCINE -26 91 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 944 89 3H-RAUWOLSCINE -26 91 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2803 941 53 3H-MK912 -1 19 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 3H-MK912 -1 19 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 3H-MK912 -1 19 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 3H-MK912 -1 19 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 3H-MK912 -1 19 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
2105 3005 34 3H-RX821002 -58 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 3005 34 3H-RX821002 -58 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 3005 34 3H-RX821002 -58 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 3005 34 3H-RX821002 -58 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 3005 34 3H-RX821002 -58 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
1343 1858 55 3H-MK912 -9 9 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1858 55 3H-MK912 -9 9 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1858 55 3H-MK912 -9 9 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1858 55 3H-MK912 -9 9 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1858 55 3H-MK912 -9 9 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
15897 2817 0 3H-CLONIDINE -134 36 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
215 2817 0 3H-CLONIDINE -134 36 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
CHEMBL1979333 2817 0 3H-CLONIDINE -134 36 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
11957583 214440 0 3H-Yohimbine - 1 Pig 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 391 1 2 3 3.4 C1CN=C(N1)NC2=C(C=C(C=C2Cl)I)Cl.Cl None
2801 161325 56 3H-RX821002 -14 28 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
CHEMBL1200710 161325 56 3H-RX821002 -14 28 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
CHEMBL415 161325 56 3H-RX821002 -14 28 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
6852400 214160 0 3H-RAUWOLSCINE -131 21 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 361 0 1 2 4.8 CC(C)(C)C1(CCN2CC3C4=CC=CC=C4CCC5=C3C(=CC=C5)C2C1)O None
73759726 214160 0 3H-RAUWOLSCINE -131 21 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 361 0 1 2 4.8 CC(C)(C)C1(CCN2CC3C4=CC=CC=C4CCC5=C3C(=CC=C5)C2C1)O None
3337 214441 0 3H-CLONIDINE -27 40 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
65801 214441 0 3H-CLONIDINE -27 40 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
66264 214441 0 3H-CLONIDINE -27 40 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
91452 214441 0 3H-CLONIDINE -27 40 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
5268 3599 34 3H-MK912 -60 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3599 34 3H-MK912 -60 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3599 34 3H-MK912 -60 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
2726 906 64 3H-RAUWOLSCINE -64 72 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 906 64 3H-RAUWOLSCINE -64 72 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 906 64 3H-RAUWOLSCINE -64 72 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 906 64 3H-RAUWOLSCINE -64 72 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 906 64 3H-RAUWOLSCINE -64 72 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
4158 203630 21 125I-Clonidine -2 20 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL1722 203630 21 125I-Clonidine -2 20 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL796 203630 21 125I-Clonidine -2 20 Human 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
484 2814 45 3H-Yohimbine -14 35 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2814 45 3H-Yohimbine -14 35 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2814 45 3H-Yohimbine -14 35 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
3952 1857 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 1857 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 1857 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 1857 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 1857 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 1857 33 3H-Yohimbine -9 12 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
1222 1634 44 3H-RAUWOLSCINE -100 32 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 1634 44 3H-RAUWOLSCINE -100 32 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 1634 44 3H-RAUWOLSCINE -100 32 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 1634 44 3H-RAUWOLSCINE -100 32 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 1634 44 3H-RAUWOLSCINE -100 32 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
523 4043 90 35S-GTPGammaS -1 5 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
5707 4043 90 35S-GTPGammaS -1 5 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
CHEMBL297362 4043 90 35S-GTPGammaS -1 5 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
DB11477 4043 90 35S-GTPGammaS -1 5 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
2142 3047 54 3H-RAUWOLSCINE -2 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 3H-RAUWOLSCINE -2 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 3H-RAUWOLSCINE -2 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 3H-RAUWOLSCINE -2 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 3H-RAUWOLSCINE -2 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 3H-RAUWOLSCINE -2 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
11634155 190881 35 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 4 0 4 3.2 COc1cc2c(cc1OC)[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2 None
6018 190881 35 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 4 0 4 3.2 COc1cc2c(cc1OC)[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2 None
CHEMBL519344 190881 35 None -1 3 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 317 4 0 4 3.2 COc1cc2c(cc1OC)[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2 None
463 1378 17 None -67 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 1378 17 None -67 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 1378 17 None -67 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 1378 17 None -67 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 1378 17 None -67 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
237 203157 43 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
CHEMBL546257 203157 43 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
CHEMBL554190 203157 43 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
CHEMBL7568 203157 43 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
2181 3079 0 None -11 34 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 3079 0 None -11 34 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 3079 0 None -11 34 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 3079 0 None -11 34 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 3079 0 None -11 34 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
1530 2151 44 None -70 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
3827 2151 44 None -70 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
7206 2151 44 None -70 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
CHEMBL534 2151 44 None -70 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
DB00920 2151 44 None -70 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
4601 205020 29 None -2 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 None
CHEMBL1201023 205020 29 None -2 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 None
CHEMBL900 205020 29 None -2 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 None
5467 204212 40 None -6 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC None
CHEMBL84158 204212 40 None -6 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 328 8 1 5 1.2 CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC None
1577 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
164512405 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
2537 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
5355 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
5501 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
643497 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
688272 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
958 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
960 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
CHEMBL196677 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
CHEMBL26 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
CHEMBL267044 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
DB00391 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
DB16021 3647 104 None -2 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 341 6 2 5 0.6 CCN1CCCC1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N None
657255 197406 29 None -10 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 None
CHEMBL588119 197406 29 None -10 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 337 12 2 3 5.6 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 None
3157 1442 69 None -61 12 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
7170 1442 69 None -61 12 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
954 1442 69 None -61 12 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
CHEMBL707 1442 69 None -61 12 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
DB00590 1442 69 None -61 12 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2A adrenergic receptor, from human clones.Binding affinity against Alpha-2A adrenergic receptor, from human clones.
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
1016 3690 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2561 3690 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2733526 3690 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
5384 3690 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
CHEMBL83 3690 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
DB00675 3690 75 None -12 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
4011 81996 43 None -35 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
CHEMBL21731 81996 43 None -35 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
26757 206239 29 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 None
CHEMBL972 206239 29 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 None
219050 3321 21 3H-RX821002 -38 21 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
52 3321 21 3H-RX821002 -38 21 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
CHEMBL431367 3321 21 3H-RX821002 -38 21 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
240 931 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
2769 931 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
44279790 931 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
660 931 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL1729 931 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL560739 931 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
DB00604 931 39 None -12 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
214 3799 52 None -75 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2740 3799 52 None -75 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
5566 3799 52 None -75 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
66064 3799 52 None -75 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL422 3799 52 None -75 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00831 3799 52 None -75 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
209 3008 94 None -100 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2113 3008 94 None -100 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4748 3008 94 None -100 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL567 3008 94 None -100 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00850 3008 94 None -100 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2435 3533 78 None -123 48 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3533 78 None -123 48 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3533 78 None -123 48 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3533 78 None -123 48 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3533 78 None -123 48 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
1042 1551 20 None -97 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
148 1551 20 None -97 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
443884 1551 20 None -97 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
CHEMBL119443 1551 20 None -97 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
DB01253 1551 20 None -97 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
2726 906 64 None -64 72 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 906 64 None -64 72 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 906 64 None -64 72 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 906 64 None -64 72 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 906 64 None -64 72 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
134 2478 19 None -74 67 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
1775 2478 19 None -74 67 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
9681 2478 19 None -74 67 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
CHEMBL1065 2478 19 None -74 67 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
DB00247 2478 19 None -74 67 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
2351 3234 60 None -9 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
2820 3234 60 None -9 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
5035 3234 60 None -9 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
CHEMBL81 3234 60 None -9 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
DB00481 3234 60 None -9 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
150 2473 18 None -45 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
1764 2473 18 None -45 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
8226 2473 18 None -45 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
CHEMBL1201356 2473 18 None -45 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
DB00353 2473 18 None -45 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
6726 1254 46 None -10 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
7151 1254 46 None -10 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
749 1254 46 None -10 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
CHEMBL648 1254 46 None -10 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
DB01176 1254 46 None -10 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 266 3 0 2 3.0 CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
1222 1634 44 None -100 32 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 1634 44 None -100 32 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 1634 44 None -100 32 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 1634 44 None -100 32 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 1634 44 None -100 32 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
6075 149575 36 None -11 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
CHEMBL395110 149575 36 None -11 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
3584 3718 60 None -251 14 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 3718 60 None -251 14 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 3718 60 None -251 14 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 3718 60 None -251 14 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 3718 60 None -251 14 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
66265 93579 12 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL248702 93579 12 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
2801 161325 56 None -14 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
CHEMBL1200710 161325 56 None -14 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
CHEMBL415 161325 56 None -14 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 None
4735 193445 92 None -9 10 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
CHEMBL361506 193445 92 None -9 10 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
CHEMBL55 193445 92 None -9 10 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
1225 1443 24 None -22 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3958 1443 24 None -22 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667477 1443 24 None -22 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL860 1443 24 None -22 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
DB01142 1443 24 None -22 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
2865 4079 67 None -64 53 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4079 67 None -64 53 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4079 67 None -64 53 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4079 67 None -64 53 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4079 67 None -64 53 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
41 1629 0 3H-RX821002 -5 16 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
72036 1629 0 3H-RX821002 -5 16 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
CHEMBL1765294 1629 0 3H-RX821002 -5 16 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
2142 3047 54 3H-PRAZOSIN -2 36 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 3H-PRAZOSIN -2 36 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 3H-PRAZOSIN -2 36 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 3H-PRAZOSIN -2 36 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 3H-PRAZOSIN -2 36 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 3H-PRAZOSIN -2 36 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
102 4064 44 3H-RX821002 -5 49 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 3H-RX821002 -5 49 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 3H-RX821002 -5 49 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 3H-RX821002 -5 49 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 3H-RX821002 -5 49 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
191 399 92 None -41 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
201 399 92 None -41 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
2170 399 92 None -41 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
CHEMBL1113 399 92 None -41 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
DB00543 399 92 None -41 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
3561 18886 34 None -1 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl None
CHEMBL1289 18886 34 None -1 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl None
4098 32289 24 None -13 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 None
CHEMBL1255739 32289 24 None -13 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 None
CHEMBL1411979 32289 24 None -13 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 None
164512323 214260 0 3H-RAUWOLSCINE -5 5 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214260 0 3H-RAUWOLSCINE -5 5 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
441383 20133 54 None -2 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL1306 20133 54 None -2 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
1548955 88153 17 None -1 18 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 None
2800 88153 17 None -1 18 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 None
CHEMBL2355051 88153 17 None -1 18 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 None
135398745 2869 108 None -93 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2869 108 None -93 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2869 108 None -93 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2869 108 None -93 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1212 1632 45 None -165 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1632 45 None -165 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1632 45 None -165 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1632 45 None -165 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1632 45 None -165 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3389 215982 0 None -1 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 549 12 0 6 6.8 CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1 None
46780481 107045 18 3H-RAUWOLSCINE -47 53 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107045 18 3H-RAUWOLSCINE -47 53 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107045 18 3H-RAUWOLSCINE -47 53 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107045 18 3H-RAUWOLSCINE -47 53 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
3191 102385 93 None -8 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
CHEMBL305660 102385 93 None -8 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
1028 287 69 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 287 69 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 287 69 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 287 69 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 287 69 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 287 69 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
4543 169982 36 None -5 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 None
CHEMBL1201156 169982 36 None -5 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 None
CHEMBL445 169982 36 None -5 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2ccccc21 None
162265 200587 19 None -12 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 200587 19 None -12 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 200587 19 None -12 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
213 3792 50 None -6 43 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 3792 50 None -6 43 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 3792 50 None -6 43 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 3792 50 None -6 43 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 3792 50 None -6 43 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2286 3134 48 None -13 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
4927 3134 48 None -13 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
7282 3134 48 None -13 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
CHEMBL643 3134 48 None -13 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
DB01069 3134 48 None -13 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
2695 3780 76 None -9 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3780 76 None -9 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3780 76 None -9 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3780 76 None -9 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3780 76 None -9 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
2162 41273 97 None 1 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl None
CHEMBL1491 41273 97 None 1 6 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl None
12488 1627 51 None -6 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
941361 1627 51 None -6 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
CHEMBL30008 1627 51 None -6 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
DB04841 1627 51 None -6 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
2520 202310 65 None -6 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
CHEMBL1280 202310 65 None -6 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
CHEMBL6966 202310 65 None -6 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
4209 3114 71 None -3235 33 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3114 71 None -3235 33 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3114 71 None -3235 33 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3114 71 None -3235 33 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3114 71 None -3235 33 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3114 71 None -3235 33 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
1201549 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
333 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
7601 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL1201203 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL438151 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
DB00245 590 22 None -33 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
103 4089 56 None -54 53 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4089 56 None -54 53 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4089 56 None -54 53 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4089 56 None -54 53 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4089 56 None -54 53 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
11057 175575 19 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
3468 175575 19 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
CHEMBL459265 175575 19 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
CHEMBL64894 175575 19 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
1547484 927 70 None -5 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
654 927 70 None -5 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
9072 927 70 None -5 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
CHEMBL43064 927 70 None -5 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
DB00568 927 70 None -5 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
3294 1975 106 None -47 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 1975 106 None -47 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 1975 106 None -47 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 1975 106 None -47 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 1975 106 None -47 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
12574 2567 84 None -4 5 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
4810 2567 84 None -4 5 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
CHEMBL19236 2567 84 None -4 5 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
DB09242 2567 84 None -4 5 Human 8.2 pKi = 8.2 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
1613 2316 44 None -7 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2316 44 None -7 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2316 44 None -7 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2316 44 None -7 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2316 44 None -7 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
15387 214209 0 None -1 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 5 0 2 3.5 CC1CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F None
5472 204104 69 None -1 3 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 None
CHEMBL1717 204104 69 None -1 3 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 None
CHEMBL833 204104 69 None -1 3 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 None
100 3745 52 None -33 55 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3745 52 None -33 55 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3745 52 None -33 55 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3745 52 None -33 55 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3745 52 None -33 55 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
180 397 50 None -58 38 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
200 397 50 None -58 38 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2160 397 50 None -58 38 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
CHEMBL629 397 50 None -58 38 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
DB00321 397 50 None -58 38 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2284 3133 27 None -12 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
4926 3133 27 None -12 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
7281 3133 27 None -12 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
CHEMBL564 3133 27 None -12 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
DB00420 3133 27 None -12 28 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
228 441 26 None -5 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
33 441 26 None -5 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
6005 441 26 None -5 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
CHEMBL53 441 26 None -5 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
DB00714 441 26 None -5 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
104870 98423 39 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98423 39 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98423 39 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
68617 203816 60 None -3 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL1709 203816 60 None -3 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL809 203816 60 None -3 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
4209 3114 71 None -173 33 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3114 71 None -173 33 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3114 71 None -173 33 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3114 71 None -173 33 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3114 71 None -173 33 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3114 71 None -173 33 Bovine 8.2 pKi = 8.2 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
277 1274 55 None -33 45 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
2913 1274 55 None -33 45 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
765 1274 55 None -33 45 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
CHEMBL516 1274 55 None -33 45 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
DB00434 1274 55 None -33 45 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
15897 2817 0 3H-CLONIDINE -134 36 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
215 2817 0 3H-CLONIDINE -134 36 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
CHEMBL1979333 2817 0 3H-CLONIDINE -134 36 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
2803 941 53 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
2803 941 53 35S-GTPGammaS -3 19 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 35S-GTPGammaS -3 19 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 35S-GTPGammaS -3 19 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 35S-GTPGammaS -3 19 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 35S-GTPGammaS -3 19 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
102 4064 44 35S-GTPGammaS -154 49 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 35S-GTPGammaS -154 49 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 35S-GTPGammaS -154 49 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 35S-GTPGammaS -154 49 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 35S-GTPGammaS -154 49 Mouse 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2683 3774 57 3H-RAUWOLSCINE 1 3 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
5487 3774 57 3H-RAUWOLSCINE 1 3 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
7308 3774 57 3H-RAUWOLSCINE 1 3 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
CHEMBL1079 3774 57 3H-RAUWOLSCINE 1 3 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
DB00697 3774 57 3H-RAUWOLSCINE 1 3 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
102 4064 44 3H-PRAZOSIN -158 49 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 3H-PRAZOSIN -158 49 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 3H-PRAZOSIN -158 49 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 3H-PRAZOSIN -158 49 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 3H-PRAZOSIN -158 49 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2726 906 64 3H-RX821002 -38 72 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 906 64 3H-RX821002 -38 72 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 906 64 3H-RX821002 -38 72 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 906 64 3H-RX821002 -38 72 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 906 64 3H-RX821002 -38 72 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
2435 3533 78 3H-CLONIDINE -123 48 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
2435 3533 78 3H-RAUWOLSCINE -123 48 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3533 78 3H-CLONIDINE -123 48 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3533 78 3H-RAUWOLSCINE -123 48 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3533 78 3H-CLONIDINE -123 48 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3533 78 3H-RAUWOLSCINE -123 48 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3533 78 3H-CLONIDINE -123 48 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3533 78 3H-RAUWOLSCINE -123 48 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3533 78 3H-CLONIDINE -123 48 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3533 78 3H-RAUWOLSCINE -123 48 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
1028 287 69 3H-Yohimbine -120 29 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 287 69 3H-Yohimbine -120 29 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 287 69 3H-Yohimbine -120 29 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 287 69 3H-Yohimbine -120 29 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 287 69 3H-Yohimbine -120 29 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 287 69 3H-Yohimbine -120 29 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
214 3799 52 3H-CLONIDINE -75 29 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2740 3799 52 3H-CLONIDINE -75 29 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
5566 3799 52 3H-CLONIDINE -75 29 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
66064 3799 52 3H-CLONIDINE -75 29 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL422 3799 52 3H-CLONIDINE -75 29 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00831 3799 52 3H-CLONIDINE -75 29 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
None 214574 0 3H-CLONIDINE -8 40 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 149 2 1 2 1.2 CC(C(=O)C1=CC=CC=C1)N None
2202 3083 91 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
4850 3083 91 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
49 3083 91 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
CHEMBL1371770 3083 91 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
DB12478 3083 91 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
212 3746 43 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
2639 3746 43 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
941651 3746 43 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
CHEMBL1201 3746 43 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
DB01623 3746 43 None -6 25 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
242 467 117 None -26 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 467 117 None -26 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 467 117 None -26 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 467 117 None -26 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 467 117 None -26 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
135398737 944 89 None -26 91 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 944 89 None -26 91 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 944 89 None -26 91 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 944 89 None -26 91 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 944 89 None -26 91 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
26987 936 29 None -158 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
6063 936 29 None -158 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
671 936 29 None -158 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
CHEMBL1626 936 29 None -158 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
DB00283 936 29 None -158 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
1960 2815 64 None -10 26 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 2815 64 None -10 26 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 2815 64 None -10 26 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 2815 64 None -10 26 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 2815 64 None -10 26 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2A adrenergic receptorBinding affinity for human Alpha-2A adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
2274 3124 53 None -10 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4917 3124 53 None -10 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
7279 3124 53 None -10 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL728 3124 53 None -10 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00433 3124 53 None -10 32 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
124 2933 44 35S-GTPGammaS -4 32 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 35S-GTPGammaS -4 32 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 35S-GTPGammaS -4 32 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 35S-GTPGammaS -4 32 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 35S-GTPGammaS -4 32 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2105 3005 34 None -58 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 3005 34 None -58 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 3005 34 None -58 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 3005 34 None -58 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 3005 34 None -58 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
117590588 96077 34 None - 1 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O None
14969 96077 34 None - 1 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O None
CHEMBL262777 96077 34 None - 1 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 1447 13 19 25 0.1 CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O None
102 4064 44 None -47 49 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 None -47 49 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 None -47 49 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 None -47 49 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 None -47 49 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
213046 2353 55 None -12 8 Human 8.1 pKi = 8.1 Binding
antagonistantagonist
Drug Central 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 None
4168 2353 55 None -12 8 Human 8.1 pKi = 8.1 Binding
antagonistantagonist
Drug Central 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 None
7461 2353 55 None -12 8 Human 8.1 pKi = 8.1 Binding
antagonistantagonist
Drug Central 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 None
CHEMBL1237021 2353 55 None -12 8 Human 8.1 pKi = 8.1 Binding
antagonistantagonist
Drug Central 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 None
DB08815 2353 55 None -12 8 Human 8.1 pKi = 8.1 Binding
antagonistantagonist
Drug Central 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 None
2585 790 100 None -28 22 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 790 100 None -28 22 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 790 100 None -28 22 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 790 100 None -28 22 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 790 100 None -28 22 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
68712 99874 57 None -1 5 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 99874 57 None -1 5 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
5524 214717 0 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 215 1 2 3 1.9 C1CCC2=C(C1)C=CC=C2NC3=NCCN3 None
240 931 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
2769 931 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
44279790 931 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
660 931 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL1729 931 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL560739 931 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
DB00604 931 39 None -3 25 Rat 8.1 pKi = 8.1 Binding
Compound was evaluated for the binding affinity at Alpha adrenergic receptorCompound was evaluated for the binding affinity at Alpha adrenergic receptor
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
2389 3279 114 None -35 67 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3279 114 None -35 67 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3279 114 None -35 67 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3279 114 None -35 67 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3279 114 None -35 67 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
6761 67457 17 None -6 18 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
CHEMBL1909072 67457 17 None -6 18 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
133 2460 48 None -23 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
1723 2460 48 None -23 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
28693 2460 48 None -23 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
CHEMBL19215 2460 48 None -23 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
DB13520 2460 48 None -23 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
124 2933 44 None -16 32 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 None -16 32 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 None -16 32 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 None -16 32 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 None -16 32 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
11079 2693 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
3369 2693 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
4436 2693 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
5509 2693 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
CHEMBL761 2693 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
DB06711 2693 59 None 1 4 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
1816 2504 99 None -33 16 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
4205 2504 99 None -33 16 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
7241 2504 99 None -33 16 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
CHEMBL654 2504 99 None -33 16 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
DB00370 2504 99 None -33 16 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptorInhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
135398737 944 89 None -10 91 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 944 89 None -10 91 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 944 89 None -10 91 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 944 89 None -10 91 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 944 89 None -10 91 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
931 214716 0 35S-GTPGammaS -2 4 Mouse 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 128 0 0 0 2.8 C1=CC=C2C=CC=CC2=C1 None
135 2496 38 None -5 57 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2496 38 None -5 57 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2496 38 None -5 57 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2496 38 None -5 57 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2496 38 None -5 57 Bovine 8.1 pKi = 8.1 Binding
Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
3952 1857 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 1857 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 1857 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 1857 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 1857 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 1857 33 None -2 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
11978813 713 72 None -9 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
5014 713 72 None -9 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
7672 713 72 None -9 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
CHEMBL2105760 713 72 None -9 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
DB09128 713 72 None -9 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
3658 4044 47 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4044 47 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4044 47 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4044 47 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4044 47 None -4 8 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
10219 188210 30 None -1 5 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
CHEMBL493439 188210 30 None -1 5 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
CHEMBL50588 188210 30 None -1 5 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
129211 3692 75 None -120 16 Human 8.1 pKi = 8.1 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 3692 75 None -120 16 Human 8.1 pKi = 8.1 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 3692 75 None -120 16 Human 8.1 pKi = 8.1 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 3692 75 None -120 16 Human 8.1 pKi = 8.1 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 3692 75 None -120 16 Human 8.1 pKi = 8.1 Binding
Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
37 766 56 None -3 17 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
460 766 56 None -3 17 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
54746 766 56 None -3 17 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
CHEMBL1201087 766 56 None -3 17 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
DB00248 766 56 None -3 17 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
115237 55296 113 None -8 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55296 113 None -8 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
2216 442 46 35S-GTPGammaS 1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
229 442 46 35S-GTPGammaS 1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
7117 442 46 35S-GTPGammaS 1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
CHEMBL647 442 46 35S-GTPGammaS 1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
DB00964 442 46 35S-GTPGammaS 1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
41 1629 0 3H-MK912 -5 16 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
41 1629 0 3H-RX821002 -5 16 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
72036 1629 0 3H-MK912 -5 16 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
72036 1629 0 3H-RX821002 -5 16 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
CHEMBL1765294 1629 0 3H-MK912 -5 16 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
CHEMBL1765294 1629 0 3H-RX821002 -5 16 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
102 4064 44 3H-MK912 -5 49 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 3H-MK912 -5 49 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 3H-MK912 -5 49 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 3H-MK912 -5 49 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 3H-MK912 -5 49 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
None 214578 0 3H-CLONIDINE 2 28 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 464 4 8 12 -0.6 C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O None
68712 99874 57 35S-GTPGammaS -9 5 Mouse 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 99874 57 35S-GTPGammaS -9 5 Mouse 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
None 214366 0 3H-CLONIDINE -724 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 772 16 4 10 5.5 CN(C)CCONC(=CC=C1C=CC(=O)C=C1)C2=CC=CC=C2F.CN(C)CCONC(=CC=C1C=CC(=O)C=C1)C2=CC=CC=C2F.C(=CC(=O)O)C(=O)O None
213 3792 50 125I-Clonidine -6 43 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 3792 50 125I-Clonidine -6 43 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 3792 50 125I-Clonidine -6 43 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 3792 50 125I-Clonidine -6 43 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 3792 50 125I-Clonidine -6 43 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
242 467 117 3H-CLONIDINE -26 51 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 467 117 3H-CLONIDINE -26 51 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 467 117 3H-CLONIDINE -26 51 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 467 117 3H-CLONIDINE -26 51 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 467 117 3H-CLONIDINE -26 51 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
242 467 117 3H-CLONIDINE -26 51 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 467 117 3H-CLONIDINE -26 51 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 467 117 3H-CLONIDINE -26 51 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 467 117 3H-CLONIDINE -26 51 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 467 117 3H-CLONIDINE -26 51 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
119570 3110 90 3H-CLONIDINE -69 40 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 3110 90 3H-CLONIDINE -69 40 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 3110 90 3H-CLONIDINE -69 40 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 3110 90 3H-CLONIDINE -69 40 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 3110 90 3H-CLONIDINE -69 40 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2726 906 64 3H-RAUWOLSCINE -64 72 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 906 64 3H-RAUWOLSCINE -64 72 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 906 64 3H-RAUWOLSCINE -64 72 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 906 64 3H-RAUWOLSCINE -64 72 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 906 64 3H-RAUWOLSCINE -64 72 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
135398737 944 89 3H-RAUWOLSCINE -26 91 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 944 89 3H-RAUWOLSCINE -26 91 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 944 89 3H-RAUWOLSCINE -26 91 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 944 89 3H-RAUWOLSCINE -26 91 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 944 89 3H-RAUWOLSCINE -26 91 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
11954259 214201 0 3H-CLONIDINE -263 43 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 443 5 0 5 3.5 CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C None
4209 3114 71 35S-GTPGammaS -3235 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3114 71 35S-GTPGammaS -3235 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3114 71 35S-GTPGammaS -3235 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3114 71 35S-GTPGammaS -3235 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3114 71 35S-GTPGammaS -3235 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3114 71 35S-GTPGammaS -3235 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
31101 720 39 None -12 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 720 39 None -12 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 720 39 None -12 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 720 39 None -12 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 720 39 None -12 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
2389 3279 114 None -69 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3279 114 None -69 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3279 114 None -69 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3279 114 None -69 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3279 114 None -69 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
12575 1957 28 UNDEFINED -5 16 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
54459 1957 28 UNDEFINED -5 16 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
CHEMBL10316 1957 28 UNDEFINED -5 16 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
1209 1628 69 None -1 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
203 1628 69 None -1 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
3386 1628 69 None -1 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
CHEMBL41 1628 69 None -1 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
DB00472 1628 69 None -1 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
5268 3599 34 3H-RAUWOLSCINE -60 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3599 34 3H-RAUWOLSCINE -60 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3599 34 3H-RAUWOLSCINE -60 17 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
135 2496 38 None -4 57 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2496 38 None -4 57 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2496 38 None -4 57 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2496 38 None -4 57 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2496 38 None -4 57 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
2142 3047 54 None -2 36 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 None -2 36 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 None -2 36 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 None -2 36 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 None -2 36 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 None -2 36 Rat 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
102 4064 44 None -15 49 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 None -15 49 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 None -15 49 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 None -15 49 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 None -15 49 Pig 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
1593 2308 60 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
30668 2308 60 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
9868 2308 60 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
CHEMBL17860 2308 60 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
DB04948 2308 60 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
2803 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 None -1 19 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
134551 355 25 None -3 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
271 355 25 None -3 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
885 355 25 None -3 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
CHEMBL1403281 355 25 None -3 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
2216 442 46 None 1 6 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
229 442 46 None 1 6 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
7117 442 46 None 1 6 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
CHEMBL647 442 46 None 1 6 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
DB00964 442 46 None 1 6 Human 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
None 214264 0 3H-RAUWOLSCINE 1 3 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 200 3 1 1 2.8 CC1=C(C(=CC=C1)C)CCC2=CN=CN2 None
2142 3047 54 None -2 36 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 None -2 36 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 None -2 36 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 None -2 36 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 None -2 36 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 None -2 36 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX781094 from alpha2 adrenergic receptorDisplacement of [3H]RX781094 from alpha2 adrenergic receptor
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
124 2933 44 None -5 32 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 None -5 32 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 None -5 32 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 None -5 32 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 None -5 32 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
164512323 214260 0 3H-RAUWOLSCINE -5 5 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 214260 0 3H-RAUWOLSCINE -5 5 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
11954259 214201 0 3H-CLONIDINE -263 43 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 443 5 0 5 3.5 CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C None
3337 214441 0 3H-CLONIDINE -27 40 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
65801 214441 0 3H-CLONIDINE -27 40 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
66264 214441 0 3H-CLONIDINE -27 40 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
91452 214441 0 3H-CLONIDINE -27 40 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
209 3008 94 3H-CLONIDINE -100 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2113 3008 94 3H-CLONIDINE -100 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4748 3008 94 3H-CLONIDINE -100 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL567 3008 94 3H-CLONIDINE -100 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00850 3008 94 3H-CLONIDINE -100 23 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2803 941 53 3H-Yohimbine -5 19 Pig 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 3H-Yohimbine -5 19 Pig 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 3H-Yohimbine -5 19 Pig 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 3H-Yohimbine -5 19 Pig 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 3H-Yohimbine -5 19 Pig 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
11293787 147681 0 UNDEFINED -77 3 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 None
CHEMBL393597 147681 0 UNDEFINED -77 3 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 None
2181 3079 0 3H-RAUWOLSCINE -11 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 3079 0 3H-RAUWOLSCINE -11 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 3079 0 3H-RAUWOLSCINE -11 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 3079 0 3H-RAUWOLSCINE -11 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 3079 0 3H-RAUWOLSCINE -11 34 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
2202 3083 91 3H-RX821002 -1 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
4850 3083 91 3H-RX821002 -1 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
49 3083 91 3H-RX821002 -1 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
CHEMBL1371770 3083 91 3H-RX821002 -1 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
DB12478 3083 91 3H-RX821002 -1 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
None 214579 0 UNDEFINED -8 28 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 610 6 10 16 -1.7 CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O None
2142 3047 54 None 1 36 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3047 54 None 1 36 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3047 54 None 1 36 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3047 54 None 1 36 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3047 54 None 1 36 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3047 54 None 1 36 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligandBinding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
11954224 214174 0 None -446 59 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
107715 199260 18 None -6 20 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL1255837 199260 18 None -6 20 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL601773 199260 18 None -6 20 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
931 214716 0 35S-GTPGammaS -2 4 Mouse 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 128 0 0 0 2.8 C1=CC=C2C=CC=CC2=C1 None
102 4064 44 None -5 49 Human 8.0 pKi = 8.0 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4064 44 None -5 49 Human 8.0 pKi = 8.0 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4064 44 None -5 49 Human 8.0 pKi = 8.0 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4064 44 None -5 49 Human 8.0 pKi = 8.0 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4064 44 None -5 49 Human 8.0 pKi = 8.0 Binding
Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2803 941 53 None 1 19 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 941 53 None 1 19 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 941 53 None 1 19 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 941 53 None 1 19 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 941 53 None 1 19 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards alpha-2D adrenergic receptorBinding affinity towards alpha-2D adrenergic receptor
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
10531 1392 18 None -5 24 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
121 1392 18 None -5 24 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
888 1392 18 None -5 24 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
CHEMBL1732 1392 18 None -5 24 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
DB00320 1392 18 None -5 24 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
2601 3721 30 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 3721 30 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 3721 30 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 3721 30 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 3721 30 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
124 2933 44 None -4 32 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 None -4 32 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 None -4 32 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 None -4 32 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 None -4 32 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin)
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
124 2933 44 3H-MK912 -4 32 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2933 44 3H-MK912 -4 32 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2933 44 3H-MK912 -4 32 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2933 44 3H-MK912 -4 32 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2933 44 3H-MK912 -4 32 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
12575 1957 28 35S-GTPGammaS -5 16 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
54459 1957 28 35S-GTPGammaS -5 16 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
CHEMBL10316 1957 28 35S-GTPGammaS -5 16 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
1588 2294 24 None 2 43 Human 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 2294 24 None 2 43 Human 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 2294 24 None 2 43 Human 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 2294 24 None 2 43 Human 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 2294 24 None 2 43 Human 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
1576 214575 0 3H-CLONIDINE -15 40 Human 5.0 pKi = 5.0 Binding
NoneNone
PDSP KiDatabase 163 3 1 2 1.5 CC(C(=O)C1=CC=CC=C1)NC None
1343 1858 55 35S-GTPGammaS -9 9 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1858 55 35S-GTPGammaS -9 9 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1858 55 35S-GTPGammaS -9 9 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1858 55 35S-GTPGammaS -9 9 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1858 55 35S-GTPGammaS -9 9 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
None 214579 0 3H-CLONIDINE -8 28 Human 5.0 pKi = 5.0 Binding
NoneNone
PDSP KiDatabase 610 6 10 16 -1.7 CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O None
21830793 91403 5 3H-8-OH-DPAT -630 46 Bovine 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 None
CHEMBL2413154 91403 5 3H-8-OH-DPAT -630 46 Bovine 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 None
None 214265 0 3H-RAUWOLSCINE -16 3 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 334 4 1 4 4.6 CN(C)CCCN1C2=C(C=C(C=C2)O)SC3=C1C=C(C=C3)Cl None
484 2814 45 3H-RAUWOLSCINE -9 35 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2814 45 3H-RAUWOLSCINE -9 35 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2814 45 3H-RAUWOLSCINE -9 35 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
1593 2308 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
30668 2308 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
9868 2308 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
CHEMBL17860 2308 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
DB04948 2308 60 None 5 4 Human 8.4 pKi = 8.4 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2A</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
1816 2504 99 None -33 16 Human 7.7 pKi = 7.7 Binding
Inhibition of [<sup>3</sup>H]rauwolscine binding.Inhibition of [<sup>3</sup>H]rauwolscine binding.
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 15771415
4205 2504 99 None -33 16 Human 7.7 pKi = 7.7 Binding
Inhibition of [<sup>3</sup>H]rauwolscine binding.Inhibition of [<sup>3</sup>H]rauwolscine binding.
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 15771415
7241 2504 99 None -33 16 Human 7.7 pKi = 7.7 Binding
Inhibition of [<sup>3</sup>H]rauwolscine binding.Inhibition of [<sup>3</sup>H]rauwolscine binding.
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 15771415
CHEMBL654 2504 99 None -33 16 Human 7.7 pKi = 7.7 Binding
Inhibition of [<sup>3</sup>H]rauwolscine binding.Inhibition of [<sup>3</sup>H]rauwolscine binding.
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 15771415
DB00370 2504 99 None -33 16 Human 7.7 pKi = 7.7 Binding
Inhibition of [<sup>3</sup>H]rauwolscine binding.Inhibition of [<sup>3</sup>H]rauwolscine binding.
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 15771415
2695 3780 76 None -9 6 Human 6.7 pKi = 6.7 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
5504 3780 76 None -9 6 Human 6.7 pKi = 6.7 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
7310 3780 76 None -9 6 Human 6.7 pKi = 6.7 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
CHEMBL770 3780 76 None -9 6 Human 6.7 pKi = 6.7 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
DB00797 3780 76 None -9 6 Human 6.7 pKi = 6.7 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
174174 519 46 None -43651 14 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 289 4 1 4 1.9 OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C 29860464
260 519 46 None -43651 14 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 289 4 1 4 1.9 OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C 29860464
320 519 46 None -43651 14 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 289 4 1 4 1.9 OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C 29860464
CHEMBL517712 519 46 None -43651 14 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 289 4 1 4 1.9 OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C 29860464
DB00572 519 46 None -43651 14 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 289 4 1 4 1.9 OCC(c1ccccc1)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C 29860464
1960 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
1960 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
1960 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
439260 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
439260 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
439260 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
505 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
505 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
505 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
CHEMBL1437 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL1437 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
CHEMBL1437 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
DB00368 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00368 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
DB00368 2815 64 None -10 26 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
1028 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
1028 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
1028 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
139148732 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
139148732 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
139148732 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
479 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
479 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
479 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
5816 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
5816 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
5816 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
CHEMBL679 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL679 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
CHEMBL679 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
DB00668 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00668 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
DB00668 287 69 None -30 29 Human 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9824686
1343 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
1343 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9283709
1343 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
3519 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
3519 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9283709
3519 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
522 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
522 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9283709
522 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
CHEMBL862 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
CHEMBL862 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9283709
CHEMBL862 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
DB01018 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
DB01018 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9283709
DB01018 1858 55 None -9 9 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
12575 1957 28 None -5 16 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 35224877
54459 1957 28 None -5 16 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 35224877
CHEMBL10316 1957 28 None -5 16 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 35224877
213046 2353 55 None -12 8 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 20404009
4168 2353 55 None -12 8 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 20404009
7461 2353 55 None -12 8 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 20404009
CHEMBL1237021 2353 55 None -12 8 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 20404009
DB08815 2353 55 None -12 8 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 20404009
2435 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
2435 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
2435 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
2435 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
2435 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
395 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
395 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
395 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
395 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
395 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
520 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
520 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
520 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
520 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
520 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
5386 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
5386 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
5386 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
5386 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
5386 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
CHEMBL844 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
CHEMBL844 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
CHEMBL844 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
CHEMBL844 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
CHEMBL844 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
DB00484 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
DB00484 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9227000
DB00484 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
DB00484 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
DB00484 714 98 None -4 12 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
2803 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
2803 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
2803 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
2803 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
516 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
516 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
516 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
516 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
704 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
704 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
704 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
704 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
CHEMBL134 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
CHEMBL134 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
CHEMBL134 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
CHEMBL134 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
DB00575 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
DB00575 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
DB00575 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
DB00575 941 53 None -1 19 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
124 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
124 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
124 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9227000
124 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
2032 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
2032 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
2032 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9227000
2032 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
4636 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
4636 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
4636 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9227000
4636 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
CHEMBL762 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
CHEMBL762 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
CHEMBL762 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9227000
CHEMBL762 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
DB00935 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
DB00935 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
DB00935 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9227000
DB00935 2933 44 None -4 32 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
313 2652 0 None -2 6 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 29860464
121850 717 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 2573535
121850 717 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 7996470
525 717 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 2573535
525 717 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 7996470
CHEMBL216097 717 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 2573535
CHEMBL216097 717 0 None 38 3 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 7996470
2216 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 8784451
229 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 8784451
7117 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 8784451
CHEMBL647 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 8784451
DB00964 442 46 None 1 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 8784451
12576 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
71310 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
CHEMBL353972 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
DB11481 511 87 None -2 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
521 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
521 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
521 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
521 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
521 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
5311068 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
5311068 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
5311068 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
5311068 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
5311068 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
835 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
835 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
835 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
835 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
835 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
CHEMBL778 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
CHEMBL778 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
CHEMBL778 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
CHEMBL778 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
CHEMBL778 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
DB00633 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
DB00633 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
DB00633 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
DB00633 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
DB00633 1377 64 None -6 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
108094 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
108094 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
526 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
526 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
528 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
528 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
CHEMBL10332 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
CHEMBL10332 3368 22 None -1 4 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
102 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
102 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
102 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
102 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
3659 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
3659 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
3659 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
3659 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
8969 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
8969 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
8969 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
8969 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
CHEMBL15245 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
CHEMBL15245 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
CHEMBL15245 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
CHEMBL15245 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
DB01392 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
DB01392 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
DB01392 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
DB01392 4064 44 None -5 49 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
2995 202700 49 None -12 22 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL1696 202700 49 None -12 22 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL72 202700 49 None -12 22 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
179 396 107 None -35 50 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
2159 396 107 None -35 50 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
963 396 107 None -35 50 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
CHEMBL243712 396 107 None -35 50 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
DB06288 396 107 None -35 50 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC None
3337 214441 0 None -27 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
65801 214441 0 None -27 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
66264 214441 0 None -27 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
91452 214441 0 None -27 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)CC1=CC(=CC=C1)C(F)(F)F None
119570 3110 90 None -69 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 3110 90 None -69 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 3110 90 None -69 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 3110 90 None -69 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 3110 90 None -69 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
46780481 107045 18 None -47 53 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107045 18 None -47 53 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107045 18 None -47 53 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107045 18 None -47 53 Human 8.1 pKi None 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
1588 2294 24 None 2 43 Human 10.3 pKi None 10.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
28864 2294 24 None 2 43 Human 10.3 pKi None 10.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
43 2294 24 None 2 43 Human 10.3 pKi None 10.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL157138 2294 24 None 2 43 Human 10.3 pKi None 10.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB00589 2294 24 None 2 43 Human 10.3 pKi None 10.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
523 4043 90 None -1 5 Human 5.7 pKi None 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
5707 4043 90 None -1 5 Human 5.7 pKi None 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
CHEMBL297362 4043 90 None -1 5 Human 5.7 pKi None 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
DB11477 4043 90 None -1 5 Human 5.7 pKi None 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
4209 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
4209 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
4209 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
4893 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
4893 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
4893 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
503 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
503 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
503 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
5385 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
5385 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
5385 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
CHEMBL2 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
CHEMBL2 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
CHEMBL2 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
DB00457 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
DB00457 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
DB00457 3114 71 None -3235 33 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
122211 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 1353247
122211 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7908642
122211 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7996470
524 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 1353247
524 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7908642
524 458 0 None -239 6 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7996470
2726 906 64 None -64 72 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
2726 906 64 None -64 72 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
621 906 64 None -64 72 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
621 906 64 None -64 72 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
83 906 64 None -64 72 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
83 906 64 None -64 72 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
CHEMBL71 906 64 None -64 72 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
CHEMBL71 906 64 None -64 72 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
DB00477 906 64 None -64 72 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
DB00477 906 64 None -64 72 Human 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
228 441 26 None -5 24 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
33 441 26 None -5 24 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
6005 441 26 None -5 24 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
CHEMBL53 441 26 None -5 24 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
DB00714 441 26 None -5 24 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
2202 3083 91 None -1 21 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
4850 3083 91 None -1 21 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
49 3083 91 None -1 21 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
CHEMBL1371770 3083 91 None -1 21 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
DB12478 3083 91 None -1 21 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
2105 3005 34 None -58 33 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
47811 3005 34 None -58 33 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
48 3005 34 None -58 33 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
CHEMBL531 3005 34 None -58 33 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
DB01186 3005 34 None -58 33 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
5268 3599 34 None -60 17 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 7996470
53 3599 34 None -60 17 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 7996470
CHEMBL300555 3599 34 None -60 17 Human 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 7996470
37 766 56 None -3 17 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
460 766 56 None -3 17 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
54746 766 56 None -3 17 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
CHEMBL1201087 766 56 None -3 17 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
DB00248 766 56 None -3 17 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
31101 720 39 None -12 35 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
35 720 39 None -12 35 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
403 720 39 None -12 35 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
CHEMBL493 720 39 None -12 35 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
DB01200 720 39 None -12 35 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
499 4014 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 1353247
499 4014 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7908642
499 4014 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7996470
5685 4014 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 1353247
5685 4014 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7908642
5685 4014 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7996470
CHEMBL25554 4014 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 1353247
CHEMBL25554 4014 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7908642
CHEMBL25554 4014 15 None -16 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7996470
2142 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
2142 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
4920903 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
4920903 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
502 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
502 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
5775 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
5775 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
CHEMBL597 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
CHEMBL597 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
DB00692 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
DB00692 3047 54 None -2 36 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
136 3240 28 None -3 16 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
223 3240 28 None -3 16 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
643606 3240 28 None -3 16 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
CHEMBL10347 3240 28 None -3 16 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
2601 3721 30 None -1 21 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
443951 3721 30 None -1 21 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
56 3721 30 None -1 21 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL73151 3721 30 None -1 21 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB13399 3721 30 None -1 21 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666